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SUMMARY
This thesis investigated the changes in the microflora and humoral immune response 
with periodontal therapy. Scaling and root planing (SRP) has been shown to reduce 
the microbial load and produce clinical improvement. Generally, culture techniques 
have been used to analyse the microflora in periodontitis, but this technique is now 
recognised as having many errors and limitations. Polymerase chain reaction is a 
very sensitive and accurate technique for detecting bacteria and was used in these 
studies to investigate the flora in adult periodontitis (AP) and generalised early-onset 
periodontitis (GEOP) subjects before and after SRP. In addition, the effect of SRP 
on the systemic and local humoral immune response in AP patients was assessed. 
The antibody response is thought to be protective and the response of the humoral 
immune system to SRP may reflect this. The relationship between the microflora 
and humoral immune response was also determined. Antibody serostatus has been 
shown to have a relationship with baseline clinical parameters and affect the 
magnitude of both the clinical and humoral immune response to SRP. Serostatus 
was assessed and its effect on other parameters investigated in AP patients. 
Checkerboard DNA-DNA hybridisation is a relatively new technique with which to 
determine the content of periodontal plaque samples, but, although it has been 
shown to be more sensitive than culture, it has not been compared to other microbial 
assays such as PCR. Another aspect of this thesis was to compare PCR and the 
Checkerboard technique for microbial analysis. Smoking has been shown to be a 
risk factor for periodontal disease, and smoker patients tend to have greater 
periodontal destruction levels and respond less well to periodontal therapy. The
effect of smoking on the AP and GEOP patients was also investigated, and in the AP 
patients, the humoral immune response between smokers and non-smokers was 
compared.
Fifty seven untreated patients, 33 AP and 24 GEOP, were recruited for this study. 
Clinical parameters were recorded and GCF and plaque samples taken before and 
after SRP. There were 10 AP smokers and 12 GEOP smokers. In addition, venous 
blood was collected from AP subjects before and after therapy. Plaque samples 
were analysed for the presence of P. gingivalis, P. intermedia, B. forsythus, A. 
actinomycetemcomitans and T. denticola using both PCR and Checkerboard. GCF 
and serum samples were analysed by ELISA for antibody titres and serum antibody 
avidity to these organisms.
Comparison of AP and GEOP subjects at baseline showed that GEOP subjects have 
lower BOP and GCF volume, which may have resulted from the greater proportion 
of smokers in this group. GEOP subjects also had deeper pocketing and higher 
prevalences of B. forsythus and A. actinomycetemcomitans. The higher prevalence 
of these bacteria may be due to the deeper pocketing but also suggests a role for 
these organisms in GEOP. SRP produced significant clinical improvement and the 
reductions in PD and AL were in keeping with previously published data. However 
SRP produced few significant changes in the micro flora in AP subjects and this 
probably reflects the sensitivity of PCR. GEOP subjects had significant reductions 
in the flora in response to SRP which mirrored the greater reduction in pocket depth 
(PD) seen in these patients compared to AP subjects. Bleeding on probing (BOP),
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suppuration (Supp) and bacterial prevalences were related to pocket depth in AP 
subjects and the magnitude of the reduction of PD related to initial PD in both AP 
and GEOP subjects. Post-SRP, B. forsythus and T. denticola were associated with 
deep pockets in AP and P. intermedia in GEOP patients. In AP subjects the 
presence of P. gingivalis, P. intermedia, B. forsythus, and T. denticola were inter­
related and, in GEOP, T. denticola was always detected with B. forsythus.
The comparison of PCR and Checkerboard showed roughly 60% agreement and the 
higher bacterial prevalences using PCR reflected the lower detection limit of this 
technique. However, a number of technical problems prevented optimal analysis by 
Checkerboard. Using Checkerboard to analyse microbial prevalence before and 
after SRP produced a higher number of significant reductions in the flora compared 
to PCR suggesting that the sensitivity of PCR masked the reductions in bacterial 
load.
SRP produced little change in systemic and local antibody titres and also antibody 
avidity, in contrast to previous reports. The results suggest that the poor immune 
response may have been a factor in the onset of disease. Serostatus had little effect 
on clinical parameters, and high responder and low responder patients responded 
similarly to therapy. The poor response of high responder patients paralleled the 
poor host response generally. High responder patients displayed generally higher 
systemic and local antibody titres to all organisms but similar clinical parameters to 
low responder subjects, suggesting that other underlying mechanisms are also 
involved in the disease process. The correlation of anti P. gingivalis serum and GCF
xxv
titres with PD and the presence of the organism may indicate its pathogenicity in AP 
subjects, but also the greater numbers of the organism in deeper pockets. P. 
gingivalis, A. actinomycetemcomitans, and T. denticola systemic and local antibody 
titres correlated suggesting greater systemic input, whereas P. intermedia and B. 
forsythus may have greater local production or destruction. The failure of the local 
response to B. forsythus may allow it to be pathogenic.
The Modified Gingival Index (MGI) and BOP were found to be lower in smokers 
than non-smokers at baseline, which is in keeping with the vasoconstrictive effects 
of nicotine. However, PD, plaque levels, and the microflora were not significantly 
different. Smokers responded less well to SRP, with lower reductions in PD and 
microbial prevalences. The poorer response may reflect the effects of smoking on 
the host, and the lower reduction in the microflora may be due to the more anaerobic 
pockets in smokers or impaired host clearance from the effects of smoking. 
Reduced antibody titres and avidity were noted in smokers compared to non- 
smokers, again reflecting the effect of smoking on the host immune response. 
However, in both smokers and non-smokers, SRP produced little change in antibody 
titre and avidity. The reduced titres and avidity in smokers compared to non- 
smokers, suggests that differences in the host response rather than the microflora 
may be responsible for the greater destruction seen in some smokers.
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CHAPTER 1
INTRODUCTION
1.1 General introduction
Periodontal disease is a widespread infectious disease. Because of an increase in 
the average life span, a decrease in carious tooth loss and an increasing elderly 
population, its incidence is increasing (Papapanou, 1996). There is thus a need 
for better understanding and management of the disease. Although the last thirty 
years have seen a great deal of effort directed towards these goals, leading to 
improved diagnosis, altered treatment modalities and an enhanced range of 
treatments available, much is still unknown.
In particular, the aetiology and pathogenesis associated with the microbial 
origins of the disease need further investigation. This thesis reports laboratory 
studies on the nature of the periodontal microflora and the associated humoral 
immune response with emphasis on changes induced by treatment. It begins 
with a survey of published reports of the basic concepts of the periodontal 
diseases and their treatment, making special reference to the microbial aetiology, 
and then extends to cover the humoral immune responses. Clinical and 
microbial methods of diagnosis and treatment are reviewed, followed by an 
explanation of the methods actually applied in this study, enabling the results to 
be interpreted in the context of other published investigations.
1.1.1 The clinically healthy periodontium
The periodontium is defined as “the tissues investing and supporting the teeth” 
(Hassell, 1993). This consists of the alveolar bone, root cementum, periodontal
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ligament, and the gingivae. Together these form a functional unit (Lindhe & 
Karring, 1997), and of these, only the gingiva is clinically visible.
The gingiva is normally pink in colour, has a scalloped outline, a firm texture, 
stipling, and is demarcated apically from the oral mucosa by the mucogingival 
line. Attached keratinsed gingiva extends coronally from the mucogingival line 
and is firmly bound to the underlying periosteum by collagen fibres. The 
corono-apical width of the attached gingiva can vary significantly from tooth to 
tooth. The free gingival margin, which is normally about 1.5mm in the corono- 
apical dimension, surrounds but is not attached to each tooth. In health the 
gingiva completely fills the embrasure space between the teeth, and this part is 
termed the papilla (Wennstrom, 1988).
The gingival sulcus consists of the tooth surface on one side and sulcular 
epithelium of the free gingiva on the other. The sulcular epithelium is 
continuous coronally with the oral epithelium and apically with the junctional 
epithelium. The junctional epithelium extends from the base of the sulcus to the 
amelo-cemental junction, about 2.5mm, and is attached to the tooth surface by its 
basement lamina and hemidesmosomes.
Healthy gingiva does not bleed on gentle probing, and the depth of the gingival 
sulcus is minimal. The alveolar bone is located 1mm apically to the cemento- 
eramel junction, but healthy periodontium may show recession and reduced 
bene height.
Histologically, no inflammatory infiltrate is present, and classically only a few 
polymorphonuclear leukocytes (PMN’s) can be seen within the connective tissue 
and junctional epithelium. Recently, a number of investigations have shown that 
an inflammatory infiltrate, comprising both PMN’s and small round 
mononuclear cells is always present in gingival biopsies from clinically healthy 
gingivae (Seymour et al., 1983; Brecx et al., 1987; Kinane & Lindhe, 1997), and 
indeed Wennstrom (1988) suggested that the term “clinically healthy” is 
preferable to “normal” periodontium.
“Clinically healthy” periodontium produces the complex exudate, gingival 
crevicular fluid (GCF). It is normally produced in small amounts in health and 
reaches the sulcus via the junctional epithelium. It has the effect of flushing out 
the sulcus and enters the oral cavity to form part of the saliva. Its components 
are mainly derived from microbial products, interstitial fluid, locally produced 
factors of host origin, plasma and tissue degradation/turnover products 
(Cimasoni, 1983).
1.1.2 The “diseased” periodontium 
Classification
Periodontal disease is a general term which could be used to refer to all diseases 
affecting the periodontium. However for the purposes of this discussion we will 
consider periodontal disease to refer to the two most common conditions: 
gingivitis and periodontitis.
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Gingivitis
Gingivitis refers to pathological inflammatory changes that are limited to the 
gingiva. These are seen clinically by a change in colour (redness), texture and 
appearance (swelling) of the gingiva, with an increased tendency to bleeding on 
probing. All these effects are reversible and are associated with increased 
vascularity. The increased vascularity also leads to an increase in local 
temperature, and GCF. The main aetiological factor in gingivitis is dental plaque 
(Loe et al., 1965). Other factors have only a secondary role by either enhancing 
plaque accumulation e.g. overhanging margins, or increasing host susceptibility 
to plaque e.g. pregnancy.
Periodontitis
If the disease process affects the deeper structures of the periodontium resulting 
in loss of periodontal support, it is called periodontitis. It is associated with the 
presence of periodontal pockets, bleeding on probing (BOP), and bone loss. 
Periodontal disease has been broadly classified by Attstrom & van der Velden 
(1994) as follows:
1) Adult periodontitis (AP)
2) Early-onset periodontitis
a) Prepubertal (PPP)
b) Localised early-onset (previously LJP) (LEOP)
c) Generalised early-onset (previously GJP and RPP) (GEOP)
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3) Necrotising periodontitis
There is considerable overlap within the classification defined above. For 
example, a systemic disease such as diabetes may contribute to the development 
of a non-responsive, so-called “refractory” periodontitis. HIV-associated 
periodontitis can be classified as periodontitis associated with systemic disease, 
although it usually manifests as a necrotising ulcerative periodontitis. The age of 
onset is difficult to determine retrospectively making it difficult to differentiate 
between GEOP and AP. Furthermore, these two forms of periodontitis often 
have the same clinical presentation, again making differentiation difficult.
Definitions of Adult and Early-onset Periodontitis.
Prepubertal periodontitis (PPP) affects pre-teenage children and can be localised 
or generalised (Page et al., 1983b). Localised prepubertal periodontitis affects 
children from about 4 years of age with attachment loss and alveolar bone loss 
around the primary molars and incisors only. There is moderate plaque and 
calculus accumulation with moderate signs of gingival inflammation and 
bleeding on probing at the diseased sites. The generalised form affects the 
primary dentition as soon as it erupts and there is severe generalised attachment 
loss and alveolar bone loss, frequently leading to premature exfoliation of teeth 
in the primary dentition. It is associated with severe marginal and attached 
gingival inflammation. Unlike the localised form of prepubertal periodontitis, 
the generalised form is frequently associated with host defects and/or systemic 
conditions (Page et al., 1983b; Watanabe, 1990) such as neutrophil dysfunction
(Page et al., 1983b; Schenkein & Van Dyke, 1994), leukocyte adhesion 
deficiency (Meyle, 1994), Papillon Lefevre syndrome (Hart & Shapira, 1994).
Localised early-onset periodontitis (LEOP) has an age of onset between puberty 
and 25-30 years (Baer, 1971; Schenkein & Van Dyke, 1994). There is 
attachment loss of 4mm or more in at least two permanent first molars and 
incisors; at least one first molar must be affected. To be classified as LEOP, 
there cannot be attachment loss of 4mm or more affecting more than two teeth 
other than first molars and incisors.
Generalised early-onset periodontitis (GEOP) affects people below 35. In this 
form attachment loss of 4mm or more affects at least eight teeth, with three or 
more non- molar or incisor teeth involved (Page et al., 1983a; Schenkein & Van 
Dyke, 1994).
Adult periodontitis (AP) is found in subjects 35 years and over. It affects all 
teeth and is not limited to a few particular teeth.
Prevalence of Early-onset periodontitis
Most studies in adolescents report prevalence estimates of LJP below 1% 
(Papapanou 1996). Loe & Brown (1991) estimated the prevalence of LJP at 
0.53% and GJP at 0.13%. Studies in Europe have reported a prevalence for LJP 
and GJP between 0.06% and 0.5% (van der Velden et al., 1989; Saxen et al., 
1980; Neely et al., 1992). The incidence of LJP in Caucasians has been reported
at 0.1%, 0.2% in Asians and 0.8% for Afro-Caribbeans (Saxby et al., 1984). 
From a number of studies it has become evident that EOP patients are 
particularly prone to further deterioration especially at a young age and the 
deterioration appears to be more marked at the initially affected sites (Albandar 
et al., 1991, 1993; Kallestal et al., 1991). Longitudinal observations in the 
absence of any conventional oral hygiene or dental care have revealed a 
relatively small subset (8%) that experienced extremely rapidly progressive 
disease and could represent early-onset periodontitis, in contrast to the majority 
(81%), which probably represented adult periodontitis (Loe et al., 1986). EOP is 
a rare form of periodontal disease with LEOP affecting 1 or 2 in a 1000 and 
GEOP even rarer.
Prevalence of adult periodontitis
Although there have been many studies examining AP prevalence, there are 
difficulties in comparing them (Papapanou, 1996). Frequently the rapidly 
progressing disease in early to late twenties has been included in AP, rather than 
being classified separately as it is now. The 1976-77 North Carolina survey 
found that incipient periodontitis occurred among Caucasians mostly after the 
age of 40, whilst established periodontitis was uncommon before 60 (Hughes et 
al., 1982). Brown et al. (1989) analysing the data from a 1981 US survey 
reported the prevalence of periodontitis as 36%, and this increased with age. 
Reporting the 1985-86 survey, Brown et al. (1990) found that on average 13.4% 
of subjects had pockets of 4-6mm, which increased with age (5.7% at 18-24 
years to 18.1% at 55-65 years). Advanced disease (pockets over 7mm) were
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found in an average 0.6% of the study population, again increasing with age. 
The authors also noted that men were 1.5 times more likely to have deeper 
pockets than women and Afro-Caribbeans twice as likely as Caucasians. Jenkins 
et al. (1989) reported that of 800 dentate subjects aged between 16-73 years, 
14.4% were affected by bone loss and 1% by generalised advanced bone loss. In 
their study of a Swedish population, Soder et al. (1994) found that 83% had no 
pocketing over 5mm, 5% had a 5mm pocket on one tooth, 7% on 2-5 teeth, 2% 
6-9 teeth and 3% greater than 10 teeth. A study on a Greek population 
(Diamanti-Kipioti et al., 1995) reported that between 8% and 18% of their 
subjects had bone loss of more than 6mm, which increased with age as well.
Therefore it appears that severe forms of AP affect a considerable number, but 
probably not more than 10% of the population (Papapanou, 1996; Brown & Loe,
1993). This percentage increases with age and appears to reach a peak at the age 
of 50-60 years (Papapanou, 1996). Increased tooth loss occurring after this age 
may account for the subsequent decline in prevalence. Studies in elderly 
populations have supported the conclusion of Papapanou (1996) finding that 
moderate attachment loss was frequent and widespread but severe disease 
affected relatively limited proportions (Locker & Leake, 1993; Beck et al., 
1990).
Therefore the current view is that periodontal disease is subject related, with a 
significant subset of individuals within a given population suffering from 
advanced periodontal destruction.
Risk factors
The term “risk factor” may indicate an aspect of personal behaviour or life-style, 
an environmental exposure, or inborn or inherited characteristic, which is known 
to be associated with disease-related conditions. A number of longitudinal 
studies have shown that smoking is a true risk factor for periodontal disease 
(Grossi et al., 1994, 1995; Ismail et al., 1990; Locker & Leake, 1993) and that 
certain microorganism species, and angular bony defects are risk factors 
(Haffajee et al., 1991a; Beck, 1994; Papapanou et al, 1989; Papapanou & 
Wennstrom, 1991). It is unclear if ageing per se is a risk factor or if its effect is 
due to the prolonged exposure of older subjects to true aetiological factors. 
Papapanou (1996) identified three main risk factors; smoking, diabetes mellitus 
and HIV infection. He also noted two other factors which may contribute; 
periapical pathology and malocclusion. However, different factors may be of 
importance in distinct population groups. Hence, race (Beck et al., 1990) or age 
(Grossi et al., 1994) appear to be significant determinants of the interaction 
between certain factors and disease expression.
1.1.3 Models of pathogenesis
Three models of pathogenesis have been described to explain destruction of the 
periodontium: the continuous paradigm, the random burst theory and the 
asynchronous multiple burst hypothesis.
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The continuous paradigm postulates slow, constant and progressive destruction, 
and is supported by cross-sectional studies (Russell, 1967; Loe et al., 1978). The 
random burst theory proposes short periods of destruction punctuated by periods 
of resolution occurring randomly in time and at random sites within the subject 
(Socransky et al., 1984). By contrast, the asynchronous multiple burst 
hypothesis proposes that destruction occurs within a defined time frame and then 
resolution or remission follows. This hypothesis suggests that many sites would 
show bursts of activity over a limited period of time and then these sites would 
become inactive indefinitely. None of these proposed mechanisms can be 
established or refuted by presently available data (Williams & Paquette, 1997). 
However assessment of progression by pocket depth or attachment will, almost 
by definition, lend themselves to the detection of bursts during longitudinal 
trials.
1.1.4 Stages of pathogenesis
The Kinane and Lindhe (1997) revision of the 1976 classification of Page and 
Schroeder is outlined below.
1) Initial stages
Normal “clinically healthy” gingiva has been described above. Within 24 hours 
of plaque accumulation, the blood vessels beneath the junctional epithelium 
dilate and the resulting increased permeability allows the ingress of fluid and 
exudate into the tissues. GCF volume increases with concomitant increase in 
inflammatory and immune molecules. Loe et al. (1965) showed the increase in
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GCF volume was proportional with gingival inflammation. Leukocytes, mainly 
neutrophils and lymphocytes, migrate into the tissues and accumulate in the 
junctional epithelium and around blood vessels, mediated by expression of 
adhesion molecules and a chemoattractant gradient from host and microbial 
factors. Lymphocytes are retained in the tissues on contact with antigens, 
cytokines and adhesion molecules. Within 2 to 4 days the cellular response is 
well established
2) Early gingivitis
After approximately seven days the signs of early gingivitis become apparent. 
An increase in blood vessels results from the opening up of previously inactive 
capillary beds. Lymphocytes and neutrophils are the predominant cellular 
infiltrate, with at this stage very few plasma cells (<10%). Apoptosis of 
fibroblasts starts to make room for the inflammatory infiltrate (Takahashi et al., 
1995).
3) Established gingivitis
The progression of early gingivitis leads to further enhancement of the 
inflammatory state and established gingivitis. There is an increase in fluid 
exudation and leukocyte migration. The classical Page & Schroeder lesion 
(1976) is rapidly dominated by plasma cells but in humans it may take from 3 to 
4 weeks (Payne et al., 1975) to over six months (Brecx et al., 1988) for this to 
occur. A large number of plasma cells are present in the coronal connective 
tissue and around blood vessels, comprising between 10 to 30% of the cellular
11
infiltrate. There is some tissue destruction, mainly collagen loss, and 
proliferation of the dentogingival epithelium in an attempt to maintain epithelial 
integrity and a barrier to microbial entry. The pocket epithelium loses its 
attachment to the tooth and has a heavy leukocyte infiltrate. The established 
lesions can remain at this stage as a stable condition (Lindhe et al., 1975; Page et 
al., 1975) or progress to periodontitis. The reasons for progression are unclear 
but may result from an increase in plasma cells in the lesion (Liljenberg et al., 
1994).
4) Periodontitis
The pocket depth increases as the epithelium moves apically, establishing an 
“anaerobic niche”. Alveolar bone loss and fibre damage result from 
inflammatory and immunopathologic tissue damage. At this stage plasma cells 
may be greater than 50% of the cellular infiltrate.
1.1.5 Differences between AP and GEOP
Longitudinal observations in the absence of any conventional oral hygiene or 
dental care have revealed a relatively small subset (8%) that experienced 
extremely rapidly progressive disease and could represent early-onset 
periodontitis, in contrast to the majority (81%), which probably represent adult 
periodontitis (Loe et al., 1986). Given the widely accepted view that the 
initiation of periodontitis is bacterial (Kinane & Lindhe, 1997), the vastly 
different rates of progression suggest that there may be corresponding 
aetiological or pathogenic differences between early-onset periodontitis and
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adult periodontitis, either in the causative bacteria or in the effectiveness with 
which the host resists the infection (Ranney, 1993). The short time 
manifestation in early-onset periodontitis patients of clinically detectable lesions 
is generally interpreted as being an expression of either particular or aggressive 
causative agents or high levels of susceptibility of the individual patient, or a 
combination of the two. Host susceptibility may result from systemic disease 
(Ranney, 1993), immunological response (Ebersole, 1990), neutrophil 
dysfunction (Schenkein & Van Dyke, 1994) or from genetic aspects of the host 
(Tonetti & Mombelli, 1997). One aspect of this thesis is to examine the 
differences in the micro flora between AP and GEOP patients. A review of the 
microflora of these forms of periodontal disease is to be found in section 1.4.
1.2 Microbial origins of pathogenesis
Currently the primary cause of periodontitis is considered to be bacterial 
infections of long standing, the composition of which may vary from individual 
to individual and to a lesser extent from site to site (Listgarten, 1986).
1.2.1 Dental Plaque
Dental plaque forms a microbial biofilm on colonised surfaces (Marsh & 
Bradshaw, 1995). Biofilms are defined as “matrix-enclosed bacterial
populations adherent to each other and/or to surfaces” (Costerton et al., 1994) 
and can be considered as ecological communities that have evolved to permit 
survival of the community as a whole (Costerton et al., 1995). This structure 
provides a means by which the different bacterial species can benefit from each
other and can offer a measure of protection from the host defences (Darveau et 
al., 1997). The dental plaque biofilm has adapted to grow in a highly specialised 
ecological niche. It appears that several members of the biofilm community 
participate in extending the expanding biofilm along the tooth surface.
The dental plaque associated with the periodontally healthy tooth is 
predominantly that of early supragingival plaque. The bacterial load associated
2 3with gingival health is relatively low (10 -10 isolates typically) (Newman et al., 
1978; Slots, 1977; Tanner et al., 1996). It is characterised by a predominantly 
coccoid microbiota, including many Gram-positive species especially 
streptococci and actinomyces, with about 15% Gram-negative species (Newman 
et al., 1978; Slots 1977; Tanner et al., 1996). Cultural studies of such plaques 
indicate that this microbiota is composed predominantly of facultative bacteria 
(Listgarten, 1976).
The gingivitis-associated microbiota are characterised by a marked increase in 
the microbial mass (104-106 organisms) as well as a corresponding increase in 
the proportion of Gram-negative bacteria, motile rods and filaments (15-50%) 
(Tanner et al., 1996, Slots et al., 1978).
In adult periodontitis, an abundant, complex microbiota is observed in
5 8periodontal pockets, with an increased total microbial load (10 -10 
microorganisms) (Tanner et al., 1996). This bacterial population is 
predominantly Gram-negative, and includes a large proportion of spirochetes
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preferentially distributed on the periphery, or tissue side, of the microbial mass. 
Cultural studies indicate that this microbiota is predominantly anaerobic 
(Listgarten, 1976). Dark-field microscopy studies have produced similar results 
(Listgarten & Hellden, 1978).
1.2.2 Formation of supragingival dental plaque
Within minutes after a tooth surface is freshly cleaned, a pellicle forms that 
consists of proteins and glycoproteins found in saliva and crevicular fluid. 
Pellicle formation, in addition to enhancing initial bacterial colonisation, 
provides surfaces for additional bacterial attachment (Skopek & Liljemark,
1994). Within hours the first bacteria colonise the surface, and are mostly Gram- 
positive, facultative cocci and coccobacilli; mainly Streptococcus and 
Actinomyces species. Veillonella species, and Gram-negative anaerobic cocci 
are also early colonisers.
The earliest foci of bacterial accumulation are localised to surface pits and 
fissures but can also be found on isolated protected portions of the smooth 
surfaces. In time the bacteria spread over larger sections of the smooth surfaces, 
with thicker accumulations at protected sites e.g. interdental surfaces and 
gingival margins. Plaque grows in thickness primarily through cell division of 
adherent bacteria. During the first day the surface is gradually covered by 
colonies of dividing bacteria that initially spread laterally along the tooth surface. 
Once the available surface is covered, the proliferating bacteria begin to grow 
away from the tooth in the form of columnar microbial colonies (Listgarten et
al., 1975). Around day 3 filamentous bacteria can be found on the surface of the 
predominantly coccoid plaque. Several species of coccoid bacteria are able to 
aggregate with the filamentous bacteria (Listgarten et al., 1975). Recently it has 
been shown that these filamentous bacteria may be Fusobacterium species, and 
that they coaggregate with all other oral bacteria (Whittaker et al., 1996). 
Therefore, it has been proposed that this organism plays a major role in plaque 
formation. Competitive growth among the predominantly coccoid microbial 
colonies continues for approximately 1 week. At that time filamentous bacteria 
begin to penetrate the coccoid plaque from the surface, gradually replacing the 
coccoid microbiota with a predominantly filamentous microbiota. The process 
may continue for approximately 2 more weeks. By then the columnar microbial 
colonies have disappeared and been replaced with a dense mat of filamentous 
bacteria orientated more or less perpendicularly to the colonised surface. This 
new structural organisation remains relatively unchanged over time and can be 
considered as the typical, relatively stable structure of mature, supragingival 
dental plaque (Listgarten et al., 1975, Listgarten, 1976). Plaque doubling times 
are rapid in early development and slower in more mature films (Weiger et al.,
1995).
1.2.3 Formation of subgingival dental plaque
The undisturbed growth of supragingival plaque gradually results in soft tissue 
alterations in the adjacent gingiva. Beginning within a few days of undisturbed 
plaque formation, the gingival margin begins to show typical inflammatory 
changes including redness and swelling. The latter changes result in the creation
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of a deepened gingival sulcus, which provides a relatively anaerobic 
environment for the development of an anaerobic microbiota. Anaerobic bacteria 
that colonise this subgingival region include motile rods and spirochaetes. They 
are able to increase their mass by contributing to the deepening of the sulcus, 
thereby increasing the volume of their ecological niche. Because many of the 
subgingival organisms are motile, the structural organisation is quite different 
from that supragingivally.
A relatively thin layer of adherent bacteria covers the tooth surface. Rods and 
filaments tend to be arranged in a palisading pattern, with the long axis of the 
cells perpendicular to the tooth surface. Unique bacterial aggregates, resembling 
test-tube brushes, can be found attached to the adhering plaque and extending 
into the space between the bacterial layer and the adjacent soft tissue wall. The 
“bristles” of these test-tube brush formations are Gram-negative filamentous 
bacteria, probably Fusobacterium species (Whittaker et al., 1996). The bulk of 
the subgingival microbiota consists of a complex mixture of predominantly 
anaerobic bacteria that surround and cover the test-tube brush formations. The 
lack of well-defined microbial colonies in this environment may be due to the 
high degree of motility of the resident bacteria. The peripheral region of the 
subgingival microbiota is composed of a high concentration of spirochetes that 
are in direct contact with the gingival tissue wall as well as the apical lining of 
the sulcus or pocket (Theilade, 1985). Sometimes layers of leukocytes, mostly 
neutrophils that have migrated out of the junctional epithelium, separate the 
bacterial mass from the sulcular or pocket epithelium.
The bottom of the sulcus or pocket is formed by the coronal, desquamative 
surface of the junctional epithelium, which is attached to the tooth surface on one 
side and to the gingival connective tissue on the other (Schroeder, 1977). This 
portion of the junctional epithelium is subject to bacterial as well as mechanical 
injuries, which may result in enlarged intercellular spaces and vertical tears in 
the epithelium. These alterations in the integrity of the junctional epithelium 
allow a gradual apical colonisation of the tooth surface by coccoid cells and rods 
(Schroeder & Listgarten, 1977; Vrahopoulos et al., 1992a, b). Irregularities in 
the root surface may shelter plaque microorganisms and contribute to their 
retention at such sites. The tendency for bacteria to colonise tooth surfaces 
freshly exposed because of disruptions in the junctional epithelium leads to a 
gradual deepening of the sulcus or pocket.
Thus, a distinctive subgingival microbiota, predominantly composed of Gram- 
negative, anaerobic bacteria, including a number of motile species, becomes 
established in the gingival sulcus between 3-12 weeks after the beginning of 
supragingival plaque formation. The establishment of this subgingival 
microbiota is dependent on a series of inter-related events: the successive 
colonisation of the tooth surface by different bacterial populations. Each of these 
microbial populations appears to facilitate the colonisation of this region by the 
next wave of bacterial settlers, with the ultimate establishment in the subgingival 
region of a predominantly anaerobic, Gram-negative microbiota. Most bacterial 
species currently suspected of being periodontal pathogens are anaerobic, Gram-
negative species whose main ecological niche is the subgingival region. In this 
protected environment they are in an excellent position to participate in the 
destruction of periodontal tissues, with the resulting maintenance and expansion 
of their subgingival habitat.
Subgingival plaque increases its growth environment by causing epithelial cells 
and attachment level to move apically, thereby creating deeper pockets. The 
mechanism by which this occurs is unknown but almost certainly involves 
combating the innate host defence system. Although gingival crevicular fluid 
(GCF) is the main nutritional component of the subgingival microbiota, it 
contains a potent array of host defence products. It appears that a combination of 
bacteria rather than just one act co-ordinately to further dental plaque biofilm 
growth. Bacterial biofilms are very resistant to removal and can be resistant to 
antibiotics (Anwar et al., 1992) as well as opsonisation and complement- 
mediated phagocytosis and killing (Jensen et al., 1990). The high level of 
resistance of biofilm bacteria probably involves limited access and the formation 
of microcolonies that are shielded from the external environment (Lawrence et 
al., 1991). The resistance of subgingival biofilms to normal host defences has 
important consequences for the patient and for periodontal therapy. Subgingival 
biofilms cannot be removed by daily oral hygiene methods, including 
subgingival irrigation, or by the use of antimicrobial agents in oral rinses or 
tooth pastes. Physical removal is essential. It is for this reason that scaling and 
root planing is an essential component of all forms of successful treatment for
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periodontitis. Because of the nature of biofilms, this requirement is unlikely to 
change (Darveau et al., 1997).
1.3 Treatment of periodontal disease
Regardless of the type of periodontal disease, the sequence of treatment for most 
patients generally begins with establishing good oral hygiene and a thorough 
debridement, usually scaling and root planing. Scaling is defined as 
“instrumentation of the crown and root surfaces of the teeth to remove plaque, 
calculus, and staining”. Root planing is defined as “a definitive treatment 
procedure designed to remove cementum or surface dentine that is rough, 
impregnated with calculus, or contaminated with toxins or microorganisms” 
(The American Academy of Periodontology, 1989).
There is considerable evidence supporting scaling and root planing (SRP) as an 
essential and effective component of therapy for periodontal disease (Cobb,
1996). The clinical benefits of SRP are derived from the removal of the 
subgingival microflora and therefore a delay in the re-population of pathogenic 
microbes allowing some healing to take place (Mousques et al., 1980). 
However, it appears that the subgingival microflora has supragingival origins as 
the quantity, composition and rate of subgingival plaque recolonisation is, to 
some degree, dependent upon supragingival plaque accumulation (Pedrazzoli et 
al., 1991; Magnusson et al., 1984; Sbordone et al., 1990a). Consequently, 
effective control of the supragingival plaque combined with frequent subgingival 
therapy is critical for long-term control of periodontitis.
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1.3.1 The effect of scaling and root planing on pocket depth
The effect of SRP is generally related to initial pocket depth. At sites with an 
initial PD of 1 to 3mm, there seems to be a very slight gain in PD, if any, and an 
attachment loss of about 0.34mm (Hill et al., 1981; Pihlstrom et al., 1981; 
Nordland et al., 1987). Pockets with an initial depth of 4 to 6mm reduced in 
depth by an average of 1.3mm and gained 0.55mm attachment (Hill et al., 1981; 
Pihlstrom et al., 1981; Nordland et al., 1987; Loos et al., 1989; Badersten et al., 
1984a; Pedrazzoli et al., 1991). Deep sites of 7mm and greater gained the most 
attachment, on average 1.2mm and reduced in depth by 2.16mm (Hill et al., 
1981; Pihlstrom et al., 1981; Nordland et al., 1987; Loos et al., 1989; Becker et 
al., 1988; Mousques et al., 1980; Renvert et al., 1985; Claffey et al., 1988).
1.3.2 Healing after scaling and root planing
After treatment, histologic studies (Waerhaug, 1978) described the regeneration 
of the root-epithelial surface as a long-junctional epithelial attachment, which 
precludes the formation of a new connective tissue attachment. Re­
establishment of the new epithelium appears to occur within one to two weeks 
(Waerhaug, 1978). Concomitant with the formation of the new attachment are 
gradual reductions in the clinical inflammation, that appear correlated to 
reductions in the inflammatory cell infiltrate, and GCF (Tagge, 1975; Biagini et 
al., 1988).
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1.3.3 Non-responding sites
Although SRP usually brings a reduction in PD, there are some sites that do not 
respond to therapy (Badersten et al., 1985a, b; Claffey & Egelberg, 1994), which 
ranged from 10 to 22% of sites in patients in these studies. Further more these 
non-responder sites seem to be clustered within a small percentage of patients 
(Grbic & Lamster, 1992; Claffey & Egelberg, 1995).
1.3.4 Effect of scaling and root planing on bleeding on probing
Bleeding from the base of the pocket has traditionally been used as an indicator 
of disease activity. However, studies have reported weak correlations between 
BOP and disease progression (Badersten et al., 1985c, 1990; Claffey & 
Egelberg, 1995; Lang et al., 1986), and Lang et al. (1990) suggested that the 
absence of bleeding is a better indicator of stability. Regardless of the lack of 
correlation between BOP and risk for further attachment loss, it would appear 
that SRP will predictably reduce the level of inflammation, with a mean 
reduction of 57% (Cobb, 1996).
1.3.5 Effect of scaling and root planing on the microflora
Studies designed to determine the effect of scaling and root planing on the sub­
gingival microflora have consistently reported significant reductions in the 
percentage of motile rods and spirochaetes, P. gingivalis, A. 
actinomycetemcomitans, and other Gram-negative anaerobic micro-organisms, 
and a concomitant increase in the percentage of cocci and non-motile microbes 
(Slots et al., 1979; Magnusson et al., 1984; Hinrichs et al., 1985; Lavanchy et al.,
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1987; Loos et al., 1989; van Winkelhoff et al., 1988; Southard et al., 1989; 
Shiloah & Patters, 1996; Renvert et al., 1990a; Lowenguth et al., 1995; 
Rosenberg et al., 1989; Hakkarainen et al., 1986). Several of these studies note 
that improvement in clinical parameters such as decreased probing depth, and 
decreased bleeding are associated with the decrease in the above (Hakkarainen et 
al., 1986; Slots et al., 1979). Mombelli et al. (1994a, b) noted that it was much 
more difficult to eradicate organisms from deep bleeding pockets. The reasons 
why in some cases a given bacterium is below detection level after treatment and 
in others is not, are not well understood (van der Velden & Schoo, 1997).
1.3.6 Repopulation of pockets
The microbes which repopulate the pocket may represent residual organisms 
following SRP (Renvert et al., 1990a) or the downgrowth of organisms from 
supragingival plaque (Waerhaug, 1978). A. actinomycetemcomitans seems to be 
especially difficult to eradicate from pockets (Renvert et al., 1990a), which may 
be due to its ability to invade the periodontal tissues (Christersson et al., 1987a,
b). However, Sbordone et al. (1990a) showed that all their study organisms had 
similar levels of reduction and the re-colonisation of the subgingival plaque was 
taking place 21 days after treatment and reached pre-treatment levels at about 60 
days. Several studies have demonstrated that the microbial re-population of 
subgingival pockets can be severely inhibited by continual and effective oral 
hygiene (Dahlen et al., 1992; Katsanoulas et al., 1992; McNabb et al., 1992). As 
mentioned above it is more difficult to eradicate the microflora of deep bleeding 
pockets.
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1.4 Review of the microbiology of periodontal disease
Studies in both humans and animals have shown that periodontal inflammation 
and destruction of periodontal tissues are initiated and supported by the bacteria 
of dental plaque. The concept of microbial specificity in the aetiology of 
periodontal disease has emerged in the last three decades (Loesche, 1976, 
Socransky, 1977). Previously it was believed that periodontal disease resulted 
from the gross accumulation of dental plaque. This hypothesis explained 
previous clinical experiences when investigators linked the universal presence of 
gingival inflammation and periodontal pocket formation with apparently 
ubiquitous presence of abundant plaque (Tanner, 1988). Loesche (1976) 
suggested that periodontal disease be considered as non-specific because:
1) The lack of bacterial invasion. Bacterial invasion has been demonstrated, 
but it does not appear, as yet, to be part of an acute phase of disease 
progression.
2) Their apparent non-specific nature.
3) Their chronicity, and
4) Their universality.
This non-specific theory has been disregarded because the 300-400 bacterial 
species in the oral cavity show different characteristics and therefore must play 
different roles (Dahlen, 1993). Although periodontal diseases are polymicrobial 
infections, cross-sectional and longitudinal studies of the predominant cultivable 
microflora reveal that only a small number of species are associated with human
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periodontal disease (Moore et al., 1983; Theilade, 1986; van Winkelhoff et al., 
1988; Haffajee & Socransky, 1994).
The specific plaque hypothesis suggests that a specific agent may be responsible 
for periodontal destruction. The concept of bacterial specificity has been further 
supported by clinical observations, by therapeutic effect of control of these 
bacteria, and by experimental models of periodontitis in both gnotobiotic and 
conventionally maintained animals. However, the continued finding of 
increased numbers of a range of species in periodontitis patients, the presence of 
suspected agents in inactive sites, the failure of “specific” antibiotics to stop 
disease progression, and the absence of these agents in some active sites 
indicates that the specific plaque hypothesis may not be valid (Tanner, 1988).
In the last few years it has become clear that a number of organisms are involved 
in the disease process. A number of proposed pathological agents are not 
capable of initiating a mono-infection (Mayrand & McBride, 1980; Dahlen et al., 
1989b), but if these (P. gingivalis, P. intermedia, P. micros) are excluded, the 
microbial mixture loses its capacity to produce experimental infections. This 
theory has been supported by further microbiological findings especially those 
reporting an increase in number of bacterial species in periodontitis patients 
(Moore, 1987) and bacterial cluster patterns that may be related to disease 
(Socransky et al., 1998). Even so only three organisms have been designated 
aetiological agents: A. actinomycetemcomitans, P. gingivalis and B. forsythus 
(Consensus report, American Academy of Periodontology 1996).
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Given their preponderance in subgingival plaque, it is unsurprising that a variety 
of Gram-negative organisms have been implicated in the aetiology of periodontal 
disease. These species include A. actinomycetemcomitans, P. gingivalis, P. 
intermedia, Capnocytophaga species, B. forsythus, F. nucleatum & C. rectus, as 
well as certain Gram-positive species such as Eubacterium (Moore et al., 1983, 
Moore, 1987; Haffajee & Socransky, 1994). A more complete list is shown in 
table 1.1 (adapted from Darveau et al., 1997).
Periodontal disease occurs in an area inhabited by many bacteria, and there are 
many problems in identifying specific aetiological agents. Numerous microbial 
species have been identified in supra- and sub-gingival plaques, and 30 to 100 
may be recovered from a single site. Many of these species are difficult or 
impossible to culture and identify. Even though there is a variety of methods 
available to identify plaque bacteria that do not rely on bacterial viability, there 
is no current method that is able to identify and accurately quantitate all the 
bacterial species present in subgingival plaque. Sites in an individual do not 
actively progress at all times with respect to attachment loss, and the flora at 
these sites may not reflect a “disease-associated” flora. Different sites in a 
subject have their own individual flora and these sites may vary in their disease 
activity depending on the bacteria colonising that site. It is likely that hosts 
differ in their threshold susceptibility, and what may cause disease in one subject 
may not have an effect in another. Bacterial pathogens may exist in a carrier 
state and are sometimes compatible with health. Bacterial species present in
Table 1.1 Species commonly found in periodontal pockets
P. gingivalis
A. actinomycetemcomitans 
P. intermedia
B. forsythus
Black-pigmented Bacteroides 
T. denticola 
Other Spirochaetes 
F. nucleatum
C. rectus
Capnocytophaga species 
E. corrodens 
Eubacterium species 
Selenomonas species 
P. micros
Streptococcus species 
Veillonella species 
Actinomyces species 
Enteric rods
H. pylori
Herpes group viruses
lower numbers in plaques associated with health, are likely to play little role in 
progressive disease. However opportunistic species may grow as a result of the 
disease rather than being the cause. It is becoming increasingly apparent that 
progressive periodontitis is a mixed infection, the result of a combination of 
bacteria rather than one specific agent. The situation is further compounded 
because most bacteria in subgingival plaque have a number of clonal types or 
subspecies, and these do not display the same level of virulence. The inability to 
distinguish virulent from avirulent clonal types has hindered understanding of 
the role of the microflora in the disease process. Inadequate reproducibility and 
measurement errors make it difficult to associate specific microorganisms with 
active disease. For example, the physical constraints of a pocket may make it 
difficult to obtain a representative sample.
1.4.1 Criteria for defining periodontal pathogens
Given the range and nature of the problems with identifying 
periodontopathogenic bacteria, a number of criteria have been defined 
(Socransky, 1977; Socransky & Haffajee, 1992). The criteria include
association, elimination, animal pathogenicity, host responses, and production of 
virulence factors. The criterion of association requires that the suspected 
pathogenic species be more frequently detected and at higher levels in cases than 
controls. For example the species should be higher in actively progressing sites 
than in healthy sites, gingivitis sites, non-progressing sites, or sites showing f 
improvement. Longitudinal assessment might also show an increase in the 
species prior to or concomitant with measured disease progression. The
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fundamental basis of elimination studies is that treatment administered to 
subjects with a given form of disease should influence both the clinical status of 
the disease and members of the associated microbiota. It is reasonable to expect 
that successful therapy will diminish the level of a pathogen, improve the clinical 
situation, and halt disease progression. Failure to eliminate or diminish the level 
of the pathogen should be linked with a lack of clinical improvement and may 
ultimately lead to further progression at that site or in that subject. Testing of 
pathogenicity in animal model systems continues to be used to further support or 
refute possible pathogens. In spite of concerns with animal model systems, they 
can provide additional evidence of roles for certain species in disease and are 
particularly useful in defining virulence factors. The host response can also be 
used to discriminate periodontal pathogens. A periodontal pathogen that causes 
destructive periodontal disease often will elicit an elevated immunological 
response, either locally or systemically. If a species (or its antigens) gains access 
to underlying periodontal tissues and causes damage, it seems likely that the host 
will produce antibodies or a cellular immune response directed at that species. 
Thus the host response could act as a pointer to the pathogen(s). In certain 
circumstances the pathogen may diminish aspects of the host immune response. 
Finally the ability of certain species to produce virulence factors has been used to 
support possible roles of such species in periodontal diseases. The production of 
unique biochemical determinants by pathogens may be important in disease and 
an indicator of the potential of the species to contribute to disease progression.
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Using these criteria the role of a number of proposed pathologic agents in AP 
and GEOP will be discussed in the next section. However only those criteria 
relevant to this section will be discussed. As a number of excellent reviews have 
extensively covered virulence factors and animals studies for these agents (Holt 
et al., 1999; Fives-Taylor, 1999; Haffajee & Socransky, 1994), these will not be 
discussed in this review. However some virulence factors will be mentioned 
where relevant. In addition, since part of this thesis is concerned with the 
humoral immune aspects of periodontal disease, this criterion will be discussed 
separately and in some detail.
1.4.2 Microbiology of Adult Periodontitis
This section reviews the possible microorganisms that may be aetiological agents 
in Adult periodontitis. The change in definitions of periodontal disease over the 
years has resulted in many papers grouping GEOP and AP together. Where 
possible the 1996 AAP guidelines have been applied to papers to separate the 
two groups. If this has not been possible and the paper is thought to be relevant 
it has been included in the AP section.
Table 1.1 shows the species/organisms that are commonly isolated form 
periodontal pockets and which may be aetiological agents. Each 
species/organism will be reviewed in turn.
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Porphyromonas gingivalis
Porphyromonas gingivalis is a Gram-negative anaerobic non-motile 
asaccharolytic (non-carbohydrate fermenter) short or coccal rod. It is a member 
of the black-pigmented anaerobes group. The normal habitat of P. gingivalis is 
the oral cavity and most likely the gingival sulcus (Olsen et al., 1999). The 
organism is rarely found in supragingival plaque or outside the oral cavity (van 
Winkelhoff et al., 1988).
A large number of studies have investigated the role of P. gingivalis in 
periodontal disease. There is no need to list all the studies in the text of this 
thesis. Instead a number of studies have been listed in table 1.2 and referred to 
where appropriate. Some studies report an absence or very low prevalence 
(<10%) in healthy subjects (Table 1.2). Others report high levels in subjects 
without “clinical evidence of periodontal disease” (Mombelli et al., 1998) (Al- 
Yahfoufi et al., 1994; Dahlen et al., 1992; Gmiir & Guggenheim, 1994; Kojima 
et al., 1993; Di Murro et al., 1987; McNabb et al., 1992). Generally in AP 
patients, the prevalence and levels of P. gingivalis are raised compared to health 
and gingivitis (table 1.2). P. gingivalis may be found in 13% to 100% of 
patients and 33% to 81% of sites (Table 1.2). The prevalence of P. gingivalis is 
linked to age and seems to increase as age increases (Rodenburg et al., 1990).
P. gingivalis correlates well with pocket depth and comprises a considerably 
higher proportion of the subgingival microbiota in deeper pockets (table 1.2). It 
has been linked with bleeding on probing (Albandar et al., 1990; Socransky et
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Table 1.2 P. gingivalis in AP: Association and effect of therapy
Criterion References
Increased prevalence in 
disease
Increased in AP subjects Slots et al., 1979; Spiegel 
et al., 1979; Moore et al., 
1983; White etal., 1981; 
Grossi et al., 1994; Tanner 
et al., 1979; Zambon et al., 
1981, 1985; Riviere et al., 
1996b; Mombelli et al., 
1998; Riggio et al., 1996; 
Wikstrom et al., 1993; 
Rodenburg et al., 1990; 
Slots et al., 1986; Slots, 
1986; Loesche et al., 1985; 
Savitt & Socransky, 1984; 
Riviere et al., 1996b; Slots 
et al., 1991; Africa et al., 
1985; van Winkelhoff et 
al., 1986; Simonson et al., 
1992; van der Weijden et 
al., 1994; Ali etal., 1996; 
Socransky et al., 1991; 
Wolff et al., 1993; 
Papapanou et al., 1993; 
Gunaratnam et al., 1992; 
Christersson, 1992; 
Komman et al., 1991; 
Mombelli et al., 1991a; 
Kojima, 1993; Ali et al., 
1992; Haffajee et al., 
1988a; Mombelli et al., 
1995; Ashimoto et al., 
1996; Soderetal., 1993; 
von Troil-Linden et al., 
1995
Decreased in health/ 
gingivitis
Okuda et al., 1988; White 
et al., 1981; Tanner et al., 
1998a; Spiegel et al.,
1979; Adler et al., 1995; 
Savitt & Socransky, 1984; 
van Winkelhoff et al., 
1986
Presence correlates with 
deep sites
Ali et al., 1996; Socransky 
etal., 1991; Wolff etal., 
1993; Wikstrom et al., 
1993; Beck et al., 1992;
Albandar et al., 1990; 
Haffajee et al., 1991b; 
Christersson et al., 1992; 
Mombelli et a l, 1991a; 
Kigure et al., 1995; 
Kojima, 1993
Increased in progressing/ 
active sites
Slots et al., 1986a; 
Albandar et al., 1990; 
Dzinketal., 1985, 1988; 
Moore et al., 1991; Slots et 
al., 1986; Tanner et al., 
1987a; Haffajee 1991b
Response to treatment Decrease after SRP Renvert et al., 1997; 
Danser et al., 1996; 
Hellstrom et al., 1996; 
Haffajee et al., 1997a; 
Nieminen et al., 1995; 
Preber et al., 1995; Shiloah 
& Patters, 1994;
Sigurdsson et al., 1994; 
Socransky & Haffajee 
1993; Rosenburg et al., 
1993; Wikstrom et al., 
1993; Ali et al., 1992; 
Goodson et al., 1991; 
Maiden et al., 1991; 
Mombelli et al., 1995; 
Renvert et al., 1990a; 
Loesche et al., 1985; Slots 
et al., 1985; Simonson et 
al., 1992; Haffajee et al., 
1995, 1988a
Decrease after surgery Danser et al., 1996; 
Nieminen et al., 1996; 
Mombelli et al., 1995; 
Sigurdsson et al., 1994; 
Rosenburg et al., 1993; Ali 
et al., 1992; Renvert et al., 
1990c
Decrease after antibiotics Flemmig et al., 1998; 
Haffajee et al., 1996; 
Nieminen etal., 1996; 
Renvert et al., 1990a; 
Lowenguth et al., 1995; 
Kommanetal., 1994; 
Rosenburg et al., 1993; 
van Steenberghe et al., 
1993; van Winkelhoff et
al., 1992; Goodson et al., 
1991; Maiden et al., 1991; 
Pedrazzoli et al., 1992; 
Walker etal., 1990; 
Kulkami et al., 1991; 
Gusberti et al., 1988; 
Loesche et al., 1984
al., 1991; Christersson et al., 1992; Mombelli et al., 1991a; Kojima et al., 1993), 
suppuration (Socransky et al., 1991), and bone loss (Tanner et al., 1984; van der 
Weijden et al., 1994). In active/progressing sites P. gingivalis is detected with a 
much higher frequency and in greater numbers (Table 1.2). In spite of the 
overwhelming evidence implicating P. gingivalis as a pathogen in periodontal 
disease, studies by Moore et al. (1983) and Kojima et al. (1993) reported that the 
presence of P. gingivalis was not the cause of the disease process but a result of 
it.
Improvement in clinical condition is related to reduction or elimination of P. 
gingivalis (Haffajee et al., 1997a; Newman et al., 1994). Scaling and root 
planing (SRP) has been shown to be very effective in reducing the levels of P. 
gingivalis in sites, less so in patients, but not very effective in eliminating the 
organism (Table 1.2). After SRP, the presence of P. gingivalis correlates with 
probing depth and bleeding on probing (Wikstrom et al., 1993).
Surgery is equally as effective in reducing P. gingivalis, though does not 
generally eliminate the organism (Table 1.2). Both systemic and locally applied 
antimicrobials effectively reduce P. gingivalis levels, but as above, do not 
eliminate the organism (Table 1.2).
An increased number of P. gingivalis is linked to the progression of sites after 
treatment (Tanner et al., 1987a; Socransky & Haffajee et al., 1993). Refractory 
subjects also harbour high levels of P. gingivalis (Walker & Gordon, 1990; Choi
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et al., 1990), but not relapsing sites (Slots et al., 1986). An absence or low 
prevalences and proportions indicate non-progression and continued health 
(Beck, 1994; Wennstrom et al., 1987; Bragd et al., 1987; Machtei et al., 1997; 
Page & Beck, 1997).
The high occurrence of P. gingivalis in AP lesions, together with the organism’s 
pathogenic potential have resulted in the organism being named as an 
aetiological agent in periodontal disease, especially AP (Consensus report, 
American Academy of Periodontology, 1996). If P. gingivalis is an endogenous 
organism, treatment will not eradicate it. Perhaps the goal of treatment should 
be its reduction below a certain level, maybe that detectable by culture or DNA 
probe, as its absence in these tests seems to be the best indication of disease 
remission.
A ctinobacillus actinomycetemcomitans
A. actinomycetemcomitans is a small, non-motile, Gram-negative saccharolytic 
capnophilic round-ended rod. It is thought to be one of the main aetiological 
agents in LJP (Zambon, 1985; Slots et al., 1980; Slots & Ting, 1999). In 
younger patients it has been extensively studied, but less so in adults. As age 
increases its prevalence decreases (Rodenburg et al., 1990; Slots et al., 1990a).
There are also a great number of studies which have examined the role of A. 
actinomycetemcomitans in adult periodontal disease. For the sake of brevity, a
number of references have also been placed in a table and referred to in the text 
(Table 1.3).
Most periodontally healthy adults show low or no detectable levels of 
subgingival A. actinomycetemcomitans (Table 1.3), although in some study 
populations it has also been detected with considerable frequency in minimally 
diseased subjects (Al-Yahfoufi et al., 1994; Dahlen et al., 1989a; Gmiir & 
Guggenheim, 1994; McNabb et al., 1992). However it has been linked to AP 
(Table 1.3), and its prevalence ranges from 10% to 100% of patients and 35% to 
45% of sites (Table 1.3). Zambon (1985) reported that 36% of the population 
carry A. actinomycetemcomitans normally and that the prevalence in AP was 
only slightly higher than that of the normal population, but also much lower than 
that of early-onset periodontitis.
A number of reports indicate that the presence of A. actinomycetemcomitans 
correlates with active/progressing sites (Table 1.3), deep pockets (Table 1.3), 
bleeding on probing (Socransky et al., 1991; Dzink et al., 1985; Ebersole et al., 
1994b; Mombelli et al., 1994b), and suppuration (Socransky et al., 1991). Other 
authors have found no such correlations (Albandar et al., 1990; Skaar et al.,
1992).
There are five known serotypes of A. actinomycetemcomitans, a-e (Asikainen et 
al., 1991; Gmtir et al., 1993). Although patients usually only have one serotype 
(Ebersole et al., 1994b), there are mixed reports about which is more prevalent,
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Table 1.3 A. actinomycetemcomitans in AP: Association and effect of treatment
Criterion References
Increased prevalence in 
disease
Increased in AP subjects Savitt & Socransky, 1984; 
Grossi et al., 1994; 
Mombelli et al., 1994a; 
Bonta et al., 1985; Cao et 
al., 1990; Mombelli et al., 
1998; Rodenburg et al., 
1990; van der Weijden et 
al., 1994; Ali etal., 1996; 
Wolff etal., 1993; 
Papapanou et al., 1993; 
Gunaratnam et al., 1992; 
Riggio et al., 1996; 
Haffajee et al., 1988a; 
Christersson et al., 1992; 
Komman, 1991; Slots et 
al., 1980, 1990a; Zambon 
et al., 1983b; Mombelli et 
al., 1995
Decreased in health/ 
gingivitis
Tanner et al., 1998; Cao et 
al., 1990; Slots & Ting, 
1999
Presence correlates with 
deep sites
Wolff etal., 1993; Slots et 
al., 1980; Tanner et al., 
1979; Socransky et al., 
1991; Ebersole et al.,
1994; Mombelli et al., 
1994a
Increased in progressing/ 
active sites
Slots et al., 1986a, b; 
Tanner et al., 1987a; Dzink 
etal., 1983, 1985, 1988
Response to treatment Decrease after SRP Flemmig et al., 1998; 
Renvert et al., 1997; 
Nieminen et al., 1996; 
Preber et al., 1995; 
Mombelli et al., 1994a, b; 
Shiloah et al., 1994; 
Sigurdsson et al., 1994; 
Rosenburg et al., 1993; 
Wikstrom et al., 1993; 
Goodson et al., 1991; 
Maiden et al., 1991; 
Listgarten et al., 1991; 
Renvert et al., 1990 a, c
Decrease after surgery Rosenburg et al., 1993; 
Danser et al., 1996; 
Nieminen et al., 1996; 
Haffajee et al., 1988b; 
Mombelli et al., 1995; 
Sigurdsson et al., 1994; 
Renvert et al., 1990c
Decrease after antibiotics Flemmig et al., 1998; 
Nieminen et al., 1996; 
Renvert et al., 1996; 
Komman et al., 1994; 
Muller et al., 1993; van 
Winkelhoff et al., 1992
serotypes a or b, though b seems to be more commonly found (Haffajee et al., 
1984; Asikainen et al., 1997; Saarela et al., 1992; Asikainen et al., 1991; 
Zambon et al., 1983a). Serotype c is related to health (Asikainen et al., 1991). 
Interestingly Mombelli et al. (1994a) reported that in their study population, the 
majority of patients showed only limited numbers of positive samples and then 
low counts. A small number of patients displayed a high number of positive 
samples and high counts. This suggests that there are some subjects who are 
more susceptible to infection by A. actinomycetemcomitans or that there is 
variation in virulence and pathogenic potential (Mombelli et al., 1998).
Treatment of A. actinomycetemcomitans infected patients is difficult especially 
deep pockets and high counts of A. actinomycetemcomitans (Mombelli et al., 
1994b; Renvert et al., 1990b, 1996; Bragd et al., 1987; van Winkelhoff et al., 
1992; Christersson et al., 1985). SRP reduces the levels of A.
actinomycetemcomitans (Table 1.3), but is very often quite ineffective with only 
minimal reduction reported. This failure of SRP may reflect the ability of A. 
actinomycetemcomitans to invade gingival tissue (Saglie et al., 1985; 
Christersson et al., 1987a, b; Meyer et al., 1991).
Periodontal surgery, while more effective than SRP, also often fails to control 
effectively subgingival A. actinomycetemcomitans (Table 1.3). Although 
conventional surgery reduces A. actinomycetemcomitans numbers better than 
SRP, resective surgery seems to be more effective in eliminating A. 
actinomycetemcomitans (Ali et al., 1992), as any infected tissue is removed
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rather than providing a nidus for re-infection. Systemic antibiotics have the 
potential to eliminate A. actinomycetemcomitans from pockets and gingival 
tissue. Combined with SRP and/or surgery they may markedly reduce A. 
actinomycetemcomitans infection (Table 1.3). Locally applied antibiotics have 
had mixed reports, but seem generally less effective than systemic antibiotics 
(Hitzig et al., 1997; van Steenberghe et al., 1993; Goodson et al., 1991; Maiden 
et al., 1991). Although one report by Lowenguth et al. (1995) eliminated A. 
actinomycetemcomitans from their patient population.
Given the virulence of A. actinomycetemcomitans some authors have suggested 
elimination of A. actinomycetemcomitans should be the goal of any periodontal 
therapy, as failure to eliminate A. actinomycetemcomitans can lead to continued 
attachment loss or reduced healing (Zambon, 1996). However, it should be 
borne in mind that elimination probably only means a reduction below the level 
of detection of the microbiological test used. A. actinomycetemcomitans will 
probably still be present in the pocket or tissue, albeit at a reduced level below 
that required to cause disease. Higher levels of A. actinomycetemcomitans have 
been reported in sites that continue to lose attachment after treatment (Haffajee 
et al., 1995), and in relapsing patients (Komman, 1991). Very low levels of A. 
actinomycetemcomitans (<0.01%), while difficult to achieve, are commensurate 
with non-progression of periodontitis (Bragd et al., 1987) and the absence of A. 
actinomycetemcomitans is a good predictor for no further attachment loss 
(Wennstrom et al., 1987).
A. actinomycetemcomitans may be a major pathogen in AP, but probably only in 
a subset of susceptible patients (Mombelli 1994a; Slots & Ting, 1999). Given its 
decreasing prevalence with age, it is likely that other organisms are more 
involved in the disease process.
Prevotella intermedia
P. intermedia is also a member of the black-pigmented anaerobes group. It is a 
Gram-negative, short round-ended rod. The organism is generally detected in 
higher frequencies and proportions in adult periodontitis sites and subjects 
ranging from 29% to 100% of subjects and 13% to 88% of sites than in health 
and gingivitis (Table 1.4). Similarly P. intermedia has been detected in some 
study populations with minimal disease (Al-Yahfoufi et al., 1994) and at similar 
levels in healthy subjects (Grossi et al., 1994; Slots et al., 1990a).
Its presence correlates with an increase in disease severity especially pocket 
depth (Table 1.4). In addition, P. intermedia has been associated with bleeding 
on probing (Socransky et al., 1991; Dzink et al., 1985; Mombelli et al., 1991a), 
suppuration (Socransky et al., 1991), and bone loss (van der Weijden et al., 
1994). Again not all studies report these correlations (Christersson et al., 1992; 
Albandar et al., 1990).
Both the frequency of detection and levels of P. intermedia are increased in 
active/progressing periodontitis lesions (Table 1.4). P. intermedia has been
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Table 1.4 P. intermedia in AP: Association and effect of treatment
Criterion References
Increased prevalence in 
disease
Increased in AP subjects Wikstrom et al., 1993; 
Rodenburg et al., 1990; Slots 
et al., 1986a; Loesche et al., 
1985; Savitt & Socransky, 
1984; Slots etal., 1991; 
Africa et al., 1985; van 
Winkelhoff et al., 1986; 
Dibart et al., 1998; Moore et 
al., 1983; van der Weijden et 
al., 1994; Ali etal., 1996; 
Socransky et al., 1991; 
Dahlen et al., 1992; Wolff et 
al., 1993; Papapanou et al., 
1993; Gunaratnam et al., 
1992; Haffajee et al., 1988a; 
Christersson et al., 1992; 
Komman et al., 1991; 
Mombelli etal., 1991a;
Adler et al., 1995; Slots et 
al., 1990a
Presence correlates with 
deep sites
Beck et al., 1992; Haffajee et 
al., 1991b; Ali etal., 1996; 
Socransky et al., 1991;
Wolff et al., 1993; Mombelli 
et al., 1991a
Increased in 
progressing/ active sites
Slots et al., 1986 a, b; Dzink 
et al., 1988; Tanner et al., 
1987a; Moore et al., 1991; 
Dzink et al., 1985
Response to treatment Decrease after SRP Ali et al., 1992; van 
Winkelhoff et al., 1988; 
Renvert et al., 1990a; 
Wikstrom et al., 1993; Bragd 
et al., 1987; Socransky et al., 
1993
Decrease after surgery 
and/or antibiotics
van Steenberghe et al., 1993; 
Ali et al., 1992; Kulkami et 
al., 1991; Loesche et al., 
1991; Haffajee etal., 1988b, 
1984; Pedrazzoli et al.,
1991; Socransky et al., 1993
detected attached to epithelial cells in increased numbers at diseased sites (Dzink 
et al., 1989; Dibart et al., 1998).
In response to treatment, clinical improvement is generally accompanied by a 
concomitant decrease in P. intermedia (Table 1.4). Studies investigating the 
effect of SRP on the frequency of detection and levels of P. intermedia report a 
decrease after treatment (Table 1.4), although Loesche et al. (1985) reported that 
SRP had no effect on P. intermedia levels. Mombelli et al. (1991a) suggested 
that they would not expect the levels of P. intermedia to change as much as other 
organisms because P. intermedia seems to be more of a commensal. Similarly 
studies employing surgical methods and/or antibiotics also report lower P. 
intermedia with clinical improvement (Table 1.4).
In recurrent or refractory patients, continued or recurring high levels of P. 
intermedia have been reported (Slots et al., 1986; Tanner et al., 1987a; Komman,
1991). An absence of P. intermedia or low levels in the microflora (<2%) are 
associated with continued periodontal health (Wennstrom et al., 1987; Beck et 
al., 1992; Bragd et al., 1987). Dahlen et al. (1992) showed that continuing good 
oral hygiene can keep the levels of P. intermedia low in periodontal pockets.
Strains of P. intermedia that show identical phenotypic traits have been 
separated into two species, P. intermedia and P. nigrescens (Shah & Gharbia,
1992). This distinction makes earlier studies of this species difficult to interpret, 
since data from the two species may have been pooled.
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P. intermedia is a likely candidate for a periodontopathogenic organism, but to a 
lesser extent than P. gingivalis.
Bacteroides forsythus
B. forsythus is a slow growing, Gram-negative, anaerobic, spindle-shaped, 
fusiform organism, and also belongs to the black-pigmented anaerobes group. It 
was reported by Tanner et al. (1979) as a “fusiform” Bacteroides and classified 
as B. forsythus in the mid-eighties (Tanner et al., 1986). There are surprisingly 
few reports about the pathogenicity of B. forsythus in periodontal disease, even 
though it has been named an aetiological agent (Consensus report, American 
Academy of Periodontology, 1996). B. forsythus has been associated with AP 
(Gmiir et al., 1989; Tanner et al., 1998a; Haffajee et al., 1988a; Lai et al., 1987), 
although Lai et al. (1987) showed that very similar levels of B. forsythus were 
found in gingivitis and AP sites. There is great variation in its prevalence, from 
10% (Haffajee et al., 1988a) to 100% (Christersson et al., 1992). The organism 
has been strongly associated with active/progressing lesions (Grossi et al., 1994; 
Dzink et al., 1983, 1988; Tanner et al., 1987a, 1989, 1998a; Dibart et al., 1998) 
and its numbers increase with increasing pocket depth (Socransky et al., 1991; 
Dzink et al., 1985; Christersson et al., 1992; Machtei et al., 1997). Its presence 
has also been linked with bleeding on probing (Tanner et al., 1989; Christersson 
et al., 1992) and bone loss (Tanner et al., 1984).
38
A few studies have shown that clinical improvement after either SRP or surgery 
and/or antibiotics is accompanied by a decrease in frequency of detection and 
levels of B. forsythus (Haffajee et al., 1995, 1997a, 1988c; Socransky & 
Haffajee, 1993). Sites which lost attachment had high levels of the organism 
(Haffajee et al., 1995; Socransky & Haffajee, 1993) and it has been associated 
with further attachment loss after treatment (Tanner et al., 1987a).
There are so few reports about B. forsythus, it is difficult to assign a role for it in 
AP. This presumably reflects the difficulty of culturing the organism. Further 
studies are required that do not rely on its viability to determine its role in AP.
Other Black-pigmented Anaerobes
Other members of this group include B. fragilis, B. gracilis, B. ureolyticus, and 
P. melaninogenica. B. gracilis has been linked to progressing sites (Tanner et 
al., 1987b), but in general this group is not particularly pathogenic. After 
treatment numbers seem to decrease (Pedrazzoli et al., 1991), although slight 
increases in P. melaninogenica (Haffajee et al., 1988c), and B. fragilis and B. 
ureolyticus (Haffajee et al., 1997a) have been reported. As a group these 
bacteria are not good predictors of attachment loss (Macfarlane et al., 1988).
Spirochaetes
Spirochaetes are a group of motile helical rods with tight regular or irregular 
spirals and flagella. They are fastidious and very difficult to culture. Oral 
spirochaetes belong to the genus Treponema, and there are currently four named
39
human species; T. denticola, T. vincentii, T. pectinovarum, and T. socranskii. 
Other strains representing a number of additional species have been isolated but 
not yet fully characterised (Tanner et al., 1994).
Spirochaetes are likely aetiological agents in ANUG (Loesche et al., 1982; 
Listgarten & Socransky, 1964; Riviere et al., 1991). Their role in AP is less 
clear due to their difficulty to culture. The use of microscopy in periodontal 
studies has identified small, medium and large spirochaetes, but cannot identify 
individual species. Thus the role of pathogenic species may have been obscured 
by non-pathogenic species (Haffajee & Socransky, 1994). Healthy sites exhibit 
few, if any, spirochaetes, gingivitis sites low to moderate levels, and deep 
pockets harbour many (Riviere et al., 1995, 1996a). Spirochaete numbers are 
generally increased in AP subjects and are often found with a very high 
prevalence (60-100%) (Loesche et al., 1985; Savitt & Socransky, 1984; Riviere 
et al., 1992, 1995, 1996a; Slots et al., 1991; Moore et al., 1983, 1991, 1987; 
Armitage et al., 1982). Spirochaetes have been linked with increasing pocket 
depth, bleeding on probing and bone loss (Omar et al., 1991; Tanner et al., 1984; 
Savitt & Socransky, 1984).
Pathogen-related oral spirochaetes (PROS) comprise the major proportion of 
spirochaetes (Riviere et al., 1995). These organisms have been found at healthy 
and gingivitis sites (Riviere et al., 1996a). T. denticola also comprises a large 
proportion of spirochaetes (Barron et al., 1991; Riviere et al., 1995). This 
spirochaete is generally found in much higher numbers in AP patients compared
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to health and gingivitis (Simonson et al., 1992; Riviere et al., 1996b). T. 
denticola can be absent from healthy patients (Riviere et al., 1995), and also 
linked to initial periodontitis (Riviere et al., 1997). High levels of spirochaetes 
have been reported in refractory patients (Walker et al., 1993).
Periodontal therapy reduces the prevalence and proportion of spirochaetes. SRP 
has been shown to decrease significantly the level of spirochaetes including T. 
denticola (Loesche et al., 1985, 1992b; Macfarlane et al., 1988; Listgarten & 
Levin, 1981; Simonson et al., 1992; Katsanoulos et al., 1992; Haffajee et al., 
1997a; Slots et al., 1985). Improved clinical condition is linked with reduction 
in T. denticola levels (Simonson et al., 1992; Haffajee et al., 1997b). Surgical 
and antimicrobial therapy has a similar effect on T. denticola and other 
spirochaetes (Mombelli et al., 1995; Walker & Gordon, 1990; Kulkami et al., 
1991; Loesche et al., 1984, 1991; Lundstrum et al., 1984; van Oosten et al., 
1986; Gusberti et al., 1988; Quee et al., 1987). However MacFarlane et al. 
(1988) reported that spirochaetes are poor predictors of future disease activity.
From these studies it is clear that spirochaetes play a major role in the 
pathogenesis of AP. However confusion exists over which species are involved, 
and again further investigation is required using non-culture reliant techniques 
able to distinguish species.
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Fusobacterium nucleatum
F. nucleatum is a Gram-negative, anaerobic, spindle-shaped rod that has three 
subspecies; nucleatum, vincentii and polymorphum. The species is often the 
most common isolate in AP subgingival plaque samples (Tanner et al., 1989; 
Haffajee et al., 1988a), occurring in 80-100% of AP patients (Wikstrom et al., 
1993; Savitt & Socransky, 1984; Slots et al., 1991; Papapanou et al., 1993; 
Mombelli et al., 1995) and approximately 7-10% of isolates (Dzink et al., 1985, 
1988). Commonly it is found in increased numbers in AP subjects compared to 
health and gingivitis (Grossi et al., 1994; Moore et al., 1983; Savitt & Socransky, 
1984; Lippke et al., 1991) and active sites (Dzink et al., 1988; Tanner 1987a; 
Moore et al., 1991). Its presence may correlate with pocket depth (Dzink et al., 
1985), but Albandar et al. (1990) suggested that F. nucleatum did not correlate 
with attachment loss, pocket depth nor bleeding on probing. Tanner et al. (1984) 
linked F. nucleatum with bone loss, but found similar proportions in active and 
inactive sites. The organism has also been correlated with refractory 
periodontitis (Haffajee et al., 1988c; Walker et al., 1993).
Wikstrom et al. (1993) reported an increase in F. nucleatum levels after SRP, 
whereas Haffajee et al. (1997a) reported similar levels. However surgery and/or 
antibiotics are effective in reducing F. nucleatum levels (Mombelli et al., 1995; 
Kulkami et al., 1991; Haffajee et al., 1988b).
Overall, F. nucleatum is a likely candidate for AP and has been suggested to 
play a major role in the framework of the plaque biofilm (Whittaker et al., 1996).
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Campylobacter rectus
C. rectus is a Gram-negative, anaerobic short motile vibrio and was previously 
classified as Wolinella recta. Studies have reported the prevalence of the 
organism to be from 15% to 81% of AP patients and 24% to 94% of sites (Rams 
et al., 1993; Wikstrom et al., 1993; Riviere et al., 1996b; Slots et al., 1991; 
Dahlen et al., 1992; Papapanou et al., 1993; Gunaratnam et al., 1992; Komman, 
1991; Mombelli et al., 1995). It has been found with both higher frequency and 
numbers in AP subjects compared to health and gingivitis (Lai et al., 1992; 
Riviere et al., 1996b; Moore et al., 1983; Haffajee et al., 1991c; Lippke et al., 
1991; Socransky et al., 1991; Dibart et al., 1998; Moore et al., 1987; Tanner et 
al., 1989, 1998a). Grossi et al. (1994) and Dahlen et al. (1992) found no 
differences between healthy and periodontitis subjects. C. rectus has been 
associated with active disease (Rams et al., 1993; Albandar et al., 1990; Dzink et 
al., 1988; Tanner et al., 1987a, b, 1989, 1998a; Haffajee et al., 1991b; Moore et 
al., 1991; Dzink et al., 1985). Its presence has also been correlated with bleeding 
on probing (Tanner et al., 1989; Albandar et al., 1990), deep pockets (Albandar 
et al., 1990; Dzink et al., 1985), and bone loss (Tanner et al., 1984).
In response to effective treatment, whether it be SRP, surgery or antibiotics, the 
levels of C. rectus decrease (Rams et al., 1993; Wikstrom et al., 1993; Tanner et 
al., 1987b; Haffajee et al., 1988b, 1984; Mombelli et al., 1995), but high levels 
remain in active/non-responder sites (Haffajee et al., 1988b). Its levels may also 
be kept low by good oral hygiene (Dahlen et al., 1992). However the presence 
of C. rectus is linked to the recurrence of disease (Lai et al., 1992; Haffajee et
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al., 1991b) but it is a poor predictor of further attachment loss (Rams et al.,
1993).
C. rectus would seem to be an important pathogen in AP.
Capnocytophaga species
Capnocytophaga species are Gram-negative, long fusiform bacteria, and include
C. ochracea, C. sputigena, and C. gingivalis. The genus has been found in 12% 
to 94% of AP patients and 27% to 88% of sites (Mombelli et al., 1995; 
Wikstrom et al., 1993; Ali et al., 1996; Papapanou et al., 1993; Gunaratnam et 
al., 1992; Komman, 1991). However there seems little difference between 
health and disease (Dahlen et al., 1992; Papapanou et al., 1993) or the levels are 
higher in health (Grossi et al., 1994; Haffajee et al., 1991b, c; Dzink et al., 1985). 
Haffajee et al. (1991b) reported that C. ochracea was related to a decreased risk 
of disease progression, even though it has been found with high frequency in 
refractory patients (Komman, 1991).
There are mixed reports regarding the outcome of treatment. Levels after SRP or 
surgery may increase (Mombelli et al., 1995), stay the same (Wikstrom et al., 
1993; Haffajee et al., 1997a), or decrease (Ali et al., 1992) with clinical 
improvement.
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The species seems to be associated with health or gingivitis (Darveau et al., 
1997) rather than AP. The high numbers perhaps indicate a commensal nature to 
the species.
Eikenella corrodens
E. corrodens is a Gram negative, capnophilic, asaccharolytic, regular small rod 
with blunt ends. It has been recognised as a pathogen in other diseases (Haffajee 
& Socransky, 1994). It can be found in as low as 10% and as high as 70% of 
subgingival AP plaque samples (Komman, 1991; Wikstrom et al., 1993; Savitt 
& Socransky, 1984; Riviere et al., 1996b; Papapanou et al., 1993; Wolff et al.,
1993) though it is often present in healthy subjects (Chen et al., 1992). E. 
corrodens has been reported to be more frequently detected in AP patients 
(Savitt & Socransky, 1984; Dzink et al., 1985; Chen et al., 1989; Riviere et al., 
1996b; Chen et al., 1992) and active sites (Dzink et al., 1988; Tanner et al., 
1987a, b). One report finds a negative correlation between the organism and 
clinical measurements, such as pocket depth and bleeding on probing (Albandar 
et al., 1990).
After successful SRP, Haffajee et al. (1997a) found little change in the 
prevalence and numbers of E. corrodens, but Wikstrom et al. (1993) reported a 
significant increase in E. corrodens which correlated with the pocket depth after 
treatment. Following surgery and/or antibiotics levels of E. corrodens are much 
reduced (Tanner et al., 1987b; Haffajee et al., 1984).
E. corrodens is not one of the predominant periodontopathogenic organisms but 
may play a limited role in periodontitis (Chen et al., 1992).
Eubacterium  species
Eubacterium species are Gram-positive, strictly anaerobic, small, pleomorphic 
rods. They can be difficult to culture. The most common members of the 
species are E. nodatum, E. brachy, and E. timidum. These species have been 
associated with AP (Moore et al., 1983; Uematsu et al., 1992) and active lesions 
(Moore et al., 1991). More recently Grossi et al. (1994) found a slight decrease 
in Eubacterium species in AP patients. Haffajee et al. (1997a) reported only a 
slight decrease in numbers after successful SRP. Eubacterium species appear to 
be promising candidates as periodontal pathogens, but efforts to investigate the 
species have been hampered by its difficulty to grow in culture. Further 
investigation is required with modem diagnostic microbiological techniques.
Selenomonas species
Selenomonas species are Gram-negative, curved, saccharolytic rods, and in a few 
reports have been linked with AP (Tanner et al., 1989; Lai et al., 1989), but more 
so early disease progression (Tanner et al., 1998a; Moore et al., 1991). Tanner et 
al. (1998a) reported an increase in S. noxia in gingivitis compared to health and 
in AP over gingivitis. After successful SRP, Haffajee et al. (1997a) reported 
similar levels. Little seems to be known about this species and further study is 
required to determine its role in AP.
Peptostreptococcus micros
P. micros is a Gram-positive, anaerobic, small asaccharolytic coccus. It has been 
found more frequently and in higher numbers in AP (Moore et al., 1983), but 
mainly at sites of periodontal destruction (Tanner et al., 1987a; Moore et al., 
1991; Haffajee et al., 1991c; Dzink et al., 1988; Rams et al., 1992). High levels 
are found in active sites after surgical and antibiotic therapy (Haffajee et al., 
1988b) and P. micros is linked to disease progression (Haffajee et al., 1991b). 
Thus P. micros would seem to be a promising candidate for a periodontal 
pathogen in AP.
Streptococcus species
Streptococcus species are commonly found in the oral cavity, and include S. 
mutans group, S. salivarius group, S. milleri group, and S. oralis group. 
Although the species may be aetiological agents of disease elsewhere in the 
body, these streptococci seem to be more associated with health than AP (Dzink 
et al., 1988; Tanner et al., 1989; Haffajee et al., 1991c). One member of the S. 
milleri group, S. intermedius, has been linked with active sites in AP and 
refractory patients (Tanner et al., 1987a; Dzink et al., 1988; Magnusson, 1991; 
Walker et al., 1993; Haffajee et al., 1988a, c). Although the data is limited, it 
appears that only S. intermedius may be associated with periodontal disease.
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Veillonella species & Actinomyces species
These two species are associated with health (Tanner et al., 1998a), gingivitis 
sites (Tanner et al., 1989) or inactive sites (Dzink et al., 1985, 1988). As the 
pocket depth increases levels of V parvula decrease (Socransky et al., 1991) 
and increased levels of V. parvula are associated with decreased risk of disease 
progression (Haffajee et al., 1991c). After periodontal therapy, SRP, surgery or 
antimicrobials, levels of V. parvula increase (Haffajee et al., 1988b, 1997a), 
presumably in relation to the decreased pocket depth.
Enteric rods
These are non-oral Gram-negative facultatively anaerobic rods commonly found 
in the intestinal system. Ali et al. (1996) showed that roughly 60% of AP 
patients were positive for these organisms, and Slots et al. (1990b) that 
Enterobacteriaceae, Pseudomonadaceae, and Acinetobacter species were 
cultured from 14% of patients. These species frequently constituted a major part 
of the culturable subgingival flora. Their role in periodontal disease is yet to be 
determined, but they are pathogenic at other body sites (Slots et al., 1990b).
Helicobacter pylori
H  pylori is a Gram-negative micro-aerophilic bacterium which is recognised as 
being an aetiological agent of chronic gastritis, peptic ulcer disease and gastric 
cancer (Lee et al., 1993; Forman et al., 1991). A recent study by Riggio & 
Lennon (1999) demonstrated the presence of H. pylori in 33% of subgingival
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plaque samples from deep AP pockets. Its role, if any, in periodontal disease is 
yet to be determined.
Herpes group viruses
Recent reports from Slots’ group have shown that Human Cytomegalovirus 
(HCMV), Epstein-Barr virus -1 & -2 (EBV), Herpes Simplex virus (HSV), 
Human Papilloma virus (HPV) and Human Immunodeficiency virus (HIV) are 
detectable in periodontal subgingival plaques (Parra & Slots, 1996; Contreras & 
Slots, 1996; Contreras et al., 1999). HCMV has been detected in 60% of 
periodontal patients and 30% of gingivitis patients, and is the most common. 
EBV has been found in 30% of periodontal patients, HSV 20%, HPV 17%, and 
HIV 7%. These were not found in gingivitis patients (Parra et al., 1996). There 
is an increase in positive sites for all these viruses with increasing pocket depth 
(Contreras & Slots, 1996). Contreras & Slots (1996) suggested that the viruses 
may impair host defences, promote attachment and colonisation of periodontal 
pathogens, cause cytopathic effects, alter the inflammatory mediator and 
cytokine response, and cause tissue damage. In a later paper this group showed 
associations between EBV-1 and HCMV with P. gingivalis, P. intermedia, B. 
forsythus, T. denticola, and P. nigrescens in subgingival plaque samples 
(Contreras et al., 1999). HSV and EBV-2 showed no significant associations. 
The role of these viruses in periodontal disease is promising, but much remains 
to be investigated.
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1.4.3 Microbiology of Generalised Early-onset Periodontitis
GEOP has previously been called rapidly progressive periodontitis (RPP), 
generalised juvenile periodontitis (GJP), and post juvenile periodontitis. A 
review of the microbiology literature is complicated because of the many 
different criteria that have been used to define this disease entity in the past and 
very often patients with this form of periodontitis have been included as part of 
an adult periodontitis group. Subjects diagnosed as RPP or GJP have been 
included in this section.
Porphyromonas gingivalis
P. gingivalis has also been implicated in GEOP in a number of studies 
(Vandesteen, 1984; Kamagata et al., 1989; Abu Fanas et al., 1991; Nishimura et 
al., 1990; Masunaga et al., 1990; Kamma et al., 1994, 1995; Conrads & Brauner, 
1993; Listgarten et al., 1995; Sasaki et al., 1989; Lopez et al., 1995; 1996; 
Moore et al., 1982; Loesche et al., 1985), and is often the predominant organism 
(Vandesteen, 1984; Kamagata et al., 1989; Abu Fanas et al., 1991; Nishimura et 
al., 1990; Kamma et al., 1994; Lopez et al., 1995). Wilson et al. (1985) found 
that 8 to 16 percent of the cultivable microflora was P. gingivalis and suggested 
that P. gingivalis was involved in the aetiology of GEOP. Similarly Albandar 
and co-workers (1997) found that P. gingivalis was significantly associated with 
generalised disease in 13 to 19 year olds and was found in much higher levels in 
GEOP patients than healthy controls. In their study of Chilean GEOP subjects, 
Lopez et al. (1995) found P. gingivalis in 80% of patients, 80% of affected sites
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and in only 10% of unaffected sites. Kamma and colleagues (1994) investigated 
the presence of P. gingivalis in 73 GEOP lesions in ten patients and reported that 
in pockets over six millimetres deep P. gingivalis predominated. Similarly 
Loesche et al. (1985) reported significantly higher proportions of P. gingivalis 
(as well as P. intermedia and B. melaninogenicus) in GEOP subjects. 
Conversely Ou Yang (1994) found a negative correlation with numbers of P. 
gingivalis subgingivally and pocket depth. Williams et al. (1985) did not detect 
P. gingivalis in their study. P. gingivalis is also frequently isolated with P. 
intermedia (Vandesteen, 1984; Abu Fanas et al., 1991; Masunaga et al., 1990; 
Conrads & Brauner, 1993), A. actinomycetemcomitans (Kamagata et al., 1989; 
Masunaga et al., 1990; Listgarten et al., 1995), F. nucleatum (Nishimura et al.,
1990) or a combination of these including B. forsythus (Kamma et al., 1994, 
1995; Sasaki et al., 1989).
Abu Fanas et al. (1991) used antibiotics in the treatment of GEOP patients and 
had significant reductions in bleeding on probing and pocket depth with a 
significant reduction in mean percentage of black-pigmented Bacteroides. 
Masunaga et al. (1990) linked a reduction in pocket depth to the reduction of 
numbers of B. gingivalis and B. intermedia.
Actinobacillus actinomycetemcomitans
A number of researchers have found A. actinomycetemcomitans in GEOP 
patients (Kamagata et al., 1989; van Winkelhoff et al., 1989; Masunaga et al., 
1990; Muller et al., 1993, Nakagawa et al., 1996; Listgarten et al., 1995; Kamma
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et al., 1995; Sasaki et al., 1989; Sbordone et al., 1990b; Matsue et al., 1990; 
Lopez et al., 1995). The frequency and numbers of the organism are increased, 
with Lopez et al. (1995) finding A. actinomycetemcomitans in 60% of GEOP 
patients and 50% of affected sites. However, Vandesteen (1984), Williams et al. 
(1985), Moore et al. (1982) and Lopez et al. (1996) could not detect A. 
actinomycetemcomitans in GEOP patients, and, although A. 
actinomycetemcomitans is present in some patients, other organisms such as P. 
gingivalis, P. intermedia, F. nucleatum and B. forsythus are found with greater 
frequency and numbers (Kamagata et al., 1989; Nishimura et al., 1990; 
Masunaga et al., 1990; Sasaki et al., 1989). Listgarten et al. (1995) reported that 
serotype b was the most common, followed by serotype a and then serotype c.
van Winkelhoff et al. (1989) demonstrated that the elimination of A. 
actinomycetemcomitans by hygiene phase therapy and antibiotics from ten 
GEOP patients resulted in clinical improvement and that the one patient who was 
still A. actinomycetemcomitans positive after treatment did not improve 
clinically. Conversely, Masunaga et al. (1990) reported that the levels of A. 
actinomycetemcomitans were not changed by scaling and root planing, and the 
reduction in pocket depth was due to the elimination of Bacteroides intermedius 
(P. intermedia) and Bacteroides gingivalis (P. gingivalis).
Prevotella intermedia
P. intermedia has also been associated with GEOP. It has been found at a higher 
prevalence and in higher numbers (Vandesteen, 1984; Kamagata et al., 1989;
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Abu Fanas et al., 1991; Masunaga et al., 1990; Kamma et al., 1994; Conrads & 
Brauner, 1993; Moore et al., 1982; Lopez et al., 1995, 1996; Loesche et al., 
1985), and it can be the predominant organism (Williams et al., 1985; Sasaki et 
al., 1989). In two studies by Lopez et al. (1995, 1996) they reported that P. 
intermedia was found in all GEOP patients and sites in one group and in 40% of 
similar patients and sites in another group. Moore et al. (1982) found P. 
intermedia to make up 2.9% of the flora in young adult humans with severe 
periodontal disease, which was an increase compared to healthy subjects. P. 
intermedia was shown by Albandar et al. (1997) to be of higher prevalence and 
proportions in progressing sites in 13 to 19 year olds. Masunaga et al. (1990) 
also demonstrated that the reduction in B. intermedius levels (as well as B. 
gingivalis) was required for a reduction in pocket depth.
The majority of studies on the microbiology of GEOP have been directed 
towards A. actinomycetemcomitans, P. gingivalis, and P. intermedia detection 
and there are far fewer investigations which have addressed the role/presence of 
other periodontal pathogens.
Other organisms in Generalised Early Onset Periodontitis
Kamma et al. (1994, 1995), Sasaki et al. (1989), and Listgarten et al. (1995) 
detected B. forsythus in GEOP patient’s subgingival plaque samples and 
reported a maximal detection frequency of 53.4 percent (Kamma et al., 1994).
F. nucleatum has also been detected in GEOP patients and sometimes at high 
levels (Abu Fanas et al., 1991; Nishimura et al., 1990; Kamma et al., 1994, 1995;
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Lopez et al., 1995; Moore et al., 1982). Lopez et al. (1995) found a greater 
prevalence of F. nucleatum in affected patients and sites compared to health. In 
their comprehensive study, Moore et al. (1982) reported that 83% of sites were 
positive for F. nucleatum, but this prevalence was very similar to healthy and 
gingivitis patients. Abu Fanas et al. (1991) reported a reduction of the mean 
percentage of F. nucleatum with a reduction in bleeding on probing and pocket 
depth.
Other organisms have been detected or isolated from subgingival plaque samples 
of GEOP patients, and include Campylobacter species (Lopez et al., 1995) 
including Campylobacter rectus (Moore et al., 1982), Eikenella corrodens 
(Masunaga et al., 1990; Lopez et al., 1995), Streptococci (Kamma et al., 1994), 
other Bacteroides species (Abu Fanas et al., 1991; Williams et al., 1985; Loesche 
et al., 1985), Capnocytophaga species (Kamma et al., 1995; Lopez et al., 1995), 
Eubacterium species (Moore et al., 1982) and spirochaetes (Kamma et al., 1995; 
Lopez et al., 1995; Moore et al., 1982). Moore et al. (1982) in their analysis of 
the GEOP flora reported that there was a significant increase in the levels of 
Eubacterium species, treponemal counts, Treponema denticola, large treponemes 
and Mycoplasma species in progressing sites. A later study (Loe & Brown,
1991) reassessed a group of LJP patients 6-7 years after initial diagnosis of 
LJP/EOP. In these subjects they reported that progressing sites had significantly 
increased levels of C. concisus, Eubacterium species, P. gingivalis and 
Campylobacter. In their wide ranging studies of Chilean GEOP subjects, Lopez 
et al. (1995) found spirochetes in 27% of affected sites and 10% of non-affected
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sites. They also linked Capnocytophaga species with GEOP, which was the 
most prevalent species in their study. Also in this study, they could find no 
significant differences in the levels of E. corrodens and Campylobacter species 
between healthy and diseased sites. Williams et al. (1985) reported that 
Wolinella species was not associated with disease.
One study (Kamma et al., 1995) examined the relationship between pocket depth 
and prevalence of periodontal pathogens. In severe lesions they found that P. 
gingivalis, B. forsythus, F. nucleatum, A. actinomycetemcomitans and 
Campylobacter species predominated. In medium lesions B. forsythus, P. 
gingivalis, P. intermedia, F. nucleatum and Capnocytophaga species were 
detected, and in minimal lesions Streptococcus species, Actinomyces species, C. 
ochracea, Haemophilus segnis and Veillonella parvula were present.
Often more than one organism has increased prevalence and numbers in GEOP 
pockets (Abu Fanas et al., 1991; Masunaga et al., 1990; Kamma et al., 1995; 
Listgarten et al., 1995; Lopez et al., 1995, 1996; Moore et al., 1982).
1.4.4 Overview
Microbial aetiology of periodontal disease is complex. Clearly many species are 
involved, perhaps in a synergistic manner. Tables 1.5 and 1.6 rank the 
involvement of the agents on the evidence discussed in AP and GEOP. There is 
strong evidence to implicate P. gingivalis and A. actinomycetemcomitans in AP.
B. forsythus, P. intermedia, C. rectus, E. nodatum, T. denticola and other
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Treponemes are also implicated, but to a lesser degree. In GEOP patients there 
is evidence to suggest that periodontal infection is also a mixed microbial 
infection, with strong evidence for involvement of A. actinomycetemcomitans, P. 
gingivalis and P. intermedia. Other bacteria are probably involved but generally 
there are too few studies to reach conclusions, and thus further investigation is 
needed. Obviously these organisms do not occur alone and some studies have 
suggested groupings (Socransky et al., 1998; Soder et al., 1993). Equally not all 
are always present (Wolff et al., 1993; Socransky et al., 1991). Tanner et al.
(1994) suggested that only 60% of the flora have been cultured, and there are 
many species of spirochaetes whose role is unclear. There is a need for studies 
that do not rely on the viability or ability of an organism to grow in culture.
This overall research project includes as one of its aims an investigation of the 
presence of P. gingivalis, P. intermedia, B. forsythus, A. actinomycetemcomitans 
and T. denticola in both AP and GEOP patients using polymerase chain reaction 
(PCR). In addition the effect of scaling and root planing on the prevalence of 
these five organisms will be investigated.
1.5 Immunological aspects of periodontal disease
Infections associated with periodontal disease stimulate broad-ranging immune 
responses, and published studies on antibodies to the major periodontal 
organisms are considered in this section. The basic concepts of the immune 
response are well established and the summary below is intended merely to 
establish a basic background on which to introduce the study objectives for this 
humoral response investigation before and after treatment.
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1.5.1 Basic Concepts
The immune system is a collection of tissues, cells and molecules whose 
function is to protect the host against infectious agents (Sharon, 1998). Immune 
responses may be subdivided into two broad divisions, termed innate and 
adaptive immunity. These two types of immunity differ in certain key properties 
including specificity and memory.
Innate immunity represents an important first line of defence against infectious 
agents. This type of immunity is present from birth, is not enhanced by prior 
exposure, lacks memory and does not display antigenic specificity. Innate 
immunity entails a number of elements, both cellular and non-cellular. Physical 
barriers such as the skin and mucous membranes represent a component that 
infectious agents must breach to gain access to the host. The washing action of 
fluids such as tears, saliva, urine and possibly gingival crevicular fluid may keep 
surfaces clear of invading organisms, and may also contain bacteriocidal agents. 
The normal flora of the body can also act as an effective buffer against infection, 
by inhibiting the growth of pathogenic organisms by competition for nutrients or 
production of inhibitors. Phagocytic cells in the blood stream and tissues can 
destroy invading agents. These include polymorphonuclear leukocytes (PMN’s), 
monocyte/macrophages, and natural killer cells. Finally there are the soluble 
components. These are a range of molecules that can damage cell walls, aid 
phagocytosis and cell recruitment or prevent cellular infection, and include 
lysozyme, cytokines, acute phase proteins, complement components and 
interferons.
57
The persistence of an infection in spite of an innate immune response typically 
leads to induction of an adaptive immune response. Adaptive immune responses 
are characterised by 1) specificity for the offending antigen(s), 2) memory, 
which allows a more rapid and heightened response upon re-infection by the 
same or closely related antigen, 3) diversity, the ability to respond to a wide 
range of different antigens, and 4) self versus non-self recognition. The adaptive 
immune response can be subdivided into cell-mediated and humoral immunity. 
Humoral immunity is mediated by antibodies, whereas cell-mediated immunity 
involves the direct action of immune cells.
1.5.1.1 Role of B-lymphocytes
The cells mainly involved in adaptive immunity are antigen-presenting cells and 
lymphocytes. The former include macrophages, dentritic cells in the follicles of 
lymph nodes, Langerhan’s cells of the skin and mucous membranes, and B- 
lymphocytes. These cells present antigens to B-lymphocytes and T-helper 
lymphocytes. The activated T-helper cells then produce cytokines that’stimulate 
B-cells to differentiate into antibody producing cells. B-cells are produced in 
the bone marrow and are programmed to produce only one antibody. They 
display this on their surface and when bound by the specific antigen, a triggering 
signal causes the B-cell to develop into an antibody-producing cell. The 
activated B-cell then proliferates to produce a large number of antibodies by 
clonal expansion. Clonal expansion not only produces antibody-producing 
plasma cells but also a proportion of quiescent cells expressing the antibody on
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their surface. These memory cells provide a relatively large pool ready to 
produce a much more rapid and intense antibody response on further antigen 
challenge.
1.5.1.2 Role of T-lymphocytes
T-cells act by another mechanism to destroy invading viruses, mycobacteria and 
protozoa that attempt to evade host defences by proliferating inside host cells. 
T-cells differentiate within the thymus and will only recognise foreign antigen 
when it is on the surface of a host cell in association with cell surface markers of 
the major histocompatibility complex (MHC).
Killing of virally infected cells can be achieved by two mechanisms, one 
involving NK cells and the other cytotoxic T-cells. Apart from a direct effect on 
infected cells, NK cells can also kill by the process of antibody-dependent cell- 
mediated cytotoxicity (ADCC). NK cells have a receptor for the Fc portion of 
antibody molecules and can bind to antibodies directed against virally coded 
surface antigens.
A sub-population of cytotoxic T-cells produces a wide range of surface receptors 
similar to the surface antigen receptors on B-cells. These T-cells are 
programmed to recognise only one antigen when it is found in association with a 
class I MHC receptor. The cytotoxic T-cell can thus bind to the infected cell and 
destroy it.
T-helper cells will bind to an antigen for which they are programmed when it is 
found in association with a class II MHC receptor on the surface of an infected 
macrophage. They then produce lymphokines re-triggering the microbiocidal 
mechanisms of the macrophage.
Cytotoxic T-cells are also capable of acting in this way. In a similar fashion to 
that of B-cells, T-cells are selected and activated by antigen and expanded by 
clonal proliferation to produce a large clone of activated T-cells and also a pool 
of quiescent memory cells.
I.5.1.3 Immunoglobulins
Antibodies are glycoproteins that are present in serum and fluids. They bind 
specifically to foreign antigens and are induced when the lymphoid system 
interacts with immunogenic materials on or produced by microorganisms.
The immunoglobulin molecule is Y-shaped and consists of four peptide chains, 
two identical heavy and two identical light chains. The light chains with parts of 
the heavy chain form the Fab region that has antigen-binding properties and 
contains considerable variability. The remainder of the heavy chains form the Fc 
region which is relatively constant and can bind with cell receptors or 
complement. There are five different types of heavy chain and these define the 
immunoglobulin classes that exist in humans; IgA, IgD, IgE, IgG and IgM.
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IgG is the most important serum immunoglobulin and after prolonged exposure 
to most antigens, antibody activity is mainly associated with this isotype (75% of 
serum immunoglobulin). It is the predominant antibody in a secondary immune 
response. There are four subclasses, IgGl-4, which respond to different 
antigens. IgG2 is found frequently in response to polysaccharide antigens, 
whereas IgGl and IgG3 are primarily directed to proteins and viral antigens, and 
IgG4 associated with allergic-type reaction. IgG possesses the unique property 
among immunoglobulin classes of being able to cross the placenta.
IgA is adapted to defend the exposed external and internal surfaces of the body. 
It is found predominantly in sero-mucous secretions e.g. lung secretions, saliva 
and secretions of the gastro-intestinal and urinary tract. In serum it is 
monomeric, but, in these fluids, dimeric with a joining (J) chain and a secretory 
component. IgA antibodies essentially coat microorganisms and thereby inhibit 
their adherence to mucosal cells. There are two subclasses, IgAl and IgA2.
IgM is the first immunoglobulin to appear in the immune response. It consists of 
five immunoglobulin molecules linked together by J chains and as such has a 
high capacity to agglutinate/aggregate bacteria. IgM activates the classical 
complement cascade efficiently.
The exact function of IgD has not yet been determined but may be important in 
B cell differentiation. IgE is involved in atopic or allergic reactions and also 
appears in response to parasitic infections.
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1.5.2 Avidity
1.5.2.1 Basic concepts
The overall strength of antigen-antibody bonds is known as antibody avidity or 
functional affinity. The B-cell selection process brings about maturation of IgG 
antibody affinity which is initially low and increases during subsequent weeks 
and months (1 to 7 months). A few days after antigenic contact, the antibodies 
produced still originate from unmutated plasma cells. At the end of the first 
month, there are mutations in the antibody variable region and an increase in IgG 
antibody affinity. Avidity maturation seems to be proportional to antigen dose. 
Low doses of antigen give rise to a more rapid maturation and higher doses to a 
slower maturation. Therefore, low avidity antibodies are produced during the 
first stage of infection when a high level of antigens is present (Gutierrez & 
Maroto, 1996).
There are four main intermolecular forces involved in antibody-antigen 
interactions; 1) electrostatic forces caused by the attraction between ionic groups 
with opposite charge, 2) hydrogen bonding, 3) hydrophobic bonding and 4) van 
der Waals forces. In general the complementary electron cloud shapes on the 
combining sites of the antibody and the surface determinant antigen enable the 
two molecules to fit together so that the intermolecular distance becomes very 
small and the non-specific protein interactions (as above) are considerably 
increased.
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1.5.2.2 Methods of measuring avidity
The measurement of the avidity of specific IgG antibodies for serodiagnosis can 
be carried out using methods such as agglutination, radio-immunoassay, 
complement fixation, ELISA, IFA, electroblotting and electrophoresis. It is 
necessary to denature the reaction and denaturing substances can either be 
included in the dilution of the serum or applied after the formation of the 
antigen-antibody complex. Denaturing substances include diethylamine, 
potassium thiocyanate, guanidine and urea. In this study thiocyanate 
disassociation was used to determine avidity, as previous studies have shown its 
efficacy (Mooney et al., 1994, 1995).
1.5.3 Humoral immune response and periodontal disease
1.5.3.1 Introduction and important considerations
Periodontal infection can stimulate an immune response, similar to infections at 
other sites in the body. This response is also directed towards eliminating and/or 
neutralising the infectious agent. Humoral immune responses in periodontal 
disease can provide strong evidence of previous or current infection by a 
periodontal pathogen. However, before any discussion of the specific humoral 
immune response in periodontal disease, a number of issues should be addressed.
Firstly the organisms to which the response is being directed must be considered. 
Microbial aetiology and pathogenesis must be taken into account as bacteria may 
provoke an immune response but not fulfil other criteria for pathogenesis. For a 
detailed study of the microbiology of AP see section 1.4.2. In addition
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antibodies may be detected to non-oral bacteria and non-bacterial antigens 
(Berglund, 1971, Mallison et al., 1989). The use of a large battery of micro­
organisms, including many of doubtful relevance, may lead to erroneous 
conclusions or an apparent lack of focus. In this study P. gingivalis, P. 
intermedia, B. forsythus, A. actinomycetemcomitans and T. denticola were 
chosen for particular attention because of their strong association with adult 
periodontal disease (Consensus report, American Academy of Periodontology, 
1996; Haffajee & Socransky, 1994; Riviere et al., 1995, 1996a, Tanner et al., 
1998a).
Secondly, the choice between whole bacterial cells and particular antigens is 
important (Wilton et al., 1991). In this study it was decided to use whole cells 
because antibody avidity was to be investigated. The use of single antigen may 
reflect only the response to that particular antigen and not the whole cell. By 
using whole cells the global range of interactions against each organism can be 
determined and, therefore, the overall response may yield information that would 
be lost by concentrating on a particular antigen, which may or may not be an 
important antigen.
Thirdly, and related to the last point, there is the matter of antibody function. 
Demonstrations of an association between host antibody response and 
periodontal disease may only be academic unless it can be related to the 
biological function of the antibody. These functions, which include the ability to
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opsonise bacteria and the ability to bind strongly to fimbriae, may relate to 
antibody avidity.
Fourthly, we must consider whether local antibody levels in the GCF or systemic 
levels or both are of importance; and whether local levels are merely a reflection 
of serum levels or whether significant antibody production by gingival plasma 
cells is taking place. This is important in the consideration of subject and site 
susceptibility to disease onset and progression.
Finally, the assay of these antibodies before and after treatment may provide 
useful information on the relationship between the titre and avidity and disease 
progression at both subject and site levels, and their changes following therapy.
1.5.3.2 Response to Gram-positive organisms
Most studies concerned with the humoral immune response to oral 
microorganisms have tended to concentrate on Gram-negative organisms, but 
there have been some that have focused on Gram-positive organisms.
An early study by Taubman et al. (1982) reported similar levels of IgG and IgM 
antibody directed towards A. naeslundii, A. viscosus, E. brachy, S. mutans and 
S. sanguis in LEOP, GEOP, AP and healthy subjects. Haffajee et al. (1988c) 
concluded that relatively abundant constituents of Gram-positive flora in 
subgingival plaque, e.g. Actinomyces species, S. mutans and S. sanguis, do not 
provoke a significant humoral immune response even in patients whose flora
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contain a large proportion of these organisms. This same group also showed that 
these bacteria do not contain antigens that cross-react with Gram-negative 
constituents of the plaque (Taubman et al., 1982; Ebersole 1986).
Studies of these organisms by other groups have also failed to demonstrate 
increased titres in periodontal disease (Doty et al., 1982; Ranney et al., 1981; 
Gilmour & Nisengard, 1974). These have generally shown a wide variation and 
a lack of discrimination between diseased and healthy groups.
It seems that differences in the humoral immune response to Gram-positive 
bacteria do not appear to occur between periodontitis patients and healthy 
controls. Both Tew et al. (1985a) and Nisengard & Beutner (1970) reported 
increased titres to Gram-positive organisms but the use of different methodology 
may account for these opposing studies. It seems reasonable to suggest that 
there are no abnormal changes in the humoral immune response to the Gram- 
positive flora in periodontal disease.
1.5.3.3 Response to Gram-negative organisms
Similar to the microbiological studies, studies of the humoral immune response 
to Gram-negative organisms have tended to concentrate on P. gingivalis and A. 
actinomycetemcomitans. To a lesser extent, antibody titres to other organisms 
such as P. intermedia, spirochaetes, and Capnocytophaga species have been 
investigated, perhaps because of a lack of response or difficulty culturing some 
species.
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P. gingivalis
Mouton et al. (1981) investigated the serum IgG, IgM and IgA antibody response 
to P. gingivalis in various patients groups, including healthy subjects, and age 
groups. This paper was important in establishing a number of points:
1) Based upon the humoral immune response, P. gingivalis was probably 
aetiologic in periodontal disease.
2) This response was probably protective.
3) Diseased and healthy individuals could be distinguished in terms of their 
antibody response to this organism.
4) There were indications of differences in the response in different periodontal 
disease states.
Also this report established that detectable levels of antibody to P. gingivalis 
were found in a significant proportion of healthy adults and that there was a 
correlation between antibody levels and age. IgG and IgM antibodies were 
detectable in children as young as six months, and children aged 6-12 years 
demonstrated significantly higher antibody levels than younger children.
These findings have been confirmed and extended by this and other research 
groups. Periodontitis patients, especially AP and GEOP, demonstrate higher 
antibody titres to P. gingivalis than healthy patients (Altman et al., 1982; 
Ebersole et al., 1982; Taubman et al., 1982; Suzuki et al., 1984; Naito et al., 
1984; Farida et al., 1986; Gunsolley et al., 1990; Lopatin et al., 1991; 
Zafiropoulos et al., 1992; Kinane et al., 1993; Mooney & Kinane 1994).
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Ebersole et al. (1982) reported that 58% of AP patients and 50% of RPP patients 
had increased titres compared to health. Eighty five percent of control subjects 
showed no elevations in antibody to any of the organisms tested and, 
interestingly, 20% of AP patients also.
This group in a later study (1986) confirmed these findings and suggested that 
increased antibody titres may reflect colonisation by the organism or 
pathogenicity. Ebersole et al. (1984b) had previously shown a significant 
relationship between elevated systemic IgG and the ability to culture the 
organism from subgingival plaque.
Generally it would appear that there is a positive relationship between serum 
antibody and P. gingivalis. There are, however, a significant number of studies 
reporting no differences between patients and controls or even lower antibody 
levels in patients (Baranowska et al., 1989; Tew et al., 1985a; Farida et al., 1986; 
Doty et al., 1982).
A. actinomyceiemcomilans
An early study of antibody response to A. actinomycetemcomitans linked this 
response specifically to LJP by demonstrating the presence of these antibodies in 
these patients but not in normal subjects (Genco et al., 1980). Ebersole et al. 
(1980) also showed an association between increased levels and frequency of 
antibody to A. actinomycetemcomitans and LJP. These authors elaborated on 
this in a later study (Listgarten et al., 1981) in which they showed a significantly
68
increased level of IgG antibody to A. actinomycetemcomitans serotype b in 90% 
of LJP patients, but only 40% of RPP and 25% of AP patients. These findings of 
high A. actinomycetemcomitans antibody titres in LJP but not RPP and AP 
patients have been confirmed by more recent reports (Genco et al., 1985; 
Vincent et al., 1985; Farida et al., 1986; Schenck, 1989; Ebersole et al., 1987a, 
1991; Zafiropoulos et al., 1992). Tew et al. (1985a) reported no obvious 
differences between disease and health in IgG titres to A. 
actinomycetemcomitans and a later report by this group found decreased IgG 
titres with increased disease severity (Gunsolley et al., 1987). Ebersole et al.
(1990) found a correlation between antibody titres and periodontal destruction. 
In a later study this group (1992) found a positive correlation between titre to A. 
actinomycetemcomitans and the number of teeth infected, but a negative 
correlation between IgG levels and the proportion of A. actinomycetemcomitans 
in subgingival plaque samples.
The A. actinomycetemcomitans titre in AP patients appears similar or slightly 
higher than that in healthy patients (Ebersole et al., 1982; Genco et al., 1985; 
Vincent et al., 1985; Farida et al., 1986). Overall A. actinomycetemcomitans is a 
likely aetiological agent in LEOP, less so in GEOP and not in AP.
P. intermedia
Two studies by Ebersole et al. (1986) and Tew et al. (1985a) examined antibody 
responses to various members of the Bacteroides genus. Although elevated 
responses to other Bacteroides species were detected in some patients, especially
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P. intermedia, P. gingivalis was the most consistent in eliciting an antibody 
response. Other studies have reported similar antibody responses between AP, 
GEOP, LEOP and healthy subjects (Doty et al., 1982; Taubman et al., 1982; 
Naito et al., 1984; Wheeler et al., 1994; Gmiir et al., 1985). Zafiropoulos et al.
(1992) correlated P. intermedia titres with P. gingivalis titres and also reported 
P. gingivalis titres greater than A. actinomycetemcomitans, which were in turn 
greater than P. intermedia titres in AP subjects. P. intermedia seems to elicit 
little response in disease, which may reflect its opportunistic and commensal 
nature.
Other Gram-negative organisms
Antibody responses to other Gram-negative organisms have generally failed to 
demonstrate any consistent and convincing association between these responses 
and the occurrence and extent of periodontal disease. Vincent et al. (1985), 
Naito et al. (1984), and Ebersole et al. (1987a, 1988) could not demonstrate any 
association between antibody levels to Capnocytophaga species and particular 
disease classifications. However Tolo & Schenck (1985) reported increased 
IgG, IgM and IgA titres to C. ochracea and also E. saburreum. Increased titres 
to F. nucleatum have been found by a number of authors (Vincent et al., 1985; 
Naito et al., 1984; Tolo & Schenck, 1985). Antibodies to E. corrodens were 
found to be slightly higher in AP patients than in healthy subjects by Naito et al. 
(1984). The results would generally indicate that other Gram-negative organisms 
play little part in the aetiology of periodontal disease, but in a small group of 
patients they may have a role.
70
Response to spirochaetes
There have been some studies of antibodies directed towards spirochaetes. Jacob 
et al. (1982) showed increased titres to T. denticola in AP patients compared to 
health. However, most studies have not shown significant differences (Tew et 
al., 1985a; Aukhil et al., 1988; Lai et al., 1986; Mangan et al., 1982). This may 
reflect difficulty in culturing the organisms, a lack of antigenicity by 
spirochaetes, immunosuppression by spirochaete products (Ebersole & 
Taubman, 1994), or that spirochaete colonisation is limited to subgingival 
plaque. Spirochaetes have been shown to be antigenic in other parts of the body 
and in animals, and are known to invade tissues in ANUG.
1.5.3.4 Avidity and periodontal disease
There have been very few reports dealing with antibody avidity in relation to 
periodontal disease. Ebersole et al. (1990) studied the increase in avidity in the 
non-human primate, Macaca fascicularis, following immunisation with tetanus 
toxoid, which they used as a prototype bacterial exotoxin. They found that IgG 
avidity increased from 0.9M to 1.72M following primary immunisation, and to 
2.56M after secondary immunisation. Lopatin et al. (1991) demonstrated that 
avidity of antibody rose to a similarly high level in rabbits post-immunisation 
with P. gingivalis, but that human antibodies to this organism appear to be of 
generally low avidity. In this study IgG antibodies to P. gingivalis were of 
significantly higher avidity in periodontitis patients than in controls. Lopatin & 
Blackburn (1992) and also Mooney et al. (1993) reported increased titres to P.
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gingivalis in periodontitis patients compared to health, but that the avidity of 
these antibodies was not significantly higher. In the study by Mooney et al.
(1993) A. actinomycetemcomitans antibody avidity was lower than that for P. 
gingivalis, and that IgG avidity correlated with titre, but not IgM or IgA. 
Lopatin et al. (1991) had previously reported no significant relationship between 
titre and avidity. A later study by Mooney et al. (1994) showed that IgM and 
IgG avidity was lower in RPP patients when compared to AP. Interestingly AP 
antibody avidity was significantly higher for P. gingivalis antibodies than control 
subjects but A. actinomycetemcomitans antibody avidity was similar. Chen et al.
(1991) demonstrated that IgG avidities to P. gingivalis were lower in RPP 
patients than in control subjects. Another recent study of titre and avidity of IgG 
antibodies to P. gingivalis in RPP patients by Whitney et al. (1992) also showed 
lower avidities in RPP patients than in controls. Sjostrdm et al. (1992) showed 
that IgG antibodies in low-titre sera from control subjects were significantly 
more effective in opsonising A. actinomycetemcomitans than IgG antibodies in 
low-titre sera from RPP patients. This study suggests a crucial link between 
antibody avidity and function. O’Dell and Ebersole (1995) hypothesised that 
antibody avidity to A. actinomycetemcomitans could help to explain the 
relationship between the active host response and chronic infection with this 
pathogen. Their data suggested that both antibody levels and avidity could 
contribute to variation in host resistance to infection and disease associated with 
A. actinomycetemcomitans. Underwood et al. (1993) have demonstrated that 
anti-A actinomycetemcomitans antibodies are important in promoting 
phagocytosis and killing of A. actinomycetemcomitans. They suggest that
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subjects who develop high levels of highly avid antibodies against this organism 
may have greater resistance to continued and repeated infection by this pathogen.
It appears that the various forms of disease produce antibodies of differing 
avidity and suggests that 1) the quality of the immune response may have a 
bearing on the aetiology, and 2) different organisms may have differing 
relevance. The low avidity antibodies compared to other antibodies, such as 
tetanus toxoid or streptokinase (Lopatin & Blackburn, 1992), may result from a 
failure of biologic function of antibody against bacterial infection (Mooney et 
al., 1993). Alternatively, Lopatin et al. (1991) suggested that low avidity 
antibody resulted because P. gingivalis and other organisms act as 
immunoadsorbants. More realistic is the theory of oral tolerance (Lopatin et al., 
1991). This suggests that low avidity antibodies arise from either high antigenic 
doses at the onset of infection, chronic exposure or in utero exposure. Early 
chronic exposure to low doses either in utero or in early life might compromise 
the ability of the host to mount an effective immune response. Children have 
been shown to have higher avidity to periodontal pathogens than adults, which is 
suggestive of chronic exposure (Lopatin et al., 1991).
1.5.3.5 Local responses
Most studies investigating the humoral immune response have concentrated on 
systemic antibody levels. Much less work has been done on the relationship 
between local antibody levels and local disease status. A number of studies have 
reported increased antibody levels to pathogens in GCF (Ebersole et al., 1985c;
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Naito et al., 1984; Martin et al., 1986; Genco et al., 1985). However
Baranowska et al. (1989) found no significant difference in the level of specific 
IgG to P. gingivalis in GCF between healthy and diseased sites within the same 
individual.
Tew et al. (1985b) found no obvious differences in the clinical parameters of 
pocket depth and attachment level between sites with elevated antibody to P. 
gingivalis and/or A. actinomycetemcomitans, and those with normal or low 
levels. They concluded that elevated antibody in GCF may relate to changes in 
disease activity that are not detectable by normal clinical assessments. More 
recently, Kinane et al. (1993) found a correlation between P. gingivalis antibody 
titres and gingival inflammation and pocket depth, but not for A.
actinomycetemcomitans antibodies. They concluded that antibodies are 
protective because in patients with greater disease and inflammation there are 
lower levels of antibodies. Suzuki et al. (1984) demonstrated that local 
production of IgG to P. gingivalis was markedly increased in AP compared with 
RPP patients, suggesting that disease progression was influenced by local 
antibody production. Challacombe et al. (1986) reported similar findings in 
patients with high and low periodontal disease indices.
There are conflicting reports about the correlation between serum and GCF
titres. Some studies report a correlation suggesting that the primary source of
antibodies is from the serum (Naito et al., 1984; Genco et al., 1985; Kinane et 
al., 1993; Baranowska et al., 1989). Other studies disagree, demonstrating that
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GCF levels do not reflect serum levels and suggesting that there is local 
production (Martin et al., 1986; Smith et al., 1985; Ebersole et al., 1985c). 
Recently a study by Mooney and Kinane (1997) showed that systemic and local 
antibody production contributes to the overall GCF antibody profile. This would 
make sense given the fact that the majority of the cellular infiltrate in the 
periodontitis lesion are IgG producing plasma cells, and is reflected in the 
antibody composition of the GCF, which is primarily IgG (Holmberg & 
Killander 1971, Smith et al., 1985, Kinane & Lindhe 1997).
Lamster et al. (1990) found that P. intermedia GCF and serum antibodies 
correlated but P. gingivalis antibodies did not and that this local deficiency in 
IgG to P. gingivalis may lead to local disease. Califano et al. (1997) reported a 
similar lack of antibody to B. forsythus and came to the same conclusion.
Ebersole et al. (1985a) and Ebersole & Cappelli (1994) showed that the 
frequency and distribution of antibody in GCF is related to colonisation by the 
target organism. The later study also showed that the pattern of antibody 
response to A. actinomycetemcomitans is characteristic of localised host-parasite 
interactions. Therefore antibodies may play an important role in the gingival 
sulcus in relationship to colonisation and clinical presentation.
Mooney & Kinane (1997) also found that periodontitis sites had significantly 
lower antibody levels than gingivitis sites, which supported the findings of 
Danielsen et al. (1993) in that more extensive reactions, i.e. high antibody titres,
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to organisms may be a prerequisite for successful reduction or elimination of 
bacteria. OuYang (1993) had previously corroborated these findings by showing 
that periodontitis patients had lower GCF levels of antibody to P. gingivalis, 
when related to serum levels, than gingivitis patients.
Failure of a local immune response appears to be related to periodontal disease at 
these sites. The failure in production may result from a biological failure 
(Mooney & Kinane 1997), failure of the organism to stimulate an immune 
reaction (Califano et al., 1997) or degradation of immunoglobulins by the 
bacteria in the pocket (Kilian, 1981). Local antibody are derived from both local 
and systemic antibody production.
1.5.3.6 Effect of therapy on the humoral immune response
An early study by Tolo et al., (1982) investigated the effect of therapy on 
antibody levels. They reported a mixture of increases and decreases in antibody 
titres to different organisms, but the only clear pattern was a decrease in P. 
gingivalis antibody titre post-therapy. Ebersole et al. (1985b) found a general 
increase in antibody levels after treatment, which peaked at 2 to 4 months and 
returned to pre-treatment levels 8 - 1 2  months later. The increase was most 
marked for P. gingivalis, P. intermedia, A. actinomycetemcomitans, E. corrodens 
and C. concisus antibody titres. In this study if the organism was detected in 
subgingival plaque then there was an increase in antibody titre after therapy. 
This suggests that the increase in titre may result from inoculation of the 
organism into the bloodstream and the subsequent reaction results in the
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increased titre. Further studies have not found a clear pattern in the immune 
response. Aukhil et al. (1988) reported a general reduction in antibody levels 
after treatment, significantly for S. sanguis and P. gingivalis. However antibody 
levels to Capnocytophaga species, B. melaninogenicus and T. denticola were 
unchanged. A similar reduction to P. gingivalis, both locally and systemically, 
was found by Murray et al. (1989) in treated patients compared to untreated 
patients. OuYang (1993) reported elevations in the GCF/serum ratio of antibody 
occurred one month after periodontal therapy. This suggested that local antibody 
consumption may be reduced after removal of the organism and that the 
GCF/serum ratio of antibody level might be used as a significant indicator in 
evaluation of treatment effectiveness. Most recently, Horibe et al. (1995) 
demonstrated that mean antibody levels to P. gingivalis and P. intermedia 
decreased significantly after treatment, and although titres to P. loeschii, F. 
nucleatum, A. actinomycetemcomitans, E. corrodens and Capnocytophaga 
species decreased slightly, these were not significant. Their results suggested 
that the change in serum IgG titres was related to the suppression of these 
pathogens in subgingival plaque.
Mouton et al. (1987) were able to split their patients into two groups. One group 
had low IgA titres and IgG and IgM titres to P. gingivalis similar to healthy 
subjects. This group responded poorly to treatment. The other group had 
detectable IgA titres and significantly higher IgG titres to P. gingivalis. They 
responded much better to treatment than the other group. The authors found no 
peak level of antibody after treatment, which suggested the SRP may not
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provoke active immunisation. A more recent study by Chen et al. (1991) 
reported that 33% of their RPP patients were high responder for P. gingivalis 
antibodies, that is they had over twice the median antibody titre than the control 
subjects. These high responder patients were found to have a significant 
decrease in titre post-treatment, whereas the low responder patients had a 
significant increase. Initially the avidity of the antibodies was lower than the 
controls, but post-therapy was higher. Mooney et al. (1995) also examined the 
effect of SRP on antibody response to P. gingivalis and A. 
actinomycetemcomitans in high responder and low responder periodontitis 
patients. Overall there were significant increases in A. actinomycetemcomitans 
IgG, IgA and IgM titres, no change in A. actinomycetemcomitans antibody 
avidity, significant increase in P. gingivalis IgG titres and significant increase in 
P. gingivalis IgA avidity. When the results were analysed by sero-status, high 
responder patients for IgG antibodies to P. gingivalis showed a significant 
increase in antibody avidity and a better outcome of treatment. The low 
responder patients had an increase in titre but no change in avidity, whereas the 
high responder patients were found to have an increase in avidity but little 
change in titre. The authors concluded that SRP affects the magnitude and 
quality of the humoral immune response, that the effect is dependent on initial 
sero-status and initial sero-status may have a bearing on the treatment outcome. 
The responses to P. gingivalis and A. actinomycetemcomitans may reflect their 
role in the disease or the age of the patients.
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In general it seems that treatment may increase or decrease antibody titres 
depending on the organism and sero-status of the patient. The change in avidity 
also depends on the sero-status before treatment. These studies have examined 
P. gingivalis and A. actinomycetemcomitans. Little is known about the other 
putative pathogens and an investigation into these is warranted. Also the effect 
of the presence or absence of the organism on sero-status and treatment outcome 
requires further investigation. In spite of the fact that B. forsythus is a named 
aetiological agent, there is very little information about the humoral immune 
response to this organism. In this thesis antibody titres to P. gingivalis, P. 
intermedia, B. forsythus, A. actinomycetemcomitans and T. denticola were 
investigated with regard to 1) the effect of treatment on titre, 2) serostatus, and 3) 
the effect of the presence or absence of the test organisms.
1.6 Smoking and the periodontium
This section discusses the effect of smoking on the periodontium and the host, 
with particular regard to disease severity, response to treatment and periodontal 
microflora.
1.6.1 The effect of smoking on periodontal disease
Tobacco use is directly related to the incidence and prevalence of a variety of 
medical problems including cancer, low birth weight and pulmonary, 
cardiovascular and gastrointestinal disease (Bartecchi et al., 1994). In the last
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two decades there has been an increasing awareness of the role of tobacco use on 
the prevalence and severity of periodontal diseases.
A number of studies have shown that smoking is a risk factor in periodontal 
disease (Haber & Kent, 1992; Locker & Leake, 1993; Grossi et al., 1994, 1995; 
Oliver et al., 1998; Bergstrom, 1989; Ismail et al., 1990; Beck et al., 1990; 
Homing et al., 1992). Risk assessment analysis of the data collected determined 
that tobacco users are 2.5 to 8.4 times more likely to develop periodontal disease 
than are non-smokers (Beck et al., 1990; Haber & Kent, 1992; Grossi et al., 
1994; Bergstrom & Preber, 1994; Stoltenberg et al., 1993; Beck & Slade, 1996; 
Beck, 1994). In addition to increased incidence, smokers tend to exhibit 
increased severity of periodontal disease (Beck, 1994; Bergstrom & Preber 1994; 
Grossi et al., 1994, 1995; Kamma et al., 1999). Smokers have increased pocket 
depths (Ismail et al., 1983; Solomon et al., 1968; Feldman et al., 1987; 
Bergstrom, 1989; Goultschin et al., 1990; Haber et al., 1993) and attachment loss 
(Gonzalez et al., 1996; Machtei et al., 1997) compared to non-smokers. Haber et 
al. (1993) showed that the mean number of sites with PD greater than or equal to 
4mm was higher in smokers than non-smokers and similar results have been 
found by Bergstrom (1989). Interestingly, an earlier study (Preber & Bergstrom, 
1986a) reported that the only difference in PD between smokers and non- 
smokers was that smokers had significantly deeper upper palatal pocketing.
Both cross-sectional (Bergstrom et al., 1991, Bergstrom & Eliasson, 1987; 
Feldman et al., 1983; Bergstrom & Floderus-Myrhed, 1983) and longitudinal
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(Bolin et al., 1986; Feldman et al., 1987; Grossi et al., 1994, 1995; Bergstrom & 
Preber, 1994) studies have shown that smokers have greater alveolar bone loss.
The severity of the periodontal destruction may be related to the number of 
cigarettes and pack years smoked (Martinez-Canut et al., 1995; Goultschin et al., 
1990; Grossi et al., 1994, 1995; Haber & Kent, 1992; Jette et al., 1993). 
Gonzalez et al. (1996) positively correlated the severity of periodontal 
attachment loss, pocket depth and bone loss with serum cotinine levels. Cotinine 
is a major metabolite of nicotine and its level is directly related to the level of 
smoking. Hence it is a quantitative method for measuring tobacco usage.
Smoking has also been associated with increased tooth loss (Bergstrom & 
Floderus-Myrhed, 1983; Feldman et al., 1987; Ahlqvist et al., 1989; Heckert et 
al., 1986; Osterberg et al.; 1986), tooth mobility (Feldman et al., 1987) and more 
furcation involvement in patients (Mullally & Linden, 1996).
There are conflicting reports about the effect of smoking on gingival bleeding. 
Some studies indicate decreased bleeding in smokers (Bergstrom & Floderus- 
Myrhed, 1983; Preber & Bergstrom, 1985; Feldman et al., 1983; Bergstrom, 
1990; Preber & Bergstrom, 1986a), whilst others report increased bleeding 
(Macgregor et al., 1985; Amo, 1958). Bergstrom (1989) showed in his study 
population that gingival index did not notably differ between smokers and non- 
smokers. Generally it would appear that smokers have less gingival 
inflammation than non-smokers, and this would follow given that nicotine has
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vasoconstrictive properties (Bounaneaux et al., 1988; Michel et al., 1988). The 
reduced level of gingival inflammation is corroborated by reduced gingival 
crevicular fluid volumes in smokers (Kinane & Radvar, 1997).
Smokers may have poorer oral hygiene and higher plaque scores than non- 
smokers (Schei et al., 1959; Sheiham, 1971; Preber et al., 1980; Preber & 
Bergstrom, 1985; Locker, 1992; Eklund et al., 1994; Holm, 1994), which could 
be the cause of the increased periodontal destruction in these patients. Two early 
studies (Preber & Kant, 1973; Sheiham, 1971) indicated that smoking had no 
effect on the periodontium. However a number of more recent studies have 
controlled for plaque levels and reported more disease in smokers (Ismail et al., 
1983; Preber & Bergstrom, 1990; Bergstrom, 1989; Bergstrom, 1987a; Linden et 
al., 1994) or have shown similar plaque levels (Preber & Bergstrom, 1986a).
A number of reports indicate that smokers have an increased build up of calculus 
compared to non-smokers (Pindborg, 1947, 1949; Feldman et al., 1987; Preber & 
Bergstrom, 1990; Anerud et al., 1991; Christen et al., 1985). However it is 
unclear what effect this may have.
Tobacco use has also been implicated in refractory periodontitis (Macfarlane et 
al., 1992; Bergstrom & Blomlof, 1992; Haber, 1994; Magnusson et al., 1996). 
Macfarlane et al. (1992) reported that 90% of refractory periodontitis patients 
were smokers. It has also been suggested that smoking is significantly involved 
in GEOP (Monteiro da Silva et al., 1997; Schenkein et al., 1995; Salvi et al.,
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1997; Haber et al., 1993). Haber et al (1993) reported that in 19-40 year olds the 
prevalence and severity of disease were increased in smokers. Schenkein et al.
(1995) found smoking to be more prevalent in GEOP patients. In these patients 
smoking had a significant effect on attachment loss. Also these patients had 
more affected teeth and greater mean attachment loss than non-smokers. Salvi et 
al. (1994) in their review of periodontal risk factors suggested that half of 
periodontal disease in patients under 33 years of age may be smoking related.
Tobacco use has also been implicated in other oral conditions, such as ANUG 
(Pindborg, 1947, 1949), leukoplakia (Christen et al., 1979), and oral cancer 
(Bastiaan et al., 1976). Also subjects who smoke seem to be at a greater risk for 
further breakdown (Haber, 1994; Kaldahl et al., 1996a; Machtei et al., 1997).
1.6.2 The effect of smoking on periodontal therapy
Given the effect of smoking on the prevalence and severity of periodontal 
disease, and its multitude of effects on the host, it is not surprising that smoking 
has an effect on periodontal therapy.
Studies have consistently shown that smokers respond less well to scaling and 
root planing (Ah et al., 1994; Preber & Bergstrom, 1986b; Preber et al., 1995; 
Kaldahl et al., 1996b; Kinane & Radvar, 1997; Haffajee et al., 1997a; Machtei et 
al., 1998; Grossi et al., 1997), with as much as 50% greater improvement in PD 
reduction in non-smokers (Machtei et al., 1998). After non-surgical therapy 
there seems to be a greater reduction in gingival index in some smoker
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populations (Preber & Bergstrom, 1986b) whereas, in other smoker subjects, a 
similar reduction is found to that of non-smokers (Kaldahl et al., 1996b).
Similarly tobacco users have a poorer response to surgical periodontal therapy 
(Ah et al., 1994; Preber & Bergstrom, 1990; Kaldahl et al., 1996b), even after 
accounting for differences in plaque scores (Kaldahl et al., 1996b). Preber & 
Bergstrom (1990) reported that during maintenance post-surgery smokers 
experienced a greater loss of horizontal attachment level, and patients with a 
higher incidence of breakdown tended to be smokers at the initial examination 
(Kaldahl et al., 1996a).
Kinane & Radvar (1997) reported that there was a poorer response in smoker 
subjects to anti-microbial therapy. They found that the response in deeper 
pockets is more greatly affected by smoking than in shallower pockets. A 
greater degree of recession was reported among non-smokers, perhaps due to the 
greater vasoconstriction in smokers and the less tissue swelling leading to less 
tissue shrinkage. This theory is supported by the findings of Preber & 
Bergstrom (1986b) who showed that after non-surgical treatment there was 
significantly less gingival index reduction in smokers, which may be expected if 
there was less gingival inflammation to start with.
A poorer success rate with guided tissue regeneration (GTR) has been reported 
in smokers (Rosenburg & Cutler 1994; Tonetti et al., 1995) and the stability of 
GTR is associated with an absence of cigarette smoking (Cortellini et al., 1996).
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Miller (1987) showed that smoking had a major deleterious effect on periodontal 
grafts, and Bain & Moy (1993) found that implants had a greater risk of failure 
in tobacco users.
It has been suggested that the poorer response is due to poorer oral hygiene in 
smoker patients but a number of studies have controlled for plaque levels and 
shown that the less favourable response was not due to poorer plaque scores (Ah 
et al., 1994; Tonetti et al., 1995; Ismail et al., 1983).
Cessation of smoking may restore normal periodontal healing responses as 
similar responses between former smokers and those who have never smoked 
have been reported (Grossi et al., 1997) and that a past history of smoking was 
not deleterious to the response to therapy (Kaldahl et al., 1996b).
1.6.3 Smoking and the periodontal microflora
Smokers are colonised by the same microorganisms as non-smokers (Zambon et 
al., 1996; Preber et al., 1992; Stoltenberg et al., 1993; Kamma et al., 1999), but 
generally in greater numbers (Kamma et al., 1999; Zambon et al., 1996).
There are conflicting reports whether or not smokers harbour a particular 
microflora. Preber et al. (1992) examined 145 patients, of whom 83 smoked, 
sampling one site over 6mm pocket depth per patient and investigated the 
presence of A. actinomycetemcomitans, P. gingivalis and P. intermedia by 
culture. They found no significant differences in bacterial counts or relative
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frequencies between smokers and non-smokers. Interestingly in 10% of these 
patients A. actinomycetemcomitans, P. gingivalis and P. intermedia were not 
detected. Stoltenberg et al. (1993) similarly found no differences in the 
prevalence of A. actinomycetemcomitans, P. gingivalis, P. intermedia, E. 
corrodens, and F. nucleatum between smokers and non-smokers. The authors 
suggested that smoking was more of a risk factor for periodontitis than the 
presence of the five microorganisms.
However, increased numbers and prevalence of A. actinomycetemcomitans, P. 
gingivalis and P. intermedia in smokers were reported by Zambon et al (1996). 
This group also found increased levels of Capnocytophaga species and E. 
saburreum in non-smokers, but no differences in the levels of C. rectus, F. 
nucleatum and P. intermedia. In general smokers had higher mean levels of 
subgingival infection with A. actinomycetemcomitans, P. gingivalis, B. 
forsythus, C. rectus and F. nucleatum. Smoking was a predictor for B. forsythus 
infection and smokers were at a higher risk of A. actinomycetemcomitans, and P. 
gingivalis infection. The relative risk of infection by B. forsythus, A. 
actinomycetemcomitans, and P. gingivalis increased with the number of pack 
years. In this study attachment loss rather than pocket depth was examined and 
the samples taken from a wide range of attachment loss scores rather than just 
deep pockets. This may account for the differences between this study and the 
two quoted previously.
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In a study of GEOP patients Kamma et al. (1999) found that smokers again 
harboured greater numbers of bacteria with significantly higher prevalence and 
numbers of S. sanguis, P. micros, C. concisus, E. coli, B. forsythus, C. gracilis, 
C. rectus, P. gingivalis, S. sputigena, C. albicans and A. fumigatus. Non- 
smokers had higher levels of S. intermedius, A. naeslundii, A. israelii and E. 
lentum. In this study the deepest sites were selected, but similar findings were 
reported to the study by Zambon et al. (1996).
In response to non-surgical therapy, Grossi et al. (1997) reported a lower 
reduction in B. forsythus and P. gingivalis levels when compared to the reduction 
in former and never smokers. Conversely Preber et al. (1995) found similar 
reductions in A. actinomycetemcomitans, P. gingivalis and P. intermedia in both 
smoker and non-smoker groups.
It is unclear why smokers may harbour a different microflora compared with 
non-smokers. Smoking has been shown to decrease the relative temperature of 
diseased sub-gingival sites compared with non-smokers (Dinsdale et al., 1997), 
which may favour colonisation by certain organisms. In vitro exposure to smoke 
reduces the viable number of microorganisms (Bardell et al., 1979, 1981; Ertal et 
al., 1991), but how this may affect the subgingival microflora is unknown. 
Periodontal pockets are more anaerobic (Kenney et al., 1975) and the decreased 
oxygen tension may favour the colonisation and growth of anaerobic bacteria 
(Loesche et al., 1983). Smoking increases bacterial adherence to epithelial cells 
(Venditto et al., 1992) and once colonised deep periodontal pockets may offer an
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especially favourable environment for the growth of anaerobic 
periodontopathogens by virtue of reduced oxygen tensions (Mettraux et al., 
1984). The reduced oxygen tension may favour particular organisms such as B. 
forsythus, A. actinomycetemcomitans or P. gingivalis. It is possible that the 
impaired defence mechanisms i.e. the reduced phagocyte ability of macrophages 
and neutrophils, may facilitate the colonisation of pockets or allow the 
establishment of a particular microflora.
1.6.4 Smokeless tobacco
The effect of smokeless tobacco is unclear and yet to be demonstrated. There are 
a number of reports linking it to disease (Robertson et al., 1990; Hoge et al., 
1983; Offenbacher et al., 1985; Christen et al., 1985) but this seems to be mainly 
recession and white patches at the site of application (Robertson et al., 1990).
This study aimed to examine the effect of smoking on scaling and root planing in 
AP and GEOP subjects. It also examined the effect of smoking on the 
microflora as a whole and in these patient groups. In addition, in AP subjects, 
the antibody titres to a number of periodontal organisms were compared between 
smokers and non-smokers.
1.7 Microbial diagnostic techniques
1.7.1 Introduction
The many techniques generally available for assessing the extent of the presence 
of microorganisms in infections have been widely applied in the study of
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periodontal disease. Tests are useful for: 1) determining causative agents, 2) 
assessing disease activity for treatment planning, 3) monitoring the effects of 
treatment, 4) deciding on recall intervals, 5) diagnosing the various forms of 
periodontal disease, 6) treatment planning for a new patient, 7) assessing 
prognosis especially for refractory patients and 8) motivating patients if 
particular organisms are present and changing oral hygiene habits (Genco et al., 
1986; Mombelli 1992, 1994).
Techniques may be classified as: growth in culture, microscopical,
immunological, enzymatic, and DNA-technology based.
The usefulness of these tests suffers from a number of problems general to all. 
Only a fraction of the organisms in the periodontal pocket have been identified 
(Tanner et al., 1994). There are problems with which sites to select, when to 
sample these sites and interpretation of results (Tanner & Goodson, 1986). 
Prospective studies have failed to demonstrate the prognostic value of microbial 
assays (Macfarlane et al., 1988; Nieminen et al., 1995; Listgarten et al., 1991). 
Currently there is a lack of a suitable gold standard and also a test that provides a 
comprehensive picture of the flora. Periodontal disease is a poly-infection and 
monitoring just a few organisms may be erroneous. It seems that in a clinical 
situation microbial assays still need validation (Smith, 1994). They are however 
good tools for research purposes.
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1.7.2 Growth in culture
Traditionally, microbial culturing has been the preferred means for examination 
of the oral microflora. The major advantage of culturing is its ability, in 
principle, to identify all major components of the oral microbiota. Culturing is 
also a prerequisite for determination of the in vitro antimicrobial susceptibility of 
a given pathogen.
Unfortunately microbial culturing is time-consuming, expensive, technique- 
sensitive and requires personnel with considerable knowledge of microbiology, 
especially for the recovery of the many fastidious organisms in the oral cavity 
and periodontal pocket. Available microbiological media and incubation 
atmospheres may not reliably grow B. forsythus, P. gingivalis, Treponema 
species, and other fastidious bacteria. The large spirochaetes and other 
organisms observed by direct microscopy have not yet been cultured (Tanner et 
al., 1994).
Most oral samples can be processed by use of anaerobic processing and 
incubation conditions. Oral microbial isolation can take place on non-selective 
or selective media. Non-selective culture media aim at growing all microbes in 
the same proportions as those that are present in a sample. However no available 
medium fulfils this criterion with the end result that some species are over­
represented and others under-represented. Some form of selective pressure has 
been demonstrated by non-selective media as different rates for recovery of
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black-pigmented anaerobes have been reported from the same sample on 
different non-selective media (Moore, 1987).
An ideal selective medium contains anti-microbial agents that are capable of 
suppressing all organisms other than the one for which the medium is designed. 
Full recovery of the study organism and total suppression of the contaminating 
flora are often mutually exclusive. Detection limits for organisms in periodontal 
pockets to be identified by culturing are on average 104-105 and 103 cells for 
non-selective and selective media respectively (Zambon & Haraszthy, 1995).
Conventional taxonomic methods include colony morphology, microscopic 
features, oxygen tolerance and comprehensive biochemical characterisation.
Although refined by the use of the spiral plater, selective media, improved 
anaerobic chambers, and better defined and expedient methods for identification 
of cultivable species, bacterial culture is still cumbersome, time-consuming and 
costly (Zambon & Haraszthy, 1995).
The tests not reliant on cell viability are only as accurate as the primary reference 
method which has been microbiological culture. It is becoming increasingly 
apparent that culture is not a suitable reference, because of its inability to 
adequately grow all the bacteria present in the periodontal pocket (Cattabriga & 
Pedrazzoli, 1996). We are thus left with an inadequate “gold standard”, against 
which to measure new diagnostic methods.
91
1.7.3 Direct Microscopy
Freshly mounted plaque samples may be examined by dark-field or phase- 
contrast microscopy, which shows the number and morphological features of the 
microorganisms present. Direct microscopic examination of plaque samples 
represents a quick, easy and inexpensive means for screening a microbial 
sample.
Four major groups of microbial morphotypes are distinguishable: coccoid cells, 
nonmotile rods, motile rods and spirochaetes. Inflammatory cells and oral 
protozoa that are present in the sample can be evaluated as well. By examining a 
sample for size, shape and motility of its bacterial content, it is possible to 
differentiate between a health-associated and disease-associated sample 
(Listgarten & Hellden, 1978). Therefore it is possible to measure the success of 
treatment by comparing samples from before and after.
One major disadvantage of direct microscopy is its inability to identify bacteria 
at the species level. Also it provides no guidelines for antimicrobial medication 
and it is possible to confuse similar morphotypes e.g. small rods for cocci (Slots 
& Taubman, 1992). Given the inevitable variations in sampling, dispersion, 
slide preparation, morphotype identification and interpretation, there are 
problems with representativity and reproducibility (Wilson et al., 1985). Gram 
staining can be used to differentiate between Gram-positive and Gram-negative 
organisms, but may be difficult to interpret because old or dead Gram-positive
92
cells lose their ability to retain the stain. Gram staining does not provide 
information about the species present.
1.7.4 Immunologic assays
Immunologic assays are based on the detection of antigen-antibody reactions 
between antigens of the target organism and specific antisera raised against it. 
The reaction can be revealed using a variety of procedures including direct and 
indirect immunofluorescence assays (IFA) (Zambon et al., 1986), particle 
concentration fluorescence immunoassay (Jolley et al., 1984), flow cytometry 
(Komman et al., 1984), enzyme-linked immunosorbent assay (ELISA) 
(Simonson et al., 1988), membrane assay (Louie & Larjava, 1994) and latex 
agglutination (Newman & Nisengard, 1988).
Direct IFA employs both monoclonal and polyclonal antibodies conjugated to a 
fluorescein marker which binds with the antigen to form a fluorescent 
immunocomplex detectable under a microscope. Indirect IFA employs a 
secondary fluorescein-conjugated antibody that reacts with the primary antigen- 
antibody complex. IFA is a relatively simple technique providing both 
qualitative and quantitative information about bacteria present in mixed 
subgingival samples (Zambon et al., 1986).
Particle immunofluorescence immunoassay involves the use of polystyrene 
beads as a substrate (Jolley et al., 1984) coated with antigens which then react 
with the specific fluorescein labelled antibodies yielding a fluorescent signal
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detectable by a fluorimeter. A modification of this technique using bacteria, 
termed bacterial concentration fluorescence immunoassay (BCFIA), has been 
developed to detect putative periodontopathic bacteria in plaque samples (Wolff 
et al., 1991, 1992).
Cytofluorography (Komman et al., 1984) involves labelling of bacterial cells 
with species-specific antibodies and a second fluorescein conjugated antibody. 
The immunocomplex suspension is scanned by the flow cytometer, but the cost 
of the required equipment precludes widespread usage.
ELISA involves the detection of the antigen-antibody complex with a 
colorimetric reaction catalysed by an enzyme linked to the antibody. Although it 
has been used to detect periodontal pathogens (Simonson et al., 1988), its main 
use has been to detect and quantitate the humoral immune response towards 
these organisms (Ebersole & Taubman, 1994).
Latex agglutination immunoassay (LA) is based on the binding of the antibody 
(or antigen) to latex beads and its subsequent agglutination or clumping on 
exposure to its specific antigen (or antibody), which can be scored. Rapid LA 
tests have been developed for A. actinomycetemcomitans, P. gingivalis, and P. 
intermedia (Nisengard et al., 1992).
Membrane immunoassay involves linkage between the antigen and a membrane 
bound antibody to form an immunocomplex that is later revealed through a
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colorimetric reaction. One form has been marketed commercially and detects A. 
actinomycetemcomitans, P. gingivalis, and P. intermedia (Snyder et al., 1994).
Immunologic assays are valuable because rapid, quantitative results can be 
obtained for organisms in direct oral specimens, which is particularly important 
for organisms that are difficult to grow. These tests require neither viability of 
test organisms nor aseptic sample handling, and may additionally provide 
serotyping information. Immunoassays are based on either polyclonal or 
monoclonal antibody reagents. Since the accuracy of immunodiagnostic tests 
depends on the quality of reagents used and the method of specimen processing, 
the results must be interpreted with care (Slots & Taubman, 1992). The 
inclusion of appropriate positive and negative controls is crucial.
Polyclonal antibodies are inexpensive to produce, but are often lacking in 
specificity because of cross-reactivity with different monoclonal species. 
Monoclonal antibodies can be generated against both major and minor antigens. 
They can provide high serologic specificity because of reduced risk of microbial 
taxa sharing the antibody recognising epitope. However the sensitivity may be 
low if the specific epitopes are inherently few on each cell, are not expressed, are 
destroyed or are masked (Slots & Taubman, 1992).
1.7.5 Enzymatic methods
In addition to the methods mentioned above, several assays for microbial 
enzymes are available. In general these tests do not detect specific bacterial
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species. Instead these tests indicate the presence of destructive enzymes 
produced by a group of mainly but not exclusively periodontal pathogens. The 
microbial enzymes that may be used include collagenase, peptidases, trypsin-like 
enzymes, neutral proteases and elastase. However a number of these enzymes 
are also produced by the host especially collagenases, and it may be difficult to 
differentiate between host-derived and bacterial enzymes.
The periodontal pathogens P. gingivalis, B. forsythus, T. denticola, and also 
some Capnocytophaga species that are not usually found to be periodontopathic, 
invariably produce a trypsin-like peptidase (Laughon et al., 1982; Loesche et al., 
1987; Tanner et al., 1985). This enzyme is able to catalyse the hydrolysis of the 
synthetic substrate, N-benzoyl-DL-arginine-2, naphthylamide (BANA), yielding 
a product assayed by colorimetric reaction that is the basis for the Perioscan test 
(Loesche et al., 1990).
SK-013 is a similar colorimetric test capable of demonstrating the presence in 
subgingival plaque samples of a bacterial peptidase which catalyses the 
hydrolysis of a synthetic substrate (N-carbobenoxy-glycil-glycil-arginyl) that is 
specifically produced by P. gingivalis, B. forsythus, and T. denticola (Seida et 
al., 1992).
Both these tests cannot distinguish between the 3 periodontopathogens and other 
species that may also produce these enzymes (Loesche et al., 1990).
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1.7.6 DNA-technoIogy based
The tests in this group can be subdivided into two main categories: DNA probes 
and polymerase chain reaction (PCR).
1.7.6.1 Deoxyribonucleic acid probes
Considerable interest has been directed towards the development of 
deoxyribonucleic acid (DNA) probes and their use in the diagnosis of infections. 
DNA probes are able to shorten the time required to identify pathogens, detect 
organisms directly in clinical specimens and reduce the overall costs associated 
with processing samples (Tenover, 1988). DNA probes identify organisms by 
nucleic acid content rather than products. Since every properly classified species 
has some unique nucleotide sequences that distinguish it from every other 
species, each microorganism’s genetic composition is a fingerprint that can be 
used for its identification.
A DNA probe is simply a piece of DNA, with a detectable label, that binds to a 
target nucleic acid molecule under appropriate conditions. Hybridisation is the 
process whereby two simple strands of nucleic acid come together to form a 
stable double-stranded molecule.
The hybridisation reaction consists of four components: the probe, the target 
(contained in the sample), the reporter molecule and the hybridisation method. 
The sample serves as a source of nucleic acid to be analysed and may be a
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clinical specimen. The nucleic acid in the sample is referred to as the target 
DNA (or RNA) and the label on the probe is referred to as the reporter molecule.
1.7.6.2 Types of DNA probes
There are three major types of DNA probes used in the detection of bacterial 
species: whole genomic, cloned and oligonucleotide. Whole genomic and 
cloned probes are usually several hundred to several thousand bases long (long 
probes), whereas oligonucleotide probes are generally shorter than 100 bases, 
often 16-30 (short probes).
Whole genomic probes
Whole genomic probes are produced by isolating DNA from an organism and 
labelling it with a reporter group. The advantages of whole genomic probes are 
that they are the simplest to make and they generally detect all strains of a 
phylogenetically coherent species. The major disadvantage is that whole 
genomic probes often cross-react with closely related species.
Cloned probes
There are two types of cloned probes: random and specific. Cloned probes are 
produced by cutting into fragments the DNA of the target organism with a 
restriction endonuclease, anywhere for random probes and either side of the 
desired DNA sequence for specific probes. These can then be inserted into a 
vector, usually a small plasmid from E. coli, sealed to produce a double-stranded
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circular molecule and introduced into E. coli. The plasmid containing the DNA 
insert will replicate in E. coli making hundreds of copies.
Both randomly and specifically cloned probes require extensive validation 
against DNA from the target and also related species. The randomly cloned 
probe that reacts with strains of the target species but not with other species is 
selected. The advantage of cloned probes is that they are more specific (less 
cross-reactive) than whole genomic probes. However the disadvantage is that 
they require extensive validation especially the randomly cloned probes.
Oligonucleotide probes
Oligonucleotide probes are designed upon sequence information for the target 
DNA (or RNA). These probes display “exquisite” specificity (Tenover, 1988), 
and, under stringent conditions, may be capable of detecting a change in a single 
base pair of a DNA or RNA sequence, which will be enough to prevent binding 
of the probe to the target DNA. The specificity of short probes, as with long 
probes, varies much more with the temperature and salt concentration. Thus it is 
important not to vary these conditions. They are relatively simple to prepare and 
are very stable over time. Because of their short size, they hybridise to target 
DNA at very rapid rates (sometimes as little as 30 minutes), in contrast to long 
probes which often require much longer (4-16 hours) even with rate enhancers 
such as dextrane sulphate.
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Short probes can only be labelled with a single reporter molecule, thus may be 
10- to 100-fold less sensitive than long probes. The usual target for short probes 
has been the 16S rRNA. This region is a good target as all eukaryotic and 
prokaryotic organisms possess this molecule. There are regions of this molecule 
that are extremely variable for different species, providing unique targets and 
there are 10 000 copies of the molecules (ribosomes) in a typical bacterial cell 
providing a greatly amplified target. (Tenover, 1988). These probes still 
require extensive validation.
1.7.6.3 Reporter groups for detecting DNA probe hybridisation reactions
There are four major classes of reporter groups widely used for probe detection: 
radioactive, enzyme, fluorescent and chemiluminescent.
Radioactive labels
Initially radioactive labelling was the most common method used to detect and 
quantitate hybridisation reactions. The isotopic label is directly incorporated
32into the probe by nick translation. P has been the most commonly used and its 
incorporation does not radically change the hybridisation characteristics of the 
probe. After hybridisation the binding of the DNA probe to the target can be 
detected by autoradiography or scintillation counting. This method has one of
32the highest sensitivities of all the labelling methods but P has a short half life
125(roughly 14 days) requiring frequent probe preparation. An alternative is I 
with a half life of 60 days, but there are safety concerns with both probes that 
require careful technique, proper storage and disposal.
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Enzyme labels
Horseradish peroxidase and alkaline phosphatase are the two most common 
enzyme labels. The enzyme may be attached directly to the DNA or to a second 
detector group after a primary label has been incorporated into the DNA 
sequence, such as the Biotin-Avidin system. After the addition of a substrate, a 
colorimetric product is produced.
Fluorescent labels
Instead of a colorimetric reaction, the use of a photoreactive substrate produces a 
fluorescent reaction that can be measured by a fluorometer.
Chemiluminescence
Chemiluminescence is the production of light by a chemical reaction. Both 
horseradish peroxidase and alkaline phosphatase may be used with luminol and 
an enhancer molecule or a substituted dioxetane respectively. The light emitted 
can be detected by a luminometer (and captured on computer software) or by 
radiographic film.
1.7.6.4 The hybridisation reaction
1) Stringency
After a double-stranded DNA molecule is denatured to single strands, it is 
capable of re-associating with either a DNA or RNA strand of complementary 
sequence. The degree and specificity of binding depends on the temperature,
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pH, use of a denaturant such as formamide, and the salt concentration of the 
reaction buffer. Nucleic acid molecules can tolerate a certain number of 
mismatched base pairs and still form stable duplexes as long as a significant 
number of base pairs do match and form bonds. The greater the degree of 
mismatched bases along the strands of nucleic acid, the more likely the two 
molecules are to come apart. The degree of mismatch that can be tolerated in a 
hybridisation reaction and still maintain a double-stranded molecule is referred 
to as the “stringency” of hybridisation. Under conditions of high stringency, 
only exact matches of DNA will anneal and stay together. Under conditions of 
low stringency (e.g. low temperature, high salt concentration, low formamide 
concentration) two DNA strands that are only 80-90% homologous may bind 
together and result in a positive hybridisation signal. If the stringency of a 
reaction is changed, the specificity of the probe will change. The range of 
conditions that can be tolerated without affecting the specificity of a probe vary 
depending on the length of the probe and the percentage of guanine and cytosine 
residues in the probe. The shorter the probe, the more narrow the range of 
temperature and salt concentration that can be tolerated.
2) Formats
Hybridisation reactions can be performed in four formats: on a solid support, in 
solution, in situ or by using the Southern blotting procedure after gel 
electrophoresis. Most DNA probe reports in the literature have used a solid 
support especially filter hybridisation (Tenover, 1988).
In a filter hybridisation reaction the sample is spotted directly on the filter or 
concentrated into a small area by placing in vacuum manifold. The sample is 
lysed and the DNA denatured by addition of NaOH. Once denatured the DNA is 
attached to the filter by baking and more recently by ultraviolet light. The filter 
is prehybridised with non-homologous DNA, such as salmon or herring sperm, 
to prevent non-specific binding of the probe to the filter. After hybridisation the 
filter is washed at various temperatures determined by the stringency of the 
reaction. Both nitro-cellulose and synthetic nylon filters have been used.
The second format is to carry out the hybridisation reaction in solution. In this 
format both target and probe are free to move, maximising the chance that 
complementary sequences will align and bind. Solution hybridisations go to 
completion 5- to 10-fold faster than those on solid supports. After the 
hybridisation step, the nascent duplexes are removed from solution by the 
addition of hydroxyapatite and quantitated by scintillation counting or 
spectrophotometry.
The third format is in-situ hybridisation. In most instances in-situ hybridisation 
is carried out on formalin-fixed paraffin embedded tissues and allows one to 
examine the tissue by other methods e.g. haemotoxylin and eosin staining.
The last format for hybridisation is the Southern hybridisation gel. In this 
technique purified DNA is cleaved with restriction endonucleases and the
fragments separated by size using electrophoresis through agarose. The DNA is 
transferred to a filter, baked and is then ready for hybridisation.
1.7.6.5 Advantages of DNA probes
The use of DNA probes can simplify the identification of bacteria. The 
technique is faster, less labour intensive and less costly than culture. The direct 
detection of infectious agents overcomes problems with slow growing or non- 
culturable organisms. It removes the need for viable cells and esoteric 
identification protocols. The technique is more comprehensive and uses the 
same methodology for all species. Additionally samples may be stored and it 
can detect organisms within tissues.
1.7.6.6 Disadvantages of DNA probes
Initially the use of DNA probes requires extensive preparation and testing. 
Construction of DNA probes is only feasible when bacterial species have already 
been isolated and characterised. However it is extremely unlikely that all of the 
species of periodontopathic bacteria have been identified as only about 60% of 
oral microorganisms can be cultured (Dewhirst & Paster, 1991). DNA probes 
are unable to detect yet to be identified species. The technique does not allow 
for antimicrobial sensitivity, although it is possible to detect the presence of 
resistance genes by using the appropriate probe (Lacroix & Walker, 1995). It 
provides semi-quantitative counts but no information about proportions of target 
bacteria in samples. There may be cross-reactivity of DNA probes between
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homologous species, and false positives/negatives if the wrong reaction 
conditions are used.
1.7.6.7 DNA probes in the detection of periodontopathic organisms
The first probes developed for use in the detection of periodontopathogens were 
whole genomic probes (French et al., 1986). They detected A.
actinomycetemcomitans, P. gingivalis, and P. intermedia with 100% accuracy 
even in low quantities in mixtures of A. viscosus. However there was cross­
reactivity between the A. actinomycetemcomitans probe and a related species, 
Haemophilus (French et al., 1986; Strzempko et al., 1987), and also a low level 
of cross-reactivity between the P. intermedia and other black-pigmented 
Bacteroides. Roberts et al. (1987) developed genomic probes to Bacteroides 
species but these also suffered from problems with cross-reactivity. These whole
3 6genomic probes have a detection limit between 10 and 10 (Strzempko et al., 
1987, Savitt et al., 1988, Lippke et al., 1991).
To overcome the problem of cross-reactivity, cloned DNA (French et al., 1986; 
Di Rienzo et al., 1991) and oligonucleotide probes (Chuba et al., 1988; Dix et al., 
1990; Gersdorf et al., 1993; Moncla et al., 1990) were developed. The 
oligonucleotide probes were directed towards bacterial 16S rRNA, which 
removed the problem of cross-reactivity but selection of the appropriate 
sequence was important (Moncla et al., 1990). The higher specificity of the 
oligonucleotide probes was counteracted by their generally higher detection 
limits (104-105 cells, Gersdorf et al., 1993), although some studies did report
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detection limits of around 103 cells (Chuba et al., 1988; Dix et al., 1990). More 
recently the products from polymerase chain reactions have been labelled and 
used as DNA oligonucleotide probes (Preus & Russell, 1994; Lotufo et al., 1994; 
Bodinka et al., 1994). These proved to be very specific and, because they were 
much longer, had lower detection limits.
32The first probes were P labelled and later biotinylated probes were developed. 
More recently streptavidin/alkaline phosphatase, and horseradish peroxidase 
methods were tested (Smith et al., 1989) with detection limits of 104-105 cells 
and 105-106 cells respectively. Recently non-radioactive digoxigenin (DIG) 
labeled probes have been used (Preus & Russell, 1994; Socransky et al., 1994; 
Lotufo et al., 1994; Bodinka et al., 1994) by random priming techniques 
(Feinberg & Vogelstein, 1983) and digoxigenin labeled dUTP.
DNA probes have been developed and used to detect the following organisms in 
plaque samples, in addition to those mentioned above, B. forsythus (Lippke et 
al., 1991), F. nucleatum (Maiden et al., 1991), E. corrodens (Lippke et al., 
1991), C. rectus (Soder et al., 1993), T. denticola (Loesche et al., 1992b).
1.7.6.8 Comparison of DNA probes with other techniques
Although some authors feel that there is no sufficiently accurate gold standard 
for the identification and enumeration of periodontal microorganisms (Loesche 
et al., 1992a), culture is the most commonly used method for assessing the 
performance of DNA probes.
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In general DNA probes detect much higher frequencies of bacteria than culture 
(Savitt et al., 1988, Komman et al., 1992; Ali et al., 1994; Yasui et al., 1993; 
Gersdorf et al., 1993; Slots & Chen, 1993), although some studies have found 
similar detection frequencies (Loesche et al., 1992b; Tanner et al., 1998b). The 
agreement between the two methods ranges from 55% (Slots & Chen, 1993) to 
83% (Tanner et al., 1997b), with sensitivity values of 82% to 100% (Tanner et 
al., 1998b; Gersdorf et al., 1993), and with specificity values of 38% to 100% 
(Slots & Chen, 1993; Gersdorf et al., 1993). The disagreement between two 
techniques reflects the lower detection limits of the DNA probes, the accuracy of 
identification of the organism by DNA probes, and the need for viable cells for 
culture which is dependent on sampling, transport, processing and growth 
conditions (Ali et al., 1994; Gersdorf et al., 1993; Slots & Chen 1993). The 
comparison of the probes against the less sensitive “gold standard” culture 
results in the varying specificity and sensitivity scores. Oligonucleotide probes 
generally have lower detection limits than whole genomic probes, 10 versus 
105, and this is generally reflected in the lower sensitivity and specificity scores 
for these probes when compared to culture. Maiden et al. (1991) reported 
agreement from 35.6% for P. gingivalis to 77.2% for A. actinomycetemcomitans, 
comparing oligonucleotide probes to culture. Sensitivity varied from 0.26 to 
0.95 and specificity 0.21 to 0.93. P. gingivalis and F. nucleatum 
oligonucleotide probes were much more sensitive than culture, and the figures 
reflect the lower detection limits for the probes.
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Melvin et al. (1994) reported a 59% to 76% agreement comparing DNA probes 
with ELISA identification. Although DNA probes were better for detecting T. 
denticola and had about 1000-fold lower detection limit, ELISA was better for 
detecting P. gingivalis and C. rectus. Again the figures reflect the different 
detection limits. Loesche et al. (1992a) reported similar accuracies, 88-97%, for 
DNA probes and ELISA compared to culture, and the detection frequencies for 
the two methods were generally similar. The same group reported (Loesche et 
al., 1992b) 90% agreement between DNA probes and the BANA enzyme test. 
However the BANA test could not distinguish between species making its use 
questionable.
A number of studies have compared IFA and DNA probes. Listgarten et al. 
(1995) found IFA much more sensitive, but both techniques were superior to 
culture. In this study the detection limit for the DNA probes was 5x10s cells. 
Other studies using lower detection limits for the probes have found DNA probes 
to be as or more sensitive than IFA (Zappa et al., 1990; Loesche et al., 1992b; 
Tanner et al., 1998b). In these studies there was no cross-reactivity of the DNA 
probes or antibodies with other species.
Given the accuracy of DNA probes, its superiority to culture, and its comparable 
performance to ELISA and IFA, DNA probe technology is an excellent tool to 
detect periodontal microorganisms.
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1.7.7 Checkerboard DNA-DNA Hybridisation
1.7.7.1 Development and use of the technique
A major problem with DNA-DNA hybridisation assays has been the limitation in 
the number of DNA probes that could be simultaneously hybridised with large 
numbers of DNA samples. Previous methods that have been used only evaluated 
a large number of samples against a small number of DNA probes or a small 
number of samples against a large number of DNA probes (Smith et al., 1989). 
This limited the usefulness of these results especially as a large number of 
bacteria may be found in a periodontal pocket (Moore & Moore, 1994).
Socransky and co-workers (1994) developed a technique whereby large numbers 
of samples could be screened against a large number of DNA probes, called 
Checkerboard DNA-DNA hybridisation. The method used was based on the use 
of Slotblot devices previously employed for the detection of multiple antigen- 
antibody reactions on a single solid support membrane (Kazemi et al., 1990; 
Levin & Branton, 1986). After denaturation, the DNA samples were loaded into 
lanes using a Minislot apparatus and fixed to the nitro-cellulose membrane by 
ultraviolet light or baking. By rotating the membrane 90° from its original 
orientation, the DNA probes were then run across the face of the membrane, 
allowing each probe to come into contact with part of the bound sample (Figure 
1.1). Use of the Minislot apparatus allowed up to 45 samples and 45 probes to 
be hybridised at any one time. Using randomly DIG-labelled whole 
chromosomal probes (Feinberg & Vogelstein, 1983), incubation with an anti- 
digoxigenin antibody conjugated with alkaline phosphatase and a suitable
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Figure 1.1 Diagram of the essential features of the Minislot and Miniblotter 
devices (reproduced from Socransky et al. 1994).
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The samples are loaded into lanes on a membrane placed between the halves of 
the Minislot device. The probes are placed in lanes in the Miniblotter device 
allowing hybridisation with the membrane-bound samples
Figure 1.2 Diagrammatic representation of “checkerboard” hybridisation format. 
Only a few channels are shown for simplicity (reproduced from Socransky et al. 
1994)
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chemiluminescent substrate, the hybridisation reactions could be detected on 
radiographic film. The characteristic pattern of the hybridisation reactions gives 
the technique its name (Figure 1.2).
Checkerboard hybridisation offers a number of advantages for DNA-DNA 
hybridisation. The principal advantage is that large numbers of DNA, RNA, 
tissue, bacterial or viral samples can be screened with multiple probes at the 
same time. The technique is relatively economical in that it uses smaller 
volumes of reagents and probes. A large number of reactions are performed per 
membrane, so there is less outlay for nylon or nitro-cellulose membrane. 
Thirdly, because of the large number of reactions possible per membrane, it is 
quicker and less labour intensive than previous DNA probe techniques.
The detection limit is similar for other techniques using whole genomic probes: 
lowest limit is about 104 cells (Haffajee et al., 1997a). The technique is also 
suitable for oligonucleotide probes (Socransky et al., 1994).
The Checkerboard technique has been used to identify a large number of disease 
and health-associated organisms in periodontal patients (Haffajee et al., 1995, 
1997a; Tanner et al., 1998a; Papapanou et al., 1997b)
1.7.7.2 Comparison of the Checkerboard technique with other methods
Three studies to date have compared the Checkerboard technique to culture, 
Maiden et al. (1997), Papapanou et al. (1997a) and Tanner et al. (1998a).
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The studies by Maiden et al. (1997) and Tanner et al. (1998a) used the same 
patients but samples were compared from separate but adjacent sites, rather than 
the same site. Both studies showed similar results, with culture yielding higher 
B. forsythus and C. rectus prevalences, and the Checkerboard technique higher 
P. intermedia, P. nigrescens, F. nucleatum subsp vincentii, S. oralis, S. sanguis 
and V parvula prevalences. However, there are problems with comparing 
samples from different sites, when the microflora between sites may vary 
considerably (Moore & Moore, 1994).
A better study by Papapanou et al. (1997b) split each of 283 subgingival plaque 
samples in two; one of which was analysed by culture and the other by the 
Checkerboard technique for ten periodontal organisms. The Checkerboard 
technique resulted in higher prevalence figures for P. gingivalis, P. intermedia!P. 
nigrescens, F. nucleatum and B. forsythus. If these species were used as the 
reference, the Checkerboard technique detection sensitivities ranged from 0.17 to
0.86, specificities 0.17 to 1.0 and diagnostic accuracies from 0.51 to 0.81 
depending on the bacterial species. The authors suggested that these differences 
may be due to difficulty in identifying similar species by biochemical tests, 
division of non-homologous samples, cross-reactivity of the probes especially in 
large plaque samples, and incorrect stringency conditions for the whole 
chromosomal probes. However, there was “reasonable” agreement between the 
two techniques.
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1.7.8 Polymerase chain reaction
1.7.8.1 Basic concepts
The polymerase chain reaction (PCR) is an in vitro technique that allows the 
amplification of a specific DNA region that lies between two regions of known 
DNA sequence. It allows the amplification of as little as one copy of the specific 
target sequence to generate large quantities of DNA. PCR is quick, generally 
taking 4-6 hours, accurate and a reliable technique. PCR amplification of DNA 
is achieved by using oligonucleotide primers. These are short (usually 15-30 
bases in length), single-stranded DNA molecules which are complementary to 
the ends of a defined sequence of DNA. Two primers are required for PCR 
amplification. One primer is complementary for a sequence downstream and 
one primer is complementary for a sequence upstream. Figures 1.3 and 1.4 show 
the typical PCR cycle. Potentially, after 20 cycles of PCR there will be 220- fold 
amplification, assuming 100% efficiency during each cycle. In practice PCR 
amplification is not unlimited as the amount of enzyme becomes limiting after 
25-30 cycles and also due to thermal denaturation of the enzyme during the 
process.
If primers are selected that amplify a specific region of an organism that is 
unique to that organism, this technique can be used to detect and identify that 
organism by visualising and sizing the product DNA, usually by gel 
electrophoresis. The product appears as a discrete band on the gel that can be
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Figure 1.3 The polymerase chain reaction (reproduced from Zambon & 
Haraszthy, 1995).
1. Template DNA
2. Denature
3. Anneal primers
4. Extend primers
O e n a t i i r e
Double-stranded DNA is denatured into single stranded DNA by heating to 90- 
95°C. Cooling to 40-60°C enables the DNA primers to hybridise to specific 
locations on the single-stranded sample DNA. At 70-75°C in the presence of Taq 
polymerase, the primers extend and fill in the DNA between the 2 primers bound 
to the template of single-stranded DNA. Raising the temperature back to 90-95°C 
denatures the newly created DNA strand from the DNA template.
Figure 1.4 Repeated cycles of denaturation, annealing and extension produce 
numerous copies of the DNA segment and geometric amplification of a single 
DNA sequence (reproduced from Zambon & Haraszthy, 1995).
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sized by comparison to a base-pair ladder of known sizes. PCR can be used to 
amplify any part of the genome, DNA or RNA.
1.7.8.2 Advantages of PCR
PCR is well established as a relatively inexpensive technique, generally taking 
fewer than six hours. It does not rely on viable cells and samples may be stored 
frozen for a period of time before analysis.
1.7.8.3 Disadvantages of PCR
Specific PCR primers can only be prepared for already characterised organisms, 
although there are associated techniques applied to unknown organisms (Harper- 
Owen et al., 1999). Extensive testing of the primers is required to check 
specificity. PCR can be used quantitatively, but if so used becomes unreliable 
after about twenty cycles or so. The number of species that can be detected per 
reaction is limited. Initially only one species per reaction was detected, but 
currently up to three periodontal organisms can be detected (Conrads et al., 
1999).
1.7.8.4 Detection limit of PCR
Theoretically PCR could detect as little as one cell of a species in a sample, but, 
more realistically, 10 cells is the lowest detection limit for this technique 
(Riggio et al., 1996)
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1.7.8.5 PCR and detection of periodontopathic microorganisms
PCR has been used to detect the presence of a number of the major 
periodontopathic bacteria using primers for the 16S rRNA sequences (Slots et 
al., 1995), 23S rRNA sequences (Haraszthy et al., 1992) or specific genes such 
as the leukotoxin A gene in A. actinomycetemcomitans (Goncharoff et al., 1993) 
or the fimbrillin gene (fimA) in P. gingivalis (Watanabe & Frommel, 1993). 
Genes coding for virulence factors are target sequences, such as the collagenase 
gene in P. gingivalis (Bodinka et al., 1994). In this instance it is not present in 
all strains but it may indicate a more virulent strain (Bodinka et al., 1994).
Table 1.7 shows the pathogens that have been investigated using PCR. It should 
be noted that PCR only detects the presence or absence of an organism and has 
not been used as a quantitative technique in the study of periodontal pathogens 
as yet. Many of the primer sequences are species-specific but cannot distinguish 
between strains (Watanabe & Frommel, 1996). PCR has also been used to 
examine the presence of viruses (Parra & Slots, 1996; Contreras & Slots, 1996) 
and yeasts (Hannula et al., 1997) in periodontal samples.
A variant of the polymerase chain reaction uses DNA segments of arbitrary 
rather than defined sequences as primers. This method, known as arbitrarily- 
primed PCR (AP-PCR) can be used for molecular typing of bacteria within the 
same species (van Steenbergen et al., 1993; Lotufo et al., 1994) and also to track 
the source of an infection, i.e. the transmission of A. actinomycetemcomitans in 
families (Preus et al., 1994). The arbitrary primers hybridise to the bacterial
114
Table 1.7 PCR identification o f periodontal bacteria. Bacteria that have been identified by PCR, 
primer target regions and references
Organism Target Reference
A. actinomycetemcomitans Leukotoxin A gene 
16S rRNA
Goncharoff et al. 1993 
Tonjum et al. 1993 
Slots et al. 1995 
Matto et al. 1998 
Griffen et al. 1992 
Furchtetal. 1996
P. gingivalis Fimbrillin gene (funA) 
16S rRNA
Collagenase gene (prtC)
Watanabe & Frommel 1993 
Riggio et al. 1996 
Slots et al. 1995 
Bodinka etal. 1994
P. intermedia 16S rRNA Conrads et al. 1997 
Riggio etal. 1998 
Slots et al. 1995
T. denticola tdp A gene 
16S rRNA
Watanabe & Frommel, 1996 
Slots et al. 1995
B. forsythus 16S rRNA Slots et al. 1995 
Meurmanetal. 1997
C. rectus 16S rRNA Slots et al. 1995
E. corrodens 16S rRNA Slots et al. 1995 
Furcht et al. 1996
P. nigrescens 16S rRNA Slots et al. 1995 
Riggio et al. 1998
H. pylori 16S rRNA Asikainen et al. 1994 
Riggio et al. 1999
B. heparinolyticus 16S rRNA Ashimoto et al. 1995
P. asaccharolytica 16S rRNA Tran et al. 1997
B. fragilis 16S rRNA Tran et al. 1997
C. pneumoniae 16S rRNA Tran et al. 1997
DNA at specific sites depending on the conditions of the assay and amplify 
corresponding regions. The amplified DNA segments from PCR are resolved on 
gel electrophoresis and the banding pattern or amplitype is compared between 
strains.
Antibiotic sensitivity may be examined by determining the presence of resistance 
genes, such as tet (M) and tet (Q) (Olsvik et al., 1995; Lacroix & Walker, 1995). 
The PCR product, which is specific for that one organism, may be labelled and 
used as a probe in DNA-DNA hybridisation (Tonjum et al., 1993; Preus & 
Russell, 1994).
Traditionally the DNA for one organism is amplified per reaction, but recently 
multiplex techniques have been introduced allowing the amplification of DNA 
from more than one organism (Wahlfors et al., 1995; Tran & Rudney, 1996; 
Garcia et al., 1998; Conrads et al., 1999). Multiplex PCR should allow quicker, 
more comprehensive and less costly analysis of samples (Conrads et al., 1999). 
By using primers that amplify sequences from all organisms, followed by 
sequencing of the product, it is possible to characterise and identify the bacterial 
DNA from periodontal samples (Riggio, personal communication). This would 
allow the identification of unculturable species (Harper-Owen et al., 1999).
1.7.8.6 Comparison of PCR with other techniques
Comparisons of PCR and culture have consistently shown that PCR is the more 
sensitive technique and recorded higher prevalences of any organisms
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investigated. (Slots et al., 1995; Riggio et al., 1996; Meurman et al., 1997; 
Wahlfors et al., 1995; Ashimoto et al., 1996). Ashimoto et al. (1996) reported 
discrepancies between 28% (A. actinomycetemcomitans) and 71% (B. forsythus), 
when comparing the two techniques. The use of selective media resulted in a 
71% similarity for A. actinomycetemcomitans, but only a 28% match was 
achieved with B. forsythus, a slow growing and difficult organism to culture. In 
addition to its greater sensitivity, PCR may also detect dead organisms. Culture 
requires viable organisms, and a reduction may occur due to transportation, 
processing of samples and culture conditions (Slots et al., 1995; Riggio et al., 
1996). PCR is quicker, with the results available in a few hours, cheaper, and 
less labour intensive, which lead one group to suggest PCR as the “gold 
standard” for identifying periodontal pathogens (Riggio et al., 1996).
A comparison of PCR and DNA probes showed that they produced similar 
results but PCR and culture did not (Ashimoto et al., 1995). Ashimoto et al. 
(1996) achieved an 84% match for B. forsythus, and 70% for P. gingivalis. 
There were similar PCR positive/DNA probe negative and PCR negative/DNA 
probe positive discrepancies for B. forsythus, but many more samples were DNA 
probe positive for P. gingivalis suggesting some cross reactivity by the DNA 
probe. Conrads et al. (1997) reported that PCR was slightly more sensitive for 
detecting P. intermedia and P. nigrescens, though oligonucleotide DNA probes 
allowed semi-quantification.
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Table 1.8 summarises the advantages and disadvantages reported for the various
assays.
In this study PCR and “Checkerboard” technique were used to investigate the 
microflora in AP and GEOP smoker and non-smoker subjects both before and 
after treatment. A comparison of the two techniques was also performed.
1.8 Aims of the study
The aims of this thesis are to:
1) a) Investigate the effect of SRP on AP and GEOP clinical and
microbiological parameters,
b) Compare clinical and microbiological parameters in AP and GEOP 
subjects before and after SRP,
c) Investigate the inter-relationship between clinical parameters and the 
microflora in AP and GEOP subjects,
2) Compare PCR and Checkerboard using all plaque samples collected,
3 ) a) Examine the effect of SRP on AP antibody titres,
b) Examine the effect of the flora on AP antibody titre and avidity,
c) Examine systemic and local AP antibody correlations,
d) Examine the effect of AP patient antibody serostatus on clinical and 
microbiological parameters, and treatment outcome,
4) a) Compare clinical and microbiological parameters in smokers and non- 
smokers before and after treatment in all patients, as well as AP and 
GEOP subjects,
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b) Compare antibody titres, avidity and serostatus in AP smokers and 
non-smokers.
1.9 Layout of thesis
After the next chapter, Methodology, the results and discussion sections of this 
thesis have been divided in four further chapters: 3) Comparison of AP and 
GEOP patients, 4) Comparison of PCR and Checkerboard, 5) The humoral 
immune response and periodontal therapy, and 6) Effect of smoking on 
periodontal therapy. In each of these chapters the relevant results are presented 
together with a discussion of these results. This arrangement is intended to 
clarify the results and discussion sections in this thesis for the reader, rather just 
grouping everything together into two chapters, which was confusing. These 
chapters are followed by a brief final chapter (7) summing up the findings in this 
thesis.
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CHAPTER 2
METHODOLOGY
This chapter describes the clinical and laboratory methods used in this thesis, 
and is split into two parts. The first part describes the selection of patients and 
sites, study outline, clinical indices and sampling techniques used. The second 
part describes the laboratory techniques used to prepare and analyse the clinical 
samples. Lastly the methods of statistical analysis are detailed.
2.1 Clinical methodology
2.1.1 Subject selection
Prior to the commencement of these studies, ethical approval was obtained from 
the Glasgow Dental Hospital Ethics Committee. Subjects participating in these 
studies were informed of the protocol and consent was obtained. All patients 
taking part in the investigation were free to withdraw from the study at any time.
Fifty seven patients with untreated periodontal disease were recruited from new 
referrals to Glasgow Dental Hospital and School between January 1996 and July 
1998. Each patient had at least two non-adjacent sites per quadrant with pocket 
depths of 5 millimetres or over, with no history of systemic disease or antibiotic 
therapy in the three month period prior to recruitment. Thirty three patients were 
aged 35 and over (mean age 47 years), and were designated adult periodontitis 
(AP) patients. Twenty four patients aged between 24 and 35 (mean age 33) at 
the time of diagnosis were designated generalised early-onset periodontitis 
(GEOP), according to the criteria of Hart et al., (1991). This states that there 
should be a generalised pattern of severe periodontal destruction with clinical 
attachment loss of at least 5mm on 8 or more teeth, 3 of which were not first
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molars and at least one of which was a permanent molar. The subject should be 
less than 35 years of age.
2.1.2 Site selection
Site selection was carried out at the screening visit, after full mouth periodontal 
pocket charting was performed using a PCP-12 periodontal probe (Ash, Densply, 
UK). In each patient, four non-adjacent sites with pocket depths equal to 5 mm 
or over were selected for sampling purposes. These sites, where possible, were 
in different quadrants and in no cases were sites with furcation involvement 
included. In order to facilitate sample collection and increase the accuracy of the 
measurements, buccal and anterior sites were preferred to lingual and posterior 
sites. Non-adjacent sites were used so as to reduce the possibility of 
contamination and ensure independence of the gingival crevicular fluid and 
plaque samples.
2.1.3 Clinical design
The patients in this study were seen at the following visits: 1) screening visit, 2) 
baseline measurements, 3) four sessions for quadrant root planing under local 
anaesthetic, 4) reassessment, and 5) post-treatment sampling visit (Figure 2.1).
At the screening visit, all study subjects signed an informed consent form. The 
medical history was checked and a full periodontal examination with pocket 
charting carried out. The patients were asked to reattend at the first available 
appointment for baseline measurements.
120
2-4 weeks
2-4 weeks
6-8 weeks
2-4 weeks
Reassessment
Screening Visit
Baseline Clinical 
Measurements and 
Sampling
Four Visits for 
Quadrant Scaling 
and Root Planing 
(4-6 weeks)
Post-treatment 
clinical 
measurements and 
sampling
Figure 2.1 Study Outline: Details of patient visits and treatment 
undertaken at each visit with time intervals between stages and duration 
of SRP
At the baseline visit the following were sampled or recorded from the study sites 
in the order listed:
1) Modified Ginigval Index (MGI) (Lobene et al., 1986) and Plaque Index (PLI) 
(Silness & Loe, 1964) from all sites.
2) Gingival crevicular fluid (GCF) samples were taken from all sites, the volume 
recorded using the Periotron 6000 and stored frozen at -20°C in separate sterile 
1.5ml micro-centrifuge tubes until analysis.
3) The first set of pocket depth (PD) measurements using an electronic pressure 
sensitive probe from all sites.
4) Bleeding on probing (BOP) and suppuration (Supp) from all sites.
5) After changing the patient’s position the second set of pocket depth 
measurements were recorded from all sites.
6) After changing the probe tip, the first set of attachment level measurements 
were recorded from all sites.
7) Again after changing the patient’s position the second set of attachment level 
measurements were taken from all sites.
8) Following probing a sub-gingival plaque sample was taken from each site 
using a different sterile scaling instrument, and transferred to 500pl of TE Buffer 
in a sterile 1.5ml micro-centrifuge tube for subsequent PCR analysis.
9) Lastly, 21ml of venous blood was drawn from the Anterior Cubital vein of 
either arm.
Following baseline measurements each subject was seen for four visits where 
oral hygiene instruction was given according to individual needs and each
121
quadrant in the patient’s mouth scaled and root planed (SRP) under local 
anaesthetic.
After a period of eight weeks to allow for healing, the subjects were re-examined 
and pocket charted to determine the success of the therapy. At the next visit the 
clinical measurements and samples were collected in the same order as before.
2.1.4 Clinical measurements
Two examiners carried out the clinical measurements and treatment (IBD for all 
the AP patients, and PJH for all the GEOP patients). The following parameters 
were recorded at each site in each patient, and a total of twice per site.
2.1.4.1 Modified Gingival Index
The Modified Gingival Index (MGI) (Lobene et al., 1986) was used to assess 
gingival inflammation and is described below:
0 Absence of inflammation
1 Mild inflammation; slight change in colour, little change in 
texture but not the entire marginal or papillary gingival unit.
2 Mild inflammation; criteria as above but involving the entire 
marginal or papillary gingival unit.
3 Moderate inflammation; glazing, redness, oedema and/or 
hypertrophy of the marginal gingival unit.
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4 Severe inflammation; marked redness, oedema and/or 
hypertrophy of the marginal or papillary gingival unit, 
spontaneous bleeding, congestion or ulceration.
The MGI was preferred to the more commonly used Gingival index (Loe & 
Silness, 1963) because it provides greater sensitivity to the earliest changes of 
gingivitis as the lower part of the scale is expanded resulting in a scoring system 
of 0-4. Since bleeding on probing is not a criterion in the MGI, it is a completely 
non-invasive procedure. A non-invasive method was essential in this study since 
GCF samples were taken after MGI scoring, and any procedures that might 
irritate the gingival tissue, and thereby alter the GCF constituent profile, had to 
be avoided.
2.1.4.2 Plaque Index
The Plaque index (PLI) of Silness & Loe (1964) was used for recording plaque 
accumulation. The scoring system is as follows:
0 No plaque in the gingival area
1 A film of plaque adhering to the free gingival margin and 
adjacent surfaces of the tooth. The plaque may only be noticed 
by running a probe across the tooth surface.
2 A moderate accumulation of soft tissue deposits within the
gingival crevice, on the gingival margin and/or adjacent tooth 
surface.
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3 An abundance of soft matter within the gingival crevice and/or on 
the gingival margin and adjacent tooth surface.
2.1.4.3 Gingival crevicular fluid collection
Sample collection was performed using filter paper strips and the fluid volume 
on the strip was measured immediately after sampling with a Periotron 6000 
(IPE Interstate, Amytiville, NY).
In the clinic, GCF was sampled after MGI and PLI scores were taken but before 
any other clinical recordings which could cause irritation of the tissue and serum 
contamination of the sample.
The site to be sampled was isolated with cotton wool rolls and supra-gingival 
plaque was carefully removed. The region was dried with a gentle stream of air 
and GCF was collected with a Whatman grade 4 paper strip (Whatman 
International Ltd., Maidstone, Kent, UK) (2x13 mm) (Griffiths et al., 1988) 
inserted into the crevice until mild resistance was felt and left in place for thirty 
seconds (Figure 2.2). Strips visually contaminated with saliva or blood were 
discarded. The sampling method is reliable and causes no significant 
disturbance of the gingival blood vessels (Gustafsson et al., 1992). The fluid 
volume on the strip was measured immediately after sampling with a Periotron 
6000 (IPE Interstate, Amytiville, NY) (Figure 2.3). The jaws of the Periotron 
were wiped with absolute ethanol and then dried between readings. The 
Periotron 6000 was reset to zero between measurements (Chappie et al., 1995).
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The strips were then placed into individual sterile micro-centrifuge tubes and 
stored at -20°C until elution. Subsequently the strips were eluted into 1ml of 
incubation buffer at room temperature using a rotary mixer for one hour. The 
strips were then discarded and the elutant aliquoted into sterile 0.5ml micro­
centrifuge tubes and stored at -20°C. The aliquots were subsequently analysed 
for IgG titres to P. gingivalis, P. intermedia, B. forsythus,
A. actinomycetemcomitans, and T. denticola.
2.1.4.4 Probing depth and attachment level assessments
In this study pocket depth (PD) and attachment level (AL) were recorded to the 
nearest 0.2 mm using the Florida probe (Florida Probe Corporation, Florida, 
USA) (Gibbs et al., 1988). The Florida probe is an electronic pressure sensitive 
probe with a constant force of 20 grams. The system consists of pocket depth 
and attachment level handpieces, a foot switch, a computer interface and a 
desktop computer (Figure 2.4). When the foot switch is pressed, the 
measurements of PD and AL are made electronically, using the pocket depth or 
attachment level handpieces. Measurements were recorded by an assistant from 
the computer screen, so that the operator was blind to the measurement. The 
probe tip has a diameter of 0.4 mm, with no visible graduation along its length 
and it reciprocates through a sleeve. The edge of the sleeve is the reference from 
which measurements are recorded.
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Figure 2.4 Florida probe monitor, computer interface and foot switch.
PD was assessed by using the point at which the probe sleeve was brought into 
contact with the gingival margin. Care was taken to ensure that the probe tip 
was held parallel to the long axis to the tooth (Figure 2.5).
A fixed reference point is required for attachment level measurements and, as 
identification of the cemento-enamel junction (CEJ) is often complicated by its 
sub-gingival location or the presence of restorations, in this study the occlusal 
plane was used. Near the end of the shank of the attachment level handpiece is a 
disc which can be placed on the occlusal surfaces of the associated teeth and 
provides a fixed reference point. The attachment level was recorded relative to 
the point at which the disc was seated on the teeth. Once the disc was seated on 
the tooth, care was taken to ensure that the probe tip was parallel to the long axis 
of the tooth.
PD and AL measurements were taken in duplicate to improve accuracy. If the 
first two measurements were more than 1 mm in disagreement then two more 
were taken and the middle two measurements recorded. After the first set of 
measurements was obtained, the patient’s position was changed before the next 
set. After each measurement the probe tip was cleaned with isopropyl alcohol.
2.1.4.5 Bleeding on probing
Bleeding on probing was visually assessed within 30s of the first set of pocket 
depth measurements by the Florida probe. It was scored as present or absent.
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Figure 2.5 Florida pocket depth probe in use
2.1.4.6 Suppuration
Suppuration was visually assessed after BOP by applying gentle pressure from 
the end of a periodontal probe in an apical-coronal direction. It was recorded as 
present or absent.
2.1.4.7 Subgingival plaque sampling
A subgingival plaque sample was taken from each site after pocket depth and 
attachment level measurements were performed in order to avoid distortion of 
the pocket, and so alter the pocket depth. Each plaque sample was taken using a 
sterile scaling instrument, usually a periodontal hoe, using a single stroke. The 
sample was immediately placed in 500pl of TE Buffer (lOmM Tris HC1 pH 7.6, 
ImM EDTA pH 8.0) in a 1.5ml micro-centrifuge tube and stored at -20°C until 
processing.
2.1.4.8 Serum collection
Twenty one millilitres of venous blood were collected from the anterior cubital 
region using butterfly needles and three 7ml red-capped Vacutainer tubes 
(Becton Dickinson Vacutainer Systems Europe, Meylan, France). The blood 
was allowed to clot overnight and then the serum removed and aliquoted for 
ELISA analysis.
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2.2 Experimental methodology
2.2.1 Experimental materials
2.2.1.1 Whatman grade 4 paper strips
Whatman grade 4 paper strips (Whatman International Ltd., Maidstone, Kent) 
were cut manually to a standard size, 13 mm in length and 2 mm wide, using a 
steel ruler and a scalpel. A line was drawn on each strip at 8 mm, indicating the 
length of paper strip to be inserted between the Periotron jaws and the part of the 
strip to be used for GCF sampling. Rubber gloves were worn during their 
preparation in order to avoid contamination of the strips by substances from the 
operator’s hands. The strips were then placed in glass universal bottles for 
autoclaving and storage.
2.2.1.2 ELISA buffers and reagents
The buffers used were as follows:
1) Coating buffer (CB): 1.59g Na2C 03, 2.93g NaHC03 was dissolved in 800ml 
distilled H20. The pH was adjusted to 9.6 at just under 1 litre, by adding 1M 
HC1 up to 1 litre in a volumetric flask. It was stored in a sterilised bottle at 4°C 
for a maximum of 1 week.
2) Incubation buffer (IB): 8g NaCl, 0.2g KH2P 0 4, 1.44g Na2HP04. 2H20 , 0.2g 
KC1, 0.5g Tween 20 (SIGMA chemical company Ltd., Poole, Dorset) dissolved 
in 800 millilitres of distilled H20 , and made up to 1 litre with the addition of lg 
of lyophilised bovine serum albumin (BSA) (SIGMA, St. Louis, USA). This 
was layered on the surface until dissolved, then mixed, and stored at 4°C for a 
maximum of 1 week (pH 7.4).
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3) Wash buffer (PBST): This was prepared at 10 times the concentration of 
incubation buffer (nil BSA) and stored at room temperature. It was diluted 1/10 
immediately before use.
2.2.1.3 Checkerboard buffers and reagents
The buffers and reagents used were as follows:
1) P 0 4 buffer (4 litres x 4): 11.36g 20 mm Na2HP04, 1.49g 1 mm EDTA, and 
1% SDS were dissolved in approximately 3 litres distilled H20  and then the 
volume made up to 4 litres with distilled H20. After autoclaving it was stored 
at room temperature for a maximum of 3 to 4 days.
2) Maleic acid (4 litres): 46.43g maleic acid, 701.3g NaCl were dissolved in 2.5 
litres of distilled H20 . The volume was made up to 4 litres with distilled H20  
and the pH adjusted to 8.0 at room temperature using about 32g NaOH pellets. 
To this 12ml Tween 20 was added and the solution autoclaved and stored at 
room temperature for a maximum of a week.
3) Blocking solution (500ml): 25ml stock block (solution 12) was added to 
475ml maleic acid.
4) Antibody solution (two membranes): 6pl antidigoxigenin (Boehringer 
Mannheim GmbH, Mannheim, Germany) was added to 100ml blocking solution.
5) Formamide (800ml): 40g AG 501-x8 resin/800ml of formamide beads were 
deionised by stirring for 30 minutes and filtering. After aliquoting into 5ml 
samples, the tubes were capped with red caps and stored at -20°C until use.
6) Denhardt’s solution (50x) (500ml): 1% Ficoll and 1% polyvinylpyrrolidone 
were dissolved in distilled H20. 1% bovine serum albumin fraction V was added
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and the solution aliquoted into 5ml samples. After capping with blue lids the 
solution was stored at -20°C until use.
7) Denatured sheared herring sperm DNA (lOmg/ml): 250mg herring sperm was 
dissolved in 25ml distilled H20  and allowed to mix overnight at 4°C. The 
solution was brought to room temperature and forced through a 50ml syringe and 
needle to shear the DNA. This was repeated four times. The DNA was 
transferred to a glass tube and boiled for 10 minutes. After cooling on ice the 
shearing and boiling process was repeated. The DNA was stored in 1.5ml micro­
centrifuge tubes at -20°C until use.
8) 20xSSC (2 litres): 350.64g NaCl and 176.5g Na Citrate were dissolved in 2 
litres of distilled H20.
9) 2xSSC (500ml): 50ml 20xSSC was added to 450 ml distilled H20 , autoclaved 
and used within a week.
10) Buffer 1 (1 litre): 11.6g maleic acid, 8.7g NaCl and 7.5g NaOH were added 
to 1 litre distilled H20, autoclaved and stored at room temperature.
11) Buffer 3 (2 litres): 31.4g Tris HC1 and 11.6g NaCl were dissolved in 1 litre 
of distilled H20. The pH was adjusted to 9.5 using about 7g NaOH. In another 
flask, 20.2g MgCl2.6H20  was dissolved in 1 litre distilled H20. The solutions 
were autoclaved separately and mixed together afterwards.
12) Stock block: 10% block (casein) was added to buffer 1. The solution was 
placed in the microwave to dissolve the casein, autoclaved and stored at 4°C 
until use.
13) Pre-hybridisation P 04 & SSC (500ml): To about 400ml distilled H20 , 88g 
NaCl, Na Citrate and 6.9g NaH2P 04 were added. The solution was topped up to
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500ml and the pH was adjusted to 6.5. The solution was autoclaved, and stored 
at 4°C until use.
14) Hybridisation P 04 & SSC (300ml): 30.7g NaCl, 16.lg Na Citrate, and 2.01g 
NaH2P 0 4 were dissolved in 300ml distilled H20. The pH was adjusted to 6.5 
and the solution autoclaved and stored at 4°C until use.
15) Hybridisation solution:
For 20ml: 9ml formamide (2 tubes minus 1ml), 0.4ml Denhardt’s, 2ml stock 
block, 8.2ml hybridisation P 04 & SSC, 2g Dextrane sulphate and 0.4ml herring 
sperm. Once the herring sperm was dissolved in the hybridisation P 04 & SSC, 
the other reagents were added and thoroughly mixed together.
For 1ml: 450pl formamide, 20pl Denhardt’s, lOOpl stock block, 41 Optl 
hybridisation P 0 4 & SSC. O.lg Dextrane sulphate and 20pl herring sperm. 
Mixing was as above.
2.2.1.4 Preparation of PCR primers
The primers used for the PCR analyses are shown in (table 2.1) with the size of 
the amplification product, target and references. The P. gingivalis primers 
targeted the fimA, fimbrillin gene, which all P. gingivalis strains possess and is 
specific for P. gingivalis. The sequences for the primers were (from 5’ to 3’) 
ATAATGGAGAACAGCAGGGAA and TCTTGCCAACCAGTTCCATTGC and the 
expected product size 131 base pairs (bp). The primer sequences for P. 
intermedia targeted the 16S rRNA and were specific for P. intermedia. These 
sequences were developed by Riggio et al. (1998) and were reported not to cross
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react with the closely related P. nigrescens. The primer sequences were (from 5’ 
to 3’) CCTAATACCCGATGTTGTCCACA and AAGGAGTCAACATCTCTGTATCC and 
the expected product size 855bp. The primer sequences for A. 
actinomycetemcomitans targeted the leukotoxin gene which all A. 
actinomycetemcomitans strains possess and had been shown not to cross react 
with related species (Goncharoff et al., 1993). The sequences were (from 5’ to 
3’) GGAATTCCTAGGTATTGCGAAACAAT and GGAATTCCTGAAATTAAGCTGG and 
the expected PCR product size was 262bp. The sequences for B. forsythus and 
T. denticola were developed by Slots et al., (1995) and were specific for B. 
forsythus and T. denticola only. Both targeted the 16S rRNA region. The B. 
forsythus primers were (from 5’ to 3’) GCGTATGTAACCTGCCCGCA and 
TGCTTCAGTGTCAGTTATACCT, and the expected product 641 bp. The T.
denticola primers were (from 5’ to 3’) TAATACCGAATGTGCTCATTTACAT and 
TCAAAGAAGCATTCCCTCTTCTTCTTA and the expected product 3 16bp. All 
primers were made by Cruachem Ltd. (Glasgow, Scotland). They were re­
suspended with sterile, distilled, de-ionised water and tested on whole genomic 
DNA for accuracy and specificity before use on plaque samples.
2.2.1.5 Preparation of Checkerboard probes
Digoxigenin-labeled, whole genomic probes were prepared by using the High 
Prime kit (Boehringer Mannheim, Mannheim, Germany) and cultured organisms 
(Papapanou et al., 1997a). Genomic DNA was extracted from A. 
actinomycetemcomitans FDC Y4, P. gingivalis FDC 381, P. intermedia ATCC
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25611, B. forsythus ATCC 43037 and T. denticola. The Checkerboard was 
performed in a dedicated laboratory in the Oral Microbiology department, 
Faculty of Odontology, University of Gothenburg, Sweden and all probes had 
been tested for accuracy and specificity previously.
2.2.2 Experimental techniques
2.2.2.1 Calibration of the Periotron 6000 and determination of GCF 
volume
In order to transform the Periotron digital readings for each paper strip into 
volumes, and also to verify the accuracy of the instrument, a calibration curve 
was constructed. First a blank paper strip was placed between the jaws of the 
machine and the instrument zeroed. Known volumes of a fifty /fifty PBS/sera 
mixture were pipetted onto the paper strips using a Hamilton micro-syringe at a 
range of volumes from 0.05-1 pi and the Periotron readings recorded. Each 
measurement was performed three times and the digital display reset to zero after 
each sample (Chappie et al., 1995). The mean value for each volume was used 
to construct a calibration curve, the slope and intercept were used to determine 
the volumes of GCF collected. The curve was analysed in two separate lines 
(fitted by regression method) as shown in Fig 2.6. The upper portion included 
volumes of 0.4 to 1.2pl, and the lower portion volumes 0.05 to 0.4pl. The 
calibration was performed each day samples were taken, in order to reduce daily 
variability due to differences in factors such as temperature and humidity.
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Figure 2.6 GCF calibration curve. There are two lines for the calculation of GCF 
volume, meeting at 400nl. The first line is for 0-400nl and has the equation, in the form 
y = mx + c, y = 3.4x + 6.41, and the second line for 400-1000nl, y = 7.93x - 469.18, 
where y is the Periotron reading, m the gradient, x the volume in nl, and c the 
intercept.
2.2.2.2 Ginigval crevicular fluid elution
GCF samples were eluted into 1ml of incubation buffer for 1 hour at room 
temperature using a rotary mixer. The strips were then discarded and the elutes 
aliquoted into 125pl samples and stored at -20°C until analysis.
2.2.2.3 Preparation of plaque samples
The plaque samples were stored at -20°C until analysis. Once thawed the plaque 
samples were vortex mixed for 30 seconds before being divided in two, as PCR 
and Checkerboard require different methods of sample preparation.
For PCR, 26pl of 10 times lysis buffer (lOOmM Tris-HCl pH 8.0, lOmM 
ethylenediamine tetra-acetic acid, 10% Triton X-100) was added to 250pl of the 
sample which was then boiled for 5 minutes. lOpl of this lysate was used in 
each PCR reaction. The samples were stored frozen in numbered, but unnamed 
microcentrifuge tubes so that the analyses could be performed blind.
For Checkerboard analysis the samples were prepared as follows. 167pl of 0.5M 
NaOH was added to the 250pl plaque sample aliquot and boiled for 10 minutes 
to denature the DNA. 0.86ml of 7.5M ammonium acetate was added to each 
tube to neutralise the reaction. A 15 x 15cm nylon membrane (Boehringer 
Mannheim GmbH, Mannheim, Germany) was mounted on 10 15 x 15cm 
Whatmann grade 3MM filter paper squares (Whatman International, Maidstone, 
Kent) in the bottom half of a Minislot apparatus (Immunetics, Cambridge, MA, 
USA) and the top screwed tightly in place. Each plaque sample was pipetted
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into a separate lane on the top of the apparatus with 20 samples per membrane. 
The aliquots were allowed to soak in for 10-15 minutes, until the lanes were dry, 
and then aspirated through the membrane by vacuum. At the bottom of each 
membrane samples containing whole genomic DNA from 105 and 106 mixed 
bacterial cells were placed to act as controls. The controls consisted of a mixture 
of the five test organisms. The DNA deposited on the membrane surface was 
fixed by exposure to ultraviolet light for 1 minute each side and then by baking 
for twenty minutes at 120°C. The membranes were stored at 4°C until 
hybridisation.
2.2.2.4 Preparation of serum samples
Blood samples were allowed to clot overnight at 4°C, centrifuged at 2000rpm for 
10 minutes and the sera removed, aliquoted into 125pi samples and stored frozen 
at -20°C until analysis.
2.2.3 Polymerase chain reaction
2.2.3.1 Polymerase chain reaction cycle
PCR amplification was carried out in a reaction volume of lOOpl consisting of 
lOpl sample lysate and 90pl of reaction mixture containing lxPCR buffer 
(lOmM Tris-HCl pH8.8, 1.5mM MgCl2, 50mM KC1, 0.1%Triton X-100), 2 units 
of Dynazyme DNA polymerase (Flowgen, Lichfield, England, UK), 0.2 mM 
dNTPs (dATP, dCTP, dGTP, dTTP) and 50 pmol of each primer. The primers 
were separated from the other components of the reaction mixture by a layer of 
wax (“hot start” PCR) preventing the reaction from starting until the wax had
135
melted upon commencement of PCR cycling. PCR cycling was carried out in an 
OmniGene thermal cycler (Hybaid, Teddington, England, UK). The cycling 
conditions for A. actinomycetemcomitans and P. intermedia comprised an initial 
denaturation for 5 minutes at 95°C, 35 amplification cycles of denaturation at 
95 °C for 1 minute, annealing of primers at 55°C for 1 minute and primer 
extension at 72°C for 1.5 minutes, followed by a final extension step at 72°C for 
10 minutes. The cycling conditions for the other organisms were the same 
except that in the amplification cycles the primer extension step lasted for 1 
minute. The reaction products were either stored at -20°C or analysed 
immediately. Negative and positive controls were included in each batch of 
samples being analysed by PCR. The negative control was a 90pl reaction 
mixture with the sample replaced by lOpl of sterile water. The positive control 
contained lOOng of genomic DNA from the relevant organism in 90pl of 
reaction mixture, with sterile water added to bring the volume to lOOpl. The 
genomic DNA for T. denticola was kindly supplied by Dr. C. Wyss, Zurich, 
Switzerland.
2.2.3.2 Analysis of PCR products
20pl of each reaction product was fractionated on a 2% agarose gel containing 
ethidium bromide (0.5p.g/ml), using a lOObp DNA ladder (Pharmacia Biotech, 
St. Albans, UK) as a size marker, and visualised and photographed using an 
ImageMaster video documentation system (Pharmacia Biotech).
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2.2.4 Checkerboard DNA-DNA hybridisation
After halving the membranes containing the plaque samples, so that two could 
be tested at the same time, they were soaked for 5-10 minutes in 2xSSC, and pre­
hybridised for 2 hours at 42°C with 50ml pre-hybridisation solution (6 tubes 
Formamide, 1 tube Denhardt’s, 5ml stock block, 12.5ml pre-hybridisation P 04 
and SSC, and 2.5ml denatured herring sperm) in a plastic bag on a shaker in a 
water bath. During pre-hybridisation, 10ml of hybridisation solution was 
prepared (4.5ml Formamide, 0.2ml Denhardt’s, 1ml stock block, 4.1ml 
hybridisation P 0 4 and SSC, lg Dextrane sulphate, and 0.2ml herring sperm). 
Varying amounts of each probe were added to 160pl of hybridisation solution, so 
that the final probe concentration was 20ng/ml, (Table 2.2) (8j l i1 of P. gingivalis 
probe was added, 6pl P. intermedia and A. actinomycetemcomitans probes, 22pl 
of B. forsythus probe, and 15pl of T. denticola probe). The probe was boiled for 
5 minutes to denature it and then stored on ice until use. The membranes were 
removed from their bags and the pre-hybridisation solution kept. The bottom 
half of a Miniblotter device was wrapped in cling-film and the membrane placed 
face up on it. The top half was screwed tightly in place, and the excess 
prehybridisation fluid aspirated with a vacuum. The probes were carefully 
pipetted into their lanes avoiding air bubbles, and the empty lanes filled using 
prehybridisation solution. The whole apparatus was wrapped in clingfilm and 
placed in a shaking water bath set at 47°C. The probes were allowed to hybridise 
overnight at a temperature of 42°C. A thermometer was placed on top of the 
apparatus so that the temperature could be checked.
Table 2.2 Checkerboard hybridisation set up: Lanes for the probes, probe 
volumes and hybridisation solution volumes
Species Lane Probe Vol. Hyb Sol Vol
P. gingivalis 2 8 152
P. intermedia 5 6 154
B. forsythus 8 22 138
A. actino 11 6 154
T. denticola 14 18 142
P. gingivalis 28 8 152
P. intermedia 31 6 154
B. forsythus 34 22 138
A. actino 37 6 154
T. denticola 40 18 114
The following day, P 0 4 buffer was heated to 70°C and the apparatus removed 
from the water bath whilst the buffer was warming. The probes were aspirated 
with a vacuum, and the membranes clipped to a frame. Once the buffer had 
heated up it was poured into a plastic tank and the frame fixed within. The 
membranes were washed for twenty minutes, followed by a wash for a further 
twenty minutes. Following a rinse with maleic acid, the membranes were soaked 
in maleic acid for 5 minutes by placing in plastic boxes on a rotator. The 
membranes were then placed in blocking solution, again in plastic boxes, for 60 
minutes to block non-specific binding sites, and then sealed in a plastic bag with 
the antibody solution for 30 minutes again on the rotator. Following soaking 
with maleic acid, the membranes were washed four times for ten minutes with 
maleic acid in plastic boxes, and then immersed in Buffer 3 for five minutes on 
the rotator in plastic boxes. Alkaline phosphate substrate solution was made up 
by adding 50pl CSPD to 4.95ml Buffer 3 for each membrane. Without allowing 
the membranes to dry out, they were placed on Whatman paper 3 MM to remove 
excess liquid, and then placed within light tight metal trays. CSPD solution was 
pipetted over the membranes with the excess re-pipetted over the membranes 
three to four times to ensure that the surface of the membrane was completely 
covered. The trays were then incubated in the dark for five minutes at room 
temperature. To remove excess solution the membranes were again placed on 
Whatman paper 3 MM, but not allowed to dry out. The membranes were placed 
in plastic bags, sealed without air bubbles and allowed to incubate in the dark at 
37°C for 20 minutes. They were then placed in the Lumi-Imager image capture 
system (Boehringer Mannheim GmbH, Mannheim, Germany) for 20 minutes,
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which detected and recorded the chemiluminescent reactions on the membrane. 
The captured image was displayed on the screen of a linked desk-top computer 
(Hewlett Packard), and printed or saved to disc. Finished membranes were 
allowed to dry out overnight and then kept at 4°C.
Samples were scored positive and absent for each organism by comparison with 
the standards on each membrane both by eye and by the software on the desktop 
computer. No attempt was made to semi-quantitate the results.
2.2.5 ELISA
Specific antibody titres were measured using enzyme-linked immunosorbent 
assay (ELISA) by the method of Ebersole et al., (1980).
2.2.5.1 Preparation of microorganisms and coating of plates
A. actinomycetemcomitans, P. gingivalis, P. intermedia, B. forsythus and T. 
denticola were prepared for coating the ELISA plates as follows. A. 
actinomycetemcomitans strain Y4 was grown on blood agar plates and harvested 
after 24 hours. P. gingivalis NCTC 11834, P. intermedia ATCC 25611, and B. 
forsythus ATCC 43037were grown on fastidious anaerobe agar and harvested 
after seven days. The organisms were harvested with swabs and dispersed into 
PBS containing O.lmM disodium EDTA (PBSE). They were then washed once 
in PBSE and fixed overnight in 10% formal saline. T. denticola ATCC 35405 
cells were grown, fixed and kindly donated by Dr C. Wyss, Zurich, Switzerland. 
After washing twice with PBSE, the fixed organisms were re-suspended in
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coating buffer (CB). The organisms were further washed once with coating 
buffer, and were used to coat the plates at the following OD600; A. 
actinomycetemcomitans 0.02, P. gingivalis 0.05, P. intermedia 0.05, B. 
forsythus 0.02, and T. denticola 0.001, as determined as optimal by previous 
workers (Mooney et al., 1994).
2.2.5.2 Analysis of sera samples
The plates were pre-washed three times with coating buffer and coated overnight 
with the whole cells at 4°C using lOOpl per well. Immulon IB plates (Dynex 
Technologies, VA, USA) were used because of their low protein-binding 
characteristics and low non-specific background. Control wells for each aspect 
of the ELISA process were arranged in the wells around the outside of the plates.
The ELISA plates were removed from the refrigerator and washed four times, 
then four more, four times again and lastly once more with wash buffer 
(4x4x4xl). The non-specific binding sites were blocked with lOOpl per well of 
incubation buffer (IB) containing 5% skimmed milk powder (Marvel, Premier 
Beverages, Stafford, UK) for 1 hour at 37°C. The plates were then washed twice 
and once again (2x1) before addition of the sera.
Human sera collected from the study patients were serially diluted from 1/100 to 
1/25600 using IB and control sera diluted to 1/1000. 50pl of sera were added to 
each well and incubated at 37°C for one and a half hours. Each serum was tested 
in duplicate and the sera samples from the same patient at different time points
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were tested on the same plate. Following incubation with the sera the plates 
were washed 4x4x4xl. Afterward the plates were incubated at 37°C for 60 
minutes with Biotin-Goat-Anti-Human IgG (Sigma, St. Louis, MI, USA) at 
1/2000 dilution in IB. The plates were then washed 4x4x4xl, and the plates 
either incubated for 60 minutes at 37°C or overnight at 4°C with 1/2000 dilution 
of extravidin peroxidase. After washing 4x4x4xl, the reactions were visualised 
using lOOpl per well of TMB Peroxidase substrate (Kirkegaard & Perry 
Laboratories, Maryland, USA) and stopped after 5-10 minutes, depending on the 
speed of the reaction, using 50pl per well of 0.12M HC1.
The reactions were read using a Dynex Technologies MRX II plate reader at 
450nm with a reference at 630nm and the results printed out. The duplicate 
results were averaged and the final titre expressed as ELISA units using the 
method of Gmur et al., (1986). The results were calculated with a regression line 
and derived equation from serial dilutions of a reference serum (Mooney et al., 
1993).
2.2.5.3 Analysis of GCF samples
The same ELISA methodology that was used for analysis of the sera samples 
was used for analysis of the GCF samples. 50pl of GCF aliquot was used per 
well instead of serum and it was not serially diluted. The samples were also 
analysed in duplicate. All the GCF samples from the same patient were tested 
together on the same plate. The results were expressed as EU/30s.
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2.2.5.4 Avidity analysis
The dissociation assay to determine antibody avidity was performed in a similar 
manner to the ELISA for the serum analysis described above. After incubation 
with serum, the wells were treated with increasing concentrations of ammonium 
thiocyanate, 0.2M to 8M. Ten wells were used per patient serum dilution, in 
duplicate, and the thiocyanate dilutions compared to a buffer blank with 100% 
binding. The plates were incubated for 60 minutes at 37°C, washed 4x4x4xl, 
and the ELISA continued as before. The concentration of thiocyanate as a 
molarity required to dissociate 50% of the bound antibody was calculated by 
linear regression. This concentration was termed the 50% inhibitory dose and 
provides a measure of the relative avidity (Macdonald et al., 1988; Pullen et al., 
1986). All the samples from the same patient were tested together on the same 
plate.
2.2.5.5 Control sera
Sera from eight clinically healthy subjects, aged between 21 and 51, mean 32 
years, were analysed by ELISA as above. The data produced was used to 
determine serostatus of the AP patients using the method of Mooney et al. 
(1995). AP patients with a serum titre greater than twice the median control sera 
titre were designated high responder and those with titres less than twice the 
control median low responder.
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2.3 Statistical analysis of data
The clinical, microbiological, and antibody titre and avidity data for each site 
and patient were statistically analysed using Minitab statistical package (Minitab, 
release 12, Minitab Inc., State College, PA) and SPSS statistical software (SPSS, 
version 5, SPSS Inc., Chicago, IL, USA). For the patient based analysis the 
clinical data were averaged from the four sites and the mean GCF antibody titre 
of the middle two values used. The patient was recorded as positive for an 
organism if one or more sites were positive for that organism. BOP, Supp and 
prevalence of the microorganisms are presented as percentages in this thesis, but 
the raw data not the percentage was used in the analysis . All patient/site data 
was used in the analyses. No patients were excluded from the analyses on the 
grounds of poor response to therapy. Decreases were scored as positive and 
increases as negative
The differences before and after treatment were compared in AP, GEOP, smoker 
and non-smoker groups. The Wilcoxon test was used to compare MGI and PLI, 
a paired t-test for PD, AL and GCF volume, and McNemar’s test for BOP, Supp, 
and the presence or absence of each organism before and after treatment.
The data was analysed for differences between AP and GEOP at baseline, after 
treatment, and to compare the changes in parameters with treatment, on a site 
and patient basis. Smoking subjects were compared to non-smokers in three 
groups; all subjects, AP subjects and GEOP subjects, and compared before and 
after treatment, and for any differences in the response to treatment. The Mann-
Whitney test was used to compare MGI and PLI, a two sample t-test for PD, AL 
and GCF volume, and Chi squared for BOP, Supp and the presence or absence of 
each organism, except when expected counts were less than five where Fisher’s 
exact test was used.
In both AP and GEOP subjects, differences in baseline, after treatment and 
change with treatment scores were analysed for BOP positive and negative sites, 
Supp positive and negative sites, PD loser and gain sites and AL loser or gain 
sites. For the change in PD or AL, ANOVA was used for PD, AL and GCF 
volume, Kruskal-Wallis test for MGI and PLI, and Chi squared for BOP, Supp 
and the presence or absence of each organism, with Fisher’s exact test used as 
above.
Serum antibody titres in AP patients were compared before and after treatment 
using Wilcoxon’s test. In smoker and non-smoker groups baseline, after 
treatment and change with treatment antibody titres were analysed using Mann- 
Whitney test. GCF titres were analysed similarly. Avidity scores were 
compared before and after treatment using a paired t-test, and a two sample t-test 
in smokers and non-smokers. Where changes in treatment were analysed, 
ANOVA was used. Subjects were separated into high responders and low 
responders groups on the basis of antibody titres from control patients. The two 
groups were statistically analysed using the same tests used to compare smokers 
and non-smokers. The effect of serostatus on the presence of organisms was 
analysed using the Chi squared test. Spearman’s rank correlation efficient was 
used to assess the relationship of sera and GCF titres with each other and PD.
Multiple regression analysis with backward elimination was performed to assess 
the effect of the clinical parameters, smoking, disease category and 
microbiological scores on pocket depth, the effect of these on the change in 
pocket depth, and the change in clinical and microbiological scores on the 
change in PD.
PCR and Checkerboard were compared statistically using McNemars’s test and 
by percentage and number of sites which agreed with each other. PCR was used 
as the “gold standard” to determine the sensitivity and specificity of the 
Checkerboard.
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CHAPTER 3
COMPARISON OF AP AND GEOP 
PATIENTS
This chapter deals with the comparison of AP and GEOP patients before and 
after SRP. In addition, the changes in clinical and microbiological parameters in 
response to SRP are examined. The inter-relationships between clinical 
parameters and the microflora are also investigated and discussed. Clustering and 
absence of bacteria are also examined. It should be noted that the prevalence of 
organisms in the microflora was determined solely by PCR in this chapter.
3.1 Comparison of AP and GEOP patients: Results
3.1.1 Demographic details
The demographic details of the patients recruited are shown in table 3.1. Thirty 
three AP subjects were recruited of whom 28 completed hygiene phase therapy. 
The average age of these patients was 47 (±7) years and the average time 
between sampling was 17.8 (±6.6) weeks. A total of 27 GEOP patients were 
recruited, 24 of whom completed therapy. Their average age was 33 (±3) years 
and all were diagnosed as GEOP before the age of thirty five. The average time 
between sampling was 16.2 (±5.2) weeks. Eight patients were dropped from the 
study due to systemic illness or antibiotic therapy not related to periodontal 
therapy or condition. The statistical analysis in this study used only the 28 AP 
patients and 24 GEOP patients who completed SRP.
3.1.2 Effect of SRP on clinical and microbiological parameters 
Adult Periodontitis
Table 3.2 shows AP clinical parameters before and after SRP. Scaling and root 
planing resulted in significant reductions in PD after treatment (5.9 (±1.0) mm at
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baseline compared to 4.4 (±1.5) mm post-treatment, p<0.001) and AL (13.4 
(±2.2) mm compared to 13 (±2.3) mm, p<0.001). MGI, PLI, percentage of sites 
with BOP and Supp were reduced significantly also. There was an increase in 
GCF volume of on average 25 nl/30s, but this was not significant.
There were no significant differences in the microflora on a patient basis (table 
3.3), although the reduction in percentage of patients positive for T. denticola 
approached significance. P. intermedia and B. forsythus decreased after SRP by 
5-10%, and T. denticola by 25%. A. actinomycetemcomitans was eliminated and 
P. gingivalis prevalence did not change.
On a site basis (table 3.4) there were significant reductions in P. intermedia, B. 
forsythus and T. denticola of about 20%. P. gingivalis decreased by about 10% 
and again A. actinomycetemcomitans was eliminated.
GEOP
Following SRP there were significant decreases in all clinical variables except 
GCF volume. PD decreased from 6.8 (±1.0) mm pre-treatment to 4.8 (±1.2) mm 
post-treatment, p<0.001, and AL from 13.8 (±1.5) mm to 12.7 (±1.7) mm, 
pO.OOl. BOP reduced by on average 40% and suppuration by 30%. GCF 
volume increased by roughly 40 nl/30s, but not significantly (Table 3.2).
There were significantly lower percentages for P. intermedia and B. forsythus in 
GEOP patients after therapy (table 3.3). P. gingivalis,
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A. actinomycetemcomitans and T. denticola were also lower post-treatment. 
A. actinomycetemcomitans was not eliminated.
All the tested for bacteria were detected at significantly lower percentages after 
treatment on a site basis, with percentage decreases ranging from just under 10% 
to almost 50% (table 3.4).
3.1.3 Comparison of AP and GEOP patients at baseline
Table 3.5 shows the average clinical measurements of the selected sites between 
the two groups. Averaged clinical parameters on a patient basis were identical 
to those on a site basis. The MGI scores were 2.5 (±0.6) for the AP patients 
compared to 1.9 (±0.8) for GEOP patients, and were significantly different
(p=0.006). The percentage of AP sites with BOP was significantly greater than 
GEOP sites. PI and Supp scores were not significantly different between the two 
patient groups. Average pocket depth measurements were significantly different 
(p=0.0002) with 5.9 (±1.0) mm for AP patients and 6.8 (±0.6) mm for GEOP 
patients. Gingival crevicular fluid (GCF) volumes were significantly different 
(p=0.015) with the average AP volume of 403 (±199.5) nl/30s and average 
GEOP volume 298.2 (±114.5) nl/30s.
The percentage of positive patients for each organism are shown in Table 3.6. 
P. gingivalis was detected in 54% of AP patients compared to 63% of EOP 
patients. P. intermedia was detected in 71% of AP patients and 79% of EOP 
patients. B. forsythus was found in 64% of AP patients and 92% of EOP
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patients. 4% of AP patients were positive for A. actinomycetemcomitans 
compared to 21% of EOP patients. T. denticola was detected in 54% of AP 
patients and 46% of EOP patients. There were significant differences between 
the groups in the detection of B. forsythus (p=0.05) and A. 
actinomycetemcomitans (p=0.04).
The comparison of the percentage of positive sites is shown in Table 3.7. 
P. gingivalis was detected in 44% of AP sites and 54% of EOP sites. 57% of AP 
sites were positive for P. intermedia and 51% of EOP sites. B. forsythus was 
found in 58% of AP sites and 83% of EOP sites. A. actinomycetemcomitans 
was detected in 2% of AP sites and 12.5% of EOP sites. 37.5% of AP sites and 
35% of EOP were positive for T. denticola. There were significant differences 
again between the two groups for the detection of B. forsythus (p=0.01) and A. 
actinomycetemcomitans (p=0.001).
3.1.4 Comparison of AP and GEOP patients after SRP
A comparison of AP and GEOP clinical parameters is shown in table 3.5. The 
values of the clinical parameters were identical on a site and when averaged for 
patient basis. Both MGI and PLI scores were significantly higher in AP patients. 
AL, GCF volume, BOP and Supp were also higher but not significantly. Pocket 
depth was, however, statistically significantly higher in GEOP subjects.
On a patient basis, table 3.6 shows higher frequencies of detection for 
P. gingivalis, P. intermedia and T. denticola in AP and, in GEOP subjects,
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higher prevalences for the other two test organisms. These differences were not 
statistically significant, although the greater percentage of AP with detectable 
P. intermedia approached significance.
Table 3.7 displays the comparison of the percentage of positive sites in AP and 
GEOP subjects after SRP. P. intermedia and T. denticola were significantly 
higher in AP subjects and A. actinomycetemcomitans significantly increased in 
GEOP sites. P. gingivalis was higher in AP and B. forsythus higher in GEOP, 
but these differences were not statistically significant.
3.1.5 The change in clinical and microbiological parameters in response to 
SRP
The change in clinical measures for AP and GEOP in response to SRP is shown 
in table 3.5. There were similar changes in both groups for MGI, PLI and BOP. 
Supp scores improved more in GEOP than AP patients and in GEOP subjects 
there was a slightly greater increase in mean GCF volume, but these were not 
statistically significantly different. GEOP patients had significantly greater 
reduction in PD 2 (±1.3) mm compared to 1.5 (±1.4) mm, (p=0.0002). A 
significantly greater reduction was noted in GEOP subjects compared to AP 
subjects 1.2 (±1.1) mm compared to 0.5 (±1.2) mm.
In GEOP patients (table 3.6) there was a greater decrease in the percentage of 
patients positive for P. gingivalis, P. intermedia, B. forsythus and A.
150
actinomycetemcomitans, but only the reduction in B. forsythus was significant. 
The decrease in T. denticola was the same for both groups.
Table 3.7 shows the greater reductions in the percentage of positive sites in 
GEOP compared to AP patients for all organisms, but only P. gingivalis and B. 
forsythus were significantly different.
3.1.6 Relationship between Pocket Depth and BOP, Supp and the
microflora 
Adult Periodontitis
The relationship between PD, BOP, Supp and the prevalence of the bacteria on a 
site basis at baseline is shown in table 3.8. 83.9% of sites were between 4-7mm 
and 16.1% over 7mm. Sites with initial pocket depths over 7mm had a 
statistically significantly greater percentage of positive sites for Supp, P. 
gingivalis, and P. intermedia. As the pocket depth increased the number of sites 
with none of the test bacteria decreased.
The response to treatment is shown in table 3.9. The deeper sites had a lower 
reduction for BOP, Supp, P. gingivalis, P. intermedia, and T. denticola. 
However only the difference in Supp scores was statistically significant. T. 
denticola prevalence did not alter in the deep sites compared to a decrease of 
26.6% in the shallower sites. P. gingivalis increased by 5.6% against a reduction 
of 12.8% in shallower sites. The change in P. intermedia was the same for both 
groups. The mean change in PD for the shallower sites was 1.4 (±1.2) mm
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compared to 2.4 (±1.7) mm for the deeper sites which was significant at 
p<0.0001. Mean change in AL was also significantly greater for the deeper site 
category.
Post-treatment 43.9% of sites were 0-4mm, 50% between 4-7mm and 7.1% over 
7mm (table 3.10). There were significantly higher numbers of positive sites for 
BOP, Supp, P. gingivalis, P. intermedia, B. forsythus, T. denticola, and a 
reduction in sites with no bacteria as the pocket depth increased.
GEOP
Table 3.8 shows the relationship between pocket depth, BOP, Supp and the 
prevalence of the bacteria on a site basis at baseline. Before treatment 54.2% of 
sites were between 4 and 7mm, and 45.8% over 7mm.
Percentage of sites with BOP increased slightly in deeper pockets but not 
significantly. Suppuration was statistically significantly higher in deeper sites. 
The prevalence of P. gingivalis, P. intermedia, A. actinomycetemcomitans and 
T. denticola decreased at deeper sites and the prevalence of B. forsythus was 
similar. 5.3% of sites had none of the bacteria investigated, but all sites over 
7mm had detectable flora.
In response to SRP pocket depth improved significantly more at the deeper sites
2.6 (±1.3) mm compared to 1.5 (±1.1) mm, p<0.0001 although gain in 
attachment was lower 1.0 (±1.1) mm to 1.3 (±1.1) mm, p=0.23 (table 3.9). The
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Table 3.10 Relationship between post-SRP pocket depth, BOP, Supp and microflora 
(percentage) in AP and GEOP patients
Pocket
Depth
No.
Sites
BOP Supp PG PI BF AA TD None
AP
0-3.99mm 48 31.3 0 20.8 20.8 18.8 0 6.3 60.4
4-6.99mm 56 55.4 10.7 37.5 39.3 48.2 0 26.8 28.6
7mm+ 8 87.5 37.5 87.5 62.5 62.5 0 37.5 0
p value 0.003 0.001 0.001 0.025 0.02 na 0.01 <0.001
GEOP
0-3.99mm 23 34.8 0 34.8 0 43.5 0 0 47.8
4-6.99mm 69 31.9 5.8 24.6 13 36.2 5.8 5.8 46.4
7mm+ 4 75 0 0 75 50 0 25 0
p value 0.2 0.2 0.3 <0.001 0.74 0.2 0.035 0.18
decrease in BOP was similar for both pocket depth categories although the 
change in suppuration was significantly greater at the deeper sites. There were 
greater reductions in P. gingivalis and A. actinomycetemcomitans at deeper sites 
but otherwise lower decreases for the other organisms. The differences in the 
reductions of P. gingivalis and B. forsythus were statistically significant.
After treatment 24% of sites were between 0-4mm, 71.9% between 4-7mm and 
4.1% over 7mm (table 3.10). There were no significant differences in the 
number of sites positive for suppuration, B. forsythus or
A. actinomycetemcomitans. BOP increased markedly in sites over 7 mm as did 
the prevalences of P. intermedia, B. forsythus and T. denticola. The higher 
percentages of P. intermedia and T. denticola at deeper sites were statistically 
significant. The number of sites with no detectable bacteria decreased sharply 
over 7mm, though these results should be interpreted with caution given the low 
number of sites over 7mm after treatment.
3.1.7 Relationship between bleeding on probing and clinical and 
microbiological parameters 
Adult Periodontitis
A comparison of clinical and microbiological parameters at AP BOP positive 
and negative sites at baseline is shown in table 3.11. Significantly more BOP 
negative sites were associated with smoking (62% compared to 23%, p=0.001). 
At baseline BOP sites had significantly more suppuration, and attachment loss. 
PD and GCF volume were higher, but not significantly compared to non-
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bleeding sites. There were no significant differences in the microflora at 
baseline. P. intermedia was slightly increased at bleeding sites and A. 
actinomycetemcomitans was not detected at non-bleeding sites.
Bleeding sites had greater though not significant reductions in Supp, PD and AL 
in response to SRP (table 3.11). Non-BOP sites had a five-fold greater increase 
in GCF volume. Bleeding sites reduced by just over half whereas half of the 
non-bleeding sites became positive after treatment. In response to therapy, P. 
intermedia and B. forsythus decreased more at bleeding sites, and P. gingivalis 
and T. denticola at non-bleeding sites. P. intermedia and A.
actinomycetemcomitans prevalence did not change in non-bleeding sites. 
However, there were no statistically significant differences.
Table 3.11 also shows the comparison of clinical and microbiological parameters 
at sites with and without BOP post-treatment. Sites which bled after treatment 
had significantly higher suppuration, pocket depths and attachment loss. Sites 
with bleeding post-SRP had higher percentages of sites with detectable test 
organisms than sites without bleeding, but these were not statistically significant.
A. actinomycetemcomitans was not detected post-treatment
GEOP
Significantly fewer BOP positive sites were found in smokers (Table 3.12). 
There were no significant differences in clinical and microbial parameters 
between BOP positive and negative sites at baseline.
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Response to therapy produced a 63% reduction in BOP at positive sites and a 
28% increase in negative sites (table 3.12). Otherwise there were no other 
statistically significant reductions in clinical parameters. The greater reduction 
in P. gingivalis at BOP negative sites compared to BOP positive sites 
approached significance. There was a reduction in the microflora at all sites.
Sites with BOP after treatment had significantly higher gingival inflammation, 
but were otherwise similar to non-bleeding sites (table 3.12). The flora was not 
significantly different also.
3.1.8 Relationship between suppuration and clinical and microbiological
parameters 
Adult Periodontitis
Suppurative sites at baseline were significantly associated with increased MGI, 
BOP, PD and AL (table 3.13). P. gingivalis and T. denticola were found at 
significantly higher frequencies in suppurative sites at baseline.
Both groups however had similar changes in response to SRP in all clinical 
parameters except GCF volume which decreased in suppurative sites and 
increased at non-suppurative sites (table 3.13). Suppurative sites reduced by 
81% and increased by 4% in negative sites. Suppurative sites had a significantly 
greater change in T. denticola, and also greater reduction in P. gingivalis, P. 
intermedia and B. forsythus.
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Post-therapy suppurative sites had significantly increased gingival inflammation, 
bleeding on probing, pocket depths, and attachment loss (table 3.13). More 
suppurating sites were from smokers than non-smokers. Significantly higher 
frequencies of P. gingivalis and B. forsythus were detected at suppurating sites, 
with increased T. denticola.
GEOP
Suppurating sites had significantly greater PD and AL at baseline (table 3.14). 
An average PD of 7.1 (±0.9) mm was recorded at suppurating sites compared to
6.6 (±1.0) mm at non-suppurating sites. The percentage prevalences of the test 
organisms were slightly, but not significantly, higher at suppurating sites.
A statistically significant reduction in BOP was noted at non-suppurating sites 
compared to suppurating sites (46% compared to 27%, 0.01) in response to SRP 
(table 3.14). Two percent of non-suppurating sites become suppurative and there 
was a decrease of 91% in the number of suppurative sites. The reduction in non­
suppurative sites for A. actinomycetemcomitans was significantly greater than 
suppurative sites, though all sites experienced a reduction in the test organisms 
after therapy (table 3.14).
Sites with suppuration after treatment had no significant differences in clinical 
parameters, though suppurative sites had a tendency for deeper pockets and more 
BOP (table 3.14). T. denticola and A. actinomycetemcomitans were not detected
156
Ta
bl
e 
3.1
4 
Co
m
pa
ris
on
 
of 
GE
OP
 
m
ea
n 
cl
in
ic
al
 a
nd
 
m
ic
ro
bi
al
 p
ar
am
et
er
s 
at 
sit
es
 w
ith
 
(+
) 
an
d 
w
ith
ou
t 
(-)
 s
up
pu
ra
tio
n 
at 
ba
se
lin
e,
 c
ha
ng
e 
in 
re
sp
on
se
 
to 
SR
P,
 a
nd
 
po
st
-S
R
P.
 
Nu
m
be
r 
of 
sit
es
 
in 
br
ac
ke
ts 
be
sid
e 
tit
le 
of 
ea
ch
 
co
lu
m
n 
an
d 
SD 
in 
br
ac
ke
ts 
be
sid
e 
nu
m
be
rs
.
p 
va
lu
e
0.3
7 
|
0.5
 
|
OOo
© na 
| | 
Z,00
m
©
I 
6800 0.3
1 
| I 
960
| 
1000
| 
£90 0.6
7 
| | 
£90
Su
pp
- 
Po
st 
(9
2)
OO
©+1,
OO
© 0.7
 
(±
0.
9)
32
.6
© 4.8
 
(±
1.
3)
12
.7 
(±
1.
7)
34
6 
(±
30
2.
8)
48
.9
Y9Z
601
38 4.
4
5.
4
Su
pp
+ 
Po
st 
(4
)
3 ,
sn
© 0.7
5 
(±
0.
5)
75
©
© 5.2
 
(±
0.
3)
12
.5 
(±
0.
3)
16
6.3
 
(±
14
7.
6)
75 25 50 50 © ©
p 
va
lu
e
600 0.
7
100
©
©
©
©V 0.
4 80
60
©
600 0.
3 ©
© 0.
5
Su
pp
- 
Ch
an
 
(6
3)
1.2
 
(±
1.
0)
0.5
 
(±
1.
1)
46 
(±
53
)
-2 
(±
13
)
1.9
 
(±
1.
3)
1.2
 
(±
1.
3)
-3
6.4
 
(±
39
2.
5)
22 35 43 Os CN
Su
pp
+ 
C
ha
n(
33
)
0.9
 
(±
0.
9)
0.3
 
(±
1.
4)
27 
(±
76
)
91 
(±
29
)
2.1
 
(±
1.
3) OO
©
+
-4
7.5
 
(±
28
4.
5)
39 46 48 so 27
p 
va
lu
e
0.
7
0.
7
0.
2
na
eoo 0.0
05 90 0.
94
0.
2
0.
2
© 0.
2 60
Su
pp
- 
Pr
e 
(6
3)
1.9
 
(±
1.
0)
1.1
 
(±
1.
1) N
<N
OO
©
(01+) 
9 
9 13
.5 
(±
1.
5)
30
7 
(±
26
5.
1)
49 49 46 so © 35
Su
pp
+ 
Pr
e(
33
)
2.0
 
(±
1.
1)
1.2
 
(±
1.
0)
67 
(±
48
)
10
0
7.1
 
(±
0.
9)
14
.4 
(±
1.
4)
28
1.4
 
(±
20
8.
2)
52 64 © r -oo OO 36
| 
C
lin
. 
Pa
ra
m
.
| 
M
G
I
| 
PL
I
| 
BO
P 
(%
)
| 
Su
pp
 
(%
)
| 
PD 
(m
m
)
s '
s''w''
<
| 
G
C
FV
ol
 (
nl
/3
0s
)
| 
Sm
ok
er
 
(%
)
| 
M
ic
ro
. 
Pa
ra
m
. 
(%
)
P.
 g
in
gi
va
lis
| 
P.
 i
nt
er
m
ed
ia
| 
B.
 f
or
sy
th
us
| +
. 
ac
tin
om
yc
et
em
| 
T. 
de
nt
ic
ol
a
in suppurative sites post-treatment and P. intermedia was found at a significantly
4
higher prevalence at these sites compared to non-suppurative sites (table 3.14).
3.1.9 Comparison of sites which gained and lost pocket depth 
Adult periodontitis
Thirteen sites increased in pocket depth and 96 decreased after therapy. Before 
treatment, there were no significant differences between these sites although 
loser sites had a tendency for lower bacterial prevalences and slightly more sites 
from smokers (table 3.15). In response to therapy, there was significantly less 
resolution of gingival inflammation, bleeding on probing and suppuration at 
loser sites. In addition pocket depth and attachment increased significantly at 
loser sites. GCF volume decreased slightly compared to an increase at gain sites. 
Gain sites had significantly greater reductions in bacterial prevalence for P. 
gingivalis, and T. denticola and loser sites recorded a slight increase in P. 
gingivalis. Loser sites had no change in percentage of positive sites for B. 
forsythus, A. actinomycetemcomitans and T. denticola. Post treatment, in 
addition to significantly deeper pockets, loser sites had significantly higher MGI, 
suppuration and attachment scores, and slightly higher bleeding. Sites which 
improved generally had lower bacterial prevalences, although there were no 
significant differences.
GEOP
Only three sites increased in pocket depth and this was not sufficient for 
meaningful analysis.
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3.1.10 Comparison of sites which gained and lost attachment 
Adult periodontitis
Twenty nine sites lost attachment compared to 80 which gained attachment. Not 
all sites which lost attachment were the same as those sites which lost pocket 
depth. At baseline sites which were to lose attachment, there was significantly 
less bleeding and a higher number were from smokers (table 3.16). These sites 
had significantly lower P. gingivalis prevalence and, in general, lower bacterial 
prevalences. Response to treatment resulted in significantly lower changes in 
bleeding on probing, suppuration and pocket depth in loser sites. There were 
lower reductions in bacterial prevalence and an increase in P. gingivalis at loser 
sites. The differences in the reductions for B. forsythus and T. denticola 
approached significance. Post-therapy loser sites had significantly greater 
gingival inflammation, suppuration and pocket depth, as well as attachment loss. 
Loser sites had a significantly higher detection frequency for P. gingivalis and, 
again in general, bacterial prevalences were higher.
GEOP
Eleven sites lost attachment and 82 gained attachment. Table 3.17 shows the 
clinical and microbial comparison of GEOP sites which gained and lost 
attachment at baseline. Clinically, sites which were to lose attachment had 
significantly lower attachment loss. There were no other significant differences 
at baseline, although the difference in suppuration approached significance. 
Before treatment, loser sites had lower prevalences for P. gingivalis and T.
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denticola, higher P. intermedia and B. forsythus, and A. actinomycetemcomitans 
was absent. These differences were not statistically significant however. Table 
3.17 also shows the change in clinical parameters in response to scaling and root 
planing at loser and gain sites. A significantly lower reduction in suppuration at 
loser sites was recorded compared to gain sites. These sites also had a lower, 
non-significant, reduction in pocket depth, and a decrease in GCF volume 
compared to an increase at gain sites. Both loser and gain sites had similar 
reductions for P. gingivalis, P. intermedia and B. forsythus. Gain sites had 
greater, but not significant, decreases in A. actinomycetemcomitans and T. 
denticola prevalences. Post-therapy, there were no significant differences 
between the sites. Loser sites had slightly higher bleeding and attachment loss 
but lower scores for the other parameters. Following SRP, loser sites showed 
higher detection frequencies for P. intermedia, B. forsythus and T. denticola and 
lower P. gingivalis. However these were not significant.
3.1.11 Relationship between the presence and absence of each organism and 
clinical and microbiological parameters 
AP sites
The presence of P. gingivalis in baseline sites was significantly related with 
suppuration and deeper pockets (table 3.18). Microbiologically, P. gingivalis 
positive sites had significantly greater frequencies of detection for P. intermedia, 
B. forsythus, and T. denticola at baseline. Although P. gingivalis positive sites 
had initially deeper pocketing, the reduction in clinical measurements was 
similar for positive and negative sites. The only significant difference was the
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significantly greater reduction in suppuration at positive sites. Twenty two 
percent of negative sites became positive for P. gingivalis after treatment. The 
percentage reductions in P. intermedia, B. forsythus, and T. denticola were 
significantly greater at P. gingivalis positive sites. Post-treatment P. gingivalis 
positive sites were associated with greater gingival inflammation, suppuration 
and pocketing. In addition, these positive sites had significantly higher 
percentages for P. intermedia, B. forsythus and T. denticola compared to 
negative sites.
Table 3.19 shows the differences in clinical measurements between P. 
intermedia positive and negative sites. P. intermedia positive sites had 
significantly greater GCF volume scores at baseline. PD, BOP and Supp were 
slightly greater but not significantly. At baseline P. gingivalis and B. forsythus 
were detected at significantly higher frequencies in positive sites compared to 
negative sites. There were no significant differences in the response to treatment 
between positive and negative sites. Positive sites had slightly greater reductions 
in pocket depth and the microflora. Negative sites gained P. intermedia, whereas 
P. intermedia was markedly reduced at positive sites. Following therapy, P. 
intermedia positive sites had significantly greater pocketing and suppuration. 
The presence of P. gingivalis and B. forsythus was significantly greater at 
positive sites than negative sites.
B. forsythus positive sites showed significantly lower MGI and PLI scores (table 
3.20). PD was significantly deeper at B. forsythus positive sites. Significantly
160
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more negative sites were associated with smokers. Before treatment P. 
gingivalis, P. intermedia, and T. denticola were significantly higher at positive 
sites. There was a significantly better improvement in plaque scores at B. 
forsythus negative sites, but a significantly better reduction in Supp at positive 
sites in response to SRP. Thirty percent of negative sites became positive for B. 
forsythus. Significantly greater reductions in P. gingivalis and T. denticola 
occurred at B. forsythus positive sites, and a slight increase in P. gingivalis was 
reported at negative sites. Sites positive after treatment had significantly higher 
gingival inflammation, plaque scores, suppuration, pocket depth, attachment 
loss, and percentage of sites from smoker subjects. At positive sites significantly 
higher prevalences of P. gingivalis, P. intermedia, and T. denticola were 
recorded.
There were only two A. actinomycetemcomitans positive sites, which was too 
small a number for a meaningful statistical analysis. Table 3.21 shows the 
clinical and microbiological parameters.
Table 3.22 shows a significantly increased number of suppurating sites and 
smokers in T. denticola positive sites compared to negative sites at baseline. At 
baseline, positive sites had significantly increased frequencies for P. gingivalis 
and B. forsythus. SRP produced a significantly greater decrease in suppurative 
sites in those positive for T. denticola compared to negative sites. Eleven 
percent of negative sites became positive for T. denticola. Significant changes in 
the prevalences of P. gingivalis and B. forsythus were noted at positive sites
161
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compared to negative sites. Post-treatment significantly greater gingival 
inflammation scores, plaque scores, and pocket depths were associated with T. 
denticola positive sites. BOP and suppuration and AL were also higher. P. 
gingivalis and B. forsythus were detected at significantly higher percentages at 
positive sites, and P. intermedia was also increased post-treatment.
GEOP sites
Table 3.23 shows the clinical measurements at P. gingivalis positive and 
negative sites. There were no significant differences at baseline or after 
treatment. Microbiologically there were no significant differences at baseline. 
The only significant difference comparing the change in clinical parameters in 
response to SRP was that P. gingivalis positive sites gained significantly more 
attachment. Just over a quarter of negative sites gained detectable P. gingivalis 
in response to therapy and there was a significantly greater reduction in
B. forsythus at these sites. After treatment the proportion of P. gingivalis 
negative sites that were in smokers was significantly higher. Post-therapy 
significantly higher levels of B. forsythus were detected at positive sites.
At baseline, detection of P. intermedia at sites was associated with significantly 
deeper pockets, as shown in table 3.24. B. forsythus was found at significantly 
higher levels in negative sites before treatment. A significantly greater reduction 
in MGI was recorded for positive sites in response to treatment. Eleven percent 
of P. intermedia negative sites became positive. The reduction in
A. actinomycetemcomitans was significantly greater at negative sites than
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positive sites. Significantly higher pocket depth and attachment loss were 
recorded at P. intermedia positive sites after treatment. All positive sites were 
from smokers. There were no significant differences in the prevalences of the 
flora.
At the outset B. forsythus positive sites had significantly lower MGI scores (table 
3.25). Before treatment T. denticola was found significantly more prevalent at 
positive sites and P. intermedia significantly increased at negative sites. In 
response to SRP the change in suppuration was significantly lower at
B. forsythus positive sites. A quarter of negative sites had detectable levels of
B. forsythus after treatment. A. actinomycetemcomitans and T. denticola were 
not found before or after treatment in negative sites. Consequently the reduction 
for these two organisms was significantly greater at positive sites. P. intermedia 
reduced significantly more at negative sites. B. forsythus positive sites post-SRP 
were not significantly different from negative sites, although BOP, suppuration 
and PD were slightly higher. However, a significantly higher number of sites 
were positive for P. gingivalis and B. forsythus, with A. actinomycetemcomitans 
and P. intermedia more frequent also.
A. actinomycetemcomitans positive sites had significantly lower MGI scores and 
GCF volume at baseline, shown in table 3.26. T. denticola was found with 
higher frequency at positive sites and this was significant. In response to SRP 
the change in MGI was significantly greater at negative sites and PLI at positive 
sites. Positive sites had a much greater reduction in T. denticola and negative
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sites a greater reduction in P. intermedia. Both of these were significantly 
different. Post-therapy all A. actinomycetemcomitans positive sites were from 
smokers and had significantly higher gingival inflammation. BOP, PD and AL 
were higher but not significantly. There were higher frequencies of 
P. intermedia, B. forsythus and T. denticola at positive sites and lower 
frequencies of P. gingivalis, but these were not significant. Only four sites were 
positive after therapy so these results should be treated with caution.
The clinical parameters for T. denticola positive and negative sites are shown in 
table 3.27. There were no significant differences before treatment. B. forsythus 
was found at all positive sites and this was statistically significant. 
A. actinomycetemcomitans was also found with significantly increased frequency 
at positive sites. In response to treatment the reduction in plaque levels at 
positive sites was significantly lower. The reductions in B. forsythus and 
A. actinomycetemcomitans were significantly greater at positive sites. There was 
a 95% decrease in the detection of T. denticola at positive sites and a 5% 
increase at negative sites. The only significant difference between negative and 
positive sites after therapy was the poorer plaque levels at T. denticola positive 
sites. B. forsythus was still detected at all positive sites and
A. actinomycetemcomitans increased compared to negative sites, almost to 
significance.
164
Ta
bl
e 
3.2
7 
Co
m
pa
ris
on
 
of 
GE
OP
 
me
an
 
cl
in
ic
al
 a
nd
 
m
ic
ro
bi
al
 p
ar
am
et
er
s 
at 
sit
es
 w
ith
 
(+
) 
an
d 
w
ith
ou
t 
(-)
 
T. 
de
nt
ic
ol
a 
at 
ba
se
lin
e,
 c
ha
ng
e 
in 
re
sp
on
se
 
to 
SR
P,
 a
nd
 
po
st
-S
R
P.
 
Nu
m
be
r 
of 
sit
es
 
in 
br
ac
ke
ts 
be
sid
e 
tit
le 
of 
ea
ch
 
co
lu
m
n 
an
d 
SD 
in 
br
ac
ke
ts 
be
sid
e 
nu
m
be
rs
.
p 
va
lu
e
0.
31
1 
eoo
I 
617'0 0.
73 r-
©
I 
660
p-CO
d
lO
©
C"
©
I 
90
o©
d
r-o
o ac
TD
- 
Po
st 
(9
1)
OO
o'+!,
OO
d
(6 
0+) 
9 
0 35
.2
4.
4
4.7
 
(±
1.
2)
12
.7 
(±
1.
7)
32
7.8
 
(±
28
8.
8)
49
.4
25
.3
12
.9
35
.2
3.
3
o
TD
+ 
Po
st 
(5
)
1.2
 
(±
1 .
1 )
1.4
 
(±
0.
9)
20 o 5.8
 
(±
1.
4)
12
.7 
(±
1.
8)
53
3 
(±
45
3)
09 40 20 10
0
20
oo
p 
va
lu
e
900
mO
©
n
o
0.
45
0.
39
190
660 0.
4
0.
14
9100
100
oq
dV
TD
- 
Ch
an
 
(6
2)
1.3
 
(±
1.
0)
0.3
 
(±
1.
1)
37 29 1.9
 
(±
1.
3)
(O' 1+) 
IT
-40
 
(±
34
1)
29 44 32 in■
TD
+ 
Ch
an
 
(3
4)
0.9
 
(±
0.
9)
0.7
 
(±
1.
3)
44 32 2.2
 
(±
1.
3)
1.2
 
(±
1.
3)
-41
 
(±
39
0)
27 29 68 00 94
p 
va
lu
e
0.
64
0.
12
890
680
OOOO
d 0.
29
0.
38
600 0.
14
0.
32
1000
9100 na
TD
- 
Pr
e 
(6
2)
1.9
 
(±
1.
1)
(0
1
+) O
'! 73 
(±
45
)
34 
(±
48
)
6.8
 
(±
1.
1)
13
.7 
(±
1.
6)
31
3 
(±
24
9)
56 59
.7 OO
in 74
.2
6.
5
o
TD
+ 
Pr
e 
(3
4)
1.8
5 
(±
0.
9)
1.3
5 
(±
1.
1)
77 
(±
43
)
35 
(±
48
)
6.8
 
(±
0.
7)
14 
(±
1.
3)
26
8 
(±
23
6)
38 44
.1
44
.1
10
0
23
.5
10
0
| 
Cl
in
. 
Pa
ra
m
.
| 
M
G
I
P h
| 
BO
P 
(%
)
| 
Su
pp
 
(%
)
| 
PD 
(m
m
)
| 
AL
 
(m
m
)
| 
G
C
FV
ol
 (
nl
/3
0s
)
| 
Sm
ok
er
 (
%
)
| 
M
ic
ro
. 
Pa
ra
m
. 
(%
)
| 
P.
 g
in
gi
va
lis
| 
P.
 i
nt
er
m
ed
ia
| 
B. 
fo
rs
yt
hu
s
| A
. 
ac
tin
om
yc
et
em
| 
T. 
de
nt
ic
ol
a
3.1.12 Relationship between the change in site microflora and change in site 
pocket depth
Sites that gained any of the test organisms showed a trend for slightly lower 
reductions in pocket depth. Sites in which P. gingivalis and B. forsythus reduced 
had significantly greater pocket depth reductions than those that gained these 
organisms (table 3.28).
3.1.13 Clustering of bacteria
Figure 3.1 displays the frequency of detection of each organism and combination 
of organisms for AP and GEOP samples at baseline. In AP samples there were 
high frequencies for combinations of P. gingivalis, P. intermedia, B. forsythus 
and T. denticola. In GEOP samples B. forsythus was detected at all T. denticola 
and A. actinomycetemcomitans positive sites. Also there were high percentages 
at sites for combinations of P. gingivalis, P. intermedia, B. forsythus and 
T. denticola, but not as high as AP samples. 23.5% of AP and 3.1% of GEOP 
samples did not have detectable bacteria.
Table 3.29 shows the effect of the presence and absence of combinations of 
organisms on individual organisms at AP sites. The effect of the presence of 
each organism on the other bacteria has already been reported in tables 3.18 to 
3.22. The analysis of the organisms showed that when any of these bacteria, P. 
gingivalis, P. intermedia, B. forsythus and T. denticola, were found, whether 
singly or in combinations with each other, they had a significant positive effect 
on the frequency of detection of the other bacteria in this group. A.
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Table 3.28 Relationship between loss or gain in site bacteria and change in site 
pocket depth. SD shown in brackets.
Ch Orgs P. gingivalis P. intermedia B. forsythus A. actinomyce T. denticola
Gain (mm) 0.56 (±1.2) 1.5 (±1.9) 0.72 (±1.0) na 1.0 (±1.8)
Loss (mm) 1.3 (±1.4) 1.8 (±1.2) 1.4 (±1.3) 2.9 (±0.6) 1.2 (±1.2)
p value 0.008 0.42 0.03 na 0.14
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Figure 3.1 Bacterial combinations in AP and GEOP subjects
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actinomycetemcomitans frequencies were too low for meaningful statistical 
analysis but the organism was always found at sites with the combination P. 
gingivalis, B. forsythus and T. denticola.
Table 3.30 shows the effect of the presence and absence of combinations of 
organisms on the prevalence of individual bacteria in GEOP patients. The 
prevalence of the individual bacteria at positive and negative sites for each 
organism has already been reported in tables 3.23 to 3.27. P. intermedia was 
detected significantly more frequently at P. gingivalis/B. forsythus positive sites 
and B. forsythus at P. intermedia/P. gingivalis positive sites. A. 
actinomycetemcomitans was found significantly more often at B. forsythus/T. 
denticola positive sites. Although the number of positive sites was small T. 
denticola was significantly more frequently detected at P. intermedia/A 
.actinomycetemcomitans, B. forsythus/A. actinomycetemcomitans and P. 
intermedia/B. forsythus/A. actinomycetemcomitans positive sites.
3.1.14 Regression analysis
Multiple linear regression with backward elimination was used to determine the 
relationship between PD and other clinical and microbial parameters in all 
patients as well as AP and GEOP subjects. In addition the relationships between 
change in PD and change in the other clinical and microbial parameters, and 
baseline clinical and microbial parameters were examined.
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In all subjects baseline pocket depth was significantly and positively related to 
MGI, presence of suppuration, AL, presence of B. forsythus, GEOP and 
negatively to smoking (p<0.001, R 46.4%). Change in PD in response to SRP 
was significantly and positively related to change in AL, change in MGI and 
GEOP, and negatively to smoking (p<0.001, R2 37.7%). Change in PD in 
relation to baseline measurements was significantly and positively related to PD 
and negatively to AL, GCF volume, presence of B. forsythus and smoking ( 
p<0.001, R2 26.9%).
In AP subjects baseline pocket depth was significantly and positively related to 
presence of suppuration, AL, and presence of B. forsythus (p<0.001, R 47.2%). 
Change in PD in response to SRP was significantly and positively related to 
change in AL, and change in MGI, and negatively to smoking (p<0.001, R 
35.4%). Change in PD in relation to baseline measurements was significantly 
and positively related to PD and negatively to AL, presence of B. forsythus and 
smoking (p<0.001, R2 24.0%).
In GEOP subjects baseline pocket depth was significantly and positively related 
to MGI, PLI, AL, presence of P. intermedia (p<0.001, R2 29.6%). Change in PD 
in response to SRP was significantly and positively related to change in AL and 
negatively to smoking (p<0.001, R2 36.3%). Change in PD in relation to 
baseline measurements was significantly and positively related to PD and MGI, 
and negatively to AL and smoking (p<0.001, R2 43.8%).
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3.2 Comparison of AP and GEOP patients: Discussion
3.2.1 Comparison of AP and GEOP patients at baseline
Although the same selection criteria were used for each patient group, and based 
on PD, there were a number of significant differences in the clinical 
measurements. AP patients appeared to exhibit significantly more gingival 
inflammation than GEOP patients. GEOP patients were found to have 
significantly lower BOP scores than AP patients, and similarly significantly 
lower GCF volumes. As the BOP score may relate to probing pressure and 
technique, it is possible that operator variation is responsible for the differences 
between AP and GEOP subjects. GCF measurements tend to be more objective 
and provide a continuous variable which relates to degree of gingival 
inflammation. The GCF samples were taken using identical paper strips, for the 
same duration, measured in the same machine and calibrated on the same curve. 
These differences in inflammation are therefore more likely to be due to the 
higher numbers of smokers in the GEOP group or that GEOP patients have less 
gingival inflammation.
In AP subjects the patient-based analysis showed that the most common 
organism was P. intermedia (72.7%), followed by B. forsythus (63.6%), P. 
gingivalis and T. denticola (both 54.4%) and lastly A. actinomycetemcomitans 
(3%). The order was slightly different in the site-based analysis. B. forsythus 
was the most common (57.6%), then P. intermedia (56.8%), P. gingivalis 
(43.9%), T. denticola (37.1%), and A. actinomycetemcomitans (1.5%). The high 
level of detection of these organisms supports the hypothesis that AP is a
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polymicrobial infection, but the low level of A. actinomycetemcomitans may 
suggest that the other organisms may be more relevant in this disease.
B. forsythus was the most commonly detected organism in GEOP patients 
(91.7%), followed by P. intermedia (79.2%), P. gingivalis (62.5%), T. denticola 
(45.8%) and A. actinomycetemcomitans (20.8%). The site-based analysis gave a 
slightly different order. Again B. forsythus was the most prevalent (83.3%), but 
followed by P. gingivalis (54.2%), P. intermedia (51.0%), T. denticola (35.4%) 
and A. actinomycetemcomitans (12.5%). The high prevalence of B. forsythus in 
both patients and sites compared to the other organisms suggests that it may be 
more closely associated with GEOP.
Both the patient and site analysis of the microflora between the two groups 
revealed significant differences between the prevalences of B. forsythus and A. 
actinomycetemcomitans in AP and GEOP subjects. GEOP patients have a 
significantly higher prevalence of both of these organisms, which may be due to 
the deeper pockets noted in our GEOP patients or perhaps their greater 
involvement in the GEOP disease process. Studies by Dzink et al. (1985) and 
Christersson (1992) have previously reported that B. forsythus is associated with 
deeper pockets. P. gingivalis and P. intermedia are also found at a higher 
prevalence in GEOP than AP patients, but this was not statistically significantly 
different, and may also reflect the deeper pocketing. The prevalence of T. 
denticola was similar between the two groups.
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Other studies that have used PCR to detect the presence of periodontopathogens 
have reported different detection rates than found in this study. Riggio et al. 
(1996) reported 24% of 43 AP patients positive for both P. gingivalis and A. 
actinomycetemcomitans. In this study we found P. gingivalis in 54.5% and A. 
actinomycetemcomitans in 3% of AP patients. In a subsequent study, Riggio et 
al. (1998) found 39% of sites and 52% of AP patients PCR-positive for P. 
intermedia. Mooney et al. (1995) reported that 29% of AP patients were positive 
for P. gingivalis and 47% for A. actinomycetemcomitans. Similarly varying 
prevalences have been reported by other authors (Christersson, 1992; Haffajee et 
al., 1988a; Dzink et al., 1985; Ashimoto et al., 1996; Moore et al., 1982) 
indicating that there is considerable variation in the detection of pathogenic flora 
and also methodolgical variation between different studies. The high levels of 
positive sites and patients for the organisms investigated in this study supports 
the polymicrobial nature of periodontal disease.
The level of T. denticola detection was similar between both disease groups 
(37.1% of AP sites and 35.4% of GEOP sites), but much higher than previously 
reported (Moore et al., 1982; Riviere et al., 1995). Riviere et al. (1995) detected 
high levels of spirochaetes in AP patients, but only 16% of sites were positive 
for T. denticola. Our higher prevalences may reflect a more accurate and 
sensitive diagnostic technique. The difficulty in culturing T. denticola may have 
masked its role in periodontal disease, and further studies using non-culture 
techniques could indicate that T. denticola may have an important role in both 
AP and GEOP.
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Kamma et al. (1994) examined a number of periodontopathogens from GEOP 
patients by culture. It was reported that in pockets over 6mm in depth, 
P. gingivalis was detected in 91.7%, B. forsythus in 53.4%, and
A. actinomycetemcomitans in 10.9% of sites. In that study the prevalence of P. 
gingivalis was higher, with B. forsythus and A. actinomycetemcomitans lower 
when compared with our study. P. gingivalis was the more prevalent 
microorganism in the study of Kamma et al. (1994), whereas B. forsythus was 
the more prevalent microorganism in our present study. The fact that two 
pathogens can be detected at different levels in two similar groups of patients 
again supports the variable and polymicrobial nature of periodontal disease. 
Christersson (1992) found a correlation between B. forsythus and P. gingivalis 
and deep pockets, but none for P. intermedia and A. actinomycetemcomitans.
3.2.2 Effect of SRP on clinical parameters
SRP significantly reduced all clinical variables except GCF volume, which 
increased slightly in both patient groups. In AP patients pocket depth reduced by 
a mean of 1.5 (±1.4) mm and GEOP patients by on average 2.0 (±1.3) mm. The 
initial average pocket depth for AP subjects was 5.9 (±1.3) mm and the reduction 
in these patients is slightly greater than that previously reported of 0.7mm to 1.3 
mm (Becker et al., 1988; Hammerle et al., 1991; Hill et al., 1981; Kaldahl et al., 
1988; Knowles et al., 1979; Pihlstrom et al., 1981; Ramfjord et al., 1987). The 
greater reduction in GEOP patients probably reflects the deeper pockets and 
perhaps differences between operators. The decrease in pocket depth is within
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the range of previous studies of 1.2mm to 2.9mm (Becker et al., 1988; 
Hammerle et al., 1991; Hill et al., 1981; Kaldahl et al., 1988; Morrison et al., 
1980; Pihlstrom et al., 1981; Ramfjord et al., 1987). The attachment gains for 
both patient groups is similar to that of previously published work. In both 
GEOP and AP patients SRP was effective in reducing pocket depth and there 
were few pockets that did not benefit from non-surgical therapy (Badersten et al., 
1984a).
It has been demonstrated that the extent of connective tissue inflammation is 
different between bleeding and non-bleeding sites (Greenstein et al., 1981; 
Harper & Robinson 1987; Passo et al., 1988). Despite the reservation of some 
authors concerning low reproducibility for bleeding on probing scores (Janssen 
et al., 1986), evidence suggests that the bleeding on probing decreases after a 
successful treatment (Caton et al., 1982; Proye et al., 1982) and therefore could 
be used as a part of a diagnostic test to evaluate treatment outcome.
BOP was significantly reduced for both patient groups and, although not as large 
as some studies have reported, still agrees with previous reports (Badersten et al., 
1984a; Magnusson et al., 1984; Nordland et al., 1987; Cercek et al., 1983). This 
may reflect differences in pocket depths, and difficulties in resolving 
inflammation in deeper pockets, the different study populations, the skills of the 
operator or the plaque control levels of the patients, which if poor may allow 
early re-colonisation and subsequent re-inflammation. However, in accordance 
with previous studies SRP is effective in reducing BOP.
172
The number of suppurating sites decreased significantly after therapy in both 
groups and indicates that SRP is effective in reducing suppuration. The 
formation of pus in some periodontal pockets suggests that in these sites the host 
defences are overwhelmed by the microbial challenge and studies by Badersten 
et al. (1985c, 1990) and Claffey et al. (1990) have shown that the presence of 
suppuration increased the positive predictive value for further breakdown. 
Following therapy there is a significant reduction in bacterial load, which will 
allow the host defences to re-establish control and promote healing. It is 
probably the effect of the removal of the bacterial load that reduces suppuration.
The reduction in gingival index reflects the decrease in inflammation as a result 
of the removal of the bacterial challenge, the healing response and the patients’ 
oral hygiene. Comparison with other studies is complicated because of the 
number of different gingival inflammatory indices that have been used over the 
years. However the reduction in both patient groups agrees with published 
reports which indicate a reduction after non-surgical therapy (Becker et al., 1988; 
Singletary et al., 1982; Lavanchy et al., 1987).
Post-therapy there were significant improvements in plaque control in both 
groups, in keeping with reported data (Magnusson et al., 1984; Cercek et al., 
1983; Badersten et al., 1984a; Nordland et al., 1987). Oral hygiene cannot 
significantly change the microflora especially in deeper sites without SRP (Kho 
et al., 1985; Beltrami et al., 1987; Smulow et al., 1983). However it is important
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to prevent re-colonisation of pockets after SRP and could influence the 
subgingival flora (Dahlen et al., 1992; McNabb et al 1992; Katsulanos et al., 
1992). Good oral hygiene is a pre-requisite for improvement in gingival 
inflammation.
The volume of GCF has been shown to be correlated with the degree of 
inflammation in the gingival tissue (Brill, 1960; Mann et al., 1963; Egelberg et 
al., 1964). The GCF volume increased slightly following therapy in contrast to a 
decrease in MGI and BOP. The decreased bacterial load which allows re­
establishment of proper host responses and increased tissue turnover due to the 
healing process may account for the slight increases found.
As reported in previous studies, SRP is effective in improving clinical condition 
and in both AP and GEOP patients.
3.2.3 Effect of SRP on the microflora 
Adult Periodontitis
Although the frequency of detection remained the same, reductions in the 
percentage of positive sites for P. intermedia, B. forsythus and T. denticola were 
found with the elimination of A. actinomycetemcomitans. However, SRP 
produced no significant decreases in the microflora in AP patients.
However on a site basis, there were decreases in the detection of all organisms. 
P. intermedia, B. forsythus and T. denticola had statistically significant
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reductions of about 20%, P. gingivalis decreased by 10% and
A. actinomycetemcomitans below the level of detection of PCR.
P. gingivalis has been reported to respond readily to SRP (Renvert et al., 1990a). 
Significant reductions in P. gingivalis detection generally occur after SRP 
(Renvert et al., 1990a; Lowenguth et al., 1995; Wikstrom et al., 1993; Renvert et 
al., 1997; Preber et al., 1995; Shiloah & Patters, 1994; Rosenburg et al., 1993; 
Ali et al., 1992; Goodson et al., 1991), although it is usually greater for sites than 
patients (Al-Yahfoufi et al., 1994; Wikstrom et al., 1993). Compared to these 
studies the decrease in P. gingivalis is low. Maiden et al. (1991) and Haffajee et 
al. (1997a) also reported a similarly low decrease of about 6-15% of sites. The 
differing results may reflect the microbiological test used, inadequate SRP, or 
the group of patients examined. A significant reduction in P. gingivalis has been 
correlated with clinical improvement and poorly responding sites still had high 
levels of P. gingivalis (Renvert et al., 1990a; Wikstrom et al., 1993; Newman et 
al., 1994). However this was not found in our study where continuing high 
prevalences were found irrespective of clinical improvement. Given the good 
clinical improvement, the response is unlikely to be the result of poor SRP. PCR 
was used to analyse subgingival plaque samples whereas culture or DNA probes 
were used in other studies quoted. The difference in the limits of detection may 
have resulted in the differing results. PCR has a much lower detection limit 
(102) compared to culture (104’6) and DNA probes (104‘5), and what may be 
negative for these two tests may still be positive for PCR. Interestingly, both
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Maiden et al. (1991) and Haffajee et al. (1997a) used DNA probes with a 
detection limit of about 104.
P. intermedia is readily reduced by treatment (Mombelli et al., 1995) and the 
response in our patient group supports previous studies (Ali et al., 1992; Renvert 
et al., 1990a; Bragd et al., 1987; Wikstrom et al., 1993).
Although B. forsythus is a named aetiological agent, there are relatively few 
studies that examine the effect of SRP on its prevalence. Haffajee et al. (1997a) 
reported its reduction from roughly 50% to 30% with SRP. The reduction in
B. forsythus compares favourably with this study.
A. actinomycetemcomitans can be very difficult to eradicate from deep 
periodontal pockets (Renvert et al., 1990a, b, 1996; Bragd et al., 1987). 
Following treatment the decrease in A. actinomycetemcomitans is often not as 
great as that for other organisms (Flemmig et al., 1998; Renvert et al., 1997; 
Nieminen et al., 1996; Preber et al., 1995; Mombelli et al., 1994 a, b; Shiloah & 
Patters, 1994; Wikstrom et al., 1993; Goodson et al., 1991; Renvert et al. 1990 a, 
b; Maiden et al., 1991). SRP eliminated A. actinomycetemcomitans from AP 
patients. Previously Ali et al. (1992) and Rosenberg et al. (1993) had reported 
similar findings using SRP. In all three patient groups there were relatively low 
levels of A. actinomycetemcomitans before treatment compared to other studies 
where A. actinomycetemcomitans was not eliminated. This may account for the 
differences between the studies. Mombelli et al. (1994b) described a subset of
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patients which was highly infected by A. actinomycetemcomitans and maintained 
high levels after treatment. Patients with only a few positive sites responded 
much better to treatment than those heavily infected patients. The current group 
of AP patients would seem to belong to Mombelli’s lightly infected group. The 
elimination of A. actinomycetemcomitans was accompanied by clinical 
improvement, but given the low prevalence of the organism before treatment, the 
effect of A. actinomycetemcomitans on the periodontal condition was probably 
not as great as the other study organisms. It should be borne in mind that 
because the level of A. actinomycetemcomitans is low the results should be 
interpreted with some degree of caution.
T. denticola levels decreased readily with SRP. SRP has been shown to be very 
effective in reducing T. denticola numbers (Simonson et al., 1992; Loesche et 
al., 1992b; Katsanoulos et al., 1992; Haffajee et al., 1997a). The decrease in 
T. denticola prevalence is similar to that reported in these studies.
Although a decrease in the pathogenic flora accompanied an improvement in 
clinical condition, multiple regression with backward elimination did not link a 
decrease in any of the test organisms with this improvement. Previous studies 
have linked the reduction or elimination of P. gingivalis (Newman et al., 1994; 
Haffajee et al., 1997a), P. intermedia (Newman et al., 1994), B. forsythus 
(Haffajee 1997a; Socransky & Haffajee 1993), A. actinomycetemcomitans 
(Goene et al., 1990; Mombelli et al., 1994b; Renvert et al., 1990a) and 
T. denticola (Haffajee et al., 1997a; Simonson et al., 1992) with clinical
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improvement in AP patients. The difference may be due again to the microbial 
test used. PCR used was not quantitative, and only gave a present or absent 
score. The studies that have found links have used quantitative or semi- 
quantitative techniques such as culture, ELISA or Checkerboard.
GEOP
In GEOP patients SRP resulted in a decrease in the prevalence of all bacteria 
which was significant for P. intermedia and B. forsythus. This pattern was 
repeated for the site analysis, where there were significant decreases for all the 
test organisms.
P. gingivalis reduced by over 10% in patients and about 30% in sites. Gunsolley 
et al. (1994) reported a decrease of about 6% in sites following SRP, but the 
prevalence of P. gingivalis was low at 6.7% before treatment. Rosenberg et al.
(1993) found a decrease in P. gingivalis positive patients from 100% before 
treatment to 67% after treatment and Sigurdsson et al. (1994) demonstrated a 
50% reduction in the number of positive sites in their study population aged 34- 
37 years.
P. intermedia reduced markedly in patients and sites, by 50% and 40% 
respectively, which suggests that SRP is very effective in reducing its numbers 
and supports the findings of Mombelli et al. (1995). Masunaga et al. (1990) 
similarly reported decreased P. intermedia detection frequencies after SRP.
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B. forsythus also demonstrated significant decreases in both patients and sites. 
Comparison with published studies is difficult however. Studies on GEOP 
patients do not appear to have investigated the effect of SRP on its prevalence, 
perhaps due to its difficulty of culture, or have included this patient group with 
Adult or Advanced periodontitis groups. Our results show that in GEOP 
subjects B. forsythus responds readily to SRP, but prevalences are still high post­
therapy compared to other organisms.
There were smaller reductions in the detection of A. actinomycetemcomitans 
compared to the other organisms, 12% of patients and 8% of sites. This is higher 
than reported in studies by Gunsolley et al. (1994), Sigurdsson et al. (1994) and 
Rosenberg et al. (1993). In all these studies A. actinomycetemcomitans was not 
eliminated from GEOP patients. Rosenberg et al. (1993) showed that SRP had 
no effect on the prevalence of A. actinomycetemcomitans, Gunsolley et al.
(1994) reported a 3% reduction and Sigurdsson et al. (1994) a 5% decrease. The 
low reduction in A. actinomycetemcomitans may reflect its ability to invade 
gingival epithelial tissue (Meyer et al., 1991), which may act a source of re­
infection.
The reductions in T. denticola were not as high as P. gingivalis, P. intermedia or
B. forsythus, but there was still a significant reduction in the number of sites 
infected. Again there appear to be few studies which have examined the effect 
of SRP on T. denticola levels. However the spirochaete does seem to respond 
readily to treatment in GEOP patients.
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Masunuga et al. (1990) linked the reductions in P. gingivalis and P. intermedia 
numbers with clinical improvement. Regression analysis of the clinical 
microbiological data from the GEOP patients failed to link reduction of any the 
organisms with clinical improvement, which may again be due to the 
microbiological test rather than the absence of a link.
Comparison of AP and GEOP
Before treatment, P. gingivalis, P. intermedia, B. forsythus and 
A. actinomycetemcomitans were more frequently detected in GEOP patients, but 
post-treatment P. gingivalis and P. intermedia were more common in AP 
patients. GEOP patients still had higher numbers of positive patients for B. 
forsythus and A. actinomycetemcomitans. T. denticola remained higher in AP 
subjects.
A. actinomycetemcomitans and B. forsythus were no longer significantly higher 
in GEOP patients following treatment, although both were still more prevalent.
A. actinomycetemcomitans was eliminated from AP patients but not GEOP 
patients which may reflect the higher prevalence of the organism in GEOP 
patients before treatment.
Compared to AP sites, pre-treatment GEOP sites had higher prevalences of P. 
gingivalis, B. forsythus and A. actinomycetemcomitans, and lower P. intermedia 
and T. denticola. Post-treatment AP sites had a significantly higher percentage
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of positive sites for P. intermedia and T. denticola, higher P. gingivalis, similar
B. forsythus and lower A. actinomycetemcomitans compared to GEOP. GEOP 
patients had greater changes for all the test organisms except T. denticola. The 
change in B. forsythus in GEOP patients and sites was statistically significantly 
greater than AP patients and sites. GEOP sites also had significantly more 
reduction in P. gingivalis, P. intermedia and A. actinomycetemcomitans 
prevalences.
The differences may reflect the greater pocket depth change in GEOP patients. 
A deeper pocket before treatment or greater change in pocket depth may be 
accompanied by a greater decrease in the flora, though Haffajee et al. (1997a) 
showed similar decreases in the P. gingivalis numbers irrespective of initial 
pocket depth.
These results suggest that it is harder to reduce bacterial levels in AP, higher 
prevalences respond better to treatment and lower prevalences may be 
eliminated. Mombelli et al. (1991b, 1994b) also reported difficulties in 
eradicating high levels of organisms. The elimination of A. 
actinomycetemcomitans and continuing higher levels of B. forsythus in GEOP 
patients supports the hypothesis that these two have a greater role in the disease 
process in GEOP than AP.
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3.2.4 Relationship of pocket depth and BOP, Suppuration and response to 
treatment
Deeper sites in both AP and GEOP patients had slightly more BOP than 
shallower sites. Both Cercek et al. (1983) and Badersten et al. (1985c) reported 
similar findings. Increased BOP at deep sites suggests a greater inflammatory 
response, which could be through an increased microbial load or the result of the 
greater destruction at these sites. The deeper sites in AP patients had a lower 
reduction in BOP than shallower sites, probably due to either difficulties in 
effectively scaling and root planing these sites or the continuing high numbers of 
the pathogens.
The increase in suppuration at deeper sites also reflects the increased bacterial 
numbers at these sites, and the resulting increased microbial challenge to the 
immune system as a result. Following therapy suppuration was linked with 
deeper AP sites but not in GEOP subjects. Increased prevalences were found for 
4 of the 5 test organisms at deeper sites after therapy in AP patients and included 
P. gingivalis and T. denticola which are associated with suppuration (Socransky 
et al., 1991). There was no clear relationship between pocket depth and 
colonisation after treatment in GEOP sites, which may account for the 
difference.
The changes in pocket depth in both disease groups and attachment in AP 
subjects were greater in deeper pockets and similar to those reported in previous
studies. Interestingly the deeper pockets in GEOP subjects recorded lower 
attachment gains than the shallower pockets. The reasons for this are unclear.
3.2.5 Relationship of pocket depth and the microflora present and response 
to therapy
In AP subjects the presence of P. gingivalis, P. intermedia, B. forsythus and 
T. denticola were related to pocket depth, both before and after treatment. 
P. gingivalis has been reported in increasing numbers in deeper pockets (Wolff 
et al., 1993; Wikstrom et al., 1993; Kojima et al., 1993; Christersson, 1992; 
Socransky et al., 1991) and its presence after therapy linked with deeper sites 
(Mombelli et al., 1991a; Wikstrom et al., 1993). Similarly P. intermedia 
numbers correlated with increasing pocket depth (Beck et al., 1992; Mombelli et 
al., 1991a; Haffajee et al., 1991b; Wolff et al., 1993). B. forsythus is also 
commonly found in increased numbers at deeper sites (Socransky et al., 1991; 
Dzink et al., 1985; Machtei et al., 1997), as have spirochaetes (Tanner et al., 
1984; Savitt & Socransky, 1984).
It is harder to reduce bacterial numbers in deeper sites (Mombelli et al., 1991b, 
1994b), as the results in this thesis also suggest. There is often a positive 
correlation between the residual probing depth following SRP and the presence 
of periodontal pathogens (Lindhe et al., 1985; Magnusson et al., 1984; Slots et 
al., 1985). This may be due to the more anaerobic conditions in deeper pockets, 
which may favour more rapid re-colonisation by anaerobic bacteria (Dzink et al., 
1985, 1988; Tanner et al., 1979), or less effective treatment as the pocket depth
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increases.
GEOP patients in general did not fit into this pattern. T. denticola and 
P. intermedia showed a trend for increasing numbers as the pocket depth 
increased but P. gingivalis, B. forsythus and A. actinomycetemcomitans did not. 
The low numbers of sites over 7 mm means that the results should be interpreted 
with caution. It may be that if the number of deep sites was increased this trend 
would become evident, or that the slightly better plaque control in these patients 
did not allow re-colonisation as quickly as AP patients and so the pattern did not 
develop.
The slight increase in P. gingivalis after treatment may have resulted from the 
time interval between the last SRP visit and sampling. If the sample had been 
taken within two weeks, there would probably have been much lower levels of 
P. gingivalis and other organisms. The three/four month delay may have 
allowed sufficient time for re-colonisation back to pre-treatment levels to have 
occurred (Magnusson et al., 1984; Sbordone et al., 1990a). Sbordone et al. 
(1990a) reported in their study that P. gingivalis prevalences returned to pre­
treatment levels more quickly than other organisms studied in their 60 day 
investigation. The similar P. gingivalis prevalences in this study before and after 
SRP in AP patients may reflect this more rapid colonisation. Differing re­
colonisation rates may also account for the differences between GEOP and AP 
sites.
3.2.6 Associations between the microflora and clinical measurements after 
treatment
A number of studies have indicated that after treatment persistent high levels of 
P. gingivalis, P. intermedia and A. actinomycetemcomitans may be associated 
with further disease progression or refractory periodontitis (Walker & Gordon, 
1990; Tanner et al., 1987a; Mombelli et al., 1994b). Therefore it is worthwhile 
to assess the relationship of the microflora on the clinical measurements post­
therapy.
A number of negative AP sites became infected after SRP by P. gingivalis, 
P. intermedia, B. forsythus and T. denticola. The analysis of loser sites did not 
indicate any significant differences in the change in flora compared to gain sites. 
It is possible then that the increase at the sites resulted from an increase in 
bacterial numbers in response to SRP, somehow stimulated by SRP, 
contamination from outside the pocket perhaps as the result of SRP and the 
release of bacteria into the mouth, or natural fluctuation in bacterial numbers.
P. gingivalis, B. forsythus and T. denticola were associated with significantly 
more gingival inflammation and deeper pockets. Wikstrom et al. (1993) 
reported a similar association between levels of P. gingivalis and pocket depth 
and BOP after treatment B. forsythus was also associated with significantly 
more suppuration and greater attachment loss. The presence of these organisms 
at these inflamed sites may indicate their pathogenicity or that these sites are an 
ideal environment. P. intermedia was associated with deeper pocketing, but not
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BOP, which may suggest that, as some believe (Dahlen, 1993; Mombelli et al., 
1991a), it is an opportunistic organism and not particularly related to disease. 
Post-treatment levels of A. actinomycetemcomitans reduced below detection, so 
no comments can be made about this organism.
In GEOP patients the results were quite different. P. intermedia was associated 
with deep inflamed sites and smoking, whereas P. gingivalis, B. forsythus and 
T. denticola were not. T. denticola was associated with poorer oral hygiene 
which may reflect the more rapid colonisation in these sites.
A. actinomycetemcomitans was also associated with deep inflamed sites from 
smokers but as only four sites were positive after therapy this should be 
interpreted with caution. Therefore it seems that GEOP sites react differently 
than AP sites to the effects of treatment. Both groups responded well to 
treatment, but the effect of the flora post-therapy is dissimilar. Whether this 
reflects different conditions in the pockets perhaps due to differing host 
responses or different strains of infecting bacteria is yet to be determined, and 
would make an interesting investigation. Previous studies have reported a link 
between P. gingivalis and BOP (Albandar et al., 1990; Mombelli et al., 1991a; 
Socransky et al., 1991; Christersson, 1992; Kojima et al., 1993). In this study no 
such link could be found. This may reflect different methodologies for 
examining the microflora used or that there is variation in the response to 
pathogens between patients and study groups.
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3.2.7 AP and GEOP loser/gain sites
Sites which lost or gained PD or AL in AP patients were generally not 
significantly different at baseline. This would suggest that these sites could not 
be predicted before treatment, and that measures other than clinical or microbial 
parameters are needed to predict breakdown. Sites which lost PD or AL had a 
lower reduction in microbial prevalence and an increase in P. gingivalis. In 
GEOP patients the low numbers of sites which increased in PD precluded 
analysis, but the sites that lost AL were not dissimilar to gain sites. There were 
no significant differences before and after SRP in clinical and microbial 
parameters between gain and loser sites, except for lower AL scores in loser sites 
at baseline. Loser sites also had a tendency for higher P. intermedia,
B. forsythus and T. denticola prevalences post-therapy.
Wikstrom et al. (1993) also showed high levels of P. gingivalis in sites with 
continued deep pocketing and BOP. Similarly sites which lost AL were reported 
by Haffajee et al. (1995) and Socransky & Haffajee (1993) to have continuing 
high levels of B. forsythus after treatment compared to sites which gained 
attachment. In addition, Simonson et al. (1992) and Haffajee et al. (1997a) 
showed that a reduction in T. denticola accompanied clinical improvement. In 
the AP patients in this current study, there was also little change in T. denticola 
prevalence at sites which lost attachment or increased in pocket depth. All of 
these studies suggest an important role for the three organisms in AP.
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As mentioned above, high levels of P. gingivalis, P. intermedia and B. forsythus 
have been linked with disease progression (Tanner et al., 1987a; Socransky & 
Haffajee, 1993), but not T. denticola (MacFarlane et al., 1988) which was a poor 
predictor of future attachment loss. It was not the intention of this study to 
monitor these sites post-SRP, so it is not known whether they experienced 
further breakdown. A further study would be to follow sites such as these over a 
period of time using PCR to investigate if high prevalences of P. gingivalis,
B. forsythus and T. denticola are good predictors of further breakdown. The 
results suggest that there are differences between AP and GEOP loser sites. 
Unfortunately the low number of GEOP PD loser sites prevented comparison, 
and another study would be to increase patient numbers to examine any possible 
differences.
This is perhaps a situation where microbial assays could be useful. The assay 
could be used to determine whether further treatment such as re-SRP, surgery or 
antibiotics, may be required. Sites which responded poorly to SRP but with high 
levels of P. gingivalis, B. forsythus and T. denticola, as determined by the assay, 
would undergo further treatment whereas similar sites with low levels, and so 
less likelihood of further breakdown, could be monitored. Again this is an 
interesting area for further investigation.
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3.2.8 Relationship between the presence or absence of the test bacteria and 
clinical parameters 
Adult Periodontitis
Sites with P. gingivalis had greater mean PD which agrees with previous studies 
(Ali et al., 1996; Socransky et al., 1991; Wolff et al., 1993; Wikstrom et al., 
1993; Beck et al., 1992; Mombelli et al., 1991a). Moore et al. (1983) and 
Kojima et al. (1993) have suggested that the presence of P. gingivalis is the 
result of deep pockets, which are an ideal environment for P. gingivalis, rather 
than the cause. However the fact that after therapy, P. gingivalis positive sites 
had higher pocket depths, bleeding on probing and gingival inflammation 
suggests that P. gingivalis has a role in the disease. The continuing high levels 
of P. gingivalis post-SRP may reflect the assay used or recolonisation by the 
organism. P. gingivalis has been shown to invade tissue (Sandros et al., 1993) 
and after removal of subgingival plaque, the bacteria within the tissue may have 
prevented satisfactory healing.
Previous studies have shown a link between P. gingivalis and BOP (Albandar et 
al., 1990; Socransky et al., 1991; Christersson, 1992; Mombelli et al., 1991a; 
Kojima et al., 1993). The large number of virulence factors produced by 
P. gingivalis probably result in the effective stimulation of an inflammatory 
response (Holt et al., 1999). The difference between these studies and the 
current study may reflect the effect of the other bacteria present in the pocket or 
aspects of the host response that disguised the effect of P. gingivalis, as after
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treatment and reduction of the other bacteria, P. gingivalis positive sites showed 
a tendency for increased BOP.
Socransky et al. (1991) previously reported a tentative link between the presence 
of P. gingivalis and suppuration. In this study there was a significant link 
between the bacteria and suppuration, which reflects the organisms’ ability to 
adversely interfere with the immune response, especially the cells. After SRP 
and the numbers of P. gingivalis were reduced slightly, these suppurating sites 
responded similarly to non-suppurating sites.
There was a tendency for P. intermedia sites to be more inflamed and display 
greater destruction, but not significantly. Both Christersson (1992) and 
Albandar et al. (1990) also failed to find a significant link between P. intermedia 
and disease. Both positive and negative sites responded similarly to treatment, 
which indicates that P. intermedia may not have had an important role in the 
disease, and is perhaps, as Mombelli et al. (1991a, b) suggested, an opportunistic 
comensal.
The role of B. forsythus in these patients in unclear and it is difficult to discern a 
pattern. B. forsythus was found in sites with less gingival inflammation but 
deeper pockets. The prevalence of B. forsythus decreased readily with treatment 
and both positive and negative sites responded similarly. This suggests that, 
similar to P. intermedia, B. forsythus may have a lesser role in the disease and its 
presence may be the result of the disease rather than the cause.
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The low prevalence of A. actinomycetemcomitans in AP subjects means that no 
meaningful conclusions can be made about its effect on the severity of the 
disease. The low levels perhaps indicate that its role may be when the patients 
are younger and at the onset of disease (Slots et al., 1980; Zambon, 1985). The 
low levels give support to the concept that A. actinomycetemcomitans numbers 
drop as one ages (Rodenburg et al 1990; Slots et al 1990a). It is possible that A. 
actinomycetemcomitans initiates the disease process in patients allowing 
colonisation by opportunists such as P. intermedia and B. forsythus, and 
continuation of the disease process by P. gingivalis, once a suitable environment 
has been established. At what age this may occur is unclear and would make an 
interesting study.
The presence of T. denticola seemed to be related to smoking, but when 
corrected for multiple comparisons this was not found to be significant. The 
increased prevalence of T. denticola in smokers may indicate why some smokers 
are more prone to ANUG, and may reflect that T. denticola favours the more 
anaerobic environment found in pockets of smokers (Mettraux et al., 1984). The 
significantly increased suppuration at positive sites may suggest T. denticola is 
pathogenic in these patients and the host is ineffective in combating its presence. 
This is corroborated by the fact that positive sites responded less well to therapy. 
T. denticola is also able to invade tissues (Saglie et al., 1985; Riviere et al., 
1991) and its continued presence may prevent a satisfactory healing response.
GEOP
In general the differences between positive and negative sites were not as 
pronounced as AP subjects. This may indicate that the host response rather than 
the pathogen is more important.
The presence or absence of P. gingivalis, P. intermedia and T. denticola had 
little effect on the clinical parameters, suggesting that these bacteria are not as 
important pathogens in GEOP as they may be in AP.
B. forsythus positive sites had lower gingival indices, GCF volumes and 
suppuration scores. The organism has been reported to be poorly immunogenic 
(Califano et al., 1997), and this may explain the differences.
Similarly A. actinomycetemcomitans positive sites had significantly lower 
gingival indices and GCF volumes. Again this may indicate lack of stimulation 
of an immune response. A. actinomycetemcomitans is implicated in LJP (Curtis 
& Darby, 2000), but its role in GEOP is less clear.
Ou Yang (1994) reported a negative correlation between P. gingivalis numbers 
and pocket depth, supporting the hypothesis that in some GEOP subjects, 
P. gingivalis is not a major pathogen. The presence of P. gingivalis, P. 
intermedia, and T. denticola could result from the presence of the pockets rather 
than the cause in this group of GEOP patients. Kamma et al. (1995) reported a 
correlation between pocket depth and numbers of P. gingivalis, B. forsythus and
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A. actinomycetemcomitans, which was not found in this study. As mentioned 
before P. gingivalis predominated their GEOP patients and not B. forsythus. It is 
probable that a combination of a susceptible patient and a particular microflora 
are required to cause disease (Curtis & Darby, 2000). Differences between the 
two studies may reflect genetic differences between the study populations which 
predispose one group to P. gingivalis infection and the other to B. forsythus 
infection, or different pathogenicities of strains of these organisms found in the 
study populations. This would be similar to the differences in A. 
actinomycetemcomitans strains found between Europeans and Afro-Caribbean 
American LJP patients (Haubek et al., 1997). An interesting area of study would 
be to examine the pathogenicity of the strains of P. gingivalis and B. forsythus 
isolated from different periodontitis populations. The existing destruction 
without detectable levels of these organisms would indicate that other organisms 
may be involved or that only a small number of these pathogenic bacteria are 
required to initiate destruction. It may be that sites with no detectable organisms 
are not active and, when undergoing a period of breakdown, the numbers of 
organisms increases. With the design of this current study, this theory was not 
investigated further. This is again another exciting area for further research.
3.2.9 Clustering of bacteria
The fact that many different species can be found in the same pocket and patient, 
and that not all species are present in all pockets suggests that 1) different
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species cause disease in different subjects, 2) periodontal disease is a mixed 
infection and 3) there may be microbial interaction and clustering involved.
Goodson et al. (1991), in their DNA probe study of the effect of tetracycline 
fibre therapy on the microflora, reported that the majority of subjects with 
detectable organisms had four or five present of the six investigated, but very 
few subjects one, two or three, suggesting that organisms tend to occur together. 
Bacterial combinations were examined by Soder et al. (1993) who reported the 
grouping of P. gingivalis, P. intermedia, T. denticola, E. corrodens, 
F. nucleatum and C. rectus at 24% of sites, and A. actinomycetemcomitans, 
P. gingivalis, P. intermedia and T. denticola at 16% of sites. 
A., actinomycetemcomitans, P. gingivalis, P. intermedia and T. denticola were 
absent in 25% of sites examined. T. denticola, E. corrodens, F. nucleatum and
C. rectus were much more prevalent in the presence of either P. gingivalis or 
P. intermedia. These two studies support findings by other techniques that 
organisms occur in combinations.
Socransky et al. (1998) reported the presence of five cluster patterns. The first 
was P. gingivalis, B. forsythus, and T. denticola, and previous studies have 
hinted at parts of this relationship (Gmur et al., 1989; Simonson et al., 1992; 
Umeda et al., 1996; Kigure et al., 1995; Soder et al., 1993). Lotufo et al. (1994) 
closely related the occurrence of B. forsythus with the presence of P. gingivalis. 
These three organisms, P. gingivalis, B. forsythus and T. denticola, are known to 
coaggregate in vitro (Grenier et al., 1992a; Onagawa et al., 1994; Yao et al.,
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1991) and produce growth factors required by each other (Grenier et al., 1992b; 
Nilius et al., 1993). This first cluster was found to be related to disease levels, 
pocket depth and bleeding on probing. After treatment clinical improvement 
was linked to a reduction in these organisms (Simonson et al., 1992; Haffajee et 
al., 1997a). This trio form the basis of the BANA and SK-013 enzyme tests 
which have shown good correlation with disease status also (Loesche et al., 
1992b; Seida et al., 1992).
The second cluster was F. nucleatum, P. intermedia, P. nigrescens, P. micros, 
E. nodatum, and C. rectus. This grouping has also been suggested in part by 
previous studies (Ali et al., 1994; Wikstrom et al., 1993; Socransky et al., 1988; 
Soder et al., 1993). Ali et al. (1994) reported P. intermedia in all F. nucleatum 
positive sites, as well as increases in T. denticola and P. gingivalis.
S. sanguis, S. oralis, S. mitis, S. gordonii and S. intermedia comprised the third 
complex. A previous study by Socransky et al. (1988) had again reported parts 
of this group and linked it with less periodontal disease and better response to 
treatment.
The fourth and fifth groupings were Capnocytophaga species, C. concisus, 
E. corrodens, A. actinomycetemcomitans serotype a and V parvula,
A. odontolyticus, A. actinomycetemcomitans serotype b, S. noxia and
A. naeslundii respectively. Wikstrom et al. (1993) had again previously reported
aspects of the fourth grouping, but had also found associations between 
P. gingivalis, P. intermedia, and Capnocytophaga species.
In this current study, P. gingivalis, P. intermedia, B. forsythus and T. denticola 
showed increased prevalences when one of the others was present in AP 
subjects, although this may reflect the deeper pocketing associated with these 
organisms rather than clustering. The low levels of A. actinomycetemcomitans 
prevent any determination of its effect on the other bacteria. Interestingly when 
one of P. gingivalis, B. forsythus and T. denticola is reduced following SRP, the 
other two also decreased indicating a grouping of these bacteria, which is 
suggestive of the first cluster of Socransky et al. (1998). Haffajee et al. (1997a) 
found that following SRP these three organisms decreased significantly, but did 
not report on the correlation between the reduction of the bacteria. In GEOP 
patients B. forsythus was significantly higher at P. intermedia negative sites and 
vice versa, suggesting an antagonistic relationship. B. forsythus was found in all 
T. denticola positive sites, confirming earlier reports by Socransky et al. (1998) 
and Umeda et al (1996) of a relationship between these bacteria. Contrary to 
these reports there was no discernible relationship with P. gingivalis.
B. forsythus was also found at all A. actinomycetemcomitans positive sites and 
T. denticola significantly increased suggesting a grouping between these three 
bacteria as well.
It is possible that one of the differences between AP and GEOP, apart from 
microflora and host response, is the manner in which the subgingival flora
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interact to form different groupings. It would also appear that, in addition to 
each subject having a unique flora, there may be unique cluster patterns.
Evidence from animal studies has shown that combinations of species were 
capable of inducing experimental abscesses, even though individual components 
in the mixture could not (Haffajee & Socransky 1994; Dahlen et al., 1989b).
The concept of microbial groupings, shown in this study and by previous studies, 
is an exciting area requiring further investigation. A number of aetiological 
agents have been identified, but we are still far from understanding the role of 
these organisms in periodontal disease. An examination of bacterial interactions 
should improve our understanding and perhaps also elucidate some aspects of 
the immune response to these organisms. It is probable that interaction between 
organisms is mutually beneficial in terms of survival, but may be also in evading 
or combating host defences. The formation of a biofilm is one example of this 
(Darveau et al., 1997).
3.2.10 Absence of organisms
Socransky et al. (1991) and Wolff et al. (1993) reported that a sizeable 
percentage of sites with severe periodontal destruction did not contain any of the 
organisms under investigation. In both studies shallower sites had a greater 
percentage of sites without detectable study organisms (37.5% and 80% 
respectively), moderate sites fewer (30.5% and 70%) and the deepest sites fewest 
(21.9% and 48%). In addition, Goodson et al. (1991) reported that in 12.6% of
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sites tested (about 1% of subjects) none of the test organisms were detected. In 
this current study 23.5% of AP sites were without detectable organisms and 
3.5% of GEOP sites. This difference between AP and GEOP could be a factor in 
the greater destruction seen in GEOP patients. In AP patients 24.5% of 
shallower sites were not positive for any of the test bacteria, and this decreased 
to 16.7% in sites over 7mm. As the pocket depth increased in GEOP subjects 
the percentage of sites with no detectable test bacteria decreased, shallower sites 
5.8% and sites over 7mm 0%. The percentages recorded in this study are less 
than those noted by Socransky et al. (1991) and Wolff et al. (1993). The 
differences in percentages between these two studies are due to the much smaller 
number of organisms investigated by Wolff et al. (1993). Wolff et al. (1993) 
examined the presence of 5 organisms, similar to this current study, and one 
would perhaps expect the results to be similar also. However, the presence of 
the bacteria in this thesis was determined by PCR, which is more sensitive than 
the method used by Wolff et al. (1993) and probably accounts for the 
differences. In all three studies the percentage of sites without detectable 
bacteria decreased as the pocket depth increased, which presumably reflects the 
suitability of deeper sites for colonisation by these anaerobic organisms. The 
lack of organisms at detectable levels in some sites, indicates that either small 
numbers of organisms are sufficient to cause disease in these sites or, more 
likely, other organisms are responsible, which supports the hypothesis that a 
wide range of organisms can cause disease. Exactly which organisms these may 
be, whether other bacteria, or viruses is yet to be determined. Studies which
examine a wide range of bacteria present in samples are required and the
Checkerboard would seem to be an ideal technique for this.
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CHAPTER 4
COMPARISON OF PCR AND THE 
CHECKERBOARD TECHNIQUE
This section deals with the comparison of PCR and Checkerboard diagnostic 
assays. A comparison of the two techniques is presented first and then the effect 
of SRP on the microflora using Checkerboard to determine prevalences is 
discussed. In addition a comparison of the prevalences of the bacteria with other 
studies using DNA probes, Checkerboard and PCR is made. All patient plaque 
samples were used in the analysis of PCR and Checkerboard. Both AP and 
GEOP patients had a third set of plaque samples taken four months after the 
post-SRP samples. These samples are only included in this section and have not 
been used elsewhere in this thesis. A total of 620 plaque samples were available 
for comparison.
4.1 Comparison of PCR and the Checkerboard technique: Results
Figures 4.1 to 4.5 show the typical analysis of the PCR products for each of the 
test bacteria. In addition, figures 4.6 and 4.7 show the typical results of the 
Checkerboard technique. After the first run (Figure 4.6), it became apparent that 
there were problems with the controls applied in Glasgow and new controls were 
applied to the membranes in Gothenberg (Figure 4.7).
The percentage of positive sites for all samples and all test organisms using PCR 
and the Checkerboard technique is shown in table 4.1. P. gingivalis was 
detected at 38.4% of sites by PCR compared to 20.5% by the Checkerboard 
technique. B. forsythus was found significantly more by the Checkerboard 
technique than PCR, 46.6% compared to 25.5%. The detection rates for A. 
actinomycetemcomitans were similar at 3.1% and 3.2% for PCR and the
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Figure 4.1 P. gingivalis PCR product analysis. Base pair ladder (BP), lanes 1-20
and positive (+) and negative (-) controls
BP 1 2 3 4 5 6 7 8 9  10 +
Figure 4.2 P. intermedia PCR product analysis. Base pair ladder (BP), lanes 1-20
and positive (+) and negative (-) controls
BP 1 2 3 4 5 6 7 8 9  10 +
Figure 4.3 B. forsythus PCR product analysis. Base pair ladder (BP), lanes 1-20
and positive (+) and negative (-) controls
BP 11 12 13 14 15 16 17 18 19 20
Figure 4.4 A. actinomycetemcomitans PCR product analysis. Base pair ladder
(BP), lanes 1 -22 and positive (+) and negative (-) controls
Figure 4.5 T. denticola PCR product analysis. Base pair ladder (BP), lanes 1-20
and positive (+) and negative (-) controls
• w  'f e d
BP 11 12 13 14 15 16 17 18 19 20
Figure 4.6 Results of Checkerboard technique (without controls). Lanes used for 
each probe and black dots indicate hybridisation reactions.
Lanes 2 5 8 11 14 28 31 34 37 41
Probe Pg Pi Bf Aa Td Pg Pi Bf Aa Td
t
Figure 4.7 Results of Checkerboard technique (with controls). Lanes (Lan) used 
for each probe (Pro) and black dots indicate hybridisation reactions. Controls 
were mixed bacteria of 105 and 106 concentrations and placed at the bottom of 
each membrane (10? above 106).
Lan 2 5 8 11 14 28 31 34 37 41
Pro Pg Pi Bf Aa Td Pg Pi Bf Aa Td
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Checkerboard technique respectively. PCR detected T. denticola at 43.7% of 
sites compared to 22.4% by the Checkerboard technique. The differences in the 
detection frequencies for all test organisms except A. actinomycetemcomitans 
were statistically significant (pO.OOOl).
The agreement and disagreement of the techniques is shown in tables 4.1 and 
4.2. There was 63.4% agreement in the detection of P. gingivalis. 27.2% of 
sites were PCR positive and Checkerboard technique negative, compared to 
9.4% Checkerboard technique positive and PCR negative. The detection of B. 
forsythus had the lowest agreement at 59.2%. The Checkerboard technique 
detected B. forsythus at 31% of sites that were PCR negative and PCR at 9.8% of 
sites that were Checkerboard technique negative. The agreement between the 
techniques in the detection of A. actinomycetemcomitans was the highest at 
94.4% with similar percentages of PCR positive/Checkerboard technique 
negative and Checkerboard technique positive/PCR negative sites. The 
techniques agreed at 59.7% of sites in the detection of T. denticola. PCR 
detected T. denticola at just over 30% of Checkerboard technique negative sites 
and Checkerboard technique at 9.5% of PCR negative sites.
Specificity and sensitivity of the Checkerboard technique is shown in table 4.3, 
using PCR as the gold standard. Sensitivity ranges from 0.1 for A. 
actinomycetemcomitans to 0.61 for B. forsythus, and sensitivity from 0.58 for B. 
forsythus to 0.97 for A. actinomycetemcomitans.
Table 4.2 Agreement and disagreement between PCR and the Checkerboard technique (XB) for 
a samples with results expressed on a sample basis
Microorganism Both +ve PCR+/XB- PCR-/XB+ Both -ve
Pg 68 169 58 325
B f 97 61 192 270
Aa 2 17 18 583
Td 80 190 60 290
Table 4.3 Specificity and sensitivity o f the Checkerboard technique compared to PCR. PCR was 
used as the “gold standard”.
Organism Sensitivity Specificity
Pg 0.29 0.85
B f 0.61 0.58
Aa 0.1 0.97
Td 0.30 0.83
Table 4.4 Effect o f SRP on the AP and GEOP microflora using the Checkerboard technique. 
Percentage o f sites positive for each organism before and after SRP
Organism AP Pre AP Post p value GEOP Pre GEOP Post p value
Pg 50 11.6 <0.0001 15.6 7.3 0.16
B f 79.6 33.9 <0.0001 57.3 26.0 0.0001
Aa 5.3 2.7 0.29 3.1 1.0 0.63
Td 35.6 8.9 <0.0001 40.6 12.5 0.0001
4.1.1 Effect of SRP on microbial prevalences as determined by the 
Checkerboard technique 
Adult Periodontitis
Table 4.4 shows the effect of treatment of the AP flora using the Checkerboard 
technique to identify the test bacteria. At baseline 50% of sites were positive for 
P. gingivalis, 79.6% for B. forsythus, 5.3% for A. actinomycetemcomitans and 
35.6% for T. denticola. After treatment there were significant reductions in the 
detection of P. gingivalis (11.6%, <0.0001), B. forsythus (33.9%, <0.0001) and 
T. denticola (8.9%, <0.0001). A. actinomycetemcomitans detection was reduced 
by approximately half following treatment but this was not statistically 
significant.
GEOP
There were fewer significant reductions in the prevalence of the test organisms 
before and after treatment in GEOP patients using the Checkerboard technique to 
identify the test organisms (table 4.4). B. forsythus decreased from 57.3% to 
26%, and T. denticola to 12.5% from 40.6%. Both were significant at p=0.0001. 
P. gingivalis was reduced from 15.6% to 7.3%, and A. actinomycetemcomitans 
reduced by 2% from 3.1% to 1%. These were not significant.
4.2 Comparison of PCR and the Checkerboard technique : Discussion
4.2.1 Comparison of the two techniques
The development of new technologies or diagnostic tests always raises the issue 
as to what is the appropriate primary test, the so-called “gold standard”. The
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definition of the “gold standard” is essential, in order to evaluate the diagnostic 
performance of the new technology (Papapanou et al., 1997a). In assessment of 
the composition of plaque microbiota, culture procedures have traditionally been 
used as the reference (Moore & Moore, 1994). It has been recognised that 
culture can no longer be regarded as devoid of methodological errors and is not a 
suitable “gold standard” (Loesche et al., 1992a; Riggio et al., 1996).
Both polymerase chain reaction and the Checkerboard technique offer significant 
advantages over culture. They are quicker, with results available in a few hours, 
cheaper and less labour intensive (Riggio et al., 1996; Papapanou et al., 1997a). 
The use of DNA probes and primers enables a more accurate identification of 
bacteria and do not rely on cell viability. Both have lower detection limits, 
which is important in detecting such organisms as A. actinomycetemcomitans 
which occur in low levels, even in severely diseased patients (Papapanou et al., 
1997b). It is difficult to detect by culture organisms which represent 1% or less 
of the flora (Moncla et al., 1991).
A comparison of the two techniques is warranted because of the possibility of 
cross-reactivity of whole genomic probes, non-optimal stringency of the 
Checkerboard technique and the accuracy of PCR. With the lower detection 
limit of PCR some disagreement would be expected, in favour of PCR. 
However the analysis showed a number of unexpected discrepancies. 
Agreement between the two techniques for P. gingivalis, B. forsythus and T. 
denticola ranged from 59.2% to 63.4% percent and perhaps could be accounted
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for by the lower detection limit for PCR. However a much lower frequency for 
P. intermedia was recorded by the Checkerboard technique suggesting more than 
just the variation in detection limits. Hence the results for P. intermedia probes 
were not included in the subsequent data analysis.
Sample analysis using the Checkerboard technique suffered a number of 
problems. The controls that were applied initially were not detected on probing 
and new controls had to be reapplied. This involved re-baking the membranes, 
which would have affected the DNA on the membrane, probably resulting in loss 
of material. The controls and samples consistently came up faintly with the P. 
intermedia probes, even after stripping of the membranes and re-probing. This 
suggested that the probes were not binding properly, but subsequent testing on 
other samples on different membranes could not find fault with them. The 
reasons for the P. intermedia probes not performing optimally are still unclear.
B. forsythus was detected much more frequently by the Checkerboard technique 
than PCR. This may have resulted from cross-reactivity of the probe or non­
specific binding. Cross-reactivity of the probe is unlikely as the probes have 
been rigorously tested and there are no reports of previous problems of B. 
forsythus probes cross-reacting to such an extent. The stringency of the 
technique is quite high and there were no problems with background 
contamination on the membranes for the other probes. Again it is possible that 
the re-baking of the membrane may have affected the results by denaturing the 
DNA further and allowing non-specific binding to this newly exposed DNA.
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A. actinomycetemcomitans was detected equally by both techniques. There were 
differences between AP and GEOP samples but overall the results were similar. 
The low prevalence of A. actinomycetemcomitans by both techniques suggests 
that A. actinomycetemcomitans was actually present in low frequencies in this 
patient group. However A. actinomycetemcomitans has been shown to clump 
together and form chains that cannot be broken up by vortexing (Fives-Taylor et 
al., 1999). If this is the case both PCR and the Checkerboard technique would 
underestimate the presence of this organism.
The plaque samples were thoroughly mixed and divided in two in an attempt to 
produce two identical samples. Robrish et al. (1976) and Olsen & Socransky 
(1981) showed that a fully homogeneous suspension of plaque samples is not 
achievable. Consequently it is likely that the plaque samples were not identical. 
However, Papapanou et al. (1997a) suggested that these errors must be 
considered random and could not introduce a systemic bias towards a specific 
direction. The results from the Checkerboard technique were read by eye and 
correlated with computer printouts of intensity of the chemiluminescence of the 
reactions, which automatically took into account the background intensity and 
controls. It is therefore unlikely to be an error in assessing the reactions visible 
by eye. Another possible explanation may be an increasing degree of non­
specific binding of whole genomic probes in the presence of plenty of target 
DNA and may reflect impaired specificity of the technology in heavy plaque 
samples. However, this would be equally applicable to both PCR and the
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Checkerboard technique, and would affect all samples. Given the discrepancies 
between these two techniques, the problems with the Checkerboard technique 
analysis and also bearing in mind the absence of an indisputable reference 
standard, no conclusions may be drawn from the comparison of these two 
techniques.
The Checkerboard technique reported greater and more significant reductions in 
the flora following therapy. A comparison with the PCR results showed that 
PCR sites had higher numbers of positive sites before treatment. This is to be 
expected given the lower detection limits of PCR and the decreased microbial 
load in pockets after treatment, which may have allowed positive detection by 
only PCR. The relatively poor reduction in the flora after treatment as monitored 
by PCR compared rather unfavourably to studies by culture and DNA probes. 
This suggests that PCR might be too sensitive, and was detecting low numbers 
of bacteria that were now associated with health rather than disease. Mombelli 
et al. (1991b) questioned the use of techniques with higher diagnostic value, and 
suggested that they may detect an organism at a level too low to have any 
pathogenic impact. In such a situation one would wish that the threshold for 
detection would coincide with the threshold for initiation of pathology. The 
problem is compounded by the fact that different organisms may have different 
thresholds for causing disease (Bragd et al., 1987; Moncla et al., 1991). As yet 
an ideal technique for the accurate detection of pathogens in subgingival plaque 
samples has yet to be developed. The Checkerboard technique is promising and 
allows the detection of many bacteria at the same time. PCR is the most accurate
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technique to date, but limited in that it can only detect a few organisms at the 
same time and as yet is not quantitative. At the moment it would seem that PCR 
is best suited for molecular analysis rather than microbial diagnosis.
4.2.2 Prevalence of periodontal microflora using DNA probe and the 
Checkerboard technique diagnostic assays
A number of studies have analysed the presence of periodontal bacteria using 
DNA probes and the Checkerboard technique. The results of the Checkerboard 
technique analysis compare favourably, except for the low prevalence of P. 
intermedia.
4.2.2.1 Prevalence of periodontal microflora using DNA probes
Using DNA probes, P. gingivalis frequencies on a subject basis range from 61% 
(Lowenguth et al., 1995) to 95% (Soder et al., 1993) for AP subjects and 68.2% 
for GEOP (Albandar et al., 1997). The organism has been detected in 31% of 
AP sites (Kojima et al., 1993) to 89% (Maiden et al., 1991). Generally 
P. gingivalis is found at high rates of detection (Savitt & Socransky 1984; 
Loesche et al., 1992b; Goodson et al., 1991; Zappa et al., 1990; Ali et al., 1994; 
Yasui et al., 1993). The number of positive sites for P. gingivalis is related to 
increasing pocket depth and the presence of bleeding on probing (Kojima et al., 
1993). The prevalence of P. gingivalis in AP patients reported in this study 
using the Checkerboard technique was 50% and is within the range of the studies 
reported above. The prevalence of P. gingivalis in GEOP was much lower than
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that reported by Albandar et al. (1997). This may reflect variations in microbial 
colonisation and aetiology between study populations.
P. intermedia has been reported in 86% (Goodson et al., 1991) to 98% (Haffajee 
et al., 1992) in AP subjects and 82% of GEOP subjects (Albandar et al., 1997), 
and from 42% to 92% of AP sites, with frequencies generally above 60% (Ali et 
al., 1994; Shiloah & Patters, 1994; Savitt & Socransky 1984; Zappa et al., 1990; 
Maiden et al., 1991; Gersdorf et al., 1993; Lippke et al., 1991; Lowenguth et al., 
1995; Soder et al.; 1993). The technical problems with P. intermedia in this 
study prevent comparison with these studies.
On a subject basis, Haffajee et al. (1992) detected B. forsythus in 26% of AP 
patients and from 52% (Tanner et al., 1997a) of AP sites to 83% (Lippke et al., 
1991). B. forsythus prevalences for AP and GEOP groups in this thesis are also 
within the range previously reported.
Using DNA probes the prevalence of A. actinomycetemcomitans in AP subjects 
ranges from 0% (Zappa et al., 1990) to 75% (Soder et al., 1993), and has been 
detected in 21% of GEOP subjects (Albandar et al., 1997). On an AP site basis 
the range is from 0% (Lowenguth et al., 1995; Zappa et al., 1990) to 44% (Savitt 
& Socransky, 1984) though it is generally low (Ali et al., 1994; Maiden et al., 
1991; Loesche et al., 1992b; Lowenguth et al., 1995; Goodson et al., 1991). The 
low prevalences of A. actinomycetemcomitans in both disease groups found in 
this thesis is in keeping with previous reports.
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Soder et al. (1993) reported that one hundred percent of AP subjects were 
positive for T. denticola and Albandar et al. (1997) 86.5% of GEOP subjects. 
Detection on a site basis ranged from 61% (Soder et al., 1993) to 87% (Loesche 
et al., 1992b). In comparison with these studies, T. denticola was found at lower 
prevalences. This may reflect differences in study populations, sampling 
techniques or detection limits of the probes used.
The majority of the site based studies used deep pockets (5mm or greater) and 
there are generally high levels for most of the above organisms.
A. actinomycetemcomitans is found in much lower levels than the other 
organisms. Overall there is good agreement between the results presented in this 
thesis and published studies. The results indicate that high prevalences of 
P. gingivalis, B. forsythus and T. denticola are found in deep sites in advanced 
periodontitis patients. The infrequent detection of A. actinomycetemcomitans 
may indicate a lesser role in advanced disease in AP subjects compared to the 
other three bacteria mentioned above.
4.2.2.2 Prevalence of periodontal microflora using the Checkerboard 
technique
The Checkerboard technique has been used to investigate the presence of a 
number of periodontal bacteria in subgingival plaque samples. Haffajee et al. 
(1995) reported the most frequently detected organisms in AP patients were 
S. mitis (49%), F. nucleatum subsp vincentii (48%), P. micros (41%), V parvula
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(40%), B. forsythus (39%), P. intermedia (37%), S. oralis (36%), F. nucleatum 
subsp nucleatum (36%), P. nigrescens (35%) and E. corrodens (35%). 
T. denticola was detected in 18% of sites and A. actinomycetemcomitans 
serotype b in 10%. The presence of P. gingivalis, P. micros, T. denticola, P. 
nigrescens, and F. nucleatum subsp nucleatum, B. forsythus and P. intermedia 
were positively correlated with pocket depth.
In a later study, Haffajee et al. (1997a) reported that P. gingivalis and 
B. forsythus colonised over 50% of sites over 6mm in AP patients. Overall 
B. forsythus was found at roughly 45% of sites, T. denticola 35% and 
P. gingivalis 20%. By far the most abundant organism was A. viscosus, which 
was detected in 48% of sites.
Tanner et al. (1998a) used the Checkerboard technique to examine the 
microbiota in health, gingivitis and initial periodontitis. Sites which lost 
attachment of more than 1.5mm were deemed active and higher mean levels of
B. forsythus and C. rectus were found in these sites compared to inactive 
periodontitis. P. gingivalis and A. actinomycetemcomitans were detected 
infrequently.
Recently, Dibart et al. (1998) used the Checkerboard technique to identify 
bacterial species present in or on crevicular epithelial cells in healthy and 
diseased sites. The most frequently detected species in healthy subjects were S. 
oralis (63%), S. intermedius (26%), and T. denticola (26%), and in periodontitis
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subjects B. forsythus (75%), P. intermedia (54%), and F. nucleatum (50%). P. 
intermedia, C. ochracea, C. rectus and B. forsythus were significantly more 
common in periodontitis sites compared to health.
In comparison with these studies from the Forsyth Dental Centre, P. gingivalis 
and B. forsythus prevalences reported in this thesis are higher. However these 
studies examined a range of pocket depths from shallow to deep, and when the 
results were stratified according to pocket depth (Haffajee et al., 1997a), at sites 
over 6mm, similar prevalences were found. In all studies
A. actinomycetemcomitans was detected infrequently, and T. denticola 
prevalences were similar.
However, Papapanou et al. (1997b), in their examination of the subgingival 
microbiota in adult Chinese subjects, reported P. gingivalis, P. intermedia, 
F. nucleatum, P. micros and C. rectus in all patients. A. actinomycetemcomitans 
was found in 83% of subjects, B. forsythus 99% and T. denticola 98%. 
P. gingivalis, P. nigrescens, P. intermedia, T. denticola and B. forsythus were 
associated with deep pockets. The high levels of detection for all organisms may 
reflect the lack of dental care in general. Oral hygiene and dental attendance 
were poor. The relatively better dental attendance and oral hygiene standards in 
Western populations may account for the differences between the study by 
Papapanou et al. (1997b) and the results in this thesis and those from Boston. 
Despite much higher prevalences in Chinese patients similar results were
produced in all studies associating P. gingivalis, B. forsythus and T. denticola 
with deeper pockets.
4.2.3 Analysis of the response of the microflora to SRP using DNA probes 
and the Checkerboard technique
Very few studies have investigated the effect of SRP on the subgingival 
microflora using DNA probes. After SRP there seems to be a marked reduction 
in the frequency of detection for A. actinomycetemcomitans, P. gingivalis, 
P. intermedia (Shiloah & Patters, 1994; Lowenguth et al., 1995) and also for 
E. corrodens, F. nucleatum and C. rectus (Lowenguth et al., 1995). This 
reduction is maintained for up to twelve months after treatment except for 
P. gingivalis which started to increase after six months (Lowenguth et al., 1995).
Haffajee et al. (1997a) investigated the effect of SRP on 57 patients and 
compared the flora before and after SRP using the Checkerboard technique. The 
mean prevalences of P. gingivalis, T. denticola and B. forsythus were 
significantly reduced after SRP, while A. viscosus showed a significant increase. 
P. gingivalis, T. denticola and B. forsythus were equally prevalent among 
current, former and never smokers, and decreased significantly post-SRP in 
never and former smokers, but increased in current smokers. Clinical 
improvement was accompanied by a modest change in the subgingival 
microflora, primarily a reduction in P. gingivalis, T. denticola and B. forsythus.
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From this study the group of patients that did not respond to treatment was 
examined in more detail (Haffajee et al., 1997b). In subjects which responded 
poorly, compared to those that responded well, A. naeslundii genospecies 2 
(A. viscosus), P. gingivalis, T. denticola, B. forsythus, C. gracilis and C. rectus 
were all found at lower levels pre-treatment.
In keeping with these previous studies, SRP produced significant reductions in 
the percentage of samples positive for P. gingivalis, B. forsythus and T. denticola 
in AP subjects and P. gingivalis and T. denticola in GEOP subjects. The 
reduction in these bacteria was also accompanied by a significant improvement 
in clinical condition, as also shown by Haffajee et al. (1997a). However studies 
using DNA probes also produced significant reductions in
A. actinomycetemcomitans prevalence, whereas the reduction observed in this 
thesis and the other Checkerboard technique reports are not as great. This may 
reflect the lower prevalences of A. actinomycetemcomitans reported using the 
Checkerboard technique or differences between assay techniques.
4.2.4 Prevalence of periodontopathogens using PCR
The prevalences of the bacteria discussed in this section are those which have 
been previously mentioned in Chapter 3 and not the overall prevalence for all 
samples as mentioned above.
Varying prevalences of periodontopathogens have been reported using PCR. In 
adult periodontitis, P. gingivalis has been detected in 28% to 79% of subjects
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(Riggio et al., 1996; Griffen et al., 1998; Wahlfors et al., 1995; Leys et al., 1994; 
Amano et al., 1999). P. gingivalis was much more prevalent in diseased patients 
than healthy subjects (Griffen et al., 1998). Similarly varying prevalences of
A. actinomycetemcomitans have been reported, from 40% to 60% in AP patients 
(Riggio et al., 1996; Wahlfors et al., 1995; Leys et al., 1994). However these 
two organisms were not often found together (Riggio et al., 1996). P. intermedia 
had been detected in 39% of AP patients using primers designed to prevent 
cross-reactivity with P. nigrescens (Riggio et al., 1998), and B. forsythus in 
89.7% of subjects (Meurman et al., 1997).
The prevalence of periodontal pathogens in advanced periodontitis (age 15-75 
years) has been investigated in two reports from Slots’ group (Slots et al., 1995; 
Ashimoto et al., 1996). The prevalences of A. actinomycetemcomitans ranged 
from between 30% to 53%, B. forsythus 86-91%, C. rectus 14-11%, 
E. corrodens 76-80%, P. gingivalis 63-70%, and P. intermedia 58-67%. 
Ashimoto et al. (1996) also detected P. nigrescens in 52% of sites and 
T. denticola in 54% of sites. The prevalence of all these organisms except 
E. corrodens was significantly higher in periodontitis patients than gingivitis 
patients (Ashimoto et al., 1996).
The prevalences of the bacteria reported in this study are generally within the 
range of the reports above. A. actinomycetemcomitans prevalences were low and 
may reflect differences in study populations, primers used, cycling conditions, 
sample collection or the reagents and thermocycler used. A comparison of
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prevalences between GEOP groups is difficult because the author is unaware of 
any studies that have used PCR to study GEOP bacterial prevalences. However, 
the comments made with regard to the AP prevalences are equally relevant to the 
GEOP prevalences.
One report studied the change in A. actinomycetemcomitans detection with SRP 
and found that there was no significant change (Takamatsu, 1997). The results 
in this thesis also produced a non-significant change in A. 
actinomycetemcomitans, but prevalences were very low to begin with.
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CHAPTER 5
THE HUMORAL IMMUNE RESPONSE IN 
ADULT PERIODONTITIS AND EFFECT OF
SRP
This chapter discusses the results obtained from the analysis of the AP patient 
antibody titres and avidity. Only the PCR analysis of the plaque samples was 
used in this chapter in the determination of the microflora.
5.1 Humoral immune response in adult periodontitis and effect of SRP: 
Results
5.1.1 Effect of SRP on serum and GCF antibody titres and serum antibody 
avidity
Tables 5.1, 5.2 and 5.3 show the effect of SRP on serum antibody titres and 
avidity and GCF antibody titres. Post-treatment P. gingivalis median serum 
titres increased slightly, but for the other test organisms there was a decrease. 
None of these changes were statistically significant. The median change in titres 
indicated slight rises in titres for P. intermedia, B. forsythus and T. denticola, but 
no changes for P. gingivalis and A. actinomycetemcomitans.
Antibody avidity decreased after therapy for four of the test organisms. The 
avidity of B. forsythus antibodies increased slightly. The decrease in avidity for 
P. gingivalis and P. intermedia antibodies was significant (p = 0.024 and 0.025 
respectively).
Post-SRP there was a slight rise in P. gingivalis median GCF antibody titres, but 
there were no statistically significant changes in the other titres.
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Table 5.1 Comparison of median serum titres before and after SRP in AP 
patients. Interquartile ranges shown in brackets. Titres shown as EU.
Organism Serum Pre Serum Post Change p value
Pg 219(8, 6229) 246 (9, 24506) 0 (-105, 201) 1
Pi 216(5, 1278) 177 (3,741) -3 (-138, 22) 0.62
Bf 753 (12, 
lxlO7)
72(10, 1x10°) .9 (-7544, 7) 0.69
Aa 36 (1, 306) 17(1,241) 0 (-32, 4) 0.88
Td 2458(1,
7.8x10s)
239(1,
814159)
-5 (-7xl07, 0) 0.4
Table 5.2 Comparison of mean antibody avidity before and after SRP in AP 
patients. SD shown in brackets. Avidity shown as concentration (M) at ID50.
Organism Avidity Pre Avidity Post Change p value
Pg 1.36 (±0.7) 1.1 (±0.5) 0.21 (±0.47) 0.024
Pi 0.86 (±0.3) 0.75 (±0.25) 0.1 (±0.23) 0.025
Bf 1.14 (±0.7) 1.2 (±0.7) -0.06 (±0.66) 0.62
Aa 0.68 (±0.4) 0.65 (±0.3) 0.03 (±0.23) 0.44
Td 0.64 (±0.3) 0.61 (±0.4) 0.03 (±0.52) 0.76
Table 5.3 Comparison of median GCF titres before and after SRP in AP patients 
treatment. Interquartile ranges shown in brackets. GCF titres shown as EU/30s.
Organism GCF Pre GCF Post Change p value
Pg 26(12, 63.3) 31 (13, 125) 3 (-3, 34) 0.2
Pi 6 (5, 8) 6 (5, 8) 0 ( - l , l ) 0.84
Bf 0 (0, 1) 0 (0, 1) 0 (0, 0) 0.6
Aa 0(0, 13) 0 (0, 34) 0 (0, 14) 0.1
Td 3 (0, 9) 1 (0, 7) 0 (-3, 2) 0.73
5.1.2 Correlations between serum titres and PD
The correlation between serum titres and PD is shown in table 5.4. P. gingivalis 
titres correlated positively with PD and this was statistically significant (R 0.52, 
p 0.005). P. intermedia and A. actinomycetemcomitans had non-significant 
positive correlations with PD. B. forsythus and T. denticola showed negative 
correlations, which were not significant with PD.
There were four significant positive correlations between serum antibody titres 
to the test organisms and no significant negative correlations. Antibody titres to 
P. intermedia and P. gingivalis (R 0.53, p 0.04), P. intermedia and B. forsythus 
(R 0.43, p 0.02), P. intermedia and T. denticola (R 0.38, p 0.047), and B. 
forsythus and T. denticola (R 0.48, 0.009) correlated positively with each other.
5.1.3 Correlations between GCF titres and PD
Correlations between GCF titres and PD are displayed in table 5.5. There was a 
significant correlation between P. gingivalis titres and PD (R 0.42, p 0.025). The 
correlations between B. forsythus and T. denticola titres approached significance. 
Local antibody titres to P. gingivalis correlated positively and significantly with
B. forsythus, A, actinomycetemcomitans and T. denticola titres, and 
P. intermedia titres significantly with A. actinomycetemcomitans titres.
B. forsythus titres correlated significantly and positively with
A. actinomycetemcomitans and T. denticola titres, and
A. actinomycetemcomitans titres with T. denticola titres.
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Table 5.4 Correlations between serum titres and PD using Spearman’s rank 
correlation (R/p value)
pd pg sera pi sera bf sera aa sera
pg sera 0.52/0.005
pi sera 0.23/0.25 0.53/0.04
bf sera -0.016/0.93 -0.12/0.55 0.43/0.02
aa sera 0.26/0.18 0.28/0.15 0.19/0.92 -0.26/0.18
td sera -0.16/0.93 0.24/0.22 0.38/0.047 0.48/0.009 0.03/0.88
Table 5.5 Correlations between GCF titres and PD using Spearman’s rank (R/p 
value)
PD Pg gcf pi gcf bf gcf aa gcf
pg gcf 0.42/0.04
pigcf -0.03/0.89 0.18/0.054
bf gcf 0.32/0.09 0.28/0.003 0.15/0.12
aa gcf 0.22/0.26 0.22/0.021 0.38/0.001 0.18/0.048
td gcf 0.33/0.09 0.21/0.026 0.15/0.12 0.57/0.001 0.21/0.027
Table 5.6 Correlation between local (across) and systemic (down) antibody titres 
(R/p value)
Sera\GCF P. gingivalis P. intermedi B. forsythus A. actino T. denticola
P. gingivalis 0.48/0.01 -0.06/0.77 0.6/0.001 0.1/0.63 0.61/0.001
P. intermedia 0.22/0.25 0.05/0.8 0.27/0.17 -0.05/0.8 0.57/0.002
B. forsythus -0.04/0.85 -0.21/0.28 -0.23/0.25 -0.3/0.12 0.04/0.85
A. actinomycetemcomitans 0.15/0.44 0.32/0.09 0.35/0.07 0.75/0.000 0.22/0.26
T. denticola -0.09/0.65 -0.05/0.8 0.22/0.25 -0.09/0.97 0.39/0.04
5.1.4 Local and systemic antibody titre correlations
Table 5.6 shows the correlations between local and systemic antibody titres. 
P. gingivalis local antibody titres significantly and positively correlated with 
P. gingivalis serum titres (R 0.48, p 0.01). P. intermedia GCF titres did not 
correlate with any serum titre, although the correlation with A. 
actinomycetemcomitans titres approached significance (R 0.32, p 0.09). B. 
forsythus GCF antibody levels significantly and positively correlated with P. 
gingivalis serum titres (R 0.6, p 0.001) and approached significant correlation 
with A. actinomycetemcomitans serum titres (R 0.35, p 0.07). A. 
actinomycetemcomitans local and systemic titres correlated significantly and 
positively (R 0.75, p<0.001), as did T. denticola local and systemic titres (R 
0.39, p 0.04). In addition, T. denticola GCF titres correlated positively and 
significantly with systemic P. gingivalis (R 0.61, p 0.001) and P. intermedia 
titres (R 0.57, p 0.002).
5.1.5 Relationship between presence or absence of each organism and 
antibody titres and avidity
5.1.5.1 Serum titres
The comparison of median serum titres in patients with and without each 
organism is shown in table 5.7. Patients were scored as positive for the organism 
if one or more sites was positive and negative if all four sites were negative.
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P. gingivalis positive patients had significantly higher titres to P. gingivalis than 
negative patients. Although there were slight differences between titres to the 
other organisms, there were no other significant differences.
In P. intermedia positive patients P. gingivalis, P. intermedia and
A. actinomycetemcomitans titres were higher and B. forsythus and T. denticola 
lower. There were no statistically significant differences though P. gingivalis 
titres approached significance.
B. forsythus positive patients had significantly lower B. forsythus antibody titres, 
near significantly increased P. gingivalis titres (p 0.09), and higher median titres 
for A. actinomycetemcomitans. Lower titres for P. intermedia and T. denticola 
were recorded in these patients.
Only one patient was positive for A. actinomycetemcomitans, and there are 
insufficient numbers of patients to make any valid statistical conclusions.
Patients who were positive for T. denticola had significantly lower titres to
B. forsythus, and almost significantly to P. intermedia. Lower titres to
A. actinomycetemcomitans and T. denticola, whereas P. gingivalis titres were 
higher, but these were not significant.
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5.1.5.2 GCF titres
A comparison of local titres at sites with and without each organism is shown in 
table 5.8. Sites that were positive for P. gingivalis had significantly higher titres 
to P. gingivalis and significantly lower P. intermedia titres. The titres for the 
other bacteria were similar. P. intermedia positive sites had similar titres to 
negative sites, and there were no significant differences. The difference between
B. forsythus titres approached significance at B. forsythus positive sites.
P. gingivalis titres were increased at these sites and P. intermedia titres
decreased, but neither were significant. Only two sites were positive for
A. actinomycetemcomitans, and so no statistical analysis would be valid. 
T. denticola positive sites had higher P. gingivalis, lower P. intermedia and 
similar titres for the other bacteria. There were no significant differences.
5.1.5.3 Antibody Avidity
A comparison of antibody avidity in patients with and without each organism is 
shown in table 5.9. Patients were scored positive and negative using the same 
criteria that were used for the serum titres. At P. gingivalis positive sites A. 
actinomycetemcomitans antibody avidity was significantly higher than negative 
sites. The avidities for the antibodies to the other organisms were similar and 
not significantly different. A. actinomycetemcomitans and T. denticola antibody 
avidities at P. intermedia positive sites were significantly higher than negative 
sites. The other antibody avidities were similar. At sites positive for
B. forsythus, P. gingivalis and P. intermedia antibody avidities were
significantly lower than negative sites. B. forsythus, A. actinomycetemcomitans
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and T. denticola antibody avidities were similar. There were too few sites 
positive for A. actinomycetemcomitans for meaningful statistical analysis. At 
T. denticola positive sites, antibodies to P. gingivalis and P. intermedia had 
significantly lower avidity to those in negative sites. Similar avidities were 
recorded for the other antibodies.
5.1.6 Systemic antibody serbstatus
5.1.6.1 Percentage of high responder and low responder patients
The percentage of patients with antibody titres two-times greater than the median 
control titres is shown in table 5.10. In descending order, 71.4% were high 
responder for T. denticola antibody titres, 67.9% for P. gingivalis, 60.7% for B. 
forsythus, 57.1% for A. actinomycetemcomitans and 25% for P. intermedia.
5.1.6.2 Comparison of high responder and low responder patients: P. 
gingivalis antibody titre
A comparison of baseline, post-SRP and change in clinical parameters, 
microbiological parameters, serum antibody titres, local antibody titres and 
antibody avidity in high responder and low responder patients for P. gingivalis 
antibody titres is shown in table 5.11.
Clinical parameters
High responder patients have significantly lower gingival inflammation scores 
and deeper pockets 6.2 ±1.4 mm compared to 5.3 ±0.9 mm, (p=0.0001). 
Attachment, GCF volume, and bleeding on probing were slightly higher and
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Table 5.10 Percentage of AP patients seropositive and seronegative for antibody 
titres to each organism.
Antibody Seropositive (%) Seronegative (%)
P. gingivalis 67.9 32.1
P. intermedia 25 75
B. forsythus 60.7 39.3
A. actino 57.1 42.9
T. denticola 71.4 28.6
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plaque levels and suppuration slightly lower than low responder patients, but not 
significantly. There were significantly fewer high responder smoker patients 
(10.5% compared to 66.7%, p<0.001). The change in clinical parameters in 
response to SRP is also shown in table 5.11. High responder patients had 
significantly lower decreases in gingival inflammation and plaque scores. These 
patients also recorded greater reductions in bleeding, suppuration and 
attachment, but these were not significant, though the reductions for bleeding 
and attachment approached significance. High responder patients recorded an 
increase in GCF volume compared to a decrease in low responder patients. 
Following therapy high responder patients recorded significantly higher plaque 
scores and deeper pockets. There were no other significant differences although 
the different GCF volumes approached significance.
Microbiological parameters
At baseline high responder patients showed increased prevalences for all test 
bacteria except T. denticola compared to low responder patients. P. intermedia 
and B. forsythus were both found at significantly higher percentages in high 
responder patients. T. denticola was found at similar levels. High responder 
patients generally recorded greater reductions in the prevalences of the test 
bacteria in response to SRP. Both P. gingivalis and B. forsythus reductions were 
significantly higher than low responder patients. Low responder patients gained
B. forsythus. Post-therapy P. gingivalis was detected in significantly more high 
responder patients, and P. intermedia and T. denticola found in more high 
responder patients. B. forsythus was more common in low responder patients.
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Serum titres
The median titre for patients with high responder titres to P. gingivalis was 637 
EU and for low responder patients 4 EU. Titres to the other organisms were 
higher in high responder patients, and this was significant for P. intermedia,
A. actinomycetemcomitans and T. denticola titres. In response to SRP, high 
responder patients recorded a decrease in antibody titre whereas low responder 
patients reported a slight decrease. A significant reduction in P. intermedia titre 
was recorded in high responder patients. Post-treatment titres to all organisms 
were significantly higher in high responder patients.
GCF titres
High responder patients recorded significantly higher GCF antibody titres to 
P. gingivalis, B. forsythus and T. denticola. In both high responder and low 
responder there was little change in GCF titre in response to SRP and no 
significant differences. Titres to these three bacteria remained significantly 
higher post-treatment in high responder patients.
Avidity
P. gingivalis antibody avidity was higher in high responder patients at baseline 
and this approached significance. The avidities of the other antibodies were 
similar. There were no significant differences in the change in antibody avidity 
between high responder and low responder patients in response to SRP. High 
responder patients had a slight increase in B. forsythus antibody avidity, and low
223
responder a slight increase in T. denticola antibody avidity. Other antibody 
avidities decreased slightly. After treatment avidity was slightly higher for P. 
gingivalis, P. intermedia and B. forsythus antibodies in high responder patients, 
but there were no significant differences.
5.1.6.3 Comparison of high responder and low responder patients: P. 
intermedia antibody titres
Table 5.12 displays the comparison of AP patients with high responder and low 
responder antibody titres to P. intermedia.
Clinical parameters
The comparison of baseline clinical measurements showed significantly greater 
attachment loss in high responder patients and deeper pockets in these patients. 
The difference in plaque scores and the smaller number of high responder 
smokers compared to low responder patients approached significance. There 
were no significant differences in the change in parameters in response to SRP 
between the two groups. The greater reduction in plaque levels and suppuration 
in low responder patients approached significance. High responder patients 
showed an increase in mean GCF volume compared to a slight decrease in low 
responder patients. Post-therapy, high responder patients had significantly 
greater attachment loss and GCF volume. There were no significant differences 
between the other parameters.
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Microbiological parameters
At baseline high responder patients had lower prevalences of P. gingivalis,
B. forsythus and A. actinomycetemcomitans and higher P. intermedia. These 
were not significantly different. T. denticola prevalence was significantly lower 
in high responder patients. In response to treatment, high responder patients 
showed greater reductions in P. intermedia, B. forsythus, and T. denticola, and 
lower reductions in P. gingivalis and A. actinomycetemcomitans. The difference 
in B. forsythus reduction was significant. Post-SRP, the prevalences for all 
bacteria were similar with no significant differences.
Serum titres
Baseline median titre for P. intermedia high responder patients was 2, 695 EU 
compared to 135 EU for low responder patients. P. gingivalis titres were also 
significantly higher in high responder patients. B. forsythus and
A. actinomycetemcomitans median titres were higher and T. denticola titres were 
lower in high responder patients, but these were not statistically significant. In 
response to SRP, P. intermedia high responder patients showed a decrease in 
P. gingivalis and P. intermedia titres but these were not significant when 
compared to low responder patients. There were significant reductions for
B. forsythus and A. actinomycetemcomitans titres in low responder patients. High 
responder titres showed a slight increase in median A. actinomycetemcomitans 
titres. T. denticola titres showed a reduction in low responder patients and 
remained the same in high responder patients. Post-SRP, P. gingivalis,
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P. intermedia and B. forsythus titres were significantly higher in high responder 
patients. Titres for A. actinomycetemcomitans and T. denticola were also higher 
and approached significance.
GCF titres
Pre-treatment, high responder patients displayed significantly greater antibody 
titres to P. gingivalis, B. forsythus and T. denticola. The higher GCF titres to 
P. intermedia in high responder patients approached significance. High 
responder patients showed an increase in P. gingivalis, P. intermedia and T. 
denticola titres in response to SRP, but only the increase in T. denticola antibody 
levels was statistically significant compared to low responder patients. Post­
treatment, high responder patients recorded significantly higher titres for P. 
gingivalis, P. intermedia, B. forsythus and T. denticola, with the increased
A. actinomycetemcomitans titres approaching significance.
Avidity
P. gingivalis antibody avidity was significantly higher in high responder patients 
than low responder. P. intermedia antibody avidity was also greater but not 
significantly. In response to SRP, high responder patients had a significantly 
greater decrease in P. gingivalis antibody avidity. Both groups had a slight 
increase in B. forsythus antibody avidity, and T. denticola antibody avidity 
increased in high responder patients. Post-treatment P. gingivalis antibody 
avidity remained significantly higher, and, although avidities were slightly 
higher in general, there were no other significant differences.
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5.1.6.4 Comparison of high responder and low responder patients: B. 
forsythus antibody titres
Table 5.13 shows the comparison of B. forsythus antibody titre high responder 
and low responder patients.
Clinical parameters
At baseline, high responder patients has significantly lower plaque scores, and 
slightly, but not significantly, greater attachment loss and pocket depth. The 
other parameters were similar when compared to low responder patients. In 
response to SRP high responder patients had significantly greater reduction in 
MGI, and a significantly lower decrease in plaque levels. High responder 
patients showed an increase in mean GCF volume compared to a decrease in 
low responder patients, which was significant. The changes in the other 
parameters were similar. Post-SRP, high responder patients had significantly 
lower MGI and pocket depth, and significantly higher GCF volume. Low 
responder patients had higher bleeding and suppuration percentages but these 
were not significantly different.
Microbiological parameters
High responder patients generally recorded lower prevalences for the organisms 
studied at baseline. Significantly higher prevalences were found for 
P. gingivalis and T. denticola in low responder patients and the prevalences for
B. forsythus and A. actinomycetemcomitans approached significance. In
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response to SRP, B. forsythus significantly decreased in high responder patients 
compared with no change in low responder patients. P. gingivalis also decreased 
in high responder patients and did not change in low responder patients but this 
was not significant. The reduction of P. intermedia, A. actinomycetemcomitans 
and T. denticola was greater in low responder patients but not significant. Post­
therapy, P. gingivalis, P. intermedia and B. forsythus prevalences were lower in 
high responder patients, with P. intermedia significantly lower. T. denticola 
prevalence was higher in high responder patients.
Serum titres
The median antibody titre to B. forsythus in high responder patients was 100, 
000 EU compared to 10 EU in low responder patients. P. intermedia and T. 
denticola titres were also significantly higher at baseline in high responder 
patients. P. gingivalis titres were slightly higher and A. actinomycetemcomitans 
slightly lower in these patients. In response to SRP, high responder patients 
recorded significantly greater reductions in P. gingivalis, P. intermedia, B. 
forsythus and T. denticola titres than low responder patients. P. gingivalis and B. 
forsythus titres in low responder patients showed a slight increase whereas P. 
intermedia and T. denticola median titres did not change. Post-treatment, P. 
intermedia, B. forsythus and T. denticola titres remained significantly higher in 
high responder patients. P. gingivalis and A. actinomycetemcomitans titres were 
higher but not significantly in low responder patients.
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GCF titres
At baseline, local titres were similar with only T. denticola titres significantly 
higher in high responder patients. P. intermedia antibody titres showed a 
tendency to increase slightly in high responder patients in response to SRP and a 
tendency to decrease slightly in low responder patients in response to SRP. This 
was statistically significant. There were no other significant differences. 
P. gingivalis titres increased in both patient groups with little change in the other 
antibody titres. Post-therapy, there were no significant differences between GCF 
titres to all organisms and antibody levels were similar.
Avidity
Before treatment, there were no significant differences in antibody avidity, 
although P. gingivalis, P. intermedia, and B. forsythus antibody avidity were 
slightly higher in high responder patients. Avidities were similar for the other 
antibodies. Both B. forsythus and T. denticola antibody avidities increased in 
high responder patients, but there were no significant differences in response to 
SRP. Following therapy, B. forsythus antibodies had higher avidity in high 
responder patients, and this approached significance.
5.1.6.5 Comparison of high responder and low responder patients:
A. actinomycetemcomitans antibody titres
The comparison of high responder and low responder A. actinomycetemcomitans 
patients is shown in table 5.14.
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Clinical parameters
Pre-treatment, high responder patients had significantly lower MGI and the 
increased pocket depth approached significance. The other parameters were not 
significantly dissimilar. Slightly more low responder patients were smokers. In 
response to SRP, high responder patients recorded significantly lower reductions 
in MGI and plaque levels. There were no significant differences in the 
reductions of the other parameters, or, in the case of GCF volume, increases. 
Following therapy, there were no significant differences between high responder 
and low responder patients.
Microbiological parameters
High responder patients had significantly higher prevalences of P. intermedia, 
and higher B. forsythus and A. actinomycetemcomitans percentages. Both 
groups had similar P. gingivalis prevalences and high responder patients lower 
T. denticola. In response to SRP, the reductions for P. gingivalis, B. forsythus 
and T. denticola were significantly greater in high responder patients. The 
decreases in P. intermedia and A. actinomycetemcomitans were also higher in 
these patients. Low responder patients recorded a slight increase in P. gingivalis 
prevalence. Post-treatment high responder patients had significantly higher 
prevalence for P. gingivalis. The prevalences of the other species were not 
significantly different.
230
Serum titres
Median titres for A. actinomycetemcomitans at baseline were, for high responder 
patients 357 EU, and 1 EU for low responder. P. gingivalis and P. intermedia 
antibody titres were also significantly higher. B. forsythus titres were 
significantly lower in high responder patients. T. denticola titres were similar. 
High responder patients recorded greater reductions in P. intermedia, B. 
forsythus and A. actinomycetemcomitans titres in response to SRP compared to 
low responder patients, where titres remained the same or decreased very 
slightly. The changes in P. gingivalis titres were similar for both groups. Low 
responder patients had a significantly greater decrease in T. denticola titre, with 
median titres unchanging in high responder patients. Post-SRP median titres for 
all organisms were higher in high responder patients but only significantly for 
P. gingivalis, A. actinomycetemcomitans and T. denticola.
GCF titres
Local titres for all organisms were higher in high responder patients, and this 
was significant for all except P. gingivalis, which approached significance. 
There were no significant differences in the changes in GCF titres in response to 
SRP. In both groups, P. gingivalis titres increased slightly and there was little 
change in the other antibody levels. Post-therapy, high responder patients’ titres 
were higher for all bacteria but only significantly for B. forsythus. The 
difference in P. intermedia titres approached significance.
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Avidity
At baseline, antibody avidities were similar for both high responder and low 
responder subjects. B. forsythus antibody avidity increased slightly in both 
groups in response to SRP. Apart from a slight increase in low responder 
T. denticola antibody avidity, there was a general decrease in avidity. There 
were no significant differences between groups. Post-SRP, high responder 
patients had slightly, but not significantly, higher avidity for B. forsythus and
A. actinomycetemcomitans antibodies, and lower avidity for T. denticola 
antibodies.
5.1.6.6 Comparison of high responder and low responder patients: T. 
denticola antibody titres
The comparison of T. denticola antibody titre high responder and low responder 
patients is shown in table 5.15.
Clinical parameters
At baseline, high responder patients had deeper pockets 6.0 ±1.4 mm compared 
to 5.6 ±0.9 mm, (p=0.08), but there were no statistical differences in the clinical 
parameters. 10% of high responder patients smoked compared to 75% of low 
responder patients who were non-smokers, and this was significant at p<0 .001. 
There were no significant differences in the reductions of the clinical parameters 
between the two groups in response to SRP. Both groups recorded an increase in 
GCF volume. High responder patients had slightly greater reductions in
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bleeding, suppuration, pocket depth and attachment loss. Post-therapy, high 
responder patients had significantly lower MGI, pocket depth and attachment 
loss. These patients also had slightly lower bleeding and suppuration.
Microbiological parameters
For all bacteria except B. forsythus and A. actinomycetemcomitans, high 
responder patients had lower prevalences before SRP. These were not 
significant, however. In response to SRP high responder patients recorded 
greater reductions in all bacteria except T. denticola and P. intermedia.
B. forsythus reduced significantly more in high responder patients compared to a 
slight increase in low responder patients. The slightly greater reduction in P. 
intermedia in low responder patients than high responder approached 
significance. Post-therapy, high responder patients had significantly lower levels 
of P. intermedia. P. gingivalis and T. denticola were detected more frequently in 
high responder patients, and there was also a lower prevalence for B. forsythus 
but these were not statistically significant.
Serum titres
n
The median titre for high responder patients for T. denticola was 5.5 x 10 EU 
compared to 1 EU for low responder patients. P. gingivalis, P. intermedia and
B. forsythus titres were also significantly greater with A. actinomycetemcomitans 
titres increased compared to low responder patients. Low responder patients 
generally showed little change in median titres in response to SRP compared to 
reductions in the titres in high responder patients. The changes in P. intermedia
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and T. denticola titres in high responder patients were significant when 
compared to low responder patients. Post-treatment,, all titres were higher and 
this was significant for all titres except A. actinomycetemcomitans titres in high 
responder patients.
GCF titres
Pre-treatment local titres for B. forsythus and T. denticola were significantly 
higher in high responder patients when compared to low responder patients. The 
other titres were similar and not significantly different. In response to SRP, 
P. gingivalis titres increased slightly more in high responder patients but not 
significantly. There was a tendency for high responder B. forsythus titres to 
decrease in high responder patients and this was significant. There was little 
change in the other antibody levels and no other significant differences. Post­
therapy, there were no significant differences in titres although the higher 
T. denticola titre in high responder patients approached significance.
Avidity
Patients high responder for T. denticola antibody titres had antibodies to 
P. gingivalis and B. forsythus of significantly greater avidity than low responder 
patients at baseline. There were no other significant differences before 
treatment. In response to SRP, in high responder subjects B. forsythus and 
A. actinomycetemcomitans antibody avidity increased slightly as did B. forsythus 
antibody avidity in low responder patients. However, most antibody avidities 
decreased and there were no significant differences between the two groups.
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After treatment P. gingivalis and B. forsythus antibody avidity remained higher 
in high responder patients with similar avidities for the antibodies to the other 
organisms in both groups.
5.2 Humoral immune response in adult periodontitis and effect of SRP: 
Discussion
5.2.1 Titres and avidity at baseline 
Serum titres
There were comparatively high titres to T. denticola and B. forsythus, similar 
titres for P. gingivalis and P. intermedia and comparatively low 
A. actinomycetemcomitans titres. The high percentage of high responder titres 
for T. denticola and B. forsythus may indicate a greater previous exposure of 
these patients to these organisms or greater pathogenicity. Just over twice as 
many patients were high responder for P. gingivalis than P. intermedia titres, 
and this also indicates the pathogencity of P. gingivalis and perhaps also the lack 
of pathogenicity of P. intermedia.
GCF titres
In general GCF titres were low. P. gingivalis produced the greatest antibody 
titre which may reflect its importance in the disease. The low titres to the other 
organisms may reflect a lack of local immune response or a lack of 
pathogenicity. There is a considerable response to B. forsythus and T. denticola, 
but this did not appear locally. The failure of the local response may allow these 
organisms to be pathogenic or the response is absorbed or degraded by the
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plaque biofilm (Kilian, 1981). The low serum and GCF titres to A. 
actinomycetemcomitans coupled with its low prevalence are consistent with 
previous reports that A. actinomycetemcomitans is not a major pathogen in AP. 
However, it suggests a previous role in these patients. The organism may have 
been involved in the onset or initial stages of the disease process, resulting in the 
residual antibody levels.
It should be noted that the low GCF titres may reflect the dilution of the sample 
in 1ml of IB to allow analysis of the IgG response to five organisms. Previous 
studies in our laboratory have diluted GCF samples in 0.5ml to allow for four 
analyses. Tests using GCF samples from withdrawn patients indicated that 
dilution to eight samples rather than four did not affect the ELISA or dilute the 
antibody titres to a level below detection.
Avidity
It was not the intent of this study to compare titres or avidity to control patients 
and so control serum were used only to establish serostatus and not as age/sex 
matched controls for comparison to health. However in the current patient 
group, avidity of all antibodies was low, especially when compared to the 
inoculation studies of Ebersole et al. (1990) and Lopatin et al. (1991). These 
studies examined the avidity of antibodies after immunisation of tetanus toxoid 
and streptokinase, and found that avidities were significantly higher than those of 
antibodies to periodontal pathogens.
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The overall failure of the humoral immune response to react may be due to oral 
tolerance (Lopatin et al., 1991), where long term exposure to an antigen produces 
poor quality antibodies.
5.2.2 Effect of SRP on antibody titre and avidity
Treatment resulted in little change in systemic and local antibody titres. A 
significant decrease in P. gingivalis and P. intermedia antibody avidity followed 
therapy, but there was little response in the avidity of the other antibodies.
Previous reports have shown mixed responses to SRP on antibody titre. Tolo et 
al. (1982) reported slight changes, but only antibodies to P. gingivalis produced 
a clear pattern. Ebersole et al. (1985b) showed marked increases for 
P. gingivalis, P. intermedia, and A. actinomycetemcomitans antibody titres. In 
contrast Aukhil et al. (1988) found significant reduction in P. gingivalis titres but 
little change in T. denticola. A significant decrease in P. gingivalis and 
P. intermedia titres was shown after SRP and surgery by Horibe et al. (1995). 
They also reported a slight but not significant decrease in 
A. actinomycetemcomitans titres. Murray et al. (1989) showed significantly 
lower titres in treated patients than untreated. More recently Mooney et al. 
(1995), before they split their patients by serostatus, reported significant 
increases in A. actinomycetemcomitans IgG and P. gingivalis IgG titres post­
therapy. However, Mouton et al. (1987) found little change in antibody levels. 
It appears that the response to therapy can produce variable responses in 
antibody titre. Previous studies on a West of Scotland patient group (Mooney et
237
al., 1995) produced conflicting results to this current study. However, there was 
wide variation in subject response to treatment, as shown by the interquartile 
range. Some patients had marked increases while other decreases but together it 
appeared there was little response.
The changes in antibody level have been related to suppression of pathogens in 
plaque (Horibe et al., 1995). In this current study there were few significant 
differences in microbial prevalence before and after treatment, which may 
explain the lack of response. It should be remembered that only four sites per 
patient were examined and not the whole mouth. Together with the use of a very 
sensitive diagnostic assay, this may have disguised any significant response. 
SRP produces an inoculation effect, but this appeared to produce little response. 
Mouton et al. (1987) had previously suggested that although there is inoculation, 
it may not provoke active immunisation. The lack of response to the presumed 
reduction in microbial load suggests a failure of the host response, which may 
have been a factor in the onset of disease in the first place. Alternatively the 
poor response may reflect the fact that all five test organisms were not involved 
in the disease process. This seems unlikely given the relationship of some of the 
bacteria with clinical parameters and antibody titres.
Murray et al. (1989) also reported a concomitant reduction in local P. gingivalis 
titres and that this was a result of removal of the subgingival flora. Ebersole, et 
al (1984b) also reported a decrease in local titres in response to treatment. 
Although there was significant reduction in bacterial prevalences, there was not a
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concomitant drop in local titres. Local antibody consumption may be reduced 
after removal of P. gingivalis (Ou Yang, 1993). If this were the case, there 
should have been an increase in antibody titres. However this was not found and 
the response more likely reflects a poor host reaction rather than microbial 
consumption. Again there was wide individual site reaction to treatment, and the 
grouping together of sites showed little response overall.
The response of antibody avidity following SRP has again produced mixed 
reports. Mooney et al. (1995) found no significant change in 
A. actinomycetemcomitans IgG antibody avidity, but a significant increase in 
P. gingivalis avidity. Holbrook et al. (1996) reported no change in 
A. actinomycetemcomitans antibody avidity during therapy. Chen et al. (1991) 
showed an increase in P. gingivalis antibody avidity after therapy in GEOP 
patients. The authors concluded that many GEOP patients do not produce 
protective levels of biologically functional antibody during the course of natural 
infection, but they may be stimulated to do so by treatment. It appears that in 
AP subjects, without regard for serostatus, these patients do not also produce 
adequate levels of biologically functional antibodies and that treatment does not 
stimulate these patients to do so. This may result from differences in the host 
response between GEOP and AP patients or the longer chronic exposure to 
antigens in AP patients. Further studies are required to investigate the response 
of avidity in the different patient categories.
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The reduction in antigen load is known to result in selection of B-cell clones 
producing higher avidity antibodies (Mooney, 1995). In this study this did not 
appear to happen, and instead lower avidity antibodies were produced. However 
there was little change in the microflora on a patient basis and this may have 
affected the result, although it is presumed that the microbial load did decrease 
with treatment.
The low levels of A. actinomycetemcomitans preclude much comment but may 
reflect the organisms’ lack of pathogenicity in AP. Hence the immune response 
would not be expected to change significantly. The fact that there are high 
responder patients to A. actinomycetemcomitans indicates previous antigenic 
challenge. It is possible that A. actinomycetemcomitans had a role earlier in the 
disease process and the titres reflect this. It is also possible that the high 
A. actinomycetemcomitans titres keep levels of the organism low preventing it 
from having further effect in these patients. However, from the clinical and 
microbiological results, it appears that P. gingivalis, B. forsythus and 
T. denticola are pathogenic, yet there is little response locally. This lack of 
response may allow these organisms to be pathogenic and cause periodontal 
destruction without recompense. Studies analysing the local and systemic 
response in patients where the microflora has been analysed from a large number 
of sites are required to clarify the effect of the flora on the humoral immune 
response.
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In this study only the serum from AP patients was included and it would be 
worthwhile to analyse the serum from GEOP patients. Mooney & Kinane
(1994) showed that GEOP patients had higher titres but lower avidity antibodies 
than AP subjects, and that the quality of the immune response may have bearing 
in the aetiology. The lack of response may reflect that whole cells were used. If 
particular antigens had been studied, there may have been a more marked 
response. Podmore et al. (1999), using serum from these AP patients, reported a 
similar lack of response to whole cells, but found a decrease in P. gingivalis 
W50 protease antibody titres post-SRP. Some studies have shown that certain 
antigens may be more immunogenic (Kinane et al., 1999). One example is the 
Rag antigen on the outer surface of P. gingivalis (Hanley et al., 1999). Further 
investigation would be to examine the effect of SRP on the antibody response to 
this and other immunodominant antigens, and to relate the response to the 
presence of the antigen before and after treatment. Using the Rag antigen as an 
example again, this antigen seems to be found more frequently on P. gingivalis 
isolated from deeper pockets (Hanley et al., 1999) and may be related to survival 
of the organism in these deeper sites. Would the reduction in P. gingivalis and 
pocket depth in response to SRP have an effect on this antigen and the humoral 
immune response towards it?
5.2.3 Serostatus
In this study 67.9% of patients were high responder for P. gingivalis antibody 
titres and is higher than previously reported by Mooney et al. (1995) (53.9%) 
and Chen et al. (1991) (33%), although Chen et al. (1991) analysed GEOP
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patients. The percentage of high responder patients for A. 
actinomycetemcomitans titres is also higher than that reported by Mooney et al.
(1995) (41.7%). Zafiropoulos et al. (1992) reported similar percentages of 
patients with elevated antibody levels to those in this study, and also similarly 
low levels for P. intermedia. The low number of high responder patients for P. 
intermedia titres could indicate that it is either not particularly immunogenic, it 
is not pathogenic, or that it is immunogenic/pathogenic only in these high 
responder patients. In this study a high percentage of patients were high 
responder for A. actinomycetemcomitans, but there was low A. 
actinomycetemcomitans. This suggests previous exposure to the organisms, 
which was probably pathogenic.
High responder patients for P. gingivalis had significantly greater pocketing and 
higher bleeding scores. Mooney et al. (1995) reported a similar trend. However 
they did not correlate serostatus with the microflora. P. gingivalis was 
significantly more prevalent in sites of high responder patients. Thus the 
increased immune response and greater pocketing may have resulted from higher 
prevalence of the organism. Interestingly Mouton et al. (1987) found high 
prevalences of P. gingivalis in their high responder group, which would support 
this hypothesis.
Serostatus generally had little significant effect on change in pocket depth. 
P. gingivalis high responder patients had a greater decrease in pocket depth, but 
generally the reduction was similar for high responder and low responder
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patients. This finding disagrees with previous observations by Mouton et al. 
(1987), Mooney et al. (1995), Ebersole et al. (1992) and Danielsen et al. (1993). 
They suggested that the prior development of a protective humoral immune 
response had a positive contribution to disease resolution during and after 
therapy. The differences between this study and those above may reflect 
differences between patient groups and the averaging of individual variations in 
the immune response. These reported studies concentrated on titres to 
P. gingivalis, P. intermedia and A. actinomycetemcomitans. It could be that the 
response to B. forsythus and T. denticola was similar to this current study.
Each different antibody serostatus reflected varying responses to the microflora. 
P. gingivalis high responder patients generally had higher prevalences of the test 
bacteria. The increased immune response to all organisms in these patients may 
be a reflection of this or the deeper sites found in these patients. Interestingly 
P. intermedia and B. forsythus were significantly higher at sites in high 
responder P. gingivalis antibody titre patients which may indicate that these sites 
are a more suitable environment or that, although the species are related and may 
share similar antigens (Vasel et al., 1996), both P. intermedia and B. forsythus 
are not targets of the antibody response to P. gingivalis in these patients. P. 
gingivalis is known to release outer membrane vesicles (Grenier & Belanger, 
1991) which can act as immunostimulants. This may have increased the 
response to the organism and so the number of subjects who were high 
responder. Sites in P. intermedia high responder patients had significantly 
higher titres to but lower prevalences of P. gingivalis and T. denticola, which
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may indicate that the immune response in these patients while not effective 
against P. intermedia, is effective against P. gingivalis and T. denticola. 
Similarly sites in B. forsythus high responder patients had lower prevalences for 
these two organisms, and similar prevalences for the other test species. Sites in 
A. actinomycetemcomitans high responder patients had significantly higher 
P. intermedia prevalence, but otherwise similar prevalences. Generally lower 
prevalences were found in sites from T. denticola high responder patients. The 
lower prevalences at sites in high responder patients may suggest an effective 
immune response. The effect is unlikely to be due to differences in pocket depth 
as there were no significant differences between high responder and low 
responder groups. However the lack of a clear pattern suggests that serostatus 
may have little effect on microbial colonisation.
5.2.3.1 Relationship between serostatus and serum titres
High responder subjects had higher serum titres to all test organisms in general. 
Given the protective nature of antibodies, it is surprising then that these patients 
did not respond significantly better clinically than low responder patients to 
treatment. This would suggest that there are other underlying mechanisms 
involved in the resolution of periodontal disease. Low responder patients had a 
tendency to show little change or no response in median titres to treatment 
compared with a reduction in high responder titres. The decrease in titre may 
reflect the decrease in microbial load (Horibe et al., 1995). Chen et al. (1991) 
and Mooney et al. (1995) also reported a decrease in titre in high responder 
patients for P. gingivalis. In these two studies, low responder patients showed an
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increase in titre after treatment, but in this current study low responder patients 
responded poorly. Mooney et al. (1995) suggested that high responder patients 
respond to treatment by production of similar titres but higher avidity antibody, 
and low responder by increased titres of similar avidity. The results of this 
current study do not support this result. However these authors only examined 
P. gingivalis and A. actinomycetemcomitans titres and did not examine 
P. intermedia, B. forsythus and T. denticola. Further studies are required to 
clarify the role of serostatus in response to treatment, and to examine titres and 
antibody avidity to other pathogens than P. gingivalis and
A. actinomycetemcomitans.
5.23.2 Relationship between serostatus and local titres
High responder patients were found to have higher local titres to all organisms. 
This suggests that serostatus is not only a systemic response but also applies to 
the local response. This would be expected given that the local response is a 
mixture of systemic and local antibody production (Mooney & Kinane, 1997). 
High responder patients may in general be more responsive to antigenic 
challenge than low responder patients. The greater local titres may also reflect a 
greater input from the systemic immune response.
It would be unrealistic to try to determine serostatus from local samples. 
Healthy subjects do not have high GCF volumes, which would make collection 
of samples difficult. In addition, these patients do not have the high numbers of 
plasma cells infiltrating the gingival epithelium or increased permeability of the
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junctional epithelium from the inflammatory reaction. Therefore they would not 
be expected to have high levels of antibodies which could be measured.
Treatment resulted in little change in local titres irrespective of serostatus. This 
failure of the humoral immune response may account for the similar clinical 
response in these patients in this study and the differences with previous studies 
(Mooney et al., 1995; Mouton et al., 1987; Ebersole et al., 1992; Danielsen et al., 
1993).
Changes at a local level may be more important in determining treatment 
outcome than the systemic response. Individual sites vary in microbial 
composition (Gunsolley et al., 1992), and presumably this is reflected in the 
local immune response. The varying immunogenicity of the flora (Califano et 
al., 1997; Lamster et al., 1990), and the consequent immune response or lack of 
response may determine the rate of disease progression and response to 
treatment. Further investigation is required to examine the relationship between 
the flora and immune response at a site level, and also the effect of the systemic 
response on the local response.
5.2.3.3 Relationship between serostatus and avidity
Papers by Mooney et al. (1995) and Chen et al. (1991) showed that avidity 
increased after treatment in high responder patients for P. gingivalis antibodies. 
In this current study B. forsythus subjects had a slight increase in avidity, but 
generally there was a decrease in avidity which was not significantly different
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from low responder patients. Interestingly Mooney et al. (1995) reported a non­
significant decrease in A. actinomycetemcomitans antibody avidity. Both 
subjects in the study by Mooney et al. (1995) and this current study responded 
well to treatment, irrespective of serostatus. It would appear that there is great 
variation in the response to treatment. High responder status to different 
organisms may produce different results, even within the same patient, and 
patient groups respond differently. Larger studies are required to try to 
determine a pattern. It could be suggested that the numbers of subjects in the 
studies reported are too small to present a representative picture. However 
finding a large number of suitable and similar patients would be difficult.
In general, although high responder patients had a higher antibody titre to all test 
organisms regardless of which organism the subject was high responder to, both 
groups responded similarly to treatment in terms of clinical condition and 
changes in avidity and local titres. The reasons for this are unclear, given the 
findings of previous studies (Mooney et al., 1995; Chen et al., 1991), and 
suggests other mechanisms in addition to the humoral response are involved. 
These mechanisms could include the the innate immune response, the 
inflammatory reaction, the T-cell response or particularly virulent strains of 
bacteria. Further investigation is required to clarify the situation., In addition, 
this study suggested that serostatus may have little effect on microbial 
colonisation. Another interesting area of investigation would be to expand on 
this using a greater number of patients and also different patient populations.
5.2.4 Relationship between the presence and absence of bacteria and serum 
antibody titres
The classification of the presence or absence on a patient basis of an organism 
from the evidence of four sites may not be representative. Clearly the organism 
may be present at other sites, and so any such classification is likely to be 
incorrect. Previous studies by Mombelli et al. (1991a, 1994a) and Gunsolley et 
al. (1992) have suggested that if deep bleeding sites are selected, it is possible to 
accurately determine if the patient harbours a particular organism. However 
although presence can be determined with some degree of certainty, a negative 
result does not mean the organism is absent, just not detected from those 
samples. In spite of this, patients that had detectable P. gingivalis had a 
significantly higher antibody titre to the organism. Interestingly, patients 
positive for B. forsythus had significantly lower titres to the organism. Ebersole 
et al. (1984b, 1986) suggested that increased titres to P. gingivalis may reflect 
colonisation and indicate pathogenicity. In this study P. gingivalis was 
associated with deeper pocketing, and supports the findings by Ebersole et al. 
(1984b, 1986). The higher titres of B. forsythus antibodies in B. forsythus 
negative patients and sites may indicate that an adequate response is effective in 
reducing the level of B. forsythus. However low titres at positive sites may 
indicate that B. forsythus is poorly immunogenic (Califano et al., 1997) or that 
the antibody response is reduced in some manner.
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5.2.5 Relationship between the presence and absence of bacteria and local 
antibody titres
The presence of P. gingivalis in a subgingival sample resulted in a significantly 
higher local antibody response, and provides further evidence for the 
pathogenicity of this organism. B. forsythus titres were slightly higher at
B. forsythus positive sites and again may suggest pathogenicity. Titres in 
general were low for B. forsythus, compared to the other organisms. The low 
response at sites suggests that the host may only mount a feeble response to this 
organism or that it only stimulates a small response locally. Ebersole et al. 
(1985a) and Ebersole & Cappelli (1994) showed that the frequency and 
distribution of antibody in GCF is related to colonisation by the target organism. 
The later study showed that the pattern of antibody response to 
A. actinomycetemcomitans was characteristic of localised host-parasite 
interactions. Therefore they suggested that antibodies may play an important 
role in the gingival sulcus in relationship to colonisation and clinical 
presentation. In this current study, A. actinomycetemcomitans was present at low 
levels and did provoke an immune response similar to that found by Ebersole et 
al. (1985a). However P. gingivalis seemed to produce a similar response. The 
lack of a response in general may have allowed colonisation and disease 
progression.
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5.2.6 Relationship between the presence and absence of bacteria and 
antibody avidity
Again for the reasons mentioned above, it is probably incorrect to examine the 
effect of the presence or absence of organisms from four sites per patient on 
avidity. This is reflected in the results, in that there seems to be little difference. 
The presence of B. forsythus and T. denticola seems to adversely affect the 
immune system to produce low avidity antibodies to P. gingivalis and 
P. intermedia. This may be an artefact produced from the analysis of only four 
sites per patient or an actual effect. The effect of periodontal bacteria on the 
systemic immune system is unclear. Periodontal bacteria especially P. gingivalis 
and A. actinomycetemcomitans can affect the local host cells and impair function 
(Holt et al., 1999; Fives-Taylor et al., 1999). In this study T. denticola was 
found frequently at suppurating sites, which would suggest that the bacterium is 
able to adversely affect white cells. It is more likely that the bacteria produce a 
local effect on the plasma cells in the gingival tissue rather than a systemic 
effect. Further work is required to clarify this, and the effect of periodontal 
pathogens on plasma cells.
5.2.7 Antibody titre correlations
Antibody titres for P. gingivalis, A. actinomycetemcomitans and T. denticola 
correlated systemically and locally, indicating that these local titres have a 
greater systemic input. The non-correlation of P. intermedia and B. forsythus 
titres may suggest a greater local production of antibodies or destruction of these 
antibodies in the gingival crevice and not the other antibodies. Mooney and
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Kinane (1997) showed that systemic and local antibody production contributes to 
the overall GCF antibody profile and is supported by these results. It appears 
that the contribution to the GCF antibody profile from systemic and local 
antibody response varies between each organism. This is in keeping with the 
variations in the flora in each site and the variation in the immunogenicity of 
each organism. The predominant cellular infiltrate in the periodontitis lesion 
comprises IgG producing plasma cells, and so one would expect local production 
of antibodies in addition to a systemic input (Mooney & Kinane, 1997).
P. gingivalis serum and local titres correlated with pocket depth. Ebersole et al. 
(1984a, 1986) reported similar findings and correlated both antibody titre and 
pocket depth with the presence of the organism. They suggested that this may 
indicate a role for P. gingivalis in the disease. Mooney and Kinane (1997) 
reported a negative correlation with pocket depth and P. gingivalis antibodies. 
These authors suggested that the response is protective because patients with 
greater disease had lower antibody levels. In this study the positive correlation 
suggests that the antibody response may not be protective and is ineffectual at 
preventing destruction. Alternatively the correlation may reflect the increased 
prevalence of P. gingivalis at deep sites, and increased titres where the organism 
is present.
Systemically, high antibody titres to B. forsythus are evident, but locally there is 
little response. This suggests that B. forsythus may be poorly immunogenic 
locally and supports the findings of Califano et al. (1997), who suggested the
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lack of an immune response to B. forsythus may allow it to be pathogenic. The 
reduced local titres compared to serum titres might result from immunoglobulin 
degradation. Kilian (1981) and Frandsen et al. (1991) have shown that 
periodontal bacteria are capable of degrading immunoglobulins. Lamster et al.
(1990) reported a similarly poor response to P. gingivalis and suggested that 
deficiency in local response may lead to disease.
A number of serum titres positively and significantly correlated with other serum 
titres. Similar results were found for local titres also. This could suggest that the 
different antibodies are responding to similar or shared antigens (Vasel et al., 
1996, Hinode et al., 1998). The correlations may also reflect clustering of micro­
organisms. Frequently P. gingivalis, B. forsythus and T. denticola titres 
correlated. In this study these three organisms have been shown to be frequently 
detected together. The immune response to these three pathogens may have 
produced high titres against all three and so produced the correlations. High 
responder patients for one antibody titre were often high responder for another. 
This general increased responsiveness may also have produced the titre 
correlations. The correlations also indicate the complex nature of the 
interactions between the host response and also the subgingival microflora.
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CHAPTER 6
EFFECT OF SMOKING ON PERIODONTAL
THERAPY
This chapter examines the effect of smoking on periodontal therapy in all smoker 
and non-smoker patients, and also AP and GEOP smokers and non-smokers. In 
addition a comparison of baseline parameters is made. The effect of smoking on 
the antibody titres and avidity in AP patients is also discussed. There were a 
total of 20 smokers (8 AP, 12 GEOP) in the 52 patients that completed SRP in 
this study. A Chi-squared analysis of the number of smokers in AP and GEOP 
groups returned a non-significant p value, 0.11. The results of the PCR assay 
were solely used in this chapter for determination of the microflora in smokers 
and non-smokers.
6.1 Effect of smoking on periodontal therapy: Results
6.1.1 Comparison of smokers and non-smokers: All subjects
6.1.1.1 Baseline
Table 6.1 compares the clinical measurements between all non-smoker and 
smoker patients. MGI scores for non-smokers and smokers were 2.4 (±0.8) and 
2.0 (±1.1) respectively, and these were significantly different (p=0.005). The 
BOP scores for each group were 90% and 66% respectively, and were 
significantly different (p 0.001). There were no other significant differences 
between the two groups.
Table 6.1 also shows the comparison of the percentage of positive non-smoker 
and smoker patients for each microorganism. Although there were differences in 
prevalence between the groups, none was statistically significant. The 
comparison of the percentage of positive sites for non-smokers and smokers for
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each organism is shown in Table 6.1. Again although there were some 
differences between the groups, none were significant.
6.1.1.2 Change in clinical and microbiological parameters in response to 
SRP
The change in clinical parameters in response to SRP is shown in table 6.1. 
Non-smokers had a greater reduction in all scores except GCF volume, where 
smokers have a slightly greater increase in volume. Non-smokers had 
significantly greater reductions in BOP (49% compared to 22.5%, p=0.01) and 
PD (2.1 ±1.4 mm compared to 1.2 ±1.2 mm, pO.OOOl).
For all except P. gingivalis and T. denticola, smokers had less of a reduction in 
the microflora on a patient basis. The prevalence of T. denticola was the same 
for both groups and, while P. gingivalis decreased in smokers, there was a slight 
increase in non-smokers. There were no statistically significant differences 
however.
Comparing the test organisms on a site basis shows that non-smokers had greater 
reductions for all except P. gingivalis in response to SRP. Only the reduction in 
B. forsythus was statistically significant compared to smokers (35.2% compared 
to 23.8%, p=0.002). P. gingivalis decreased more in smokers than non-smokers, 
but not significantly.
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6.1.1.3 Post-SRP
Post-treatment, compared to non-smokers, smokers had lower MGI and GCF 
volume scores, and a higher number of suppurating sites but these were not 
significant, though the difference in MGI scores approached significance (table 
6.1). BOP scores were the same. Smoking subjects had statistically 
significantly lower plaque scores, and higher PD (5.1 ±1.3 compared to 4.3 ±1.4 
mm, p=0.0001) and AL (13.2 ±1.9 mm compared to 12.6 ±2.1 mm, p=0.05) 
scores.
After SRP, smokers had higher prevalences of P. intermedia, B. forsythus,
A. actinomycetemcomitans and lower T. denticola and P. gingivalis, but none of 
these were statistically significant. The difference between the P. gingivalis 
frequencies was only just above significance (p=0.053). A. 
actinomycetemcomitans was eliminated in non-smokers but not smokers.
Sites in smoking subjects had significantly higher numbers of positive sites for 
P. intermedia (32.5% compared to 17.8%, p=0.02), B. forsythus (46.3% 
compared to 32%, p=0.04), and A. actinomycetemcomitans (5% compared to 0%, 
p=0.01). A. actinomycetemcomitans was eliminated or reduced below the level 
of detection in non-smokers. P. gingivalis and T. denticola were found in more 
sites in smokers, but not significantly so.
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6.1.2 Comparison of smokers and non-smokers: AP subjects
6.1.2.1 Baseline
Table 6.2 shows the comparison of the clinical and microbiological data for AP 
smokers and non-smokers. The only significant difference between the groups 
was that smokers have significantly less BOP (p=0.001). When the difference in 
the prevalence of T. denticola between AP smokers and non-smokers was 
corrected using the Bonferroni correction it was not found to be significant.
6.1.2.2 Change in response to SRP
Non-smokers had significantly greater reductions in BOP (49% compared to 
12.5%, p=0.02) and PD (1.7 ±1.4 mm compared to 1.0 ±1.3 mm, p=0.007). 
Non-smokers also had greater improvements in MGI, PLI, Supp and AL. The 
GCF volume decreased in smokers compared to an increase in non-smokers. 
These differences were not significant however.
In response to SRP, P. intermedia and T. denticola reduced more in smokers, 
B. forsythus and A. actinomycetemcomitans in non-smokers, and P. gingivalis 
did not change. B. forsythus was found to increase in smokers rather than 
decrease. None of these differences was statistically significant.
The site analysis shows similar changes in P. gingivalis percentages for both 
groups and a significantly greater reduction in non-smokers for P. intermedia 
(24% compared to 19%, p=0.02). There was an increase in B. forsythus in 
smokers and a decrease in non-smokers which was significant (p<0.001). There
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was no change in A. actinomycetemcomitans for smokers and only a slight 
change for non-smokers. A greater but non-significant reduction of T. denticola 
in smokers was noted.
6.1.2.3 Post-SRP
Post treatment AP smoking and non-smoking clinical and microbial parameters 
are shown in table 6.2 also. Smokers had deeper pockets (4.9 ±1.4 mm 
compared to 4.2 ±1.6 mm, p=0.03), but non-significant when Bonferroni 
corrected, and significantly greater attachment loss (13.8 ±2.1 mm compared to 
12.7 ±2.3 mm, p=0.02). This group also had slightly more gingival 
inflammation, BOP and Supp, but less plaque and GCF volume than non- 
smokers. However, these differences were not significant.
The prevalence of the test organisms in patients after treatment in the two groups 
was not significantly different, although smokers had higher detection rates for 
B. forsythus and lower for P. gingivalis, P. intermedia and T. denticola.
A. actinomycetemcomitans was eliminated in both groups.
However, a site analysis showed a significantly increased prevalence of
B. forsythus in smokers (65.6% compared to 25%, pO.OOOl). P. gingivalis, 
P. intermedia and T. denticola were also more frequently detected but not 
significantly. A. actinomycetemcomitans was absent.
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6.1.3 Comparison of smokers and non-smokers: GEOP subjects
6.1.3.1 Baseline
The clinical and microbiological data for EOP non-smoker and smoker groups 
are shown in table 6.3. The only significant difference in the clinical 
measurements between the two groups was that smokers again had significantly 
lower BOP (P=0.003). When the difference in pocket depth between EOP 
smokers and non-smokers is Bonferroni corrected, it is not significant.
6.1.3.2 Change in response to SRP
The change in pocket depth was the only statistically significantly different 
clinical parameter between GEOP smokers and non-smokers (1.4 ±1.1 mm and
2.6 ±1.2 mm, pO.OOOl).
In smoker patients P. gingivalis decreased, but increased slightly in non- 
smokers, which was significant (p=0.04). However, when corrected for multiple 
comparison using the Bonferroni method, it was not. Non-smoker patients had 
greater reductions for P. intermedia, A. actinomycetemcomitans and T. denticola. 
In smokers there was no reduction in A. actinomycetemcomitans and a greater 
decrease in B. forsythus compared to non-smokers, but these were not 
significantly different.
There were no significant differences when the changes in the test organisms 
were analysed on a site basis, though greater reductions were noted for 
P. intermedia, A. actinomycetemcomitans and T. denticola in non-smokers.
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6.1.3.3 Post-SRP
GEOP smokers demonstrated significantly higher pocket depths after treatment 
(5.2 ±1.3 mm and 4.4 ±1.1 mm, p=0.0024). This group also showed higher 
Supp, AL and GCF volume and lower MGI and PLI scores compared to non- 
smokers, which were not significantly different.
After therapy smoker patients had significantly lower P. gingivalis prevalence 
(25% and 75%, p=0.01) and higher P. intermedia (58.3% and 0%, p=0.002). 
P. intermedia and A. actinomycetemcomitans were eliminated in non-smoker 
subjects. Smokers also showed higher T. denticola percentages and non-smokers 
higher B. forsythus, but these were not significant.
The site analysis also showed lower P. gingivalis and higher P. intermedia in 
smokers, which was significant. P. gingivalis was found in 12.5% of smokers 
and 39.6% of non-smokers, p=0.003. P. intermedia was found at 25% of smoker 
sites but absent in non-smoker sites and the p value was <0.001. P. intermedia 
and A. actinomycetemcomitans were eliminated in non-smokers. The difference 
between A. actinomycetemcomitans was significant, p=0.04, but when corrected 
for multiple comparisons became non-significant. B. forsythus was detected 
more frequently in smokers and T. denticola in non-smokers, but not 
significantly.
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6.1.4 Smoking and serum antibody titres
Before treatment, smoker subjects had lower median titres for all the five test 
organisms, though this was only significant for P. intermedia (table 6.4). The 
differences between P. gingivalis and T. denticola titres approached significance. 
However there were no significant differences in the change in median antibody 
titres between smokers and non-smokers in response to treatment. There was a 
similar pattern after treatment to that pre-therapy. Again P. intermedia titres 
were significantly higher in non-smokers.
6.1.5 Smoking and GCF antibody titres
Smokers generally had lower median GCF antibody titres at baseline (table 6.4), 
with B. forsythus antibody titres significantly lower (p<0.0001). There were no 
significant differences in the change in median titres in response to SRP when 
smokers and non-smokers were compared. Post-therapy titres were significantly 
lower in smokers for B. forsythus and T. denticola, and also lower for P. 
gingivalis. A. actinomycetemcomitans titres were slightly higher in smokers 
post-therapy.
6.1.6 Smoking and antibody avidity
Table 6.4 also shows the differences between smokers and non-smokers for 
antibody avidity. Non-smokers had higher avidity scores for all organism 
antibodies tested. P. gingivalis avidity was significantly higher in non-smokers 
compared to smokers (1.4 ±0.73 compared to 0.9 ±0.38, p=0.023). In response 
to SRP, non-smokers had greater reductions in P. gingivalis, P. intermedia, and
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T. denticola avidities than smokers, but these were not statistically significant. 
In non-smokers B. forsythus avidity increased compared to a decrease in 
smokers. T. denticola avidity increased in smoker subjects, and
A. actinomycetemcomitans avidity had the greater reduction in smokers. 
Following therapy, P. gingivalis avidity was still significantly higher in non- 
smokers, and B. forsythus avidities were also higher in non-smokers.
6.1.7 Smoking and serostatus
Smoker subjects had fewer high responder antibody titres than non-smokers 
(table 6.5). Non-smokers had significantly more patients with high responder 
titres for antibodies to P. gingivalis and T. denticola.
6.2 Effect of smoking on periodontal therapy: Discussion
The results compared smokers to non-smokers in all patients and both disease 
groups. No attempt was made to stratify the results by pack-years due to the 
small number of smokers. In addition, former smokers were incorporated into 
the non-smoking group. All former smokers had given up five years or more 
previously, and there is evidence that, in these patients after this time, responses 
to periodontal therapy become similar to never smokers (Grossi et al., 1997).
6.2.1 Clinical parameters
6.2.1.1 Baseline
The analysis of the clinical data of smokers and non-smokers shows that smokers 
have significantly lower scores for gingival index and BOP. Reports by Preber
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Table 6.5 Relationship between smoking and serostatus. Percentage of high 
responder patients in smokers and non-smokers.
Serostatus Smoker (%) Non-smoker (%) p value
P. gingivalis 25 85 0.002
P. intermedia 12.5 30 0.33
B. forsythus 37.5 70 0.11
A. actinomycetem 37.5 45 0.72
T. denticola 25 90 0.001
& Bergstrom (1985, 1986a) found lower gingival index scores in their study 
populations. The decreased BOP in relation to non-smokers is consistent with a 
number of previous studies (Preber & Bergstrom 1985, 1986a; Bergstrom & 
Flodeus-Myrhed, 1983; Preber et al., 1980; Feldman et al., 1983; Bergstrom, 
1990; Ah et al., 1994). Hedin et al. (1981) and Kinane and Radvar (1997) 
reported lower GCF volumes in smokers compared to non-smokers, and 
although there was a lower mean GCF volume in smokers in this study, this was 
not significant. The lower gingival index score, BOP and GCF volume reflects 
the vasoconstrictive effects of nicotine and diminished peripheral blood flow as a 
result (Bounaneaux et al., 1988; Michel et al., 1988).
No significant differences were noted between plaque scores in smokers and 
non-smokers, and this supports the findings of Preber & Bergstrom (1986a). 
However it appears that generally smokers have poorer oral hygiene (Preber et 
al., 1980; Preber & Bergstrom 1986a; Locker, 1992; Eklund et al., 1994; Holm 
et al., 1994). The poorer levels of plaque control have been conjectured to be the 
reason for the differences in the severity of periodontal destruction between non- 
smokers and smokers (Preber et al., 1980; Preber & Bergstrom, 1985). However 
in this current patient group this did not seem to be the case, but it may be that in 
patient groups with poorer oral hygiene there is greater periodontal destruction.
Smoker subjects had slightly, but not significantly, lower pocket depths. Similar 
findings have been reported by other authors (Preber & Bergstrom, 1985, 1986a; 
Ah et al., 1994), but this disagrees with others that showed that smokers have
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greater pocket depths (Ismail et al., 1983; Solomon et al., 1968; Feldman et al., 
1987; Bergstrom, 1989; Goultschin et al., 1990; Haber et al., 1993).
Mullally et al. (1999) and Schenkein et al. (1995) suggested that GEOP smokers 
have greater periodontal destruction than non-smokers and AP smokers, but in 
our patient group this was not the case. The increased pocketing in GEOP 
smokers compared to AP smokers was in keeping with the increased severity of 
periodontal disease in GEOP subjects in general, and compared to GEOP non- 
smokers the mean pocket depth was slightly lower.
In the current study population there was no evidence for increased pocket depth 
in smokers, but gingival index, BOP and GCF volume were decreased, which is 
consistent with the vasoconstrictive effect of nicotine.
6.2.1.2 Effect of SRP
Post-treatment pocket depth was significantly lower in non-smokers (4.3 ±1.4 
mm compared to 5.1 ±1.3 mm, p=0.0001) and non-smokers had also a 
significantly greater reduction in pocket depth (2.1 ±1.4 mm compared to 1.2 
±1.2 mm, pO.OOOl). Previous studies have reported a poorer response in 
smokers to SRP and findings of this current study are in agreement (Ah et al., 
1994; Preber & Bergstrom, 1986b; Preber et al., 1995; Kaldahl et al., 1996b; 
Kinane & Radvar, 1997; Grossi et al., 1997; Machtei et al., 1998). Smoker 
subjects had significantly greater attachment loss after treatment. Kaldahl et al. 
(1996b) and Ah et al. (1994) reported similar findings in their patient population.
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Oral hygiene was significantly better in smokers after treatment and so the 
poorer response to therapy is probably not due to oral hygiene levels (Preber & 
Bergstrom, 1986b). There was a greater reduction in gingival index in non- 
smokers but this was not statistically significant. Non-smokers also showed 
significantly greater reduction in bleeding on probing. After treatment mean 
GCF volume in smokers remained lower than non-smokers and the increase in 
GCF volume was lower than non-smokers. These are consistent with both a 
diminished peripheral blood flow (leading to diminished GCF flow) and a 
reduced response to therapy in smoker subjects.
The poorer response of smokers to therapy is probably the result of the general 
effect of smoking on the host which compromises the response to periodontal 
treatment. The mechanisms of healing among smokers may be impaired, 
especially if fibroblast and osteoblast functions are suppressed, which may result 
in poorer tissue repair. Fibroblast function is impaired by tobacco use (Raulin et 
al., 1989; Peacock et al., 1993; Lenz et al., 1992), with a decrease in chemotaxis 
and proliferation (Nakamura et al., 1995). Fibroblasts can store and later release 
nicotine and this may impair their function (Hanes et al., 1991). Fang et al.
(1991) showed suppression of osteoblast function and proliferation in smokers 
compared to non-smokers.
The greater reduction in pocket depth in non-smokers but similar attachment loss 
changes are perhaps due to the greater reduction in gingival swelling of non- 
smokers. Non-smokers have more gingival inflammation and when this resolves
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it may lead to some recession, which when combined with greater decrease in 
pocket depth results in small AL changes. The less favourable healing could not 
be attributed to the plaque control level. This is in agreement with studies by 
Ismail et al. (1983) and Tonetti et al. (1995).
6.2.2 Microbiological parameters
6.2.2.1 Baseline
There were no significant differences in the prevalence of the five pathogens 
between smokers and non-smokers. The prevalences of P. intermedia and
B. forsythus were slightly higher in smokers. This current study’s findings are in 
agreement with Stoltenberg et al. (1993) and Preber et al. (1992). In a study of 
83 smokers and 62 non-smokers by Preber et al. (1992), the prevalence of A. 
actinomycetemcomitans, P. gingivalis, and P. intermedia from subgingival 
plaque of smokers and non-smokers was not significantly different. Stoltenberg 
et al. (1993) found no significant differences in the prevalence of P. gingivalis, 
A. actinomycetemcomitans, P. intermedia, E. corrodens, and F. nucleatum 
between smokers and non-smokers. These authors did not investigate the 
prevalence of B. forsythus and T. denticola in their patients. Zambon et al. 
(1996) reported in a study of 1, 426 subjects, of whom roughly 60% smoked, 
that there were significantly higher levels of B. forsythus,
A. actinomycetemcomitans and P. gingivalis in smokers. Although the age range 
was similar to our study, they analysed all attachment loss levels rather than just 
concentrating on the deeper sites, and this may account for the differences 
reported.
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When smokers and non-smokers were analysed in their respective disease 
groups, there was a significantly higher prevalence of T. denticola in AP 
smokers. However when corrected for multiple comparisons and the smaller 
sample numbers, these differences were not significant.
62.2.2 Effect of SRP
Following therapy P. gingivalis was detected in significantly fewer smoker than 
non-smoker patients. There were higher prevalences of P. intermedia,
B. forsythus and A. actinomycetemcomitans in smokers. 
A. actinomycetemcomitans was eliminated in non-smokers. A slight increase in 
P. gingivalis was detected in non-smoker subjects post-SRP. The sites 
comparison showed lower prevalences for all the test organisms in non-smokers, 
which was significant for P. intermedia, B. forsythus and 
A. actinomycetemcomitans. Non-smokers had greater reductions in the number 
of positive sites and this was significant for B. forsythus. P. gingivalis was 
found to decrease in more smoker patients, but the prevalence of 
A. actinomycetemcomitans remained the same in this group.
The reduction in B. forsythus is similar to that found by Grossi et al. (1997). 
They reported a lower reduction in B. forsythus levels in smokers, but also for 
P. gingivalis. However the finding in this thesis of greater P. gingivalis 
reduction is supported by Haffajee et al. (1997a), who found similar results 
comparing smoker and non-smoker groups. The higher number of P. gingivalis
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positive smoker sites but lower number of P. gingivalis positive smoker patients 
compared to non-smokers may suggest a sub-group of patients who harbour high 
levels of P. gingivalis, as Mombelli et al. (1994a) suggested may occur for 
A. actinomycetemcomitans in some patients. Preber et al. (1995) reported almost 
total eradication of A. actinomycetemcomitans but similar levels of reduction for 
smokers and non-smokers for A. actinomycetemcomitans, P. gingivalis and 
P. intermedia in response to a favourable clinical outcome after therapy. 
Renvert et al. (1998) reported slight decreases in the levels of P. gingivalis and 
P. intermedia/P. nigrescens after SRP. They suggested that the microbiological 
response found seemed to be in conformity with the clinical response with little 
influence of the smoking habits. However this study used culture to examine the 
flora, which may account for the differences.
The differences reported in the pocket depths between smokers and non-smokers 
may account for the differences in the microflora after treatment. The deeper 
pocket depths in smokers, which are more anaerobic than non-smokers (Loesche 
et al., 1983), may favour an anaerobic flora whereas the shallower less anaerobic 
pockets after treatment in non-smokers may not be a suitable environment for the 
persistence of an anaerobic flora. It is possible that the differences are due to the 
differing plaque control levels between smokers and non-smokers, but given that 
plaque control is poorer in non-smokers, who had the better improvement in the 
flora, this is unlikely.
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The poorer host response against infectious agents in smokers may also account 
for the findings. The host immune response is adversely affected in smokers 
(Seymour, 1991; Lamster, 1992). In smokers there are significantly increased 
numbers of peripheral blood leucocytes especially neutrophils (Barbour et al., 
1997). However, smoking has been shown to affect neutrophil chemotaxis, 
adherence, phagocytosis and function (Kenney et al., 1977; Kraal et al., 1977, 
1979; MacFarlane et al., 1992; Noble et al., 1975; Eichel et al., 1969), both 
systemically and locally in the periodontium. Low levels of nicotine are 
chemotactic (Totti et al., 1994) whereas high levels inhibit phagocytosis (Ryder 
et al., 1994). There is an enhanced oxygen metabolism and dysfunctional 
regulation of extracellular proteases (Barbour et al., 1997). A detrimental effect 
on the respiratory burst has also been reported (Kalra et al., 1991; Codd et al., 
1987). The proportion of circulating natural killer cells is decreased in smokers 
(Tollerud et al., 1991) and the cytotoxic activity is dose-dependently reduced 
(Hersey et al., 1983; Ginns et al., 1985; Hughes et al., 1985; Phillips et al.,
1985). Systemically there appears to be an increase in macrophage numbers but 
a decrease in function (Hoogsteden et al., 1991). There is inhibition of 
phagocytosis (Ortega et al., 1994) and the oxidative burst (Skold et al., 1993) 
from these cells however. In vitro exposure to nicotine seems to suppress the 
ability of macrophages to kill oral pathogens (Pabst et al., 1995). Plasma 
vitamin C levels are reduced in smokers, possibly affecting the ability of 
phagocytes to control oral pathogens (Tribble et al., 1993; van Antwerpen et al., 
1993). In addition there is impaired production of IgA, IgG and IgM (see 
below). These could all be potentially important factors in protecting the host
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tissues from re-infection during the healing process. Perhaps also the lower GCF 
volume in smokers results in less “washing-out” of bacteria from the gingival 
sulcus. The combination of these may result in inadequate clearance of oral 
pathogens, and so account for the increased prevalences of the test bacteria in 
smokers compared to non-smokers after SRP.
6.2.3 Humoral immune response
In general smoker subjects had a lower percentage of high responder patients, 
lower median systemic and local antibody titres to the test bacteria, both before 
and after treatment. The general lack of response in antibody titres to treatment 
reported in this study was seen in both smokers and non-smokers, though 
smokers tended to respond less well than non-smokers. A similar pattern was 
evident in a comparison of antibody avidity. Smokers had lower avidity 
molarity, both before and after treatment. However the response to treatment 
was the same for both groups.
The poorer immune response in smokers may reflect the systemic and local 
effects of smoking and nicotine on the host. The vasoconstrictive effects of 
nicotine may reduce antigen presentation and ingress of defence cells. However, 
Sopori et al. (1989) reported similar proportions of B-lymphocytes in smokers 
and non-smokers, but there seems to be a general decrease in proliferative 
responses (Sopori et al., 1989; Savage et al., 1991; Goud et al., 1992). A 
decrease in proliferative responses could result in fewer plasma cells and hence 
lower systemic and local antibody titres. The effect of smoking on B-
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lymphocytes and plasma cell proportions and numbers in the gingiva is not yet 
known. There are conflicting reports on the effect of tobacco use on T- 
lymphocytes. In some patients the numbers may increase and in others decrease 
(Ginns et al., 1982; Jezewska et al., 1989; Costabel et al., 1986). The effect may 
be race specific with a decrease in CD4+ cells reported in Negroid smokers 
(Tollerud et al., 1991) and an increase in Caucasian smokers (Jezewska et al., 
1989). There is also a decrease in proliferative responses (Chang et al., 1990), 
but the effect of smoking on cytokine production is unclear, although there may 
be an increase in IL-4 (Byron et al., 1994) and IL-2 production (Pedro et al., 
1992). The impairment of T-cell function and cytokine production could have 
an effect on antibody production.
A general reduction in immunoglobulin production has been shown (Holt et al., 
1987; Johnson et al., 1990; Finklfea et al., 1971). The concentration of serum 
IgG is reduced (Ferson et al., 1979; Hersey et al., 1983; Quinn et al., 1996). The 
results of this study support the finding of reduced serum IgG in smoker 
subjects. There are conflicting reports regarding the levels of IgM and IgA 
(Hersey et al., 1983; Ferson et al., 1979) and a reduction in salivary IgA has been 
reported (Bennett & Read, 1982). Reductions in serum IgG levels to the 
periodontopathogens, especially P. intermedia and F. nucleatum, have been 
reported (Haber, 1994). The reduction of the IgG response to P. intermedia is 
similar to that found in this study. Why titres to these organisms in particular are 
reduced is unclear and requires further investigation. Quinn et al. (1998) 
reported that the influence of smoking on IgG subclasses was dependent on race.
270
All but one of the AP patients in this study were Caucasian, so this could not be 
confirmed or refuted.
Smoking impairs the function of other host cells such as neutrophils and 
macrophages, as discussed above. Similar impairment of B-lymphocytes and 
plasma cells may again result in decreased antibody titres and also avidity, 
although the similar response to inoculation in both groups in this study argues 
against this.
Antibody titres are generally thought to be protective and absence or decrease in 
titres, especially locally, may result in disease. Therefore it seems reasonable to 
suggest that reduced antibody titres and avidity in smokers may contribute to the 
greater destruction observed in these patients. This strengthens the hypothesis 
that it is the host response rather than a difference in the flora that is responsible 
for the greater periodontal destruction.
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CHAPTER 7
METHODOLGICAL CONSIDERATIONS 
AND CONCLUSIONS
This chapter deals with methodological issues of this thesis in the first part and, 
in the second part, brings together the results and discussions from the previous 
chapters in a conclusion
7.1 Methodological considerations
7.1.1 Site Selection
Four sites per patient were selected to sample in order to provide a representative 
sample and to minimise false negatives (Haffajee & Socransky, 1992). 
Gunsolley et al. (1992) reported large variation in microbial composition 
between sites in the same subject. In order to detect P. gingivalis, P. intermedia, 
and B. forsythus using IFA or DNA probes, they and other authors have 
suggested a minimum of 2-4 sites over 5mm (Gunsolley et al., 1992; Savitt et al., 
1991; Christersson, 1992). To detects, actinomycetemcomitans, which was not 
related to disease, required a greater number of sites: up to 25 (Gunsolley et al., 
1992; Christersson, 1992).
Curettes can collect as much as 90% of the subgingival plaque and is the best 
technique to use if only a few organisms are available (Tanner & Goodson, 
1986). PCR is more sensitive than IFA or DNA probes and it was the aim only 
to detect not to quantitate. Therefore it seemed possible to detect a 
representative sample of A. actinomycetemcomitans using four deep sites per 
patient.
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In retrospect given the low prevalence of A. actinomycetemcomitans in AP, both 
by PCR and Checkerboard, perhaps a larger number of sites should have been 
used. However the prevalence of A. actinomycetemcomitans in GEOP is similar 
to that found in other studies. The use of four sites per patient appeared to 
provide representative samples of P. gingivalis, P. intermedia, B. forsythus and 
A. actinomycetemcomitans especially if the deepest pocket in each quadrant was 
used (Mombelli et al., 1991b).
7.1.2 Sample size
The study investigated the changes in the microflora and humoral immune 
response with SRP. In order to gain a reliable result with sufficient power, 
sample size was based on similar studies previously published.
Thirty patients were deemed necessary for each group (Badersten et al., 1984a, 
b; Persson et al., 1995). In the event it proved harder to recruit 30 suitable 
GEOP subjects of suitable age and medical condition. Initially 27 were recruited 
but 3 were excluded shortly after on medical grounds especially antibiotic 
consumption, or their lack of motivation (e.g. failed appointments).
Thirty-three AP patients were recruited, slightly more than thirty in an attempt to 
have a post-treatment sample size of 30 and account for drop outs. Twenty eight 
patients were sampled after treatment and the reasons for exclusion of the five 
drop-outs were similar to those above.
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7.1.3 Sampling procedures
Sterile scaling instruments, either curettes or Gracey curettes, were used to 
collect subgingival plaque samples in a single vertical stroke. Much of the 
variation in microflora between studies is due to sampling procedures (Dahlen & 
Wikstrom, 1988). It was important to standardise procedures and to obtain a 
representative sample (Tanner & Goodson, 1986).
Possible methods of collecting subgingival plaque include curettes, paper points, 
capillary tubes and barbed broaches (Tanner & Goodson, 1986). The choice of 
method was influenced by the fact that after sampling the subgingival flora 
would be disturbed by scaling and so it was not necessary to leave an intact flora. 
Curettes may remove up to 90% of the subgingival plaque and may remove up to 
10 organisms, which is much higher than other techniques (Tanner & Goodson,
1986). Such a sample size enables a representative sample to be collected and is 
the preferred technique if the candidate organism is present in low numbers. 
Although paper points have been shown to be as good as curettes (Renvert et al., 
1992; Moore et al., 1985; Dahlen et al., 1989a), there are concerns about whether 
a representative sample is produced (Baker et al., 1991) and if they can reach the 
base of the pocket (Dahlen & Wikstrom, 1988).
One criticism of curettes is that they may not reach the base of the pocket 
especially in healing sites after treatment. This did not appear to be a problem as 
samples were removed after probing had expanded the pocket.
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7.1.4 Periodontal probing
The most common and simplest method of assessing periodontal disease is by 
manual probing, be it pocket depth (PD) or attachment loss (AL). However there 
are a number of problems and errors inherent in probing measurements 
especially when determining change in pocket depth. Variation in the probing 
force may occur in the measurement of sites between examinations by the same 
examiner (Hassell et al., 1973) and between different examiners (Gabathular & 
Hassell, 1971). The thickness of the probe and its positioning around the tooth 
may influence the PD. Anatomical features such as tooth contour may not allow 
correct probe positioning. The depth measured depends on the probing force 
used and the severity of inflammation. The greater the probing force, the greater 
the PD measured (van der Welden & der Vries, 1978; Mombelli & Graf, 1986). 
The difference between the probing measurement and the histologic “true” 
pocket depth may range from fractions of a millimetre to several millimetres. 
The greater the degree of inflammation the greater the pocket depth as the probe 
penetrates the basal connective tissue of the pocket to touch bone (Listgarten, 
1980; Listgarten et al., 1976; Magnusson & Listgarten, 1980; Fowler et al., 
1982). Measurement variation increases as the time interval between replicate 
measurements increases and as the severity of the disease increases (Clark et al.,
1992).
The use of the same thickness probe, a fixed reference point and a constant 
probing force improve the accuracy and reproducibility of periodontal probing. 
The introduction of pressure-sensitive automated probes aimed to overcome
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some of these problems. These probes all use a constant force, each is a constant 
diameter, and read to a fraction of a millimetre obviating the need to round up or 
down. They allow the use of a fixed reference point if used with a stent or disc 
probe (Jeffcoat, 1991). A number of different types are available: Florida probe 
(Gibbs et al., 1988; Magnusson et al., 1988a), Interprobe (Rams & Slots, 1993), 
Toronto probe (Karim et al., 1990; Birek et al., 1987), Periprobe (Quirynen et al.,
1993), Brodontic pressure probe (Walsh & Saxby, 1989), Vine Valley probe 
(Vine Valley corporation, USA) and even a probe that determined the position of 
the CEJ (Jeffcoat et al., 1986). In this study the Florida probe was used for all 
measurements.
Studies comparing the Florida probe with conventional probing have shown that 
there is a high correlation between manual and electronic probing (Magnusson et 
al., 1988a). However in deeper sites the Florida probe consistently recorded 
lower pocket depths than manual probing, but this may be a reflection of 
rounding up or down when using a manual probe (Osborn et al., 1992). This 
consistent under-measurement may also be due to difficulty in Florida probe 
placement due to the sleeve, compressibility of the soft tissue by the sleeve and 
the effect of multiple probing on the same site. The last seems unlikely as 
multiple probing of the same site usually results in increased pocket depth. 
Similar findings have also been reported with other electronic probes (Watts, 
1987; Kalkwarf et al., 1986) with one report suggesting that manual probing is 
also more reproducible (Quirynen et al., 1993). However using the Florida 
probe, Magnusson et al. (1988b) reported that probing depth did not influence
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reproducibility and that the reproducibility was significantly superior 
(Magnusson et al., 1988a). Florida probe measurements are much more 
reproducible than conventional measurements when each site is measured twice 
and the difference between measurements is no more than a millimetre (Osborn 
et al., 1990). However a single pass is no better than a single pass with a manual 
probe. Measuring attachment levels, the standard deviation of the measurement 
differences were lower than conventional probing, which when using the criteria 
of Haffajee et al. (1983) results in a lower threshold of change with the Florida 
probe. This allows the earlier identification of loser sites and also permits a 
smaller number of subjects in a study (Clark et al., 1992).
The Florida probe offers several advantages over conventional probing:
1) It reduces measurement error.
2) There is no examiner bias as the result is displayed on a screen which can be 
turned away from the examiner.
3) Resolution at 0.1mm or 0.2mm removes the need for rounding up or down, 
and so avoids the introduction of unpredictable error distributions.
4) Hence normal distributions are more closely approximated which are likely 
to reflect changes in measurement over time and therefore decisions about 
whether a site has lost or gained attachment made at lower cut off points.
In their studies of the Florida probe Osborn et al. (1990, 1992) stressed the need 
that although the Florida probe is much more reproducible than conventional 
probing, the same examiners should measure the same subjects in a longitudinal
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clinical trial. On the basis of these studies each site was measured at least twice 
in the same group of patients by the same operator, with the difference between 
measurements no greater than 1mm. In addition the same operator always 
measured the same sites (IBD for AP and PJH for GEOP patients).
7.1.5 GCF sampling for ELISA
Methods for collecting GCF include capillary tubes and paper strips. Previous 
studies that have used capillary tubes have reported difficulty in collection and 
estimation of volume measurements (Ebersole et al., 1984a). Whatman filter 
paper has been shown to be more suitable compared to those supplied by Harco 
(Griffiths et al., 1988). Cut into strips of dimensions 2x8 mm, they are 
compatible with the dimensions of the Periotron electrodes. Recovery of human 
serum proteins including antibodies exceeds 90% (Ebersole et al., 1984a; 
Griffiths et al., 1988). This method is very suitable for sampling local antibody 
titres.
7.1.6 Inter-operator variability
Throughout this thesis two different operators examined the patients studied 
(IBD for AP patients and PJH for GEOP patients). As no inter-operator 
calibration was performed, some of the differences between operators may be 
due to operator variability rather than true differences. This is especially true for 
the more subjective parameters such as MGI and PLI. Although BOP and Supp 
are dichotomous scores, there are still differences in the way these are recorded 
between operators. As all these parameters may differ in the way they are
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recorded between operators, few inter-operator comparisons have been made and 
any significant differences treated with caution.
GCF measurements tend to be more objective and provide a continuous variable 
that relates to degree of gingival inflammation. The GCF samples were taken on 
identical paper strips, cut from the same sheet of paper, for the same duration, 
measured in the same machine, and calibrated on the same curve. In addition, 
the same chair in the same clinic was used at all times by both operators when 
sampling or treating patients. Therefore, any differences in GCF volume are 
more likely to be true differences.
Pocket depth and attachment loss were recorded in both patient groups using the 
same probes and computer interface at the same dedicated chair. The standard 
deviation, which is a measure of probing variation/error, of the two PD 
measurements for IBD at baseline was 0.46mm and for PJH was 0.43mm. 
Therefore, the difference of 1mm in PD between AP and GEOP patients at 
baseline is likely to be a true difference, and it would not be unreasonable to base 
statistical comparisons on this parameter.
7.2 Conclusions
7.2.1 Comparison of AP and GEOP subjects
A major part of this research project was to compare AP and GEOP patients and 
the effect of SRP on clinical and microbial parameters in these subjects. Initially 
GEOP patients had deeper pockets, and lower BOP and GCF scores, which
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could be due to the increased proportion of smokers in this patient group. GEOP 
subjects also showed greater prevalences for B. forsythus and 
A. actinomycetemcomitans, which may indicate greater involvement of these 
organisms in these GEOP subjects or the deeper pocketing. The higher 
prevalence of T. denticola compared to other studies in both groups perhaps 
reflects the use of PCR to determine the microbial prevalence.
In both groups, SRP was effective in reducing clinical parameters: the reduction 
in PD and AL was in keeping with other published studies. The slight increases 
in GCF may reflect resolution of inflammation or the healing process. SRP 
produced few significant changes in the microbial prevalence in AP subjects 
especially P. gingivalis which responded poorly. Again this reflects the use of 
PCR rather than a poor response to treatment. GEOP subjects had much better 
reductions in the flora which compared well with previous studies. The greater 
reduction in flora could reflect the greater reduction in pocket depth recorded in 
GEOP subjects. It suggests that it may also be harder to reduce bacterial 
numbers in AP patients.
An analysis of the relationship of pocket depth and clinical and microbial 
parameters showed that increased BOP, suppuration and bacterial prevalences 
were related to increased pocket depth in AP patients. In addition, deeper 
pocketing was linked to greater change in pocket depth following SRP. There 
were also lower reductions in the microflora in deeper sites. Deeper pocketing in 
GEOP subjects produced fewer significant differences in clinical and microbial
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parameters. Post-SRP, B. forsythus and T. denticola were associated with deep 
pocketing in AP subjects and P. intermedia in GEOP subjects.
The relationship between the flora and clinical parameters was also examined. 
Deeper pocketing was related to the presence of P. gingivalis and suppuration to 
the presence of T. denticola in AP subjects. There were no significant patterns in 
GEOP patients, suggesting differences in the way in which AP and GEOP 
patients interact with the microflora.
In both patient categories bacterial groupings were investigated. In AP subjects 
the presence of one or more of P. gingivalis, P. intermedia, B. forsythus and 
T. denticola indicated increased prevalences for the other organisms. By 
contrast, in GEOP subjects, there were no clear patterns but B. forsythus was 
always found at T. denticola positive sites. A greater number of AP sites had no 
detectable bacteria than GEOP sites, and in both groups the number of these sites 
decreased as pocket depth increased.
7.2.2 Comparison of PCR and Checkerboard
This thesis also examined the efficacy of PCR and the Checkerboard technique 
in periodontal microbial diagnosis. PCR has been suggested as the “gold 
standard”. Both these techniques are quicker, cheaper, less labour intensive and 
more accurate than culture. They also have lower detection limits. A 
comparison of the two techniques, PCR and the Checkerboard technique, 
showed roughly 60% agreement. The generally higher frequencies of detection
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for PCR may reflect its lower detection limit. However, there were some 
problems with the Checkerboard technique and the analysis was not performed 
under optimal conditions. In addition, the probes for P. intermedia were very 
faint, even against the control bacteria, and the higher detection frequency for B. 
forsythus by the Checkerboard technique may be due to cross-reactivity or non­
specific binding. Therefore no conclusions could be drawn from the comparison 
of these two techniques. In spite of these problems, both PCR and the 
Checkerboard technique appear to be good tools for periodontal microbial 
diagnosis. The Checkerboard technique offers advantages over PCR in that a 
greater number of samples can be analysed and a greater number of different 
bacteria detected, whereas PCR is much more accurate and useful for detecting 
specific DNA sequences.
7.2.3 Humoral immune response
Although serum titres appeared relatively high, there were generally low local 
antibody titres and low antibody avidity. SRP produced little change in antibody 
titres, which may reflect a poor response and suggests that the poor response 
may have been a factor in the onset of the disease.
An analysis of serostatus showed similar or higher percentages of high responder 
patients compared to previous studies. However, unlike previous studies, 
serostatus had little effect on clinical parameters and response of these 
parameters to SRP. The poor response was in keeping with the poor host 
response to therapy in general. P. gingivalis was found more commonly in high
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responder P. gingivalis antibody titre patients. These patients also had deeper 
pockets compared to low responder subjects and the increased prevalence may 
reflect the deeper pocketing. Generally there were no significant differences in 
microbial prevalences between high responder and low responder patients, which 
may indicate that serostatus has little effect on microbial colonisation in the 
patients studied. High responder patients had generally higher serum and GCF 
titres, indicating a better general response than low responder patients, but 
similar clinical parameters. This suggests that there are other underlying 
mechanisms that are involved in the disease process in these patients.
P. gingivalis serum and GCF titres were increased when the organism was 
present and also related to pocket depth. This suggests that P. gingivalis is 
pathogenic in these patients but may reflect the increased number of organisms 
in deeper sites. P. gingivalis, A. actinomycetemcomitans and T. denticola 
systemic and local titres correlated suggesting greater systemic input to local 
titres, whereas P. intermedia and B. forsythus titres may have greater local 
production or destruction. The failure of the local response to B. forsythus may 
allow it to be pathogenic.
7.2.4 Effect of smoking
Smoker subjects recorded lower MGI and BOP scores than non-smokers at 
baseline, which is in keeping with the vasoconstrictive effects of nicotine, but 
similar pocket depths. A lower reduction in pocket depth was noted in smokers, 
which probably reflects the general deleterious effects of smoking on the host
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and is similar to previous studies. There were no differences between smokers 
and non-smokers in the microflora at baseline. However, there was a greater 
decrease in the microflora in non-smokers following SRP and smokers had 
higher prevalences of P. intermedia, B. forsythus and A. actinomycetemcomitans 
post-SRP. This may reflect the deeper, more anaerobic pocketing in smokers 
post-SRP or poorer host clearance due to diminished host response. Smokers in 
general had lower antibody titres and avidity, and this again reflects the systemic 
and local effect of smoking and nicotine on the immune system. Both smokers 
and non-smokers showed the same non-responsiveness in titres to SRP. The 
reduced titres and avidity may have contributed to the periodontal destruction in 
smoker subjects and suggests that differences in host response rather than 
differences in flora between smokers and non-smokers are responsible for the 
greater destruction seen in some smoker patients.
7.2.5 Overall conclusions
This study showed that SRP is effective in producing clinical improvement in 
both AP and GEOP subjects, though there were differences between these 
groups in microflora reductions. The results suggest that the five test organisms 
may have different roles in the disease processes in the two groups. Smokers 
had similar clinical and microbial parameters to non-smokers at baseline, but 
responded less well to treatment than non-smokers reflecting the deleterious 
effects of smoking on the host. In terms of the humoral immune response, there 
was little change in antibody titre and avidity following SRP. No differences 
were found between high responder and low responder patients in their response
284
to treatment. However, smoking was associated with reduced antibody titres and 
avidity. It was concluded that PCR and the Checkerboard technique are effective 
tools for examining the periodontal microflora. The differing frequencies of 
detection between the two methods probably reflects the higher sensitivity of the 
PCR technique.
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Abstract
A number of bacterial species are involved in the aetiology of periodontitis and 
include Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella 
intermedia, Bacteroides forsythus and Treponema denticola. Several studies have 
shown differences in the microflora between the various forms of periodontal disease. 
It is recognised that smoking is a risk factor for periodontal disease, but there are 
conflicting reports on whether or not smoking has an effect on the periodontal 
microflora. We utilised the polymerase chain reaction to determine the presence of
A.actinomycetemcomitans, P.gingivalis, P. intermedia, B. forsythus and T. denticola 
in subgingival plaque samples in 33 Adult Periodontitis (AP) patients and 24 
Generalized early-onset periodontitis (GEOP) patients prior to treatment. When 
GEOP and AP patients were compared there were significant differences in the 
number of positive patients and sites for both A. actinomycetemcomitans and B. 
forsythus (p = 0.0023 and 0.00001 respectively). No statistically significant 
differences in the prevalence of these organisms were found between smoker and non- 
smoker groups. These results confirm that AP and GEOP sites harbour varied 
microflora, but show that B. forsythus and A. actinomycetemcomitans were detected to 
a significantly greater extent in this group of GEOP than in the AP patients 
investigated. Our findings do not support the hypothesis that smokers have significant 
differences in the prevalence of periodontal pathogens from non-smokers.
Key words: micro-organism; adult periodontitis; generalized early-onset
periodontitis; polymerase chain reaction; smoking
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Introduction
Periodontal disease affects the supporting structures of the teeth in 10-15% of the 
population, and is characterised by alveolar bone destruction leading eventually to 
tooth loss. The two main groups are early onset periodontitis (EOP) and adult 
periodontitis (AP). The EOP forms of the disease are further subdivided into 
prepubertal (PP), localised early-onset periodontitis (LEOP), and generalised early- 
onset periodontitis (GEOP). AP affects subjects over 35 years of age, whereas the 
EOP variants of the disease can present in the early teens.
The 1996 World Workshop (Zambon 1996) implicated a number of bacteria in the 
aetiology of periodontitis, namely Actinobacillus actinomycetemcomitans, 
Porphyromonas gingivalis, Prevotella intermedia, Bacteroides forsythus and 
Treponema denticola. It has been suggested that the microflora differs between 
GEOP and AP (Moore & Moore 1994, Haffajee & Socransky 1994). A. 
actinomycetemcomitans has been found with greater frequency and quantity in LEOP 
patients (Zambon et al 1983, Zambon 1985, Haffajee et al 1984, Slots et al 1990, 
Savitt et al 1991), and has been detected in GEOP patients by a number of authors 
(Kamma et al 1995, van Winkelhoff et al 1989). It has also been shown to be present 
in AP lesions, but less frequently and in lower numbers, with other organisms being 
more prevalent and in greater numbers (Slots et al 1990, Rodenberg et al 1990). P. 
gingivalis has been associated with AP (Savitt et al 1991, Rodenberg et al 1990), and 
also with active disease (Dzink et al 1988, Moore et al 1991), and in recurrent lesions 
(Choi et al 1990). A number of studies have associated P. gingivalis with GEOP 
(Kamma et al 1995, Sasaki et al 1989, Kamagata et al 1989, Vandesteen et al 1984). 
In both AP and GEOP, P. intermedia has been demonstrated with increased frequency
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and numbers (Vandesteen et al 1984, Kamma et al 1994, Slots & Genco 1984, Slots 
et al 1986). B. forsythus has been detected in AP periodontal sites (Gmur et al 1989, 
Haffajee et al 1997), and in GEOP sites (Kamma 1995, Kamma et al 1994, Listgarten 
et al 1995). Dzink et al (1988) and Lai et al (1987) demonstrated increased frequency 
and higher numbers in active periodontal lesions. T. denticola has been found in 
increased numbers in deep pockets of AP patients compared to healthy subjects 
(Riviere et al 1992), but to date there is little information about its detection in GEOP. 
Smoking is increasingly accepted as a risk factor for periodontitis and has been shown 
to affect various aspects of the host immune response (Barbour, et al 1997). Smoking 
may have an adverse effect on fibroblast function (Raulin, et al 1988), chemotaxis and 
phagocytosis (Kenney, et al 1977, Kraal, et al 1977), immunoglobulin production 
(Holt, et al 1987, Johnson, et al 1990), induction of peripheral vasoconstriction 
(Clarke, et al 1981), and on the outcome of treatment (Kinane and Radvar 1997). 
Epidemiological evidence indicates that cigarette smoking is a stronger risk indicator 
for periodontitis than the presence of certain suspected periodontal pathogens 
(Stoltenberg et al 1993). However, few studies have compared the oral microflora of 
smokers and non-smokers. No significant difference in the prevalence of various 
plaque bacteria was found between cultured dental plaque of smokers and non- 
smokers (Colman, et al 1976, Preber, et al 1992), or in an immunoassay of similar 
samples (Stoltenberg, et al 1993). Recently Zambon et al (1996), using 
immunofluorescence, found that smokers harboured significantly higher levels of B. 
forsythus, A. actinomycetemcomitans and P. gingivalis. Significantly higher levels of 
Capnocytophaga species and E. saburreum were demonstrated in non-smokers.
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The PCR technique is a rapid and sensitive method for the detection of bacterial DNA 
sequences. The sensitivity of PCR allows detection of periodontal pathogens in 
subgingival plaque samples below the normal level of detection of culture methods, 
immunofluorescence, enzyme-based tests and DNA probes (Ashimoto et al 1995, 
Ashimoto et al 1996, Riggio et al 1996, Riggio et al 1998, Watanabe & Frommel 
1996). Riggio et al (1996) concluded that PCR is much more sensitive than 
conventional culture methods for identification of periodontal pathogens. The aims of 
the present study were to use PCR to determine if the prevalence of the accepted 
periodontal pathogens, P. gingivalis, P. intermedia, B. forsythus, A. 
actinomycetemcomitans and T. denticola, differed between AP and EOP patients, and 
between smokers and non-smokers.
Materials and methods 
Patient selection
Fifty-seven patients with untreated periodontal disease, with no history of systemic 
disease nor antibiotic therapy within the last three months, were recruited 
consecutively from new referrals to Glasgow Dental Hospital and School between 
January 1997 and July 1998. Thirty-three patients were designated as severe adult 
periodontitis (AP) patients, based on pocket depths greater than 6mm in all sextants. 
Twenty-four patients were designated as generalised early-onset periodontitis (GEOP) 
patients based on the criteria of Hart et al (1991). The mean age and standard 
deviation of the AP group was 46.6 ±7.15 years and the EOP group 33.21 ±3.41
years. The demographic details of these patients are presented in Table 1. The study 
protocol demanded that each patient had for the purposes of sampling at least two 
non-adjacent sites per quadrant with pocket depths of at least 5mm. This study was 
approved by the Glasgow Dental Hospital Ethics Committee. All patients gave 
informed consent.
Clinical measurements
In each patient, four interproximal sites with pocket depths of at least 5mm were 
selected, where possible one site in each quadrant, and with no furcation involvement. 
At each site the modified gingival index (MGI) (Lobene, et al 1986), plaque index 
(PI) (Silness and Loe, 1964), bleeding on probing (BOP), suppuration (Supp), and 
pocket depth (PD) and attachment level (AL) were recorded. Each tooth was air- 
dried, MGI was assessed, and a pocket charting probe (PCP 12) was used to determine 
PI. Supragingival plaque was then removed and gingival crevicular fluid (GCF) 
collected using filter paper strips for 30 seconds (Adonogianaki et al 1991). The 
volume of fluid was determined using a Periotron 6000 and a previously constructed 
calibration curve. Pocket depth and attachment level were measured at each site using 
the Florida probe, and each site was measured twice to assess the variability of the 
probing measurements. BOP and Suppuration were recorded between pocket depth 
measurements. The Florida probes were cleaned with 70% isopropyl alcohol between 
measurements to reduce bacterial contamination of the sites during probing.
Collection of subgingival plaque samples
After the clinical measurements were recorded, a subgingival plaque sample was 
taken from each of the four selected sites using separate sterile curettes and a single
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vertical stroke. Each sample was immediately placed in a sterile microcentrifuge tube 
containing 0.5ml TE buffer (lOmM Tris HC1 pH7.6, ImM EDTA pH8.0). Samples 
were stored on ice before being transported to the laboratory where they were 
vortexed and stored at -20°C until analysed.
Polymerase chain reaction
For polymerase chain reaction (PCR) analysis, 90pl of vortex-mixed subgingival 
plaque was added to 10pl of lOx lysis buffer (lOOmM Tris-HCl pH 8.0, lOmM 
ethylenediamine tetra-acetic acid, 10% Triton X-100) and boiled for 5 minutes. 10pl 
of this lysate was used in each PCR reaction.
The primers used for the various PCR analyses are shown in Table 2 with the size of 
the amplification product, target and references.
PCR amplification was carried out in a reaction volume oflOOpl consisting of lOjul 
sample lysate and 90pl of reaction mixture containing lxPCR buffer (lOmM Tris-HCl 
pH8.8, 1.5mM MgCl2, 50mM KC1, 0.1%Triton X-100), 2 units of Dynazyme DNA 
polymerase (Flowgen, Lichfield, England, UK), 0.2mM dNTPs (dATP, dCTP, dGTP, 
dTTP) and 50 pmol of each primer. The primers were separated from the other 
components of the reaction mixture by a layer of wax (“hot start” PCR) preventing the 
reaction from starting until the wax had melted upon commencement of PCR cycling. 
PCR cycling was carried out in an OmniGene thermal cycler (Hybaid, Teddington, 
England, UK). The cycling conditions for A. actinomycetemcomitans and P. 
intermedia comprised an initial denaturation for 5 minutes at 95°C, 35 amplification 
cycles of denaturation at 95°C for 1 minute, annealing of primers at 55°C for 1 minute 
and primer extension at 72°C for 1.5 minutes, followed by a final extension step at 72
°C for 10 minutes. The cycling conditions for the other organisms were the same 
except that in the amplification cycles the primer extension step lasted for 1 minute. 
The reaction products were either stored at -20°C or analysed immediately. Negative 
and positive controls were included in each batch of samples being analysed by PCR. 
The negative control was a 90pl reaction mixture with the sample replaced by lOpl of 
sterile water. The positive control contained lOOng of genomic DNA from the 
relevant organism in 90pl of reaction mixture, with sterile water added to bring the 
volume to lOOpl.
Analysis of PCR products
20pi of each reaction product was fractionated on a 2% agarose gel containing 
ethidium bromide (0.5pg/ml), using a lOObp DNA ladder (Pharmacia Biotech,
St. Albans, UK) as a size marker, and visualized and photographed using an 
ImageMaster video documentation system (Pharmacia Biotech).
Data Analysis
The clinical and microbiological data for each site and patient was statistically 
analysed using the Minitab statistical package (Minitab, release 9.2, Minitab Inc., 
State College, PA). The data was analysed for differences between AP and EOP 
groups and non-smokers and smokers, on a patient and site basis. For the patient 
based analysis the clinical measurements were averaged, and the patient was positive 
for a microorganism if one or more sites were positive for that organism. The Mann- 
Whitney test was used to analyse MGI and Plaque Index scores, and two sample t- 
tests for PD and GCF volumes. The differences between BOP, Supp and all
microorganisms were assessed using the Chi squared test, except when expected 
counts were less than five where the Fisher’s exact test was used. The duplicate 
recordings of probing depth and attachment level measurements were averaged for 
each site. Statistical tests were accepted as statistically significant when the p value 
was < 0.05.
Results
Table 3 shows the average clinical measurements of the selected sites between the two 
groups. The MGI scores were 2.46 (±0.593) for the AP group (33 patients, 132 sites) 
compared to 1.92 (±0.833) for EOP group (24 patients, 96 sites), and were 
significantly different (p=0.006). PI and Supp scores were not significantly different 
between the two patients groups. Average pocket depth measurements were 
significantly different (p=0.0002) with 5.9 (±1.004) mm for AP patients and 6.8 (± 
0.631) mm for EOP patients. Gingival crevicular fluid volumes were significantly 
different (p=0.015) with the average AP volume of 403 (± 199.5)nl/30s and average 
EOP volume 298.2 (±114.5)nl/30s.
The percentage of positive patients for each organism are shown in Table 4. P. 
gingivalis was detected in 54.5% of AP patients compared to 62.5% of EOP patients. 
P. intermedia was detected in 72.7% of AP patients and 79.2% of EOP patients. B. 
forsythus was found in 63.6% of AP patients and 91.7% of EOP patients. 3% of AP 
patients were positive for A. actinomycetemcomitans compared to 20.8% of EOP 
patients. T. denticola was detected in 54.5% of AP patients and 45.8% of EOP
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patients. There were significant differences between the groups in the detection of B. 
forsythus (p=0.049) and A. actinomycetemcomitans (p=0.038).
The comparison of the percentage of positive sites is shown in Table 5. P. gingivalis 
was detected in 43.9% of AP sites and 54.2% of EOP sites. 56.8% of AP sites were 
positive for P. intermedia and 51.0% of EOP sites. B. forsythus was found in 57.6% 
of AP sites and 83.3% of EOP sites. A. actinomycetemcomitans was detected in 1.5% 
of AP sites and 12.5% of EOP sites. 37.1% of AP sites and 35.4% of EOP were 
positive for T. denticola. There were significant differences again between the two 
groups for the detection of B. forsythus (p=0.01) and A. actinomycetemcomitans
(p=0 .001).
Table 6 compares the clinical measurements between non-smoker and smoker 
patients. A Chi-squared analysis of the number of smokers in AP and GEOP groups 
returned a non-significant p value (p>0.05). MGI scores for non-smokers and 
smokers were 2.37 (±0.78) and 2.01 (±1.09) respectively, and these were significantly 
different (p=0.0052). The BOP scores for each group were 0.90 (±0.94) and 0.66 (± 
0.48) respectively, and were significantly different (P=0.001). However the standard 
deviation for each BOP group is large (AP ±0.94 and GEOP ±0.48). There were no 
other significant differences between the two groups.
Table 7 shows the comparison of the percentage of positive non-smoker and smoker 
patients for each micro-organism. Although there were differences in prevalence 
between the groups, none were statistically significant. The comparison of the 
percentage of positive sites for non-smokers and smokers for each organism is shown 
in Table 8. Again although there were some differences between groups, none were 
significant.
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Table 6 also shows the comparison of the clinical data for AP smokers and non- 
smokers. The only significant difference between the groups were that smokers have 
significantly less BOP (p=0.049). The comparison of the microflora for these AP 
groups is also shown in Tables 7 and 8. When the difference in the prevalence of T. 
denticola between AP smokers and non-smokers was corrected using the Bonferroni 
correction, it was not found to be significant.
The clinical data for EOP non-smoker and smoker groups are shown in Table 6, and 
the microbiological data in Tables 7 and 8. The only significant difference in the 
clinical measurements between the two groups is that smokers again have 
significantly lower BOP (P=0.049). When the difference in B. forsythus prevalence 
between EOP smokers and non-smokers is Bonferroni corrected, it is not significant.
Discussion
There were a number of significant differences between the two patient categories 
with respect to their clinical measurements. AP patients appeared to exhibit 
significantly more gingival inflammation than GEOP patients. GEOP patients were 
found to have significantly lower BOP scores than AP patients, and similarly 
significantly lower GCF volumes. As the BOP score may relate to probing pressure 
and technique, it is possible that operator variation is responsible for the differences 
between AP and GEOP subjects. GCF measurements tend to be more objective and 
provide a continuous variable which relates to degree of gingival inflammation. The 
GCF samples were taken using identical paper strips, for the same duration, measured
using the same Periotron machine and calibrated on the same curve. The differences 
in clinical inflammation noted between the two groups are therefore more likely to be 
due to the higher numbers of smokers in the GEOP group. Alternatively it could be 
hypothesised that GEOP patients have less gingival inflammation.
In AP subjects the patient based analysis showed that the most common organism was 
P. intermedia (72.7%), followed by B. forsythus (63.6%), P. gingivalis and T. 
denticola (both 54.4%) and lastly A. actinomycetemcomitans (3%). The order was 
slightly different in the site based analysis. B. forsythus was the most common 
(57.6%), then P. intermedia (56.8%), P. gingivalis (43.9%), T. denticola (37.1%), and
A. actinomycetemcomitans (1.5%).
B. forsythus was the most commonly detected organism in GEOP patients (91.7%), 
followed by P. intermedia (79.2%), P. gingivalis (62.5%), T. denticola (45.8%) and 
A. actinomycetemcomitans (20.8%). The site based analysis gave a slightly different 
order. Again B. forsythus was the most prevalent (83.3%), but followed by P. 
gingivalis (54.2%), P. intermedia (51.0%), T. denticola (35.4%) and A. 
actinomycetemcomitans (12.5%). The higher frequency of detection of B. forsythus 
in both patients and sites compared to the other organisms suggests that it may be 
more closely associated with GEOP.
Both the patient and site analysis of the microflora between the two groups revealed 
significant differences between the prevalences of B. forsythus and A. 
actinomycetemcomitans in AP and GEOP subjects. GEOP patients have a 
significantly higher prevalence of both of these organisms, which may be due to the 
deeper pockets noted in our GEOP patients or perhaps their greater involvement in the 
GEOP disease process. Studies by Dzink, et al (1985) and Christersson, et al (1992)
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have previously reported that B. forsythus is associated with deeper pockets. P. 
gingivalis and P. intermedia are also found at a higher prevalence in GEOP than AP 
patients, but this was not statistically significantly different, and may also reflect the 
deeper pocketing. The prevalence of T. denticola was similar between the two 
groups.
Other studies that have used PCR to detect the presence of periodontopathogens have 
reported different detection rates than found in this study. Riggio et al (1996) 
reported 24% of 43 AP patients positive for both P. gingivalis and A. 
actinomycetemcomitans. In this study we found P. gingivalis in 54.5% and A. 
actinomycetemcomtians in 3% of AP patients. In a subsequent study, Riggio et al 
(1998) found 39% of sites and 52% of AP patients PCR-positive for P. intermedia. 
Mooney et al (1995) reported that 29% of AP patients were positive for P. gingivalis 
and 47% for A. actinomycetemcomitans. Similarly varying prevalences have been 
reported by other authors (Christersson 1992, Haffajee 1988, Dzink 1985, Ashimoto 
1996, Moore 1982) indicating that there is considerable variation in the detection of 
pathogenic flora between different studies. The high levels of positive sites and 
patients for the organisms investigated in this study supports the polymicrobial nature 
of periodontal disease.
The level of T. denticola detection was similar between both disease groups (37.1% of 
AP sites and 35.4% of GEOP sites), but much higher than previously reported 
(Moore, et al 1982, Riviere, et al 1995). Riviere et al (1995) detected high levels of 
spirochetes in AP patients, but only 16% of sites were positive for T. denticola. The 
higher prevalences reported in the present study may reflect a more accurate and 
sensitive diagnostic technique. The difficulty in culturing T. denticola may have
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masked its role in periodontal disease. Further studies using non-culture techniques 
could indicate that T. denticola may have an important role in both AP and GEOP. 
Kamma et al (1994) examined a number of periodontopathogens from GEOP patients 
by culture. It was reported that in pockets over 6mm in depth, P. gingivalis was 
detected in 91.7%, B. forsythus in 53.4%, and A. actinomycetemcomitans in i0.9% of 
sites. In that study the prevalence of P. gingivalis was higher, with B. forsythus and 
A. actinomycetemcomitans lower when compared with our study. P. gingivalis was 
the more prevalent micro-organism in the study of Kamma et al (1994), whereas B. 
forsythus was the more prevalent micro-organism in our present study. The fact that 
two pathogens can be detected at different levels in two similar groups of patients 
again supports the variable and polymicrobial nature of periodontal disease. 
Christersson et al (1992) found a correlation between B. forsythus and P. gingivalis 
and deep pockets, but none for P. intermedia and A. actinomycetemcomitans.
The analysis of the clinical data of smokers and non-smokers shows that smokers 
have significantly lower scores of gingival index and bleeding on probing. The 
differences between the other measurements were not significant. Preber and 
Bergstrom (1985, 1986) reported similar findings, although they also reported that 
smokers have higher plaque scores. Hedin et al ( 1981) and Kinane and Radvar (1997) 
reported lower GCF volumes in smokers compared to non-smokers, and although the 
present study also found a lower GCF volume, this was not statistically significant.
An analysis of the AP smokers and non-smokers, and the GEOP smokers and non- 
smokers, found that in both disease groups smokers had significantly lower bleeding 
scores. All other measurements were not significantly different.
There were no significant differences in the prevalence of the five pathogens between 
smokers and non-smokers. Our findings are in agreement with Stoltenberg et al 
(1993) and Preber and Bergstrom (1992). In a study of 83 smokers and 62 non- 
smokers by Preber and Bergstrom (1992) the prevalence of A. 
actinomycetemcomitans, P. gingivalis, and P. intermedia from subgingival plaque of 
smokers and non-smokers was not significantly different. Stoltenberg et al (1993) 
found no significant differences in the prevalence of P. gingivalis, A. 
actinomycetemcomitans, P. intermedia, E. corrodens, and F. nucleatum between 
smokers and non-smokers. Zambon et al (1996) reported in a study of 1426 subjects, 
of whom approximately 60% smoked, that there were significantly higher levels of B. 
forsythus, A. actinomycetemcomitans and P. gingivalis in smokers. Although the age 
range was similar to our study, they analysed all attachment loss levels rather than just 
concentrating on the deeper sites, and this may account for the differences reported. 
When smokers and non-smokers were analysed in their respective disease groups, 
there was a significantly higher prevalence of T. denticola in AP smokers and B. 
forsythus in EOP smokers. However when corrected for multiple comparisons and 
the smaller sample numbers, these differences were not significant.
These results confirm that AP and GEOP sites harbour varied microflora, but show 
that B. forsythus and A. actinomycetemcomitans are detected to a significantly greater 
extent in GEOP than in AP patients. Our findings do not support the hypothesis that 
smokers have significant differences in the prevalence of specific periodontal 
pathogens from non-smokers.
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Number
(Sites)
Mean
Age
Min.
Age
Max.
Age
Male Female Smokers
AP 33 (132) 46.64 35 66 13 20 10
GEOP 24 (96) 33.21 26 35 9 15 12
Table 1 Number, Age, Sex and Smoking distribution of sample population.
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Clinical Measurement (n) AP (SD) (132) GEOP (SD) (96) p value
MGI 2.46 (±0.593) 1.92 (±0.833) 0.006 *
PI 1.47 (±0.723) 1.13 (±0.726) 0.1104
BOP 0.86 (±0.1876) 0.74 (±0.2707) 0.049*
Supp 0.27 (±0.2791) 0.34 (±0.3521) 0.95
PD (mm) 5.924 (±1.004) 6.791 (±0.631) 0.0002 *
GCF (nl/30s) 403.0 (±199.5) 298.2 (±114.5) 0.015 *
Table 3 Average clinical measurements for the selected sites in each patient group and 
statistical significance.
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Microorganism AP (132) GEOP (96) p value
P. gingivalis 54.5(18) 62.5(15) 0.95
P. intermedia 72.7 (24) 79.2(19) 0.95
B. forsythus 63.6 (21) 91.7 (22) 0.049*
A. actinomycetemcomitans 3(1) 20.8 (5) 0.038*
T. denticola 54.5 (18) 45.8(11) 0.95
Table 4 Percentage (and in brackets number) of positive patients for each organism 
and statistical significance.
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Microorganism AP (132) GEOP (96) p value
P. gingivalis 43.94 (58) 54.17(52) 0.95
P. intermedia 56.82 (75) 51.04 (49) 0.95
B. forsythus 57.58 (76) 83.33 (80) 0.01*
A. actinomycetemcomitans 1.52 (2) 12.5(12) 0.001*
T. denticola 37.12(49) 35.42 (34) 0.95
Table 5 Percentage (and in brackets number) of positive sites for each organism at AP 
and EOP sites, with statistical significance.
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Comparative Microflora of Adult and Early-onset Periodontitis.
I.B.Darby*, P.J.Hodge, M.P.Riggio, & D.F.Kinane (Periodontology 
and Oral Immunology Research Group, Glasgow Dental School, 
Scotland, UK)
Although a large number of species of microorganism are present in the oral cavity, 
only a few have been consistently implicated in the pathogenesis of periodontal 
disease, and include Actinobacillus actinomycetemcomitans (Aa), Porphyromonas 
gingivalis (Pg), Prevotella intermedia (Pi), Bacteroides forsythus (Bf), and 
Treponema denticola (Td). A number of studies have shown a difference in the 
microflora between the various forms of periodontal disease. The majority of these 
studies have used culture techniques for identification of the suspected periodontal 
pathogens, but some organisms are difficult to culture (Bf) or cannot be cultured 
(Td). Polymerase chain reaction (PCR) is a molecular biological approach to 
identifying organisms regardless of their ability to be cultured. We used PCR to 
examine the presence of Aa, Pg, Pi, Bf and Td in subgingival plaque samples in 25 
Adult Periodontitis (AP) patients and 18 Early-onset periodontitis (EOP) patients 
before any treatment had been undertaken. Aa was found at 15.8% of EOP sites 
compared to 1.9% of AP sites, Pg 52.6% to 43.3%, Pi 42.1% to 48%, Bf 97.4% to 
61.5%, and Td 44.7% to 40.4% respectively. There were significant differences in the 
number of positive sites for Aa and Bf (p = 0.0023 and 0.00001 respectively). These 
differences could not be attributed to differences in the clinical measurements, 
however the level of Bf detection was related to the smoking status of the patients in 
the EOP group. These findings support the fact that Bf and Aa may be more 
associated with EOP than AP.
The effect o f periodontal therapy on the humoral immune response in patients with 
chronic periodontal disease. M. PODMORE,* I.B. DARBY & D.F. KINANE. 
(University o f Glasgow Dental School, UK)
Numerous bacteria and the host humoral immune response to their antigens have been 
implicated in the pathogenesis o f periodontal disease. The aim of this study was to assess the 
effect o f initial periodontal therapy on 25 untreated adult periodontitis patients, and specifically 
assess the patient’s serum antibody titres to a range of bacteria and specific antigens. The 
antigenic targets investigated were the whole fixed bacteria o f P.g, A.a, P.i, T.d and B.f, crude 
outermembrane protein preparations o f P.g, A.a, P.i and B .f and various purified antigens 
thought to play a role; Leukotoxin (A.a), Lipopolysaccharide (P.g), Heat shock protein 60 (P.g) 
and RJA protease (p.g). Antibody titres were assayed by ELISAs. Following the initial therapy 
the average reduction in pocket depth was 2.1 mm (+ 0.9). In addition, specific antibody titres 
increased after treatment for all whole bacteria and antigens tested, for example, the antibody 
titre to P.g whole cells before treatment was 0.510 ELISA units (+ 0.180) and after treatment 
was 0.927 ELISA units (+ 0.334). This increase was statistically significant (P<0.05). 
Interestingly, P.g outer membrane protein preparations had a 119% increase in titre whereas 
antibodies to Lipopolysaccharide from P.g increased by only 25.1%.
In conclusion, periodontal therapy influenced the magnitude o f the humoral immune response to 
all o f the putative periodontal pathogens and specific antigens tested. Initial periodontal 
treatment does not increase antibody titres to certain periodontal pathogens and their antigens to 
the same extent and this may indicate the relevance o f certain candidate antigens in the disease
process.
Serum antibody response to proteases of Porphyromonas gingivalis. 
J.M.SLANEY*, I.DARBY1, S.FAWELL, J.ADUSE-OPOKU, 
M.RANGARAJAN and M.CURTIS (MRC Group, SBRLSMD, QMW, London 
and ’Glasgow Dental School, UK)
Proteases of Porphyromonas gingivalis are considered to be important microbial 
determinants in the periodontal diseases. The specific immune response to these 
factors may therefore play a critical role in the host defence to this organism. In 
the present study the serum IgG specific antibody response in adult periodontal 
patients (25) was measured by ELISA to P. gingivalis W50 whole organism and 
compared to antibody responses to the arginine protease RIA, to a recombinant 
form of this enzyme expressed in E. coli as a (his)6-tagged fusion protein and to 
lipopolysaccharide (LPS) of this organism. Purification of the (his)6-tagged 
fusion protein was performed by nickel affinity chromatography. The IgG 
antibody response to P. gingivalis whole cells was significantly correlated with 
the response to RIA (p=0.0001) but showed no correlation with the response to 
the recombinant enzyme. Futhermore there was no relationship between the 
responses to the wild type and recombinant enzymes. However there was a 
strong correlation between the IgG antibody response to RIA and to LPS 
(p=0.0001). Treatment of RIA with trifluoromethane sulphonic acid to remove 
covalently linked carbohydrate residues caused a significant reduction in the IgG 
recognition of the enzyme by on Western blots and also abolished the reactivity 
of RIA with anti-LPS monoclonal antibodies. We conclude that the IgG antibody 
response of adult periodontal patients to P. gingivalis RIA is directed primarily 
towards covalently-linked carbohydrate residues which are cross-reactive with 
the LPS of this organism. Glycosylation of this enzyme may represent an 
immune shielding device to hinder recognition of the enzyme polypeptide chain.
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